data_2ma2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ma2 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.605 ' O ' HG22 ' A' ' 423' ' ' VAL . 8.9 m-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.747 0.308 . . . . 15.0 111.037 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.698 ' O ' HG22 ' A' ' 424' ' ' VAL . 53.6 mt-30 -44.81 -57.25 3.86 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.053 -0.522 . . . . 15.0 111.607 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -68.48 -36.83 79.51 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.308 -0.406 . . . . 15.0 111.136 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 1.6 tt -57.75 -54.55 45.65 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.826 -0.625 . . . . 15.0 111.668 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 419' ' ' ASP . 1.1 t -81.32 -23.48 10.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.665 -0.698 . . . . 15.0 112.039 -177.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 420' ' ' GLN . 6.8 t -62.78 -47.46 92.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 109.047 -0.723 . . . . 15.0 109.047 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -72.97 -33.94 66.18 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.435 -0.802 . . . . 15.0 110.583 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . 0.571 ' O ' ' HB2' ' A' ' 430' ' ' MET . 2.4 t-80 -70.85 -39.38 72.99 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.678 0.275 . . . . 15.0 110.975 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . 0.53 ' O ' HG21 ' A' ' 431' ' ' VAL . 40.1 mt -68.88 -52.0 39.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.372 -0.376 . . . . 15.0 110.715 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -57.32 -43.0 82.95 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.132 0.492 . . . . 15.0 110.197 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -71.83 -24.27 61.68 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 115.559 -0.746 . . . . 15.0 110.542 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' MET . . . . . 0.65 ' O ' HG23 ' A' ' 434' ' ' VAL . 8.5 ttm -70.32 -49.82 45.52 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.36 -0.382 . . . . 15.0 110.853 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.536 HG22 ' CE2' ' A' ' 484' ' ' PHE . 1.5 t -64.56 -37.34 79.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.918 0.39 . . . . 15.0 110.033 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -71.57 -32.93 68.62 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.826 -0.625 . . . . 15.0 110.692 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.911 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 4.0 m -69.61 -41.11 76.12 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.181 -0.463 . . . . 15.0 111.09 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 430' ' ' MET . 16.4 t -75.36 -42.2 43.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.2 -0.455 . . . . 15.0 110.786 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . 0.44 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 9.8 t80 -58.32 -41.71 85.11 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.965 -0.561 . . . . 15.0 111.013 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -86.37 -26.91 24.55 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.436 -0.347 . . . . 15.0 110.933 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . 0.911 ' HB2' ' O ' ' A' ' 433' ' ' SER . 2.6 t-20 -59.73 -45.27 92.71 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.227 -0.442 . . . . 15.0 111.455 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' PHE . . . . . 0.41 ' CE2' HG22 ' A' ' 454' ' ' ILE . 54.8 m-85 -94.33 -2.09 52.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.119 -0.491 . . . . 15.0 111.494 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 1.1 t0 -120.08 54.49 1.03 Allowed 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.918 0.39 . . . . 15.0 111.16 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.26 -9.42 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.054 -0.521 . . . . 15.0 111.32 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -92.35 -3.96 54.57 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.257 -0.429 . . . . 15.0 111.219 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 61.06 51.01 61.18 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.051 -0.595 . . . . 15.0 112.664 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -103.19 -18.09 15.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.645 0.259 . . . . 15.0 111.231 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 87.8 -13.85 59.93 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.933 -0.651 . . . . 15.0 112.302 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . 0.475 ' HB2' ' SG ' ' A' ' 474' ' ' CYS . 14.4 p80 -137.77 154.37 49.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.622 0.248 . . . . 15.0 110.408 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' ILE . . . . . 0.618 ' O ' ' HA ' ' A' ' 474' ' ' CYS . 1.6 mp -85.6 98.95 6.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.072 0.463 . . . . 15.0 111.023 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 52.8 m -63.7 150.89 43.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.705 -0.68 . . . . 15.0 111.072 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -55.33 -37.91 68.05 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.069 -0.514 . . . . 15.0 111.802 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . 0.441 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -63.23 -40.25 96.92 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.522 -0.308 . . . . 15.0 111.38 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -58.55 -60.51 3.7 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.947 0.403 . . . . 15.0 110.507 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -64.61 -24.1 67.48 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.822 -0.627 . . . . 15.0 110.614 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' GLN . . . . . 0.441 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 0.2 OUTLIER -58.9 -57.05 14.76 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.724 -0.671 . . . . 15.0 111.588 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -81.05 -33.61 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.682 -0.69 . . . . 15.0 111.927 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . 0.41 HG22 ' CE2' ' A' ' 438' ' ' PHE . 56.0 mt -63.9 -38.17 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.444 0.164 . . . . 15.0 111.438 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -62.65 -21.74 65.92 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.687 0.28 . . . . 15.0 111.468 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -66.36 -23.94 71.98 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.014 -0.613 . . . . 15.0 112.7 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -116.03 -10.7 11.53 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.676 0.274 . . . . 15.0 111.208 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -127.67 74.7 78.18 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.385 -0.37 . . . . 15.0 111.007 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.04 1.93 8.15 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.189 2.593 . . . . 15.0 112.612 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -81.32 2.5 27.94 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.328 -0.396 . . . . 15.0 111.449 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.4 mp -102.16 152.3 21.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.379 -0.373 . . . . 15.0 111.041 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 50.9 m -74.67 -174.83 2.24 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.079 -0.51 . . . . 15.0 111.288 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . 0.571 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -87.79 156.93 19.17 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.22 -0.446 . . . . 15.0 111.793 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -50.08 -41.67 48.56 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.74 -0.663 . . . . 15.0 111.348 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -62.19 -26.72 68.02 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.944 -0.571 . . . . 15.0 113.35 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -88.44 -33.24 17.93 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.858 0.329 . . . . 15.0 111.433 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 463' ' ' ALA . 0.1 OUTLIER -77.65 -36.32 51.57 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.863 0.363 . . . . 15.0 110.403 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . 0.526 ' HA ' ' OE2' ' A' ' 479' ' ' GLU . 10.4 t70 -123.77 114.62 20.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.876 -0.602 . . . . 15.0 110.47 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -67.28 -33.74 75.94 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.052 -0.522 . . . . 15.0 111.542 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -79.27 -9.44 59.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.397 -0.365 . . . . 15.0 111.413 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 55.86 39.08 30.68 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.27 -0.423 . . . . 15.0 111.382 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -78.56 -0.72 30.79 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.178 -0.464 . . . . 15.0 111.593 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.47 15.09 63.3 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.494 -0.86 . . . . 15.0 111.255 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' CYS . . . . . 0.618 ' HA ' ' O ' ' A' ' 446' ' ' ILE . 1.0 OUTLIER -136.09 131.16 34.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.235 -0.483 . . . . 15.0 110.455 -178.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.485 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 16.7 mm -102.74 124.9 57.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.938 0.399 . . . . 15.0 111.136 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 12.3 t -103.59 175.71 5.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.729 -0.669 . . . . 15.0 110.823 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -58.08 -44.48 87.6 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.328 -0.396 . . . . 15.0 111.149 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 478' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.6 mt-10 -62.11 -29.62 70.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.437 . . . . 15.0 111.458 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 479' ' ' GLU . . . . . 0.526 ' OE2' ' HA ' ' A' ' 468' ' ' ASP . 5.3 mm-40 -71.69 -47.99 50.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.496 0.188 . . . . 15.0 110.862 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 60.5 mtt -70.45 -46.2 64.33 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.687 -0.233 . . . . 15.0 110.963 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 79.1 t -60.26 -52.7 58.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 120.738 0.304 . . . . 15.0 110.659 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 482' ' ' SER . . . . . 0.907 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 39.5 m -57.77 -32.96 68.01 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 116.162 -0.472 . . . . 15.0 110.183 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 483' ' ' TYR . . . . . 0.52 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 9.1 t80 -69.02 -30.01 68.31 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.904 -0.589 . . . . 15.0 111.013 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 484' ' ' PHE . . . . . 0.547 ' O ' ' HB2' ' A' ' 488' ' ' SER . 1.9 m-85 -75.16 -40.18 59.77 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.708 0.289 . . . . 15.0 110.332 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.2 tt -83.82 -18.74 36.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 15.0 110.558 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 486' ' ' ARG . . . . . 0.907 ' HB2' ' O ' ' A' ' 482' ' ' SER . 31.0 ttt180 -72.61 -52.98 13.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.433 -0.349 . . . . 15.0 110.882 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 53.4 m -89.26 19.37 4.39 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.979 -0.555 . . . . 15.0 111.354 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 488' ' ' SER . . . . . 0.547 ' HB2' ' O ' ' A' ' 484' ' ' PHE . 22.6 t . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.345 -0.389 . . . . 15.0 110.933 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.627 ' O ' HG23 ' A' ' 423' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.85 0.357 . . . . 15.0 111.114 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.701 ' O ' HG22 ' A' ' 424' ' ' VAL . 4.3 tt0 -47.96 -56.35 7.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.784 -0.643 . . . . 15.0 111.862 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.42 95.96 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.328 -0.397 . . . . 15.0 111.62 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 3.2 tt -57.49 -53.34 59.31 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.077 -0.51 . . . . 15.0 111.743 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.6 t -80.9 -22.54 10.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.736 -0.665 . . . . 15.0 111.966 -176.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 420' ' ' GLN . 9.3 t -64.07 -47.68 89.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 109.056 -0.72 . . . . 15.0 109.056 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -72.61 -33.29 66.57 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.426 -0.807 . . . . 15.0 110.584 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . 0.623 ' O ' ' HB2' ' A' ' 430' ' ' MET . 4.6 t-80 -71.02 -39.29 72.43 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.568 -0.287 . . . . 15.0 111.05 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . 0.523 ' O ' HG21 ' A' ' 431' ' ' VAL . 40.7 mt -68.88 -52.29 36.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 116.352 -0.386 . . . . 15.0 110.77 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -57.7 -43.55 85.25 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.154 0.502 . . . . 15.0 110.169 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -72.04 -22.73 61.35 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.506 -0.77 . . . . 15.0 110.548 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' MET . . . . . 0.623 ' HB2' ' O ' ' A' ' 426' ' ' HIS . 0.0 OUTLIER -70.28 -51.37 30.99 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.405 -0.361 . . . . 15.0 110.88 179.077 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.559 HG22 ' CE2' ' A' ' 484' ' ' PHE . 1.0 OUTLIER -63.87 -38.69 83.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.317 -0.402 . . . . 15.0 110.046 179.128 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -71.89 -31.69 66.68 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.823 -0.626 . . . . 15.0 110.878 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.809 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 2.6 m -68.54 -42.68 78.1 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.244 -0.435 . . . . 15.0 111.028 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.595 HG21 ' O ' ' A' ' 430' ' ' MET . 10.2 t -75.32 -41.91 43.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.271 -0.422 . . . . 15.0 110.869 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . 0.605 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 4.1 t80 -56.75 -42.67 79.74 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.037 -0.529 . . . . 15.0 110.749 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 -87.02 -23.55 24.95 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.441 -0.345 . . . . 15.0 111.229 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . 0.809 ' HB2' ' O ' ' A' ' 433' ' ' SER . 5.1 t-20 -59.97 -39.62 86.28 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.863 0.363 . . . . 15.0 110.568 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' PHE . . . . . 0.4 ' CD2' HD13 ' A' ' 454' ' ' ILE . 35.6 m-85 -94.15 -16.51 23.66 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.854 -0.612 . . . . 15.0 111.635 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . 0.605 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 0.3 OUTLIER -99.18 54.03 0.97 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.864 0.364 . . . . 15.0 111.429 -179.525 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.3 -12.85 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.327 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -88.59 -14.82 36.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.119 -0.491 . . . . 15.0 111.171 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 73.7 39.44 48.51 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.004 -0.617 . . . . 15.0 112.508 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -95.79 -17.34 21.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.623 0.249 . . . . 15.0 111.162 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 87.22 -7.73 79.51 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.911 -0.662 . . . . 15.0 112.37 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -144.92 162.18 37.51 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.717 0.294 . . . . 15.0 110.658 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' ILE . . . . . 0.835 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.6 mp -77.78 136.36 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.113 0.483 . . . . 15.0 111.265 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 48.5 m -105.76 147.8 28.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.474 -0.784 . . . . 15.0 110.711 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -50.71 -46.85 59.11 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.169 -0.469 . . . . 15.0 111.606 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . 0.404 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -65.31 -36.91 85.52 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.479 -0.328 . . . . 15.0 111.168 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -60.58 -58.71 7.34 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.295 -0.411 . . . . 15.0 110.543 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.45 -23.73 67.0 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.767 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' GLN . . . . . 0.404 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 1.5 mm-40 -61.07 -56.93 15.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.88 -0.6 . . . . 15.0 111.302 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -76.73 -32.89 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 115.804 -0.635 . . . . 15.0 111.913 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . 0.4 HD13 ' CD2' ' A' ' 438' ' ' PHE . 46.3 mt -64.71 -51.96 60.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.501 0.191 . . . . 15.0 111.244 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -55.32 -33.19 63.09 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.694 0.283 . . . . 15.0 111.46 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -66.84 -30.78 76.66 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.908 -0.663 . . . . 15.0 112.629 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' ASN . . . . . 0.445 ' O ' ' HD3' ' A' ' 459' ' ' PRO . 42.0 m-80 -94.28 -18.99 21.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.687 0.279 . . . . 15.0 111.246 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -115.8 83.29 11.47 Favored Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 116.375 -0.375 . . . . 15.0 110.936 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 457' ' ' ASN . 12.6 Cg_exo -70.78 -10.08 27.03 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.046 2.497 . . . . 15.0 112.631 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -96.53 25.25 5.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.26 -0.427 . . . . 15.0 111.034 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 2.3 tp -100.39 152.55 20.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.16 -0.473 . . . . 15.0 110.975 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 52.5 m -65.54 176.41 1.48 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.115 -0.493 . . . . 15.0 111.378 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . 0.752 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -86.84 150.49 24.09 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.239 -0.437 . . . . 15.0 111.243 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . 0.898 ' O ' HD11 ' A' ' 467' ' ' LEU . 68.1 m-85 -56.62 -48.76 76.79 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.999 -0.546 . . . . 15.0 111.506 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -68.15 -16.33 68.68 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.962 -0.637 . . . . 15.0 113.459 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -90.13 -39.33 12.93 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.101 0.45 . . . . 15.0 111.776 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.898 HD11 ' O ' ' A' ' 464' ' ' PHE . 0.6 OUTLIER -79.06 -28.76 43.18 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.762 0.315 . . . . 15.0 110.755 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -130.87 110.49 11.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.039 -0.528 . . . . 15.0 110.286 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -66.06 -28.77 69.09 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.008 -0.542 . . . . 15.0 111.454 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.556 ' N ' HD21 ' A' ' 470' ' ' ASN . 0.9 OUTLIER -76.54 -14.11 60.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.249 -0.432 . . . . 15.0 111.214 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 58.67 29.36 18.46 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.238 -0.437 . . . . 15.0 111.306 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -74.35 -4.8 38.58 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.147 -0.479 . . . . 15.0 111.767 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.52 17.57 66.81 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.464 -0.875 . . . . 15.0 111.197 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' CYS . . . . . . . . . . . . . 18.5 t -135.78 131.7 35.81 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.268 -0.466 . . . . 15.0 110.492 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.835 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 11.1 mm -98.79 122.24 50.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 15.0 110.938 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' SER . . . . . 0.473 ' H ' ' HG3' ' A' ' 479' ' ' GLU . 15.4 t -102.89 171.12 7.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.918 -0.583 . . . . 15.0 110.672 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -52.86 -45.51 67.44 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.338 -0.392 . . . . 15.0 110.915 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 478' ' ' GLU . . . . . 0.578 ' O ' ' HB2' ' A' ' 482' ' ' SER . 9.4 tt0 -62.51 -28.39 69.81 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.049 -0.523 . . . . 15.0 111.254 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 479' ' ' GLU . . . . . 0.58 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 52.1 mm-40 -70.35 -51.36 30.57 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.505 0.193 . . . . 15.0 110.84 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 44.2 mtt -70.06 -47.18 63.03 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.653 -0.249 . . . . 15.0 111.081 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 82.1 t -59.94 -53.49 47.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.68 0.276 . . . . 15.0 110.85 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 482' ' ' SER . . . . . 0.929 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 43.0 m -57.96 -32.46 67.85 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 116.267 -0.424 . . . . 15.0 110.208 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 483' ' ' TYR . . . . . 0.58 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 8.3 t80 -69.3 -31.05 69.28 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.954 -0.566 . . . . 15.0 111.199 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 484' ' ' PHE . . . . . 0.584 ' HZ ' ' SD ' ' A' ' 430' ' ' MET . 1.6 m-85 -75.9 -39.03 57.12 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.926 -0.31 . . . . 15.0 110.387 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . 0.407 ' HA ' ' OG ' ' A' ' 488' ' ' SER . 5.1 tt -83.74 -19.65 34.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 15.0 110.49 176.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 486' ' ' ARG . . . . . 0.929 ' HB2' ' O ' ' A' ' 482' ' ' SER . 32.1 ttt180 -72.08 -48.55 43.3 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.845 0.355 . . . . 15.0 110.751 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 49.5 p -82.77 19.58 1.31 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.907 -0.588 . . . . 15.0 111.439 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 488' ' ' SER . . . . . 0.407 ' OG ' ' HA ' ' A' ' 485' ' ' LEU . 67.9 m . . . . . 0 C--N 1.332 -0.187 0 CA-C-N 116.279 -0.418 . . . . 15.0 110.961 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.637 ' O ' HG21 ' A' ' 423' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.775 0.321 . . . . 15.0 110.89 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.71 ' O ' HG23 ' A' ' 424' ' ' VAL . 45.9 mt-30 -48.99 -56.66 8.23 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.878 -0.601 . . . . 15.0 111.731 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -65.91 -38.47 88.8 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.905 0.383 . . . . 15.0 111.43 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 3.4 tt -57.97 -53.09 62.11 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.862 -0.608 . . . . 15.0 111.572 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.637 HG21 ' O ' ' A' ' 419' ' ' ASP . 2.1 t -80.81 -22.7 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 CA-C-N 115.665 -0.698 . . . . 15.0 111.978 -177.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 420' ' ' GLN . 9.6 t -63.83 -48.02 88.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 109.023 -0.732 . . . . 15.0 109.023 177.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -71.7 -33.55 68.88 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.335 -0.848 . . . . 15.0 110.46 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -70.71 -39.8 73.22 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.53 -0.305 . . . . 15.0 110.915 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . 0.544 ' O ' HG23 ' A' ' 431' ' ' VAL . 38.6 mt -67.33 -52.35 43.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.358 -0.383 . . . . 15.0 110.712 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -58.37 -41.99 86.01 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.156 0.503 . . . . 15.0 110.287 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.595 ' O ' ' HB2' ' A' ' 433' ' ' SER . 89.6 mttt -71.29 -24.19 62.1 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 115.473 -0.785 . . . . 15.0 110.74 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' MET . . . . . 0.62 ' O ' HG22 ' A' ' 434' ' ' VAL . 25.2 mmm -71.63 -47.53 53.88 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.428 -0.351 . . . . 15.0 110.923 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.547 HG21 ' CD2' ' A' ' 484' ' ' PHE . 2.0 t -65.36 -39.22 84.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.325 -0.398 . . . . 15.0 110.0 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -72.62 -30.45 64.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.916 -0.584 . . . . 15.0 110.756 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.834 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 13.2 t -68.86 -43.11 76.09 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.202 -0.453 . . . . 15.0 110.91 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 430' ' ' MET . 10.6 t -76.53 -40.82 34.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.784 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . 0.553 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 2.9 t80 -56.99 -42.9 81.11 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.065 -0.516 . . . . 15.0 110.673 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -87.41 -23.6 24.47 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.361 -0.382 . . . . 15.0 111.18 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . 0.834 ' HB2' ' O ' ' A' ' 433' ' ' SER . 3.3 t30 -60.0 -38.93 84.07 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.934 0.397 . . . . 15.0 110.515 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' PHE . . . . . 0.451 ' CD2' HD11 ' A' ' 454' ' ' ILE . 33.1 m-85 -94.41 -16.65 23.24 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.802 -0.636 . . . . 15.0 111.55 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . 0.553 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 0.6 OUTLIER -99.92 53.44 0.92 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.892 0.377 . . . . 15.0 111.589 -179.323 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.8 t -70.37 -12.49 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.132 -0.485 . . . . 15.0 111.0 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -90.85 -14.96 30.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.079 -0.51 . . . . 15.0 111.048 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 76.56 41.62 24.2 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.971 -0.633 . . . . 15.0 112.509 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -97.64 -18.64 18.78 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.671 0.272 . . . . 15.0 111.149 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 86.2 -4.48 85.97 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.899 -0.667 . . . . 15.0 112.468 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . 0.674 ' HB2' ' SG ' ' A' ' 474' ' ' CYS . 11.1 p-80 -146.18 164.3 32.68 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.757 0.313 . . . . 15.0 110.807 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' ILE . . . . . 0.82 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.2 mp -76.98 135.76 25.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.215 -0.448 . . . . 15.0 110.999 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 9.9 t -106.33 147.53 29.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.823 -0.626 . . . . 15.0 110.789 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -52.42 -47.93 66.03 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.167 -0.469 . . . . 15.0 111.541 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . 0.405 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -64.72 -36.85 85.63 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.444 -0.343 . . . . 15.0 111.047 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . 0.414 ' O ' HD12 ' A' ' 454' ' ' ILE . 5.0 mm-40 -61.16 -56.56 19.36 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.317 -0.401 . . . . 15.0 110.279 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' PHE . . . . . 0.516 ' CE2' HD23 ' A' ' 461' ' ' LEU . 0.7 OUTLIER -64.99 -25.07 67.71 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.911 -0.586 . . . . 15.0 110.529 178.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' GLN . . . . . 0.405 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 2.5 mm-40 -60.66 -57.92 10.66 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.76 -0.654 . . . . 15.0 111.389 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 8.8 mm -76.0 -33.04 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.86 -0.609 . . . . 15.0 111.842 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . 0.451 HD11 ' CD2' ' A' ' 438' ' ' PHE . 28.3 mt -63.2 -47.52 91.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 120.489 0.185 . . . . 15.0 111.272 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' ARG . . . . . 0.637 ' NH2' ' HA ' ' A' ' 463' ' ' ALA . 8.1 mtt180 -54.87 -33.68 62.14 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.539 -0.3 . . . . 15.0 111.507 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -64.08 -29.3 74.52 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 121.033 -0.603 . . . . 15.0 112.612 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -97.37 -15.04 20.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.556 0.217 . . . . 15.0 111.162 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -125.47 86.66 56.88 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.39 -0.368 . . . . 15.0 111.044 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -72.53 -2.71 12.2 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.989 2.459 . . . . 15.0 112.589 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -103.35 23.54 12.35 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.319 -0.401 . . . . 15.0 110.998 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.516 HD23 ' CE2' ' A' ' 451' ' ' PHE . 1.0 OUTLIER -89.32 147.77 23.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 15.0 111.084 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 58.2 m -66.78 175.37 2.44 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.044 -0.525 . . . . 15.0 111.329 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . 0.735 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -87.88 149.11 24.3 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.114 -0.494 . . . . 15.0 111.271 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . 0.847 ' O ' HD12 ' A' ' 467' ' ' LEU . 90.1 m-85 -56.71 -47.6 79.58 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.932 -0.577 . . . . 15.0 111.47 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -69.06 -16.06 70.28 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 121.034 -0.603 . . . . 15.0 113.449 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -89.92 -38.97 13.31 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.202 0.501 . . . . 15.0 111.678 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.847 HD12 ' O ' ' A' ' 464' ' ' PHE . 0.6 OUTLIER -80.9 -28.56 35.83 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.815 0.341 . . . . 15.0 110.586 179.57 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . 0.453 ' HA ' ' OE2' ' A' ' 479' ' ' GLU . 12.4 t70 -131.65 111.93 12.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.049 -0.523 . . . . 15.0 110.213 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -62.07 -35.74 79.57 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.029 -0.532 . . . . 15.0 111.788 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -77.88 -10.58 59.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.417 -0.356 . . . . 15.0 111.456 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 57.66 34.13 24.11 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.943 0.402 . . . . 15.0 111.303 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -73.88 -4.44 34.99 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.113 -0.494 . . . . 15.0 111.716 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.72 18.04 67.78 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.489 -0.863 . . . . 15.0 111.277 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' CYS . . . . . 0.674 ' SG ' ' HB2' ' A' ' 445' ' ' HIS . 3.7 t -135.19 130.93 36.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.248 -0.476 . . . . 15.0 110.52 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.82 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 21.1 mm -98.78 123.67 51.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.892 0.377 . . . . 15.0 110.93 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 14.5 t -101.84 166.96 10.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.931 -0.577 . . . . 15.0 110.577 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -50.49 -46.98 57.38 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.34 -0.391 . . . . 15.0 110.915 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 478' ' ' GLU . . . . . 0.743 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -62.21 -30.84 71.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.031 -0.531 . . . . 15.0 111.473 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 479' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 5.7 mm-40 -69.83 -55.06 10.81 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 121.285 -0.166 . . . . 15.0 110.956 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 6.6 tpp -68.65 -48.46 63.96 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.752 -0.204 . . . . 15.0 111.228 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 76.0 t -60.51 -54.56 33.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 121.148 -0.221 . . . . 15.0 111.128 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 482' ' ' SER . . . . . 0.965 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 36.8 m -56.51 -33.61 66.18 Favored 'General case' 0 C--O 1.227 -0.088 0 CA-C-N 116.515 -0.311 . . . . 15.0 110.462 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 483' ' ' TYR . . . . . 0.549 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 8.5 t80 -70.24 -30.76 67.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.116 -0.493 . . . . 15.0 111.167 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 484' ' ' PHE . . . . . 0.547 ' CD2' HG21 ' A' ' 431' ' ' VAL . 6.0 m-85 -74.16 -41.84 60.86 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 120.888 -0.325 . . . . 15.0 110.372 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.5 tt -83.95 -16.98 42.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.396 . . . . 15.0 110.492 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 486' ' ' ARG . . . . . 0.965 ' HB2' ' O ' ' A' ' 482' ' ' SER . 5.8 tpt180 -71.59 -51.5 23.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.892 0.377 . . . . 15.0 110.844 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 52.5 m -87.55 19.37 3.38 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.961 -0.563 . . . . 15.0 111.55 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 9.3 t . . . . . 0 C--N 1.332 -0.177 0 CA-C-N 116.374 -0.376 . . . . 15.0 111.042 179.946 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.607 ' O ' HG23 ' A' ' 423' ' ' VAL . 7.6 m-20 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.826 0.346 . . . . 15.0 111.115 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.709 ' O ' HG22 ' A' ' 424' ' ' VAL . 4.0 tt0 -46.85 -57.42 4.93 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.097 -0.501 . . . . 15.0 111.624 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.82 81.78 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.345 -0.388 . . . . 15.0 111.294 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.538 HD12 ' OD2' ' A' ' 419' ' ' ASP . 1.2 tt -57.82 -53.77 54.4 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.872 -0.604 . . . . 15.0 111.618 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.7 t -80.69 -23.98 11.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.636 -0.711 . . . . 15.0 112.02 -177.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 420' ' ' GLN . 7.3 t -62.74 -47.82 91.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 109.076 -0.713 . . . . 15.0 109.076 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -71.53 -34.53 70.12 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.468 -0.787 . . . . 15.0 110.539 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -70.4 -40.07 74.11 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.569 -0.287 . . . . 15.0 110.936 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . 0.513 ' O ' HG23 ' A' ' 431' ' ' VAL . 37.2 mt -66.58 -53.61 33.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.329 -0.396 . . . . 15.0 110.676 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -57.35 -41.97 81.09 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.105 0.479 . . . . 15.0 110.275 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.592 ' O ' ' HB2' ' A' ' 433' ' ' SER . 89.0 mttt -70.24 -24.98 63.17 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.516 -0.765 . . . . 15.0 110.592 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' MET . . . . . 0.606 ' O ' HG22 ' A' ' 434' ' ' VAL . 33.7 mmm -71.81 -46.09 59.34 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.469 -0.332 . . . . 15.0 110.898 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.604 HG21 ' CE2' ' A' ' 484' ' ' PHE . 1.0 OUTLIER -64.14 -41.19 91.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.979 0.419 . . . . 15.0 109.974 178.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -72.75 -29.75 63.58 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.708 -0.678 . . . . 15.0 110.992 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.773 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 13.3 t -69.64 -43.39 72.74 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.269 -0.423 . . . . 15.0 110.996 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 430' ' ' MET . 12.7 t -75.77 -41.86 40.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.201 -0.454 . . . . 15.0 110.811 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -57.89 -42.57 84.92 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.222 -0.444 . . . . 15.0 110.706 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -84.52 -25.19 28.97 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.506 -0.315 . . . . 15.0 111.033 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . 0.773 ' HB2' ' O ' ' A' ' 433' ' ' SER . 3.1 t30 -60.38 -38.96 85.55 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.851 0.358 . . . . 15.0 110.498 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -96.81 -10.47 26.56 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.911 -0.586 . . . . 15.0 111.734 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -108.83 53.6 0.68 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.896 0.379 . . . . 15.0 111.481 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . 0.452 HG11 ' OE1' ' A' ' 450' ' ' GLU . 8.6 p -74.91 -0.13 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.132 -0.486 . . . . 15.0 110.866 178.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -86.39 -15.13 41.33 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.843 -0.617 . . . . 15.0 111.102 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 67.85 40.9 89.31 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 121.019 -0.61 . . . . 15.0 112.605 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -115.65 -15.56 11.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.651 0.262 . . . . 15.0 111.238 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 89.46 -4.93 84.18 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.876 -0.678 . . . . 15.0 112.487 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -142.64 156.72 45.1 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.793 0.33 . . . . 15.0 110.722 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' ILE . . . . . 0.651 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.7 mp -78.67 134.99 26.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 15.0 111.282 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' SER . . . . . 0.696 ' OG ' ' HG3' ' A' ' 450' ' ' GLU . 90.5 p -107.05 149.02 28.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.623 -0.717 . . . . 15.0 110.617 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -48.49 -43.54 35.01 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.182 -0.463 . . . . 15.0 111.852 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.89 -40.68 98.27 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.534 -0.303 . . . . 15.0 111.436 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . 0.696 ' HG3' ' OG ' ' A' ' 447' ' ' SER . 25.9 mt-10 -61.08 -57.72 11.38 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.399 -0.364 . . . . 15.0 110.558 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' PHE . . . . . 0.509 ' O ' ' HG2' ' A' ' 455' ' ' ARG . 3.9 t80 -61.5 -27.16 68.39 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.992 -0.549 . . . . 15.0 110.967 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -61.44 -56.65 17.8 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.029 -0.532 . . . . 15.0 111.197 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 2.1 mt -72.6 -30.14 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.908 -0.587 . . . . 15.0 111.828 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 45.9 mt -66.39 -56.32 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.752 -0.203 . . . . 15.0 111.462 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 451' ' ' PHE . 28.4 ptt180 -51.88 -33.04 34.92 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.931 0.345 . . . . 15.0 111.931 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -69.88 -34.81 71.84 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.901 -0.666 . . . . 15.0 112.83 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -92.93 -13.77 28.44 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.589 0.233 . . . . 15.0 111.39 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -116.69 85.59 17.26 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.484 -0.325 . . . . 15.0 111.036 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.37 -11.75 28.88 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.965 2.443 . . . . 15.0 112.507 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -99.51 26.24 6.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.249 -0.432 . . . . 15.0 110.926 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.7 tp -91.09 146.31 23.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.093 -0.503 . . . . 15.0 111.104 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 66.7 m -69.2 -172.55 0.44 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.08 -0.509 . . . . 15.0 111.245 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . 0.677 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -85.06 150.68 24.7 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.227 -0.442 . . . . 15.0 111.461 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . 0.53 ' HA ' HD12 ' A' ' 467' ' ' LEU . 66.0 m-85 -55.46 -51.6 66.39 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.76 -0.655 . . . . 15.0 111.226 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -68.78 -11.97 63.8 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.111 -0.566 . . . . 15.0 113.276 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -88.79 -36.17 16.23 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.078 0.439 . . . . 15.0 111.145 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' A' ' 463' ' ' ALA . 0.1 OUTLIER -85.14 -23.99 28.18 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.024 0.44 . . . . 15.0 110.055 178.351 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -135.23 111.06 9.35 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.77 -0.65 . . . . 15.0 110.008 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -61.48 -36.42 80.41 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.053 -0.521 . . . . 15.0 112.041 -178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -77.63 -9.08 58.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.532 -0.304 . . . . 15.0 111.681 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 55.45 34.1 22.3 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.442 -0.344 . . . . 15.0 111.438 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -82.09 1.99 33.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.163 -0.471 . . . . 15.0 111.511 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.22 15.28 63.0 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.457 -0.878 . . . . 15.0 110.981 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' CYS . . . . . . . . . . . . . 13.5 t -136.61 130.56 32.47 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.127 -0.536 . . . . 15.0 110.374 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.651 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 1.4 mp -103.4 127.53 57.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.964 0.411 . . . . 15.0 111.253 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 12.7 t -103.94 175.16 5.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.695 -0.684 . . . . 15.0 110.811 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -56.98 -45.3 83.03 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.324 -0.398 . . . . 15.0 111.108 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 478' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.6 mt-10 -61.15 -29.57 69.87 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.179 -0.464 . . . . 15.0 111.524 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 479' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 5.5 mm-40 -70.7 -49.03 51.42 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.401 0.143 . . . . 15.0 110.871 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 33.4 mtt -70.4 -46.22 64.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.72 -0.218 . . . . 15.0 111.02 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 88.8 t -60.24 -52.72 58.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.689 0.28 . . . . 15.0 110.607 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 482' ' ' SER . . . . . 0.89 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 40.3 m -57.73 -32.7 67.7 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 116.171 -0.468 . . . . 15.0 110.061 178.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 483' ' ' TYR . . . . . 0.531 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 8.8 t80 -69.04 -30.9 69.36 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.872 -0.604 . . . . 15.0 110.913 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 484' ' ' PHE . . . . . 0.604 ' CE2' HG21 ' A' ' 431' ' ' VAL . 0.1 OUTLIER -74.17 -40.54 62.47 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 110.243 -0.281 . . . . 15.0 110.243 179.279 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.2 tt -83.44 -18.9 37.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 15.0 110.531 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 486' ' ' ARG . . . . . 0.89 ' HB2' ' O ' ' A' ' 482' ' ' SER . 32.9 ttt180 -71.49 -52.22 19.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.345 . . . . 15.0 110.843 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 14.0 t -90.13 19.46 5.0 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.977 -0.556 . . . . 15.0 111.244 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 488' ' ' SER . . . . . 0.549 ' HB2' ' O ' ' A' ' 484' ' ' PHE . 22.8 t . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.31 -0.405 . . . . 15.0 111.004 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.658 ' O ' HG22 ' A' ' 423' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.811 0.338 . . . . 15.0 111.091 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.732 ' O ' HG22 ' A' ' 424' ' ' VAL . 4.3 tt0 -46.72 -56.52 6.04 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.781 -0.645 . . . . 15.0 111.961 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -63.51 -39.83 95.46 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.438 -0.347 . . . . 15.0 111.485 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 5.2 tp -57.33 -51.75 68.13 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.902 -0.59 . . . . 15.0 111.603 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 419' ' ' ASP . 1.1 t -81.18 -21.68 10.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 115.67 -0.696 . . . . 15.0 111.929 -177.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 420' ' ' GLN . 12.0 t -64.05 -48.22 86.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.95 -0.759 . . . . 15.0 108.95 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -72.91 -33.04 65.73 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.37 -0.832 . . . . 15.0 110.629 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . 0.638 ' O ' ' HB2' ' A' ' 430' ' ' MET . 2.2 t60 -71.26 -39.32 71.67 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.579 -0.282 . . . . 15.0 110.984 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . 0.55 ' O ' HG22 ' A' ' 431' ' ' VAL . 41.4 mt -69.29 -50.68 49.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.407 -0.361 . . . . 15.0 110.809 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -58.95 -43.27 91.22 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.088 0.471 . . . . 15.0 110.141 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 433' ' ' SER . 92.0 mttt -72.49 -23.04 60.97 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.513 -0.767 . . . . 15.0 110.516 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' MET . . . . . 0.653 ' O ' HG23 ' A' ' 434' ' ' VAL . 4.0 ttt -70.69 -49.55 45.98 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.456 -0.338 . . . . 15.0 110.8 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 427' ' ' ILE . 2.7 t -65.02 -39.07 84.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.269 -0.423 . . . . 15.0 110.008 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -71.38 -31.26 67.1 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.879 -0.601 . . . . 15.0 110.564 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.945 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 12.7 t -70.67 -41.22 72.38 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 116.217 -0.447 . . . . 15.0 111.041 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 430' ' ' MET . 19.4 t -75.1 -42.68 45.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.26 -0.427 . . . . 15.0 110.969 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . 0.615 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 14.3 t80 -59.28 -42.08 90.39 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.12 -0.491 . . . . 15.0 111.02 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -84.95 -27.95 26.18 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.548 -0.296 . . . . 15.0 110.953 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . 0.945 ' HB2' ' O ' ' A' ' 433' ' ' SER . 2.2 t30 -60.12 -44.89 94.54 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.203 -0.453 . . . . 15.0 111.393 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' PHE . . . . . 0.446 ' CE2' HG23 ' A' ' 454' ' ' ILE . 45.3 m-85 -94.78 4.84 53.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.372 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . 0.615 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 0.3 OUTLIER -126.84 55.2 1.56 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.899 0.38 . . . . 15.0 111.352 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.5 t -68.64 -8.42 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.129 -0.487 . . . . 15.0 111.325 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -87.97 -6.47 57.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.233 -0.44 . . . . 15.0 111.16 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 62.04 30.19 74.83 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.843 -0.694 . . . . 15.0 111.979 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -90.51 -18.91 24.47 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 122.307 0.243 . . . . 15.0 111.291 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 83.21 -7.33 67.87 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.91 -0.662 . . . . 15.0 112.576 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . 0.61 ' HB3' ' SG ' ' A' ' 474' ' ' CYS . 73.3 m-70 -131.84 140.21 49.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.809 0.338 . . . . 15.0 110.602 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' ILE . . . . . 0.615 HD13 ' N ' ' A' ' 446' ' ' ILE . 1.5 mp -84.98 98.57 6.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.157 -0.474 . . . . 15.0 111.013 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 29.8 m -68.29 155.33 39.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.82 -0.627 . . . . 15.0 111.016 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -53.67 -40.62 66.09 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.153 -0.476 . . . . 15.0 111.825 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . 0.553 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -62.81 -39.42 94.21 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.496 -0.32 . . . . 15.0 111.424 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . 0.438 ' OE1' ' HA ' ' A' ' 446' ' ' ILE . 49.7 mt-10 -57.13 -58.83 6.47 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.048 0.451 . . . . 15.0 110.448 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -69.05 -20.43 64.11 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.771 -0.649 . . . . 15.0 110.609 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' GLN . . . . . 0.553 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 0.4 OUTLIER -59.31 -54.91 41.39 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.877 -0.601 . . . . 15.0 111.113 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -84.32 -32.5 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.733 -0.667 . . . . 15.0 111.843 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . 0.446 HG23 ' CE2' ' A' ' 438' ' ' PHE . 57.7 mt -64.57 -40.07 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 111.664 0.246 . . . . 15.0 111.664 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 452' ' ' GLN . 32.0 ptt180 -59.67 -19.09 47.2 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.631 0.253 . . . . 15.0 111.597 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -79.32 -23.55 62.86 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.899 -0.667 . . . . 15.0 112.506 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -88.09 -27.25 22.06 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.642 0.258 . . . . 15.0 111.196 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . 0.429 ' CD1' HD11 ' A' ' 461' ' ' LEU . 2.4 t80 -121.67 87.77 46.27 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.335 -0.393 . . . . 15.0 110.817 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.41 -3.89 13.36 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.963 2.442 . . . . 15.0 112.67 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -103.54 23.66 12.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.369 -0.378 . . . . 15.0 111.011 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.429 HD11 ' CD1' ' A' ' 458' ' ' PHE . 2.9 tp -102.29 155.29 18.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.088 -0.505 . . . . 15.0 111.08 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 55.2 m -71.98 172.84 9.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.072 -0.513 . . . . 15.0 111.333 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . 0.46 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -91.54 156.64 17.52 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.115 -0.493 . . . . 15.0 111.77 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -45.83 -48.74 15.73 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.695 -0.684 . . . . 15.0 111.568 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -62.37 -23.84 64.97 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.89 -0.596 . . . . 15.0 113.637 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -88.43 -28.95 20.56 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 117.063 0.431 . . . . 15.0 111.592 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 463' ' ' ALA . 0.0 OUTLIER -77.43 -34.91 54.51 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.849 0.356 . . . . 15.0 110.252 178.524 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . 0.442 ' OD1' ' HB2' ' A' ' 470' ' ' ASN . 9.1 t70 -130.39 119.77 23.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.893 -0.594 . . . . 15.0 110.496 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -68.19 -28.05 66.93 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.104 -0.498 . . . . 15.0 111.525 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.442 ' HB2' ' OD1' ' A' ' 468' ' ' ASP . 3.9 m-80 -76.88 -10.69 59.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.252 -0.431 . . . . 15.0 111.357 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 56.24 34.03 23.25 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.289 -0.414 . . . . 15.0 111.414 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -82.42 -1.89 51.48 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.199 -0.455 . . . . 15.0 111.514 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 65.59 14.95 61.09 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.585 -0.817 . . . . 15.0 111.436 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' CYS . . . . . 0.61 ' SG ' ' HB3' ' A' ' 445' ' ' HIS . 4.2 t -135.09 130.92 36.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.248 -0.476 . . . . 15.0 110.403 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 9.5 mm -105.04 124.88 60.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.982 0.42 . . . . 15.0 111.212 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 50.5 m -103.28 174.79 5.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.707 -0.679 . . . . 15.0 110.615 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -56.02 -49.07 74.7 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.418 -0.356 . . . . 15.0 111.018 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 478' ' ' GLU . . . . . 0.684 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -61.76 -33.44 74.09 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.124 -0.489 . . . . 15.0 111.763 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 479' ' ' GLU . . . . . 0.548 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 5.4 mm-40 -69.5 -53.23 20.15 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 121.228 -0.189 . . . . 15.0 110.983 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 9.9 ttm -69.21 -48.56 61.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.754 -0.203 . . . . 15.0 111.313 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 79.4 t -60.92 -55.77 22.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.575 0.226 . . . . 15.0 111.217 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 482' ' ' SER . . . . . 0.95 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 44.5 m -54.89 -36.96 65.7 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.382 -0.372 . . . . 15.0 110.548 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 483' ' ' TYR . . . . . 0.548 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 1.9 m-85 -71.23 -26.04 62.75 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.236 -0.438 . . . . 15.0 111.321 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 484' ' ' PHE . . . . . 0.503 ' CD2' HG23 ' A' ' 431' ' ' VAL . 1.9 m-85 -73.37 -44.55 58.42 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 110.129 -0.323 . . . . 15.0 110.129 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.4 tt -84.24 -17.61 39.19 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.135 -0.484 . . . . 15.0 110.672 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 486' ' ' ARG . . . . . 0.95 ' HB2' ' O ' ' A' ' 482' ' ' SER . 30.8 ttt180 -70.97 -48.8 51.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.887 0.375 . . . . 15.0 110.758 177.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 52.2 m -82.7 19.26 1.35 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.89 -0.596 . . . . 15.0 111.469 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 C--O 1.232 0.166 0 CA-C-N 116.358 -0.383 . . . . 15.0 111.0 179.826 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.628 ' O ' HG22 ' A' ' 423' ' ' VAL . 1.1 m-20 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.857 0.36 . . . . 15.0 111.107 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.705 ' O ' HG22 ' A' ' 424' ' ' VAL . 45.4 mt-30 -47.62 -56.15 7.81 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.77 -0.65 . . . . 15.0 111.994 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -64.13 -40.94 97.25 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.384 -0.371 . . . . 15.0 111.67 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 5.0 tp -57.4 -53.3 59.65 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.041 -0.527 . . . . 15.0 111.726 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 419' ' ' ASP . 1.7 t -80.13 -23.36 11.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.674 -0.694 . . . . 15.0 112.004 -177.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 420' ' ' GLN . 8.4 t -63.22 -47.66 91.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.02 -0.733 . . . . 15.0 109.02 177.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -71.77 -34.38 69.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.422 -0.808 . . . . 15.0 110.504 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -70.53 -40.39 73.46 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.534 -0.303 . . . . 15.0 110.946 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . 0.514 ' O ' HG23 ' A' ' 431' ' ' VAL . 35.9 mt -66.36 -53.68 33.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.355 -0.384 . . . . 15.0 110.771 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -57.15 -41.83 79.89 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.105 0.479 . . . . 15.0 110.326 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.611 ' O ' ' HB2' ' A' ' 433' ' ' SER . 89.2 mttt -70.86 -24.7 62.56 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.538 -0.756 . . . . 15.0 110.749 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' MET . . . . . 0.639 ' O ' HG23 ' A' ' 434' ' ' VAL . 33.9 mtp -71.99 -47.49 51.69 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.405 -0.362 . . . . 15.0 110.891 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.59 HG21 ' CE2' ' A' ' 484' ' ' PHE . 0.8 OUTLIER -63.62 -40.98 91.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.065 0.459 . . . . 15.0 109.939 178.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -72.24 -30.35 64.8 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.666 -0.697 . . . . 15.0 110.826 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.827 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 12.2 t -68.75 -43.48 75.76 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.307 -0.406 . . . . 15.0 111.085 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 430' ' ' MET . 7.7 t -75.27 -41.97 43.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.32 -0.4 . . . . 15.0 110.848 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . 0.628 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 3.8 t80 -58.39 -41.57 85.16 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.09 -0.504 . . . . 15.0 110.967 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -85.11 -27.17 26.43 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.371 -0.377 . . . . 15.0 110.889 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . 0.827 ' HB2' ' O ' ' A' ' 433' ' ' SER . 2.7 t30 -59.36 -44.54 92.68 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.272 -0.422 . . . . 15.0 111.194 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' PHE . . . . . 0.425 ' CE2' HG23 ' A' ' 454' ' ' ILE . 33.1 m-85 -90.2 -5.91 55.87 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.019 -0.537 . . . . 15.0 111.212 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . 0.628 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 0.2 OUTLIER -109.82 53.94 0.68 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.838 0.351 . . . . 15.0 111.405 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 3.3 m -70.6 -9.22 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.21 -0.45 . . . . 15.0 111.617 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -88.92 -15.14 35.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.235 -0.439 . . . . 15.0 111.144 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 73.12 37.77 55.36 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.922 -0.656 . . . . 15.0 112.538 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -97.31 -16.39 20.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.653 0.264 . . . . 15.0 111.195 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 86.8 -7.69 78.88 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.825 -0.702 . . . . 15.0 112.374 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . 0.484 ' HB2' ' SG ' ' A' ' 474' ' ' CYS . 15.0 p80 -142.39 158.36 43.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.759 0.314 . . . . 15.0 110.712 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' ILE . . . . . 0.695 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.6 mp -77.71 135.99 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 15.0 111.165 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 14.4 t -106.19 148.11 28.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.585 -0.734 . . . . 15.0 110.767 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -50.18 -46.39 54.22 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.214 -0.448 . . . . 15.0 111.507 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . 0.461 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -65.42 -35.24 80.33 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.426 -0.352 . . . . 15.0 110.89 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -60.06 -59.56 5.23 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.241 -0.436 . . . . 15.0 110.483 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.36 -23.56 67.01 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.984 -0.553 . . . . 15.0 110.629 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' GLN . . . . . 0.461 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 5.6 mt-30 -60.14 -57.57 12.27 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.802 -0.635 . . . . 15.0 111.234 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 8.7 mm -76.6 -33.05 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.782 -0.645 . . . . 15.0 111.831 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . 0.425 HG23 ' CE2' ' A' ' 438' ' ' PHE . 48.5 mt -62.71 -46.98 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.803 -0.18 . . . . 15.0 111.133 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' ARG . . . . . 0.613 ' NH2' ' HA ' ' A' ' 463' ' ' ALA . 10.5 mtt180 -54.79 -34.33 62.56 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.718 0.294 . . . . 15.0 111.551 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -66.05 -30.84 77.74 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.994 -0.622 . . . . 15.0 112.896 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -96.95 -16.32 20.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.667 0.27 . . . . 15.0 111.293 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -132.97 85.79 44.99 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.308 -0.406 . . . . 15.0 110.983 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -72.84 1.74 6.11 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.062 2.508 . . . . 15.0 112.452 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -87.61 6.77 32.89 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.313 -0.403 . . . . 15.0 111.223 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -83.76 142.41 30.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.239 -0.437 . . . . 15.0 111.088 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 43.4 p -70.62 -172.56 0.64 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.161 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . 0.723 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -86.93 150.22 24.24 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.365 -0.38 . . . . 15.0 111.264 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . 0.903 ' O ' HD13 ' A' ' 467' ' ' LEU . 80.0 m-85 -59.14 -46.71 87.64 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.023 -0.535 . . . . 15.0 111.371 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -67.68 -16.44 67.84 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.921 -0.656 . . . . 15.0 113.225 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -90.23 -41.35 11.64 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.913 0.356 . . . . 15.0 111.705 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.903 HD13 ' O ' ' A' ' 464' ' ' PHE . 0.7 OUTLIER -76.53 -27.47 55.98 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.703 0.287 . . . . 15.0 110.842 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -128.16 112.2 14.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.203 -0.453 . . . . 15.0 110.362 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -67.02 -29.53 69.37 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.011 -0.54 . . . . 15.0 111.312 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.559 ' N ' HD21 ' A' ' 470' ' ' ASN . 0.9 OUTLIER -76.52 -13.66 60.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 15.0 111.144 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 60.65 28.05 17.76 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.199 -0.455 . . . . 15.0 111.285 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -71.42 -7.86 50.06 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.137 -0.483 . . . . 15.0 111.838 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.86 18.41 68.51 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.405 -0.902 . . . . 15.0 111.299 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' A' ' 445' ' ' HIS . 19.0 t -137.16 130.88 31.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.256 -0.472 . . . . 15.0 110.464 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.695 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 9.0 mm -93.92 120.19 42.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.959 0.409 . . . . 15.0 111.01 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' SER . . . . . 0.435 ' H ' ' HG3' ' A' ' 479' ' ' GLU . 52.9 m -103.38 173.4 6.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.819 -0.628 . . . . 15.0 110.686 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -53.74 -45.38 70.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.427 -0.351 . . . . 15.0 110.959 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 478' ' ' GLU . . . . . 0.552 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -62.38 -28.36 69.72 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.046 -0.524 . . . . 15.0 111.361 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 479' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 43.6 mm-40 -71.15 -50.05 37.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.41 0.147 . . . . 15.0 110.777 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 40.3 mtt -70.58 -46.66 63.03 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.797 -0.183 . . . . 15.0 110.958 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 481' ' ' VAL . . . . . 0.498 ' O ' HD12 ' A' ' 485' ' ' LEU . 84.1 t -59.84 -54.12 38.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.758 0.313 . . . . 15.0 110.693 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 482' ' ' SER . . . . . 0.933 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 38.6 m -56.63 -33.11 65.99 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 116.215 -0.448 . . . . 15.0 110.117 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 483' ' ' TYR . . . . . 0.555 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 8.5 t80 -69.27 -29.74 67.7 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.921 -0.581 . . . . 15.0 110.966 177.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 484' ' ' PHE . . . . . 0.59 ' CE2' HG21 ' A' ' 431' ' ' VAL . 0.1 OUTLIER -73.9 -41.93 61.42 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 110.215 -0.291 . . . . 15.0 110.215 179.259 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . 0.498 HD12 ' O ' ' A' ' 481' ' ' VAL . 5.5 mp -83.83 -17.78 39.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.308 -0.405 . . . . 15.0 110.556 177.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 486' ' ' ARG . . . . . 0.933 ' HB2' ' O ' ' A' ' 482' ' ' SER . 34.4 ttt180 -71.99 -48.26 46.1 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.323 -0.399 . . . . 15.0 110.812 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 53.3 m -80.58 19.65 0.79 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.872 -0.604 . . . . 15.0 111.502 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 54.6 m . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 116.374 -0.376 . . . . 15.0 110.926 179.834 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.605 ' O ' HG21 ' A' ' 423' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.83 0.348 . . . . 15.0 111.238 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.713 ' O ' HG21 ' A' ' 424' ' ' VAL . 53.3 mt-30 -47.25 -55.68 8.18 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.819 -0.628 . . . . 15.0 111.879 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -63.14 -40.37 97.39 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.308 -0.405 . . . . 15.0 111.51 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 4.9 tp -57.46 -53.01 62.95 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.009 -0.541 . . . . 15.0 111.673 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.605 HG21 ' O ' ' A' ' 419' ' ' ASP . 1.5 t -79.95 -22.65 11.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.658 -0.701 . . . . 15.0 111.973 -177.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . 0.713 HG21 ' O ' ' A' ' 420' ' ' GLN . 9.9 t -63.43 -47.75 90.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 109.047 -0.723 . . . . 15.0 109.047 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -71.96 -34.17 68.76 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.33 -0.85 . . . . 15.0 110.577 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -70.78 -40.42 72.61 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.612 -0.267 . . . . 15.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . 0.496 ' O ' HG22 ' A' ' 431' ' ' VAL . 36.9 mt -66.48 -53.34 36.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.362 -0.381 . . . . 15.0 110.667 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -57.24 -42.27 81.12 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.151 0.5 . . . . 15.0 110.143 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -69.87 -25.34 63.67 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.528 -0.76 . . . . 15.0 110.549 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' MET . . . . . 0.632 ' O ' HG21 ' A' ' 434' ' ' VAL . 31.7 mmm -70.67 -47.73 58.44 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.425 -0.352 . . . . 15.0 110.935 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.588 HG23 ' CE2' ' A' ' 484' ' ' PHE . 0.8 OUTLIER -62.93 -40.3 88.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.014 0.435 . . . . 15.0 110.025 179.073 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -72.53 -33.31 66.79 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.733 -0.667 . . . . 15.0 110.978 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.784 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 3.6 m -66.33 -43.47 86.05 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.344 -0.389 . . . . 15.0 111.093 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.632 HG21 ' O ' ' A' ' 430' ' ' MET . 4.9 t -75.94 -38.84 36.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.212 -0.449 . . . . 15.0 110.779 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 431' ' ' VAL . 4.4 t80 -55.92 -42.87 76.73 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.068 -0.515 . . . . 15.0 110.821 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -89.16 -24.03 22.29 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.401 -0.363 . . . . 15.0 111.284 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . 0.784 ' HB2' ' O ' ' A' ' 433' ' ' SER . 4.2 t-20 -59.95 -34.7 73.6 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.987 0.422 . . . . 15.0 110.402 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' PHE . . . . . 0.436 ' O ' ' HB3' ' A' ' 450' ' ' GLU . 7.2 m-85 -71.79 -41.63 68.07 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.622 -0.717 . . . . 15.0 111.888 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . 0.707 ' HA ' ' OE2' ' A' ' 450' ' ' GLU . 5.1 p-10 -139.53 82.29 1.87 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.144 0.497 . . . . 15.0 111.91 -178.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.9 m -72.42 -8.57 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.925 -0.579 . . . . 15.0 111.248 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -66.84 -15.39 63.58 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.049 -0.523 . . . . 15.0 111.408 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 91.04 47.3 3.64 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.931 -0.652 . . . . 15.0 112.423 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -101.3 -19.53 15.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.674 0.273 . . . . 15.0 111.207 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 78.94 -13.69 17.7 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.039 -0.6 . . . . 15.0 113.0 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -144.48 168.37 20.29 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.889 0.376 . . . . 15.0 110.806 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' ILE . . . . . 0.562 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.2 mp -74.56 126.56 35.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.021 -0.536 . . . . 15.0 111.24 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 52.9 m -106.36 147.37 29.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.743 -0.662 . . . . 15.0 110.83 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -50.03 -45.59 52.18 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.193 -0.458 . . . . 15.0 111.677 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.72 -40.19 96.14 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.48 -0.327 . . . . 15.0 111.234 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . 0.707 ' OE2' ' HA ' ' A' ' 439' ' ' ASP . 5.5 mm-40 -63.33 -56.13 18.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.433 -0.349 . . . . 15.0 110.385 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.83 -28.99 67.96 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.165 -0.471 . . . . 15.0 110.93 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -61.82 -55.87 25.41 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 115.928 -0.578 . . . . 15.0 111.081 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 2.8 mt -70.86 -28.38 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.914 -0.585 . . . . 15.0 111.624 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 30.3 mt -67.24 -56.98 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.67 -0.241 . . . . 15.0 111.183 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -47.93 -36.17 11.93 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.478 -0.328 . . . . 15.0 111.877 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -63.79 -34.05 88.89 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.986 -0.626 . . . . 15.0 112.947 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -104.24 -2.43 25.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.537 0.208 . . . . 15.0 111.345 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -128.75 79.96 73.49 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.523 -0.308 . . . . 15.0 111.155 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -75.09 -3.66 14.25 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.075 2.517 . . . . 15.0 112.543 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -107.71 26.41 10.34 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.207 -0.451 . . . . 15.0 111.013 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 2.4 tp -91.62 151.36 20.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.176 -0.466 . . . . 15.0 111.118 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 49.2 m -67.73 176.7 2.36 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.104 -0.498 . . . . 15.0 111.362 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . 0.781 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -89.05 153.11 21.26 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.128 -0.487 . . . . 15.0 111.288 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . 0.872 ' O ' HD12 ' A' ' 467' ' ' LEU . 78.1 m-85 -57.41 -49.14 77.17 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.069 -0.514 . . . . 15.0 111.437 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -68.95 -15.48 69.37 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.992 -0.623 . . . . 15.0 113.57 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . 0.499 ' OD1' ' HB3' ' A' ' 463' ' ' ALA . 5.1 m-20 -89.83 -41.6 11.74 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.1 0.45 . . . . 15.0 111.712 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.872 HD12 ' O ' ' A' ' 464' ' ' PHE . 0.6 OUTLIER -78.0 -27.74 49.05 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.747 0.308 . . . . 15.0 110.714 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -129.83 111.38 12.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.073 -0.512 . . . . 15.0 110.336 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -66.0 -30.25 70.77 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.369 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.532 ' N ' HD21 ' A' ' 470' ' ' ASN . 1.0 OUTLIER -76.38 -13.52 60.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.343 -0.389 . . . . 15.0 111.262 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 59.9 28.09 17.55 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.25 -0.432 . . . . 15.0 111.287 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -74.37 -5.26 41.3 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.201 -0.454 . . . . 15.0 111.723 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.72 17.95 67.67 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.403 -0.904 . . . . 15.0 111.265 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' CYS . . . . . . . . . . . . . 15.8 t -136.31 130.96 33.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.226 -0.487 . . . . 15.0 110.496 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.562 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 14.1 mm -95.25 120.81 45.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.899 0.381 . . . . 15.0 110.977 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' SER . . . . . 0.444 ' H ' ' HG3' ' A' ' 479' ' ' GLU . 54.3 m -103.08 171.79 7.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 15.0 110.667 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -53.47 -44.59 69.09 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.417 -0.356 . . . . 15.0 110.931 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 478' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.8 mt-10 -62.91 -28.81 70.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.075 -0.511 . . . . 15.0 111.358 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 479' ' ' GLU . . . . . 0.587 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 63.5 mm-40 -70.5 -50.26 39.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.499 0.19 . . . . 15.0 110.875 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 33.7 mtt -70.85 -46.89 61.87 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.709 -0.223 . . . . 15.0 111.168 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 82.1 t -59.81 -53.13 52.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.626 0.251 . . . . 15.0 110.71 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 482' ' ' SER . . . . . 0.947 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 47.0 m -58.25 -32.66 68.57 Favored 'General case' 0 C--O 1.227 -0.104 0 CA-C-N 116.301 -0.408 . . . . 15.0 110.15 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 483' ' ' TYR . . . . . 0.587 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 7.4 t80 -69.62 -30.16 67.83 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.93 -0.577 . . . . 15.0 111.104 177.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 484' ' ' PHE . . . . . 0.588 ' CE2' HG23 ' A' ' 431' ' ' VAL . 0.1 OUTLIER -75.18 -40.51 59.36 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.762 0.315 . . . . 15.0 110.252 179.29 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.3 tt -83.98 -17.3 40.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 15.0 110.585 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 486' ' ' ARG . . . . . 0.947 ' HB2' ' O ' ' A' ' 482' ' ' SER . 25.1 ttt180 -74.14 -47.81 33.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.859 0.362 . . . . 15.0 110.918 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 13.9 t -82.89 19.92 1.28 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.901 -0.59 . . . . 15.0 111.554 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 88.1 p . . . . . 0 C--N 1.332 -0.169 0 CA-C-O 120.792 0.329 . . . . 15.0 110.919 179.744 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.616 ' O ' HG22 ' A' ' 423' ' ' VAL . 7.6 m-20 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.787 0.327 . . . . 15.0 111.098 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.693 ' O ' HG22 ' A' ' 424' ' ' VAL . 6.5 pt20 -46.42 -56.92 5.19 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.087 -0.506 . . . . 15.0 111.784 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -68.39 -37.64 80.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.404 -0.362 . . . . 15.0 111.279 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.522 HD12 ' OD2' ' A' ' 419' ' ' ASP . 1.2 tt -57.75 -53.72 55.06 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.882 -0.599 . . . . 15.0 111.701 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 419' ' ' ASP . 1.6 t -80.78 -23.8 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 CA-C-N 115.657 -0.701 . . . . 15.0 112.05 -177.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . 0.693 HG22 ' O ' ' A' ' 420' ' ' GLN . 7.2 t -62.9 -47.87 90.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.093 -0.706 . . . . 15.0 109.093 177.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -71.92 -34.16 68.86 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.486 -0.779 . . . . 15.0 110.561 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -70.72 -39.37 73.43 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.558 -0.292 . . . . 15.0 111.04 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . 0.54 ' O ' HG22 ' A' ' 431' ' ' VAL . 37.6 mt -67.84 -51.91 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.37 -0.377 . . . . 15.0 110.732 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -58.4 -42.19 86.61 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.192 0.52 . . . . 15.0 110.303 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 433' ' ' SER . 90.2 mttt -71.15 -25.14 62.43 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.521 -0.763 . . . . 15.0 110.707 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' MET . . . . . 0.656 ' O ' HG21 ' A' ' 434' ' ' VAL . 23.3 mmm -71.45 -46.97 58.6 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.448 -0.342 . . . . 15.0 110.908 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 427' ' ' ILE . 2.6 t -65.33 -39.15 84.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.879 0.371 . . . . 15.0 110.061 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -72.16 -31.14 65.68 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.859 -0.61 . . . . 15.0 110.73 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.853 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 14.2 t -70.86 -41.88 70.82 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.196 -0.456 . . . . 15.0 111.06 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.656 HG21 ' O ' ' A' ' 430' ' ' MET . 17.8 t -75.87 -41.29 39.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.249 -0.432 . . . . 15.0 110.956 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -60.58 -41.32 94.4 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.297 -0.41 . . . . 15.0 110.815 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -83.21 -28.62 29.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.504 -0.316 . . . . 15.0 110.681 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . 0.853 ' HB2' ' O ' ' A' ' 433' ' ' SER . 2.5 t30 -60.11 -44.54 94.77 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.085 -0.507 . . . . 15.0 111.247 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' PHE . . . . . 0.484 ' CE2' HG22 ' A' ' 454' ' ' ILE . 66.6 m-85 -93.94 0.53 56.14 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.841 -0.618 . . . . 15.0 111.448 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -127.48 53.1 1.77 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.979 0.418 . . . . 15.0 111.179 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.9 t -74.39 -14.24 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.078 -0.51 . . . . 15.0 111.065 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -90.2 -14.74 32.83 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.074 -0.512 . . . . 15.0 111.032 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 64.55 60.06 7.48 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.051 -0.595 . . . . 15.0 112.796 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.44 -10.81 11.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.705 0.288 . . . . 15.0 111.223 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 88.93 -13.55 62.75 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.811 -0.709 . . . . 15.0 112.227 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . 0.625 ' HB2' ' SG ' ' A' ' 474' ' ' CYS . 9.5 p80 -141.58 156.81 45.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.602 0.239 . . . . 15.0 110.415 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' ILE . . . . . 0.776 HG12 ' H ' ' A' ' 475' ' ' ILE . 0.9 OUTLIER -82.99 100.85 6.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.366 -0.379 . . . . 15.0 111.143 -179.166 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 7.6 t -67.71 152.12 46.13 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.282 -0.417 . . . . 15.0 110.918 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -51.59 -43.11 62.38 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.07 -0.514 . . . . 15.0 111.951 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . 0.524 ' O ' ' HB2' ' A' ' 452' ' ' GLN . 42.7 mt-10 -63.03 -40.09 96.7 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.552 -0.294 . . . . 15.0 111.322 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -58.24 -56.38 22.88 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.935 0.398 . . . . 15.0 110.412 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -66.85 -23.29 66.01 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.935 -0.575 . . . . 15.0 110.608 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' A' ' 449' ' ' GLU . 2.6 mm-40 -59.1 -54.84 42.48 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.838 -0.619 . . . . 15.0 111.008 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 8.7 mm -78.98 -31.82 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 115.649 -0.705 . . . . 15.0 111.694 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . 0.484 HG22 ' CE2' ' A' ' 438' ' ' PHE . 50.2 mt -61.22 -46.86 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.494 0.188 . . . . 15.0 111.273 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -55.74 -29.97 60.42 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.552 -0.295 . . . . 15.0 111.561 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -66.0 -31.8 80.58 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.963 -0.637 . . . . 15.0 112.759 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -103.64 -11.7 17.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.607 0.242 . . . . 15.0 111.365 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -136.23 78.98 44.52 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 116.465 -0.334 . . . . 15.0 110.985 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.08 2.4 6.71 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.166 2.577 . . . . 15.0 112.624 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -85.2 5.19 31.16 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.325 -0.398 . . . . 15.0 111.285 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -87.76 142.39 27.86 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.263 -0.426 . . . . 15.0 111.063 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' SER . . . . . 0.435 ' H ' ' HG ' ' A' ' 462' ' ' SER . 5.8 p -81.39 -157.35 0.17 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.066 -0.515 . . . . 15.0 110.975 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . 0.538 ' HB2' ' OD2' ' A' ' 466' ' ' ASP . . . -85.4 148.47 25.99 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.926 0.393 . . . . 15.0 111.655 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -51.24 -46.36 62.31 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.771 -0.649 . . . . 15.0 111.121 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -63.57 -19.38 62.5 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.907 -0.588 . . . . 15.0 113.005 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . 0.538 ' OD2' ' HB2' ' A' ' 463' ' ' ALA . 7.6 m-20 -87.87 -37.11 16.78 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.765 0.282 . . . . 15.0 110.977 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 463' ' ' ALA . 0.1 OUTLIER -68.99 -34.11 74.77 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.96 0.41 . . . . 15.0 110.154 178.34 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 470' ' ' ASN . 8.5 t70 -120.34 117.17 27.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.698 -0.683 . . . . 15.0 110.413 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -64.26 -27.68 69.21 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.083 -0.508 . . . . 15.0 111.577 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.464 ' HB2' ' OD2' ' A' ' 468' ' ' ASP . 5.0 m-80 -76.94 -9.01 58.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.371 -0.377 . . . . 15.0 111.442 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 54.4 36.01 24.46 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.365 -0.38 . . . . 15.0 111.4 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -88.43 0.78 55.87 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.194 -0.457 . . . . 15.0 111.47 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 65.67 14.08 59.88 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.427 -0.892 . . . . 15.0 111.314 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' CYS . . . . . 0.625 ' SG ' ' HB2' ' A' ' 445' ' ' HIS . 1.2 m -137.69 130.7 30.32 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.202 -0.499 . . . . 15.0 110.508 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.776 ' H ' HG12 ' A' ' 446' ' ' ILE . 2.7 mp -107.89 128.92 62.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.992 0.425 . . . . 15.0 111.246 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 48.8 m -104.33 -179.58 3.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.597 -0.728 . . . . 15.0 110.784 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -62.58 -47.51 83.5 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.364 -0.38 . . . . 15.0 111.214 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 478' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -60.45 -33.95 73.29 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.252 -0.431 . . . . 15.0 111.48 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 479' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 6.8 mm-40 -66.79 -45.21 79.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.562 0.22 . . . . 15.0 110.626 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 40.3 mtt -69.76 -47.58 62.47 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.608 -0.269 . . . . 15.0 110.893 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.14 -55.61 23.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.737 0.303 . . . . 15.0 110.937 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 482' ' ' SER . . . . . 0.941 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 75.0 m -54.51 -38.79 66.92 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 116.128 -0.487 . . . . 15.0 110.605 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 483' ' ' TYR . . . . . 0.496 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 2.6 m-85 -71.58 -24.43 61.91 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.036 -0.529 . . . . 15.0 111.555 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 484' ' ' PHE . . . . . 0.485 ' CD2' HG23 ' A' ' 431' ' ' VAL . 3.7 m-85 -75.28 -43.55 50.64 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 120.843 -0.343 . . . . 15.0 110.163 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . 0.438 ' HA ' ' OG ' ' A' ' 488' ' ' SER . 5.3 tt -84.16 -18.69 35.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 15.0 110.642 176.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 486' ' ' ARG . . . . . 0.941 ' HB2' ' O ' ' A' ' 482' ' ' SER . 24.2 ttt180 -70.97 -49.57 43.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.899 0.38 . . . . 15.0 110.791 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 14.5 t -83.43 19.68 1.5 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.831 -0.622 . . . . 15.0 111.339 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 488' ' ' SER . . . . . 0.438 ' OG ' ' HA ' ' A' ' 485' ' ' LEU . 74.0 m . . . . . 0 C--N 1.331 -0.208 0 CA-C-N 116.335 -0.393 . . . . 15.0 111.001 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.64 ' O ' HG23 ' A' ' 423' ' ' VAL . 8.4 m-20 . . . . . 0 N--CA 1.466 0.366 0 CA-C-O 120.856 0.36 . . . . 15.0 111.335 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.689 ' O ' HG22 ' A' ' 424' ' ' VAL . 44.4 mt-30 -48.8 -58.05 5.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.089 -0.505 . . . . 15.0 111.864 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -68.09 -38.6 82.52 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.444 -0.344 . . . . 15.0 111.489 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.512 HD13 ' OD2' ' A' ' 419' ' ' ASP . 0.9 OUTLIER -57.36 -54.43 46.95 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.955 -0.566 . . . . 15.0 111.852 -179.241 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.7 t -81.1 -23.47 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-N 115.709 -0.678 . . . . 15.0 112.148 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 420' ' ' GLN . 7.2 t -63.28 -48.06 89.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.11 -0.7 . . . . 15.0 109.11 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -71.84 -34.0 68.92 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.488 -0.778 . . . . 15.0 110.607 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -70.57 -39.8 73.68 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.621 -0.263 . . . . 15.0 110.99 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . 0.55 ' O ' HG23 ' A' ' 431' ' ' VAL . 40.5 mt -67.61 -52.38 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 116.442 -0.345 . . . . 15.0 110.772 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -57.97 -42.04 84.21 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.096 0.474 . . . . 15.0 110.222 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.579 ' O ' ' HB2' ' A' ' 433' ' ' SER . 89.7 mttt -71.47 -24.86 62.08 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.521 -0.763 . . . . 15.0 110.737 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' MET . . . . . 0.61 ' O ' HG21 ' A' ' 434' ' ' VAL . 26.2 mtp -71.17 -47.68 56.23 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.467 -0.333 . . . . 15.0 110.937 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 427' ' ' ILE . 1.8 t -65.77 -39.03 83.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.913 0.387 . . . . 15.0 110.079 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -72.19 -30.01 64.54 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.842 -0.617 . . . . 15.0 110.681 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.767 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 13.4 t -70.25 -42.66 71.89 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.261 -0.427 . . . . 15.0 110.936 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.61 HG21 ' O ' ' A' ' 430' ' ' MET . 14.4 t -76.09 -40.37 37.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.207 -0.452 . . . . 15.0 110.77 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -58.7 -43.39 90.01 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.191 -0.458 . . . . 15.0 110.579 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -83.52 -25.3 31.15 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.451 -0.34 . . . . 15.0 110.961 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . 0.767 ' HB2' ' O ' ' A' ' 433' ' ' SER . 4.9 t-20 -60.11 -38.75 83.95 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.383 -0.372 . . . . 15.0 110.477 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' PHE . . . . . 0.488 ' CE2' HG22 ' A' ' 454' ' ' ILE . 32.6 m-85 -95.36 -12.15 26.53 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.763 -0.653 . . . . 15.0 111.581 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -106.33 54.09 0.69 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.88 0.371 . . . . 15.0 111.375 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.18 -6.46 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.194 -0.457 . . . . 15.0 111.403 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -94.0 -15.04 25.23 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.3 -0.409 . . . . 15.0 111.214 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 68.3 48.07 54.36 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.018 -0.611 . . . . 15.0 112.681 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -110.85 -18.05 13.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.649 0.261 . . . . 15.0 111.168 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 91.27 -5.2 81.06 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.921 -0.657 . . . . 15.0 112.378 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -143.29 156.92 44.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.816 0.341 . . . . 15.0 110.742 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' ILE . . . . . 0.645 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.7 mp -81.77 136.47 22.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.285 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 5.4 m -105.17 149.15 26.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.663 -0.699 . . . . 15.0 110.72 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -47.73 -46.93 30.35 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.176 -0.465 . . . . 15.0 111.776 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -64.69 -38.7 91.88 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.512 -0.313 . . . . 15.0 111.208 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -59.49 -59.07 6.04 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.275 -0.42 . . . . 15.0 110.427 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -63.18 -26.52 68.84 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.797 -0.638 . . . . 15.0 110.83 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -59.25 -56.94 15.75 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.902 -0.59 . . . . 15.0 111.288 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -78.29 -29.96 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.879 -0.601 . . . . 15.0 111.795 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . 0.488 HG22 ' CE2' ' A' ' 438' ' ' PHE . 46.6 mt -63.37 -46.14 96.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 120.397 0.141 . . . . 15.0 111.319 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -52.5 -29.22 23.96 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.802 0.297 . . . . 15.0 111.802 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -74.78 -24.65 71.69 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.833 -0.698 . . . . 15.0 112.676 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -71.6 -56.91 4.95 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.478 0.18 . . . . 15.0 111.402 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -144.59 98.71 4.9 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-O 120.628 0.251 . . . . 15.0 111.117 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.43 4.16 4.68 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.118 2.545 . . . . 15.0 112.594 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -112.29 -24.82 9.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.384 -0.371 . . . . 15.0 111.374 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.4 tp -56.77 -56.24 24.07 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.283 -0.417 . . . . 15.0 111.652 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' SER . . . . . 0.413 ' C ' HD23 ' A' ' 467' ' ' LEU . 5.7 m -135.44 109.01 7.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.766 0.317 . . . . 15.0 111.019 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . 0.657 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -77.89 106.4 9.71 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.238 -0.437 . . . . 15.0 110.944 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . 0.433 ' CE1' ' HA2' ' A' ' 473' ' ' GLY . 29.3 t80 -40.37 -42.28 1.54 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.905 -0.588 . . . . 15.0 111.99 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -59.82 -36.92 91.59 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.03 -0.605 . . . . 15.0 113.27 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 483' ' ' TYR . 6.3 m-20 -90.48 -21.41 21.88 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.569 0.581 . . . . 15.0 112.569 -178.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 463' ' ' ALA . 0.1 OUTLIER -85.83 -43.24 13.45 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.791 -0.364 . . . . 15.0 110.518 179.383 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . 0.427 ' HB2' ' CD1' ' A' ' 475' ' ' ILE . 24.0 t0 -130.07 110.9 11.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.001 -0.545 . . . . 15.0 111.231 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -85.67 -16.84 37.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.087 -0.506 . . . . 15.0 110.772 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . 0.541 ' N ' HD21 ' A' ' 470' ' ' ASN . 0.8 OUTLIER -78.6 -13.83 59.63 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.112 -0.495 . . . . 15.0 111.195 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 60.91 24.18 14.21 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.182 -0.463 . . . . 15.0 111.629 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -75.05 -3.42 32.4 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.41 -0.359 . . . . 15.0 111.645 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . 0.433 ' HA2' ' CE1' ' A' ' 464' ' ' PHE . . . 66.57 13.83 61.48 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.634 -0.793 . . . . 15.0 111.431 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' CYS . . . . . . . . . . . . . 14.8 t -133.13 130.81 39.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.374 -0.413 . . . . 15.0 110.609 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.645 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 10.8 mm -103.6 124.25 57.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 120.778 0.323 . . . . 15.0 110.99 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 53.4 m -102.44 167.47 9.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 15.0 110.812 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -53.31 -43.3 67.48 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.245 -0.434 . . . . 15.0 111.127 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 478' ' ' GLU . . . . . 0.689 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -60.4 -32.7 71.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.189 -0.459 . . . . 15.0 111.547 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 479' ' ' GLU . . . . . 0.562 ' OE1' ' HA ' ' A' ' 475' ' ' ILE . 47.6 mt-10 -67.08 -54.26 23.13 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.424 0.154 . . . . 15.0 111.095 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 58.5 mtt -70.07 -49.59 49.58 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.755 -0.202 . . . . 15.0 111.265 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 71.6 t -58.91 -56.78 14.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.57 0.224 . . . . 15.0 111.169 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 482' ' ' SER . . . . . 1.01 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 58.1 m -55.22 -36.59 66.16 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 116.457 -0.338 . . . . 15.0 110.511 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 483' ' ' TYR . . . . . 0.527 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 20.5 t80 -69.37 -26.89 64.88 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.135 -0.484 . . . . 15.0 111.253 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 484' ' ' PHE . . . . . 0.523 ' CD2' HG21 ' A' ' 431' ' ' VAL . 5.1 m-85 -76.15 -44.15 39.56 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 120.902 -0.319 . . . . 15.0 110.533 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.3 tt -83.52 -16.67 44.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.473 -0.33 . . . . 15.0 110.706 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 486' ' ' ARG . . . . . 1.01 ' HB2' ' O ' ' A' ' 482' ' ' SER . 30.7 ttt180 -75.91 -50.28 15.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.525 -0.307 . . . . 15.0 111.284 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 52.3 m -86.25 -51.1 6.48 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.183 -0.462 . . . . 15.0 111.916 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 488' ' ' SER . . . . . 0.495 ' HB3' ' O ' ' A' ' 484' ' ' PHE . 12.5 t . . . . . 0 N--CA 1.463 0.224 0 CA-C-O 120.939 0.4 . . . . 15.0 111.448 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' ASP . . . . . 0.601 ' O ' HG23 ' A' ' 423' ' ' VAL . 8.7 m-20 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.754 0.311 . . . . 15.0 110.926 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' GLN . . . . . 0.696 ' O ' HG21 ' A' ' 424' ' ' VAL . 9.6 tt0 -46.25 -57.64 4.38 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.088 -0.505 . . . . 15.0 111.578 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -68.3 -37.28 80.46 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.306 -0.406 . . . . 15.0 111.238 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' LEU . . . . . 0.408 HD13 ' OD1' ' A' ' 419' ' ' ASP . 1.4 tt -57.39 -54.56 45.39 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.791 -0.641 . . . . 15.0 111.688 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.4 t -81.29 -23.74 10.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.724 -0.671 . . . . 15.0 112.097 -177.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . 0.696 HG21 ' O ' ' A' ' 420' ' ' GLN . 7.0 t -62.64 -48.43 88.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 109.044 -0.724 . . . . 15.0 109.044 178.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -72.2 -33.96 68.03 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.428 -0.806 . . . . 15.0 110.6 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . 0.4 ' HB2' ' O ' ' A' ' 422' ' ' LEU . 2.5 t60 -70.83 -39.11 73.21 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 120.716 0.293 . . . . 15.0 110.995 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' ' 431' ' ' VAL . 36.4 mt -67.63 -54.0 26.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.328 -0.396 . . . . 15.0 110.658 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -56.93 -42.32 79.8 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.132 0.491 . . . . 15.0 110.153 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . 0.619 ' O ' ' HB2' ' A' ' 433' ' ' SER . 88.1 mttt -70.54 -25.13 62.97 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 115.545 -0.752 . . . . 15.0 110.762 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' MET . . . . . 0.603 ' O ' HG22 ' A' ' 434' ' ' VAL . 18.3 mtm -71.44 -46.54 59.79 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.546 -0.297 . . . . 15.0 110.948 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.6 HG21 ' CE2' ' A' ' 484' ' ' PHE . 0.8 OUTLIER -63.87 -41.87 93.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 121.041 0.448 . . . . 15.0 109.978 178.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -72.45 -29.6 63.83 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.642 -0.708 . . . . 15.0 110.952 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' SER . . . . . 0.844 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 13.3 t -69.43 -43.7 72.84 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.304 -0.407 . . . . 15.0 111.02 -179.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 430' ' ' MET . 12.1 t -75.16 -42.9 44.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.281 -0.418 . . . . 15.0 110.869 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' PHE . . . . . 0.47 ' CZ ' ' HG3' ' A' ' 477' ' ' ARG . 7.7 t80 -56.69 -43.64 80.7 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.113 -0.494 . . . . 15.0 110.902 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -85.55 -23.94 27.45 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.464 -0.335 . . . . 15.0 111.205 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' ASN . . . . . 0.844 ' HB2' ' O ' ' A' ' 433' ' ' SER . 4.4 t-20 -59.84 -40.24 87.85 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.429 -0.351 . . . . 15.0 110.637 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -95.71 -13.83 23.89 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.931 -0.577 . . . . 15.0 111.807 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -105.31 54.33 0.71 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.924 0.392 . . . . 15.0 111.239 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 11.1 p -71.95 -16.1 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.13 -0.487 . . . . 15.0 111.338 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 40.2 p30 -79.92 -14.26 58.75 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.144 -0.48 . . . . 15.0 111.341 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 71.29 47.14 37.83 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.869 -0.682 . . . . 15.0 112.386 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -106.5 -18.46 13.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.676 0.274 . . . . 15.0 111.192 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 89.93 -9.32 77.67 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.956 -0.64 . . . . 15.0 112.494 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -146.01 162.53 37.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.774 0.321 . . . . 15.0 110.709 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' ILE . . . . . 0.608 ' N ' HD12 ' A' ' 446' ' ' ILE . 1.7 mp -77.84 135.13 26.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.225 -0.443 . . . . 15.0 111.179 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.0 m -106.14 148.72 27.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.669 -0.696 . . . . 15.0 110.584 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -48.32 -47.46 36.8 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.257 -0.429 . . . . 15.0 111.697 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' GLU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.4 mt-10 -64.46 -38.22 90.27 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.423 -0.353 . . . . 15.0 111.329 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -58.37 -61.53 2.51 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.883 0.373 . . . . 15.0 110.605 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.7 -22.69 66.64 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.923 -0.581 . . . . 15.0 110.932 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' GLN . . . . . 0.416 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 0.9 OUTLIER -60.49 -57.55 12.27 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.938 -0.574 . . . . 15.0 111.281 179.49 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -76.87 -33.76 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 115.771 -0.65 . . . . 15.0 111.855 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 61.0 mt -62.49 -49.97 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 120.489 0.185 . . . . 15.0 111.284 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' ARG . . . . . 0.444 ' NH2' ' H ' ' A' ' 461' ' ' LEU . 0.1 OUTLIER -57.94 -30.6 66.09 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.524 -0.307 . . . . 15.0 111.521 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -70.57 -33.73 67.44 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.918 -0.658 . . . . 15.0 112.775 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' ASN . . . . . 0.428 ' O ' ' HD3' ' A' ' 459' ' ' PRO . 40.9 m-80 -90.4 -22.21 21.57 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.637 0.256 . . . . 15.0 111.189 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -115.97 84.39 13.34 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.432 -0.349 . . . . 15.0 111.034 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 457' ' ' ASN . 13.0 Cg_exo -70.83 -10.55 27.93 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.947 2.431 . . . . 15.0 112.545 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -96.84 25.55 5.2 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.318 -0.401 . . . . 15.0 110.974 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' LEU . . . . . 0.444 ' H ' ' NH2' ' A' ' 455' ' ' ARG . 0.7 OUTLIER -98.01 152.07 19.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.218 -0.447 . . . . 15.0 111.061 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 43.1 p -63.63 175.73 1.02 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.072 -0.513 . . . . 15.0 111.328 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' ALA . . . . . 0.738 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -87.76 148.42 24.73 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.184 -0.462 . . . . 15.0 111.242 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' PHE . . . . . 0.865 ' O ' HD12 ' A' ' 467' ' ' LEU . 46.0 m-85 -54.44 -48.07 72.13 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.937 -0.574 . . . . 15.0 111.477 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -70.4 -15.62 72.91 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.014 -0.613 . . . . 15.0 113.519 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' ASP . . . . . 0.482 ' OD1' ' HB3' ' A' ' 463' ' ' ALA . 4.1 m-20 -90.26 -36.67 14.59 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 117.089 0.445 . . . . 15.0 111.796 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' LEU . . . . . 0.865 HD12 ' O ' ' A' ' 464' ' ' PHE . 0.5 OUTLIER -82.08 -30.88 31.07 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.9 0.381 . . . . 15.0 110.571 179.193 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -126.47 108.75 11.46 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.976 -0.556 . . . . 15.0 110.273 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -69.22 -22.11 63.89 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.112 -0.494 . . . . 15.0 111.489 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -76.51 -14.11 60.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.226 -0.443 . . . . 15.0 111.326 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 57.38 26.61 12.7 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.224 -0.444 . . . . 15.0 111.413 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -81.23 0.05 38.44 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.257 -0.429 . . . . 15.0 111.551 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 65.89 16.04 63.34 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.469 -0.872 . . . . 15.0 111.227 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' CYS . . . . . . . . . . . . . 13.8 t -137.94 131.12 30.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.142 -0.529 . . . . 15.0 110.431 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.566 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 94.9 mt -106.84 127.24 62.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.912 0.387 . . . . 15.0 111.023 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 64.7 m -103.61 177.22 4.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.739 -0.664 . . . . 15.0 111.077 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 477' ' ' ARG . . . . . 0.47 ' HG3' ' CZ ' ' A' ' 435' ' ' PHE . 68.7 mtp180 -58.81 -46.96 86.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.21 -0.45 . . . . 15.0 111.221 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 478' ' ' GLU . . . . . 0.619 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -60.21 -32.42 71.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.215 -0.448 . . . . 15.0 111.423 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 479' ' ' GLU . . . . . 0.42 ' O ' ' HD1' ' A' ' 483' ' ' TYR . 5.5 mm-40 -66.42 -50.22 64.16 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.497 0.189 . . . . 15.0 110.778 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 60.0 mtt -69.86 -47.0 64.32 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.684 -0.234 . . . . 15.0 110.923 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 89.8 t -61.56 -54.01 40.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.702 0.287 . . . . 15.0 110.842 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 482' ' ' SER . . . . . 0.877 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 10.3 m -50.55 -47.17 57.78 Favored 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 116.034 -0.53 . . . . 15.0 110.382 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 483' ' ' TYR . . . . . 0.42 ' HD1' ' O ' ' A' ' 479' ' ' GLU . 8.0 m-85 -69.22 -22.42 63.87 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.423 -0.808 . . . . 15.0 111.856 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 484' ' ' PHE . . . . . 0.779 ' O ' ' HB2' ' A' ' 488' ' ' SER . 0.1 OUTLIER -74.03 -45.94 46.52 Favored 'General case' 0 CA--C 1.527 0.091 0 C-N-CA 120.779 -0.369 . . . . 15.0 110.1 179.05 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . 0.606 HD11 ' O ' ' A' ' 485' ' ' LEU . 1.5 tm? -84.43 -16.62 42.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.425 -0.352 . . . . 15.0 110.664 177.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 486' ' ' ARG . . . . . 0.877 ' HB2' ' O ' ' A' ' 482' ' ' SER . 21.3 ttt180 -74.36 -53.32 9.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.451 -0.34 . . . . 15.0 111.578 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 487' ' ' SER . . . . . 0.592 ' HG ' ' H ' ' A' ' 488' ' ' SER . 79.7 p -92.58 -54.49 3.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.314 -0.403 . . . . 15.0 112.058 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 488' ' ' SER . . . . . 0.779 ' HB2' ' O ' ' A' ' 484' ' ' PHE . 54.7 m . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.871 0.367 . . . . 15.0 111.492 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 50.3 pttt . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.761 0.315 . . . . 15.0 110.931 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 9.1 mt -102.57 139.07 38.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.085 -0.507 . . . . 15.0 110.889 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.605 ' O ' HG22 ' A' ' 423' ' ' VAL . 8.9 m-20 -97.52 8.95 43.68 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.048 -0.524 . . . . 15.0 111.037 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.698 ' O ' HG22 ' A' ' 424' ' ' VAL . 53.6 mt-30 -44.81 -57.25 3.86 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.053 -0.522 . . . . 15.0 111.607 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -68.48 -36.83 79.51 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.308 -0.406 . . . . 15.0 111.136 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 1.6 tt -57.75 -54.55 45.65 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.826 -0.625 . . . . 15.0 111.668 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 419' ' ' ASP . 1.1 t -81.32 -23.48 10.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.665 -0.698 . . . . 15.0 112.039 -177.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 420' ' ' GLN . 6.8 t -62.78 -47.46 92.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 109.047 -0.723 . . . . 15.0 109.047 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -72.97 -33.94 66.18 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.435 -0.802 . . . . 15.0 110.583 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . 0.571 ' O ' ' HB2' ' A' ' 430' ' ' MET . 2.4 t-80 -70.85 -39.38 72.99 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.678 0.275 . . . . 15.0 110.975 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . 0.53 ' O ' HG21 ' A' ' 431' ' ' VAL . 40.1 mt -68.88 -52.0 39.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.372 -0.376 . . . . 15.0 110.715 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -57.32 -43.0 82.95 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.132 0.492 . . . . 15.0 110.197 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -71.83 -24.27 61.68 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 115.559 -0.746 . . . . 15.0 110.542 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' MET . . . . . 0.65 ' O ' HG23 ' A' ' 434' ' ' VAL . 8.5 ttm -70.32 -49.82 45.52 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.36 -0.382 . . . . 15.0 110.853 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.536 HG22 ' CE2' ' A' ' 484' ' ' PHE . 1.5 t -64.56 -37.34 79.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.918 0.39 . . . . 15.0 110.033 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -71.57 -32.93 68.62 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.826 -0.625 . . . . 15.0 110.692 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.911 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 4.0 m -69.61 -41.11 76.12 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.181 -0.463 . . . . 15.0 111.09 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 430' ' ' MET . 16.4 t -75.36 -42.2 43.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.2 -0.455 . . . . 15.0 110.786 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . 0.44 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 9.8 t80 -58.32 -41.71 85.11 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.965 -0.561 . . . . 15.0 111.013 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -86.37 -26.91 24.55 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.436 -0.347 . . . . 15.0 110.933 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . 0.911 ' HB2' ' O ' ' A' ' 433' ' ' SER . 2.6 t-20 -59.73 -45.27 92.71 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.227 -0.442 . . . . 15.0 111.455 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . 0.41 ' CE2' HG22 ' A' ' 454' ' ' ILE . 54.8 m-85 -94.33 -2.09 52.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.119 -0.491 . . . . 15.0 111.494 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 1.1 t0 -120.08 54.49 1.03 Allowed 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.918 0.39 . . . . 15.0 111.16 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.26 -9.42 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.054 -0.521 . . . . 15.0 111.32 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -92.35 -3.96 54.57 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.257 -0.429 . . . . 15.0 111.219 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 61.06 51.01 61.18 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.051 -0.595 . . . . 15.0 112.664 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -103.19 -18.09 15.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.645 0.259 . . . . 15.0 111.231 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 87.8 -13.85 59.93 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.933 -0.651 . . . . 15.0 112.302 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . 0.475 ' HB2' ' SG ' ' A' ' 474' ' ' CYS . 14.4 p80 -137.77 154.37 49.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.622 0.248 . . . . 15.0 110.408 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' ILE . . . . . 0.618 ' O ' ' HA ' ' A' ' 474' ' ' CYS . 1.6 mp -85.6 98.95 6.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.072 0.463 . . . . 15.0 111.023 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 52.8 m -63.7 150.89 43.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.705 -0.68 . . . . 15.0 111.072 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -55.33 -37.91 68.05 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.069 -0.514 . . . . 15.0 111.802 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . 0.441 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -63.23 -40.25 96.92 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.522 -0.308 . . . . 15.0 111.38 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -58.55 -60.51 3.7 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.947 0.403 . . . . 15.0 110.507 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -64.61 -24.1 67.48 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.822 -0.627 . . . . 15.0 110.614 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' GLN . . . . . 0.441 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 0.2 OUTLIER -58.9 -57.05 14.76 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.724 -0.671 . . . . 15.0 111.588 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -81.05 -33.61 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.682 -0.69 . . . . 15.0 111.927 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . 0.41 HG22 ' CE2' ' A' ' 438' ' ' PHE . 56.0 mt -63.9 -38.17 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.444 0.164 . . . . 15.0 111.438 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -62.65 -21.74 65.92 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.687 0.28 . . . . 15.0 111.468 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -66.36 -23.94 71.98 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.014 -0.613 . . . . 15.0 112.7 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -116.03 -10.7 11.53 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.676 0.274 . . . . 15.0 111.208 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -127.67 74.7 78.18 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.385 -0.37 . . . . 15.0 111.007 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.04 1.93 8.15 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.189 2.593 . . . . 15.0 112.612 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -81.32 2.5 27.94 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.328 -0.396 . . . . 15.0 111.449 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.4 mp -102.16 152.3 21.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.379 -0.373 . . . . 15.0 111.041 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 50.9 m -74.67 -174.83 2.24 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.079 -0.51 . . . . 15.0 111.288 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . 0.571 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -87.79 156.93 19.17 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.22 -0.446 . . . . 15.0 111.793 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -50.08 -41.67 48.56 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.74 -0.663 . . . . 15.0 111.348 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -62.19 -26.72 68.02 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.944 -0.571 . . . . 15.0 113.35 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -88.44 -33.24 17.93 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.858 0.329 . . . . 15.0 111.433 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 463' ' ' ALA . 0.1 OUTLIER -77.65 -36.32 51.57 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.863 0.363 . . . . 15.0 110.403 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . 0.526 ' HA ' ' OE2' ' A' ' 479' ' ' GLU . 10.4 t70 -123.77 114.62 20.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.876 -0.602 . . . . 15.0 110.47 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -67.28 -33.74 75.94 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.052 -0.522 . . . . 15.0 111.542 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -79.27 -9.44 59.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.397 -0.365 . . . . 15.0 111.413 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 55.86 39.08 30.68 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.27 -0.423 . . . . 15.0 111.382 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -78.56 -0.72 30.79 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.178 -0.464 . . . . 15.0 111.593 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.47 15.09 63.3 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.494 -0.86 . . . . 15.0 111.255 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' CYS . . . . . 0.618 ' HA ' ' O ' ' A' ' 446' ' ' ILE . 1.0 OUTLIER -136.09 131.16 34.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.235 -0.483 . . . . 15.0 110.455 -178.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.485 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 16.7 mm -102.74 124.9 57.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.938 0.399 . . . . 15.0 111.136 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 12.3 t -103.59 175.71 5.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.729 -0.669 . . . . 15.0 110.823 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -58.08 -44.48 87.6 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.328 -0.396 . . . . 15.0 111.149 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.6 mt-10 -62.11 -29.62 70.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.437 . . . . 15.0 111.458 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . 0.526 ' OE2' ' HA ' ' A' ' 468' ' ' ASP . 5.3 mm-40 -71.69 -47.99 50.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.496 0.188 . . . . 15.0 110.862 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 60.5 mtt -70.45 -46.2 64.33 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.687 -0.233 . . . . 15.0 110.963 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 79.1 t -60.26 -52.7 58.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 120.738 0.304 . . . . 15.0 110.659 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' SER . . . . . 0.907 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 39.5 m -57.77 -32.96 68.01 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 116.162 -0.472 . . . . 15.0 110.183 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' TYR . . . . . 0.52 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 9.1 t80 -69.02 -30.01 68.31 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.904 -0.589 . . . . 15.0 111.013 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' PHE . . . . . 0.547 ' O ' ' HB2' ' A' ' 488' ' ' SER . 1.9 m-85 -75.16 -40.18 59.77 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.708 0.289 . . . . 15.0 110.332 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.2 tt -83.82 -18.74 36.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 15.0 110.558 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' ARG . . . . . 0.907 ' HB2' ' O ' ' A' ' 482' ' ' SER . 31.0 ttt180 -72.61 -52.98 13.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.433 -0.349 . . . . 15.0 110.882 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 53.4 m -89.26 19.37 4.39 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.979 -0.555 . . . . 15.0 111.354 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' SER . . . . . 0.547 ' HB2' ' O ' ' A' ' 484' ' ' PHE . 22.6 t -87.69 130.16 34.9 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.345 -0.389 . . . . 15.0 110.933 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 51.8 m -95.65 -129.45 0.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.114 -0.493 . . . . 15.0 110.842 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 5.1 t -65.93 -51.65 58.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 116.515 -0.311 . . . . 15.0 111.073 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 1.5 mp -131.47 -42.16 1.06 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.918 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -110.43 -103.75 2.78 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.961 -0.638 . . . . 15.0 112.499 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 164.91 57.63 0.02 OUTLIER Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.824 -0.703 . . . . 15.0 112.512 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -127.94 147.22 50.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.73 0.3 . . . . 15.0 110.913 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 64.1 mtt -122.56 -42.77 2.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.464 . . . . 15.0 110.979 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 126.06 64.28 0.16 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.847 -0.692 . . . . 15.0 112.482 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.295 -0.859 . . . . 15.0 110.904 179.975 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 66.1 mttm . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.723 0.297 . . . . 15.0 111.023 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 11.2 mt -140.18 110.79 6.76 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.199 -0.455 . . . . 15.0 110.814 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.627 ' O ' HG23 ' A' ' 423' ' ' VAL . 0.8 OUTLIER -153.57 126.58 8.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.144 -0.48 . . . . 15.0 111.114 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.701 ' O ' HG22 ' A' ' 424' ' ' VAL . 4.3 tt0 -47.96 -56.35 7.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.784 -0.643 . . . . 15.0 111.862 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.42 95.96 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.328 -0.397 . . . . 15.0 111.62 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 3.2 tt -57.49 -53.34 59.31 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.077 -0.51 . . . . 15.0 111.743 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.6 t -80.9 -22.54 10.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.736 -0.665 . . . . 15.0 111.966 -176.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 420' ' ' GLN . 9.3 t -64.07 -47.68 89.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 109.056 -0.72 . . . . 15.0 109.056 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -72.61 -33.29 66.57 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.426 -0.807 . . . . 15.0 110.584 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . 0.623 ' O ' ' HB2' ' A' ' 430' ' ' MET . 4.6 t-80 -71.02 -39.29 72.43 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.568 -0.287 . . . . 15.0 111.05 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . 0.523 ' O ' HG21 ' A' ' 431' ' ' VAL . 40.7 mt -68.88 -52.29 36.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 116.352 -0.386 . . . . 15.0 110.77 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -57.7 -43.55 85.25 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.154 0.502 . . . . 15.0 110.169 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -72.04 -22.73 61.35 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.506 -0.77 . . . . 15.0 110.548 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' MET . . . . . 0.623 ' HB2' ' O ' ' A' ' 426' ' ' HIS . 0.0 OUTLIER -70.28 -51.37 30.99 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.405 -0.361 . . . . 15.0 110.88 179.077 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.559 HG22 ' CE2' ' A' ' 484' ' ' PHE . 1.0 OUTLIER -63.87 -38.69 83.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.317 -0.402 . . . . 15.0 110.046 179.128 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -71.89 -31.69 66.68 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.823 -0.626 . . . . 15.0 110.878 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.809 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 2.6 m -68.54 -42.68 78.1 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.244 -0.435 . . . . 15.0 111.028 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.595 HG21 ' O ' ' A' ' 430' ' ' MET . 10.2 t -75.32 -41.91 43.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.271 -0.422 . . . . 15.0 110.869 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . 0.605 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 4.1 t80 -56.75 -42.67 79.74 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.037 -0.529 . . . . 15.0 110.749 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 -87.02 -23.55 24.95 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.441 -0.345 . . . . 15.0 111.229 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . 0.809 ' HB2' ' O ' ' A' ' 433' ' ' SER . 5.1 t-20 -59.97 -39.62 86.28 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.863 0.363 . . . . 15.0 110.568 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . 0.4 ' CD2' HD13 ' A' ' 454' ' ' ILE . 35.6 m-85 -94.15 -16.51 23.66 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.854 -0.612 . . . . 15.0 111.635 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . 0.605 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 0.3 OUTLIER -99.18 54.03 0.97 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.864 0.364 . . . . 15.0 111.429 -179.525 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.3 -12.85 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.327 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -88.59 -14.82 36.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.119 -0.491 . . . . 15.0 111.171 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 73.7 39.44 48.51 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.004 -0.617 . . . . 15.0 112.508 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -95.79 -17.34 21.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.623 0.249 . . . . 15.0 111.162 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 87.22 -7.73 79.51 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.911 -0.662 . . . . 15.0 112.37 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -144.92 162.18 37.51 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.717 0.294 . . . . 15.0 110.658 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' ILE . . . . . 0.835 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.6 mp -77.78 136.36 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.113 0.483 . . . . 15.0 111.265 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 48.5 m -105.76 147.8 28.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.474 -0.784 . . . . 15.0 110.711 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -50.71 -46.85 59.11 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.169 -0.469 . . . . 15.0 111.606 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . 0.404 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -65.31 -36.91 85.52 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.479 -0.328 . . . . 15.0 111.168 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -60.58 -58.71 7.34 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.295 -0.411 . . . . 15.0 110.543 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.45 -23.73 67.0 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.767 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' GLN . . . . . 0.404 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 1.5 mm-40 -61.07 -56.93 15.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.88 -0.6 . . . . 15.0 111.302 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -76.73 -32.89 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 115.804 -0.635 . . . . 15.0 111.913 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . 0.4 HD13 ' CD2' ' A' ' 438' ' ' PHE . 46.3 mt -64.71 -51.96 60.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.501 0.191 . . . . 15.0 111.244 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -55.32 -33.19 63.09 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.694 0.283 . . . . 15.0 111.46 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -66.84 -30.78 76.66 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.908 -0.663 . . . . 15.0 112.629 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' ASN . . . . . 0.445 ' O ' ' HD3' ' A' ' 459' ' ' PRO . 42.0 m-80 -94.28 -18.99 21.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.687 0.279 . . . . 15.0 111.246 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -115.8 83.29 11.47 Favored Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 116.375 -0.375 . . . . 15.0 110.936 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 457' ' ' ASN . 12.6 Cg_exo -70.78 -10.08 27.03 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.046 2.497 . . . . 15.0 112.631 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -96.53 25.25 5.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.26 -0.427 . . . . 15.0 111.034 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 2.3 tp -100.39 152.55 20.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.16 -0.473 . . . . 15.0 110.975 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 52.5 m -65.54 176.41 1.48 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.115 -0.493 . . . . 15.0 111.378 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . 0.752 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -86.84 150.49 24.09 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.239 -0.437 . . . . 15.0 111.243 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . 0.898 ' O ' HD11 ' A' ' 467' ' ' LEU . 68.1 m-85 -56.62 -48.76 76.79 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.999 -0.546 . . . . 15.0 111.506 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -68.15 -16.33 68.68 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.962 -0.637 . . . . 15.0 113.459 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -90.13 -39.33 12.93 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.101 0.45 . . . . 15.0 111.776 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.898 HD11 ' O ' ' A' ' 464' ' ' PHE . 0.6 OUTLIER -79.06 -28.76 43.18 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.762 0.315 . . . . 15.0 110.755 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -130.87 110.49 11.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.039 -0.528 . . . . 15.0 110.286 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -66.06 -28.77 69.09 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.008 -0.542 . . . . 15.0 111.454 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.556 ' N ' HD21 ' A' ' 470' ' ' ASN . 0.9 OUTLIER -76.54 -14.11 60.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.249 -0.432 . . . . 15.0 111.214 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 58.67 29.36 18.46 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.238 -0.437 . . . . 15.0 111.306 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -74.35 -4.8 38.58 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.147 -0.479 . . . . 15.0 111.767 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.52 17.57 66.81 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.464 -0.875 . . . . 15.0 111.197 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' CYS . . . . . . . . . . . . . 18.5 t -135.78 131.7 35.81 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.268 -0.466 . . . . 15.0 110.492 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.835 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 11.1 mm -98.79 122.24 50.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 15.0 110.938 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' SER . . . . . 0.473 ' H ' ' HG3' ' A' ' 479' ' ' GLU . 15.4 t -102.89 171.12 7.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.918 -0.583 . . . . 15.0 110.672 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -52.86 -45.51 67.44 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.338 -0.392 . . . . 15.0 110.915 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' GLU . . . . . 0.578 ' O ' ' HB2' ' A' ' 482' ' ' SER . 9.4 tt0 -62.51 -28.39 69.81 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.049 -0.523 . . . . 15.0 111.254 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . 0.58 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 52.1 mm-40 -70.35 -51.36 30.57 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.505 0.193 . . . . 15.0 110.84 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 44.2 mtt -70.06 -47.18 63.03 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.653 -0.249 . . . . 15.0 111.081 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 82.1 t -59.94 -53.49 47.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.68 0.276 . . . . 15.0 110.85 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' SER . . . . . 0.929 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 43.0 m -57.96 -32.46 67.85 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 116.267 -0.424 . . . . 15.0 110.208 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' TYR . . . . . 0.58 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 8.3 t80 -69.3 -31.05 69.28 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.954 -0.566 . . . . 15.0 111.199 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' PHE . . . . . 0.584 ' HZ ' ' SD ' ' A' ' 430' ' ' MET . 1.6 m-85 -75.9 -39.03 57.12 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.926 -0.31 . . . . 15.0 110.387 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . 0.407 ' HA ' ' OG ' ' A' ' 488' ' ' SER . 5.1 tt -83.74 -19.65 34.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 15.0 110.49 176.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' ARG . . . . . 0.929 ' HB2' ' O ' ' A' ' 482' ' ' SER . 32.1 ttt180 -72.08 -48.55 43.3 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.845 0.355 . . . . 15.0 110.751 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 49.5 p -82.77 19.58 1.31 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.907 -0.588 . . . . 15.0 111.439 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' SER . . . . . 0.407 ' OG ' ' HA ' ' A' ' 485' ' ' LEU . 67.9 m -77.25 123.5 26.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.279 -0.418 . . . . 15.0 110.961 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 41.2 p -107.79 -43.68 4.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.106 -0.497 . . . . 15.0 111.16 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 58.1 t -148.44 89.0 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.374 -0.375 . . . . 15.0 110.567 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 4.8 mp -136.1 -40.21 0.67 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.098 -0.501 . . . . 15.0 111.032 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . 142.69 -81.35 0.23 Allowed Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.915 -0.659 . . . . 15.0 112.462 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 102.44 55.37 0.85 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.871 -0.68 . . . . 15.0 112.412 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . 0.417 ' O ' ' HE2' ' A' ' 497' ' ' PHE . 99.6 mtt180 -100.78 -41.05 7.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.688 0.28 . . . . 15.0 110.991 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -105.91 130.15 53.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.25 -0.432 . . . . 15.0 110.893 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 129.75 74.23 0.14 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.938 -0.648 . . . . 15.0 112.51 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . 0.417 ' HE2' ' O ' ' A' ' 494' ' ' ARG . 84.0 m-85 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.286 -0.864 . . . . 15.0 110.933 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 97.1 mttt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.731 0.301 . . . . 15.0 110.923 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.3 mp -143.66 -70.14 0.31 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.131 -0.486 . . . . 15.0 110.902 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.637 ' O ' HG21 ' A' ' 423' ' ' VAL . 0.2 OUTLIER -172.53 140.66 1.07 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.343 -0.389 . . . . 15.0 110.89 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.71 ' O ' HG23 ' A' ' 424' ' ' VAL . 45.9 mt-30 -48.99 -56.66 8.23 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.878 -0.601 . . . . 15.0 111.731 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -65.91 -38.47 88.8 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.905 0.383 . . . . 15.0 111.43 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 3.4 tt -57.97 -53.09 62.11 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.862 -0.608 . . . . 15.0 111.572 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.637 HG21 ' O ' ' A' ' 419' ' ' ASP . 2.1 t -80.81 -22.7 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 CA-C-N 115.665 -0.698 . . . . 15.0 111.978 -177.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 420' ' ' GLN . 9.6 t -63.83 -48.02 88.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 109.023 -0.732 . . . . 15.0 109.023 177.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -71.7 -33.55 68.88 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.335 -0.848 . . . . 15.0 110.46 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -70.71 -39.8 73.22 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.53 -0.305 . . . . 15.0 110.915 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . 0.544 ' O ' HG23 ' A' ' 431' ' ' VAL . 38.6 mt -67.33 -52.35 43.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.358 -0.383 . . . . 15.0 110.712 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -58.37 -41.99 86.01 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.156 0.503 . . . . 15.0 110.287 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.595 ' O ' ' HB2' ' A' ' 433' ' ' SER . 89.6 mttt -71.29 -24.19 62.1 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 115.473 -0.785 . . . . 15.0 110.74 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' MET . . . . . 0.62 ' O ' HG22 ' A' ' 434' ' ' VAL . 25.2 mmm -71.63 -47.53 53.88 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.428 -0.351 . . . . 15.0 110.923 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.547 HG21 ' CD2' ' A' ' 484' ' ' PHE . 2.0 t -65.36 -39.22 84.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.325 -0.398 . . . . 15.0 110.0 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -72.62 -30.45 64.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.916 -0.584 . . . . 15.0 110.756 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.834 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 13.2 t -68.86 -43.11 76.09 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.202 -0.453 . . . . 15.0 110.91 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 430' ' ' MET . 10.6 t -76.53 -40.82 34.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.784 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . 0.553 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 2.9 t80 -56.99 -42.9 81.11 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.065 -0.516 . . . . 15.0 110.673 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -87.41 -23.6 24.47 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.361 -0.382 . . . . 15.0 111.18 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . 0.834 ' HB2' ' O ' ' A' ' 433' ' ' SER . 3.3 t30 -60.0 -38.93 84.07 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.934 0.397 . . . . 15.0 110.515 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . 0.451 ' CD2' HD11 ' A' ' 454' ' ' ILE . 33.1 m-85 -94.41 -16.65 23.24 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.802 -0.636 . . . . 15.0 111.55 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . 0.553 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 0.6 OUTLIER -99.92 53.44 0.92 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.892 0.377 . . . . 15.0 111.589 -179.323 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.8 t -70.37 -12.49 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.132 -0.485 . . . . 15.0 111.0 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -90.85 -14.96 30.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.079 -0.51 . . . . 15.0 111.048 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 76.56 41.62 24.2 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.971 -0.633 . . . . 15.0 112.509 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -97.64 -18.64 18.78 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.671 0.272 . . . . 15.0 111.149 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 86.2 -4.48 85.97 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.899 -0.667 . . . . 15.0 112.468 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . 0.674 ' HB2' ' SG ' ' A' ' 474' ' ' CYS . 11.1 p-80 -146.18 164.3 32.68 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.757 0.313 . . . . 15.0 110.807 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' ILE . . . . . 0.82 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.2 mp -76.98 135.76 25.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.215 -0.448 . . . . 15.0 110.999 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 9.9 t -106.33 147.53 29.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.823 -0.626 . . . . 15.0 110.789 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -52.42 -47.93 66.03 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.167 -0.469 . . . . 15.0 111.541 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . 0.405 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -64.72 -36.85 85.63 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.444 -0.343 . . . . 15.0 111.047 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . 0.414 ' O ' HD12 ' A' ' 454' ' ' ILE . 5.0 mm-40 -61.16 -56.56 19.36 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.317 -0.401 . . . . 15.0 110.279 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' PHE . . . . . 0.516 ' CE2' HD23 ' A' ' 461' ' ' LEU . 0.7 OUTLIER -64.99 -25.07 67.71 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.911 -0.586 . . . . 15.0 110.529 178.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' GLN . . . . . 0.405 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 2.5 mm-40 -60.66 -57.92 10.66 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.76 -0.654 . . . . 15.0 111.389 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 8.8 mm -76.0 -33.04 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.86 -0.609 . . . . 15.0 111.842 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . 0.451 HD11 ' CD2' ' A' ' 438' ' ' PHE . 28.3 mt -63.2 -47.52 91.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 120.489 0.185 . . . . 15.0 111.272 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' ARG . . . . . 0.637 ' NH2' ' HA ' ' A' ' 463' ' ' ALA . 8.1 mtt180 -54.87 -33.68 62.14 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.539 -0.3 . . . . 15.0 111.507 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -64.08 -29.3 74.52 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 121.033 -0.603 . . . . 15.0 112.612 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -97.37 -15.04 20.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.556 0.217 . . . . 15.0 111.162 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -125.47 86.66 56.88 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.39 -0.368 . . . . 15.0 111.044 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -72.53 -2.71 12.2 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.989 2.459 . . . . 15.0 112.589 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -103.35 23.54 12.35 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.319 -0.401 . . . . 15.0 110.998 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.516 HD23 ' CE2' ' A' ' 451' ' ' PHE . 1.0 OUTLIER -89.32 147.77 23.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 15.0 111.084 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 58.2 m -66.78 175.37 2.44 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.044 -0.525 . . . . 15.0 111.329 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . 0.735 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -87.88 149.11 24.3 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.114 -0.494 . . . . 15.0 111.271 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . 0.847 ' O ' HD12 ' A' ' 467' ' ' LEU . 90.1 m-85 -56.71 -47.6 79.58 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.932 -0.577 . . . . 15.0 111.47 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -69.06 -16.06 70.28 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 121.034 -0.603 . . . . 15.0 113.449 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -89.92 -38.97 13.31 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.202 0.501 . . . . 15.0 111.678 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.847 HD12 ' O ' ' A' ' 464' ' ' PHE . 0.6 OUTLIER -80.9 -28.56 35.83 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.815 0.341 . . . . 15.0 110.586 179.57 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . 0.453 ' HA ' ' OE2' ' A' ' 479' ' ' GLU . 12.4 t70 -131.65 111.93 12.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.049 -0.523 . . . . 15.0 110.213 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -62.07 -35.74 79.57 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.029 -0.532 . . . . 15.0 111.788 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -77.88 -10.58 59.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.417 -0.356 . . . . 15.0 111.456 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 57.66 34.13 24.11 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.943 0.402 . . . . 15.0 111.303 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -73.88 -4.44 34.99 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.113 -0.494 . . . . 15.0 111.716 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.72 18.04 67.78 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.489 -0.863 . . . . 15.0 111.277 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' CYS . . . . . 0.674 ' SG ' ' HB2' ' A' ' 445' ' ' HIS . 3.7 t -135.19 130.93 36.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.248 -0.476 . . . . 15.0 110.52 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.82 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 21.1 mm -98.78 123.67 51.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.892 0.377 . . . . 15.0 110.93 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 14.5 t -101.84 166.96 10.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.931 -0.577 . . . . 15.0 110.577 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -50.49 -46.98 57.38 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.34 -0.391 . . . . 15.0 110.915 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' GLU . . . . . 0.743 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -62.21 -30.84 71.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.031 -0.531 . . . . 15.0 111.473 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 5.7 mm-40 -69.83 -55.06 10.81 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 121.285 -0.166 . . . . 15.0 110.956 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 6.6 tpp -68.65 -48.46 63.96 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.752 -0.204 . . . . 15.0 111.228 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 76.0 t -60.51 -54.56 33.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 121.148 -0.221 . . . . 15.0 111.128 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' SER . . . . . 0.965 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 36.8 m -56.51 -33.61 66.18 Favored 'General case' 0 C--O 1.227 -0.088 0 CA-C-N 116.515 -0.311 . . . . 15.0 110.462 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' TYR . . . . . 0.549 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 8.5 t80 -70.24 -30.76 67.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.116 -0.493 . . . . 15.0 111.167 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' PHE . . . . . 0.547 ' CD2' HG21 ' A' ' 431' ' ' VAL . 6.0 m-85 -74.16 -41.84 60.86 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 120.888 -0.325 . . . . 15.0 110.372 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.5 tt -83.95 -16.98 42.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.396 . . . . 15.0 110.492 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' ARG . . . . . 0.965 ' HB2' ' O ' ' A' ' 482' ' ' SER . 5.8 tpt180 -71.59 -51.5 23.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.892 0.377 . . . . 15.0 110.844 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 52.5 m -87.55 19.37 3.38 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.961 -0.563 . . . . 15.0 111.55 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 9.3 t -121.55 157.27 31.08 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.374 -0.376 . . . . 15.0 111.042 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 52.9 m -94.56 161.0 14.38 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.046 -0.525 . . . . 15.0 110.915 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 60.1 t -148.9 90.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.2 -0.454 . . . . 15.0 110.516 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 2.4 tp -97.69 -42.04 7.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.015 -0.539 . . . . 15.0 111.032 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -118.73 -101.98 2.05 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.877 -0.678 . . . . 15.0 112.527 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 102.57 88.58 2.05 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.85 -0.69 . . . . 15.0 112.465 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -102.64 135.03 45.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.775 0.322 . . . . 15.0 110.933 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 64.8 mtt -102.13 -42.12 6.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.148 -0.478 . . . . 15.0 110.998 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 128.62 91.64 0.68 Allowed Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.849 -0.691 . . . . 15.0 112.512 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.315 -0.85 . . . . 15.0 110.862 -179.987 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . 0.57 ' HD3' ' OE1' ' A' ' 420' ' ' GLN . 97.6 mttt . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.792 0.329 . . . . 15.0 110.86 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 2.7 tp -144.49 -47.4 0.25 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.123 -0.49 . . . . 15.0 110.871 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.607 ' O ' HG23 ' A' ' 423' ' ' VAL . 7.6 m-20 -92.0 20.63 5.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.136 -0.484 . . . . 15.0 111.115 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.709 ' O ' HG22 ' A' ' 424' ' ' VAL . 4.0 tt0 -46.85 -57.42 4.93 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.097 -0.501 . . . . 15.0 111.624 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.82 81.78 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.345 -0.388 . . . . 15.0 111.294 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.538 HD12 ' OD2' ' A' ' 419' ' ' ASP . 1.2 tt -57.82 -53.77 54.4 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.872 -0.604 . . . . 15.0 111.618 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.7 t -80.69 -23.98 11.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.636 -0.711 . . . . 15.0 112.02 -177.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 420' ' ' GLN . 7.3 t -62.74 -47.82 91.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 109.076 -0.713 . . . . 15.0 109.076 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -71.53 -34.53 70.12 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.468 -0.787 . . . . 15.0 110.539 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -70.4 -40.07 74.11 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.569 -0.287 . . . . 15.0 110.936 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . 0.513 ' O ' HG23 ' A' ' 431' ' ' VAL . 37.2 mt -66.58 -53.61 33.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.329 -0.396 . . . . 15.0 110.676 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -57.35 -41.97 81.09 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.105 0.479 . . . . 15.0 110.275 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.592 ' O ' ' HB2' ' A' ' 433' ' ' SER . 89.0 mttt -70.24 -24.98 63.17 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.516 -0.765 . . . . 15.0 110.592 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' MET . . . . . 0.606 ' O ' HG22 ' A' ' 434' ' ' VAL . 33.7 mmm -71.81 -46.09 59.34 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.469 -0.332 . . . . 15.0 110.898 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.604 HG21 ' CE2' ' A' ' 484' ' ' PHE . 1.0 OUTLIER -64.14 -41.19 91.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.979 0.419 . . . . 15.0 109.974 178.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -72.75 -29.75 63.58 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.708 -0.678 . . . . 15.0 110.992 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.773 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 13.3 t -69.64 -43.39 72.74 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.269 -0.423 . . . . 15.0 110.996 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 430' ' ' MET . 12.7 t -75.77 -41.86 40.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.201 -0.454 . . . . 15.0 110.811 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -57.89 -42.57 84.92 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.222 -0.444 . . . . 15.0 110.706 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -84.52 -25.19 28.97 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.506 -0.315 . . . . 15.0 111.033 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . 0.773 ' HB2' ' O ' ' A' ' 433' ' ' SER . 3.1 t30 -60.38 -38.96 85.55 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.851 0.358 . . . . 15.0 110.498 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -96.81 -10.47 26.56 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.911 -0.586 . . . . 15.0 111.734 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -108.83 53.6 0.68 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.896 0.379 . . . . 15.0 111.481 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.452 HG11 ' OE1' ' A' ' 450' ' ' GLU . 8.6 p -74.91 -0.13 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.132 -0.486 . . . . 15.0 110.866 178.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -86.39 -15.13 41.33 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.843 -0.617 . . . . 15.0 111.102 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 67.85 40.9 89.31 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 121.019 -0.61 . . . . 15.0 112.605 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -115.65 -15.56 11.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.651 0.262 . . . . 15.0 111.238 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 89.46 -4.93 84.18 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.876 -0.678 . . . . 15.0 112.487 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -142.64 156.72 45.1 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.793 0.33 . . . . 15.0 110.722 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' ILE . . . . . 0.651 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.7 mp -78.67 134.99 26.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 15.0 111.282 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' SER . . . . . 0.696 ' OG ' ' HG3' ' A' ' 450' ' ' GLU . 90.5 p -107.05 149.02 28.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.623 -0.717 . . . . 15.0 110.617 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -48.49 -43.54 35.01 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.182 -0.463 . . . . 15.0 111.852 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.89 -40.68 98.27 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.534 -0.303 . . . . 15.0 111.436 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . 0.696 ' HG3' ' OG ' ' A' ' 447' ' ' SER . 25.9 mt-10 -61.08 -57.72 11.38 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.399 -0.364 . . . . 15.0 110.558 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' PHE . . . . . 0.509 ' O ' ' HG2' ' A' ' 455' ' ' ARG . 3.9 t80 -61.5 -27.16 68.39 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.992 -0.549 . . . . 15.0 110.967 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -61.44 -56.65 17.8 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.029 -0.532 . . . . 15.0 111.197 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 2.1 mt -72.6 -30.14 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.908 -0.587 . . . . 15.0 111.828 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 45.9 mt -66.39 -56.32 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.752 -0.203 . . . . 15.0 111.462 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 451' ' ' PHE . 28.4 ptt180 -51.88 -33.04 34.92 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.931 0.345 . . . . 15.0 111.931 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -69.88 -34.81 71.84 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.901 -0.666 . . . . 15.0 112.83 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -92.93 -13.77 28.44 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.589 0.233 . . . . 15.0 111.39 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -116.69 85.59 17.26 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.484 -0.325 . . . . 15.0 111.036 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.37 -11.75 28.88 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.965 2.443 . . . . 15.0 112.507 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -99.51 26.24 6.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.249 -0.432 . . . . 15.0 110.926 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.7 tp -91.09 146.31 23.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.093 -0.503 . . . . 15.0 111.104 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 66.7 m -69.2 -172.55 0.44 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.08 -0.509 . . . . 15.0 111.245 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . 0.677 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -85.06 150.68 24.7 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.227 -0.442 . . . . 15.0 111.461 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . 0.53 ' HA ' HD12 ' A' ' 467' ' ' LEU . 66.0 m-85 -55.46 -51.6 66.39 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.76 -0.655 . . . . 15.0 111.226 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -68.78 -11.97 63.8 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.111 -0.566 . . . . 15.0 113.276 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -88.79 -36.17 16.23 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.078 0.439 . . . . 15.0 111.145 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' A' ' 463' ' ' ALA . 0.1 OUTLIER -85.14 -23.99 28.18 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.024 0.44 . . . . 15.0 110.055 178.351 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -135.23 111.06 9.35 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.77 -0.65 . . . . 15.0 110.008 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -61.48 -36.42 80.41 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.053 -0.521 . . . . 15.0 112.041 -178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -77.63 -9.08 58.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.532 -0.304 . . . . 15.0 111.681 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 55.45 34.1 22.3 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.442 -0.344 . . . . 15.0 111.438 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -82.09 1.99 33.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.163 -0.471 . . . . 15.0 111.511 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.22 15.28 63.0 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.457 -0.878 . . . . 15.0 110.981 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' CYS . . . . . . . . . . . . . 13.5 t -136.61 130.56 32.47 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.127 -0.536 . . . . 15.0 110.374 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.651 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 1.4 mp -103.4 127.53 57.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.964 0.411 . . . . 15.0 111.253 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 12.7 t -103.94 175.16 5.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.695 -0.684 . . . . 15.0 110.811 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -56.98 -45.3 83.03 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.324 -0.398 . . . . 15.0 111.108 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.6 mt-10 -61.15 -29.57 69.87 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.179 -0.464 . . . . 15.0 111.524 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 5.5 mm-40 -70.7 -49.03 51.42 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.401 0.143 . . . . 15.0 110.871 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 33.4 mtt -70.4 -46.22 64.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.72 -0.218 . . . . 15.0 111.02 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 88.8 t -60.24 -52.72 58.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.689 0.28 . . . . 15.0 110.607 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' SER . . . . . 0.89 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 40.3 m -57.73 -32.7 67.7 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 116.171 -0.468 . . . . 15.0 110.061 178.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' TYR . . . . . 0.531 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 8.8 t80 -69.04 -30.9 69.36 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.872 -0.604 . . . . 15.0 110.913 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' PHE . . . . . 0.604 ' CE2' HG21 ' A' ' 431' ' ' VAL . 0.1 OUTLIER -74.17 -40.54 62.47 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 110.243 -0.281 . . . . 15.0 110.243 179.279 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.2 tt -83.44 -18.9 37.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 15.0 110.531 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' ARG . . . . . 0.89 ' HB2' ' O ' ' A' ' 482' ' ' SER . 32.9 ttt180 -71.49 -52.22 19.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.345 . . . . 15.0 110.843 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 14.0 t -90.13 19.46 5.0 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.977 -0.556 . . . . 15.0 111.244 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' SER . . . . . 0.549 ' HB2' ' O ' ' A' ' 484' ' ' PHE . 22.8 t -89.75 138.66 31.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.31 -0.405 . . . . 15.0 111.004 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 52.4 m -125.45 78.18 1.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.105 -0.498 . . . . 15.0 110.939 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 4.0 t -75.98 -47.08 33.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.118 -0.492 . . . . 15.0 111.16 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 1.1 mp -122.1 -42.02 2.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.183 -0.462 . . . . 15.0 110.967 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . 142.13 -55.6 0.59 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.911 -0.662 . . . . 15.0 112.48 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 109.95 -138.83 15.09 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.864 -0.684 . . . . 15.0 112.533 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -102.33 -42.13 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.727 0.299 . . . . 15.0 110.951 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 22.3 mmt -104.98 -42.34 5.35 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.263 -0.426 . . . . 15.0 111.057 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 144.78 -83.84 0.19 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.789 -0.719 . . . . 15.0 112.435 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.191 -0.909 . . . . 15.0 110.913 179.988 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . 0.532 ' N ' HD23 ' A' ' 422' ' ' LEU . 97.1 mttt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.687 0.28 . . . . 15.0 111.006 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.5 -15.51 4.02 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.338 -0.392 . . . . 15.0 111.109 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.658 ' O ' HG22 ' A' ' 423' ' ' VAL . 0.5 OUTLIER -108.95 129.77 55.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.379 -0.373 . . . . 15.0 111.091 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.732 ' O ' HG22 ' A' ' 424' ' ' VAL . 4.3 tt0 -46.72 -56.52 6.04 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.781 -0.645 . . . . 15.0 111.961 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -63.51 -39.83 95.46 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.438 -0.347 . . . . 15.0 111.485 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.532 HD23 ' N ' ' A' ' 417' ' ' LYS . 5.2 tp -57.33 -51.75 68.13 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.902 -0.59 . . . . 15.0 111.603 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 419' ' ' ASP . 1.1 t -81.18 -21.68 10.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 115.67 -0.696 . . . . 15.0 111.929 -177.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 420' ' ' GLN . 12.0 t -64.05 -48.22 86.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.95 -0.759 . . . . 15.0 108.95 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -72.91 -33.04 65.73 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.37 -0.832 . . . . 15.0 110.629 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . 0.638 ' O ' ' HB2' ' A' ' 430' ' ' MET . 2.2 t60 -71.26 -39.32 71.67 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.579 -0.282 . . . . 15.0 110.984 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . 0.55 ' O ' HG22 ' A' ' 431' ' ' VAL . 41.4 mt -69.29 -50.68 49.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.407 -0.361 . . . . 15.0 110.809 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -58.95 -43.27 91.22 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.088 0.471 . . . . 15.0 110.141 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 433' ' ' SER . 92.0 mttt -72.49 -23.04 60.97 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.513 -0.767 . . . . 15.0 110.516 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' MET . . . . . 0.653 ' O ' HG23 ' A' ' 434' ' ' VAL . 4.0 ttt -70.69 -49.55 45.98 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.456 -0.338 . . . . 15.0 110.8 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 427' ' ' ILE . 2.7 t -65.02 -39.07 84.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.269 -0.423 . . . . 15.0 110.008 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -71.38 -31.26 67.1 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.879 -0.601 . . . . 15.0 110.564 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.945 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 12.7 t -70.67 -41.22 72.38 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 116.217 -0.447 . . . . 15.0 111.041 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 430' ' ' MET . 19.4 t -75.1 -42.68 45.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.26 -0.427 . . . . 15.0 110.969 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . 0.615 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 14.3 t80 -59.28 -42.08 90.39 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.12 -0.491 . . . . 15.0 111.02 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -84.95 -27.95 26.18 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.548 -0.296 . . . . 15.0 110.953 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . 0.945 ' HB2' ' O ' ' A' ' 433' ' ' SER . 2.2 t30 -60.12 -44.89 94.54 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.203 -0.453 . . . . 15.0 111.393 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . 0.446 ' CE2' HG23 ' A' ' 454' ' ' ILE . 45.3 m-85 -94.78 4.84 53.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.372 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . 0.615 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 0.3 OUTLIER -126.84 55.2 1.56 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.899 0.38 . . . . 15.0 111.352 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.5 t -68.64 -8.42 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.129 -0.487 . . . . 15.0 111.325 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -87.97 -6.47 57.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.233 -0.44 . . . . 15.0 111.16 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 62.04 30.19 74.83 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.843 -0.694 . . . . 15.0 111.979 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -90.51 -18.91 24.47 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 122.307 0.243 . . . . 15.0 111.291 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 83.21 -7.33 67.87 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.91 -0.662 . . . . 15.0 112.576 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . 0.61 ' HB3' ' SG ' ' A' ' 474' ' ' CYS . 73.3 m-70 -131.84 140.21 49.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.809 0.338 . . . . 15.0 110.602 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' ILE . . . . . 0.615 HD13 ' N ' ' A' ' 446' ' ' ILE . 1.5 mp -84.98 98.57 6.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.157 -0.474 . . . . 15.0 111.013 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 29.8 m -68.29 155.33 39.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.82 -0.627 . . . . 15.0 111.016 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -53.67 -40.62 66.09 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.153 -0.476 . . . . 15.0 111.825 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . 0.553 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -62.81 -39.42 94.21 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.496 -0.32 . . . . 15.0 111.424 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . 0.438 ' OE1' ' HA ' ' A' ' 446' ' ' ILE . 49.7 mt-10 -57.13 -58.83 6.47 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.048 0.451 . . . . 15.0 110.448 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -69.05 -20.43 64.11 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.771 -0.649 . . . . 15.0 110.609 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' GLN . . . . . 0.553 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 0.4 OUTLIER -59.31 -54.91 41.39 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.877 -0.601 . . . . 15.0 111.113 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -84.32 -32.5 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.733 -0.667 . . . . 15.0 111.843 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . 0.446 HG23 ' CE2' ' A' ' 438' ' ' PHE . 57.7 mt -64.57 -40.07 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 111.664 0.246 . . . . 15.0 111.664 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 452' ' ' GLN . 32.0 ptt180 -59.67 -19.09 47.2 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.631 0.253 . . . . 15.0 111.597 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -79.32 -23.55 62.86 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.899 -0.667 . . . . 15.0 112.506 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -88.09 -27.25 22.06 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.642 0.258 . . . . 15.0 111.196 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . 0.429 ' CD1' HD11 ' A' ' 461' ' ' LEU . 2.4 t80 -121.67 87.77 46.27 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.335 -0.393 . . . . 15.0 110.817 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.41 -3.89 13.36 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.963 2.442 . . . . 15.0 112.67 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -103.54 23.66 12.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.369 -0.378 . . . . 15.0 111.011 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.429 HD11 ' CD1' ' A' ' 458' ' ' PHE . 2.9 tp -102.29 155.29 18.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.088 -0.505 . . . . 15.0 111.08 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 55.2 m -71.98 172.84 9.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.072 -0.513 . . . . 15.0 111.333 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . 0.46 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -91.54 156.64 17.52 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.115 -0.493 . . . . 15.0 111.77 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -45.83 -48.74 15.73 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.695 -0.684 . . . . 15.0 111.568 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -62.37 -23.84 64.97 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.89 -0.596 . . . . 15.0 113.637 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -88.43 -28.95 20.56 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 117.063 0.431 . . . . 15.0 111.592 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 463' ' ' ALA . 0.0 OUTLIER -77.43 -34.91 54.51 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.849 0.356 . . . . 15.0 110.252 178.524 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . 0.442 ' OD1' ' HB2' ' A' ' 470' ' ' ASN . 9.1 t70 -130.39 119.77 23.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.893 -0.594 . . . . 15.0 110.496 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -68.19 -28.05 66.93 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.104 -0.498 . . . . 15.0 111.525 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.442 ' HB2' ' OD1' ' A' ' 468' ' ' ASP . 3.9 m-80 -76.88 -10.69 59.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.252 -0.431 . . . . 15.0 111.357 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 56.24 34.03 23.25 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.289 -0.414 . . . . 15.0 111.414 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -82.42 -1.89 51.48 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.199 -0.455 . . . . 15.0 111.514 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 65.59 14.95 61.09 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.585 -0.817 . . . . 15.0 111.436 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' CYS . . . . . 0.61 ' SG ' ' HB3' ' A' ' 445' ' ' HIS . 4.2 t -135.09 130.92 36.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.248 -0.476 . . . . 15.0 110.403 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . . . . . . . . . 9.5 mm -105.04 124.88 60.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.982 0.42 . . . . 15.0 111.212 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 50.5 m -103.28 174.79 5.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.707 -0.679 . . . . 15.0 110.615 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -56.02 -49.07 74.7 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.418 -0.356 . . . . 15.0 111.018 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' GLU . . . . . 0.684 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -61.76 -33.44 74.09 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.124 -0.489 . . . . 15.0 111.763 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . 0.548 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 5.4 mm-40 -69.5 -53.23 20.15 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 121.228 -0.189 . . . . 15.0 110.983 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 9.9 ttm -69.21 -48.56 61.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.754 -0.203 . . . . 15.0 111.313 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 79.4 t -60.92 -55.77 22.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.575 0.226 . . . . 15.0 111.217 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' SER . . . . . 0.95 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 44.5 m -54.89 -36.96 65.7 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.382 -0.372 . . . . 15.0 110.548 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' TYR . . . . . 0.548 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 1.9 m-85 -71.23 -26.04 62.75 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.236 -0.438 . . . . 15.0 111.321 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' PHE . . . . . 0.503 ' CD2' HG23 ' A' ' 431' ' ' VAL . 1.9 m-85 -73.37 -44.55 58.42 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 110.129 -0.323 . . . . 15.0 110.129 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.4 tt -84.24 -17.61 39.19 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.135 -0.484 . . . . 15.0 110.672 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' ARG . . . . . 0.95 ' HB2' ' O ' ' A' ' 482' ' ' SER . 30.8 ttt180 -70.97 -48.8 51.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.887 0.375 . . . . 15.0 110.758 177.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 52.2 m -82.7 19.26 1.35 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.89 -0.596 . . . . 15.0 111.469 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 66.9 m -88.44 145.14 25.94 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.358 -0.383 . . . . 15.0 111.0 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 13.1 t -98.52 -120.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 15.0 110.833 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 3.4 t -69.82 -49.13 59.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 120.722 0.296 . . . . 15.0 111.122 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 8.1 mt -128.33 -42.8 1.48 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.185 -0.462 . . . . 15.0 110.944 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -174.02 55.91 0.14 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.899 -0.667 . . . . 15.0 112.511 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . -136.34 -145.21 5.0 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.904 -0.665 . . . . 15.0 112.55 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -124.67 -44.59 1.96 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.677 0.275 . . . . 15.0 110.92 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 5.1 tpt -129.62 -42.15 1.31 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.255 -0.43 . . . . 15.0 110.921 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 160.41 -78.77 0.17 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.893 -0.67 . . . . 15.0 112.564 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.232 -0.889 . . . . 15.0 110.834 179.995 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 97.5 mttt . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.7 0.286 . . . . 15.0 110.881 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 11.2 mt -142.91 110.88 5.96 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.206 -0.452 . . . . 15.0 110.789 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.628 ' O ' HG22 ' A' ' 423' ' ' VAL . 1.1 m-20 -148.41 124.27 10.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 15.0 111.107 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.705 ' O ' HG22 ' A' ' 424' ' ' VAL . 45.4 mt-30 -47.62 -56.15 7.81 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.77 -0.65 . . . . 15.0 111.994 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -64.13 -40.94 97.25 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.384 -0.371 . . . . 15.0 111.67 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 5.0 tp -57.4 -53.3 59.65 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.041 -0.527 . . . . 15.0 111.726 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 419' ' ' ASP . 1.7 t -80.13 -23.36 11.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.674 -0.694 . . . . 15.0 112.004 -177.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . 0.705 HG22 ' O ' ' A' ' 420' ' ' GLN . 8.4 t -63.22 -47.66 91.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.02 -0.733 . . . . 15.0 109.02 177.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -71.77 -34.38 69.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.422 -0.808 . . . . 15.0 110.504 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -70.53 -40.39 73.46 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.534 -0.303 . . . . 15.0 110.946 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . 0.514 ' O ' HG23 ' A' ' 431' ' ' VAL . 35.9 mt -66.36 -53.68 33.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.355 -0.384 . . . . 15.0 110.771 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -57.15 -41.83 79.89 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.105 0.479 . . . . 15.0 110.326 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.611 ' O ' ' HB2' ' A' ' 433' ' ' SER . 89.2 mttt -70.86 -24.7 62.56 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.538 -0.756 . . . . 15.0 110.749 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' MET . . . . . 0.639 ' O ' HG23 ' A' ' 434' ' ' VAL . 33.9 mtp -71.99 -47.49 51.69 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.405 -0.362 . . . . 15.0 110.891 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.59 HG21 ' CE2' ' A' ' 484' ' ' PHE . 0.8 OUTLIER -63.62 -40.98 91.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.065 0.459 . . . . 15.0 109.939 178.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -72.24 -30.35 64.8 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.666 -0.697 . . . . 15.0 110.826 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.827 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 12.2 t -68.75 -43.48 75.76 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.307 -0.406 . . . . 15.0 111.085 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 430' ' ' MET . 7.7 t -75.27 -41.97 43.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.32 -0.4 . . . . 15.0 110.848 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . 0.628 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 3.8 t80 -58.39 -41.57 85.16 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.09 -0.504 . . . . 15.0 110.967 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -85.11 -27.17 26.43 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.371 -0.377 . . . . 15.0 110.889 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . 0.827 ' HB2' ' O ' ' A' ' 433' ' ' SER . 2.7 t30 -59.36 -44.54 92.68 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.272 -0.422 . . . . 15.0 111.194 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . 0.425 ' CE2' HG23 ' A' ' 454' ' ' ILE . 33.1 m-85 -90.2 -5.91 55.87 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.019 -0.537 . . . . 15.0 111.212 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . 0.628 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 0.2 OUTLIER -109.82 53.94 0.68 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.838 0.351 . . . . 15.0 111.405 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 3.3 m -70.6 -9.22 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.21 -0.45 . . . . 15.0 111.617 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -88.92 -15.14 35.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.235 -0.439 . . . . 15.0 111.144 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 73.12 37.77 55.36 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.922 -0.656 . . . . 15.0 112.538 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -97.31 -16.39 20.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.653 0.264 . . . . 15.0 111.195 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 86.8 -7.69 78.88 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.825 -0.702 . . . . 15.0 112.374 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . 0.484 ' HB2' ' SG ' ' A' ' 474' ' ' CYS . 15.0 p80 -142.39 158.36 43.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.759 0.314 . . . . 15.0 110.712 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' ILE . . . . . 0.695 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.6 mp -77.71 135.99 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 15.0 111.165 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 14.4 t -106.19 148.11 28.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.585 -0.734 . . . . 15.0 110.767 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -50.18 -46.39 54.22 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.214 -0.448 . . . . 15.0 111.507 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . 0.461 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -65.42 -35.24 80.33 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.426 -0.352 . . . . 15.0 110.89 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -60.06 -59.56 5.23 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.241 -0.436 . . . . 15.0 110.483 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.36 -23.56 67.01 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.984 -0.553 . . . . 15.0 110.629 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' GLN . . . . . 0.461 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 5.6 mt-30 -60.14 -57.57 12.27 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.802 -0.635 . . . . 15.0 111.234 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 8.7 mm -76.6 -33.05 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.782 -0.645 . . . . 15.0 111.831 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . 0.425 HG23 ' CE2' ' A' ' 438' ' ' PHE . 48.5 mt -62.71 -46.98 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.803 -0.18 . . . . 15.0 111.133 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' ARG . . . . . 0.613 ' NH2' ' HA ' ' A' ' 463' ' ' ALA . 10.5 mtt180 -54.79 -34.33 62.56 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.718 0.294 . . . . 15.0 111.551 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -66.05 -30.84 77.74 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.994 -0.622 . . . . 15.0 112.896 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -96.95 -16.32 20.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.667 0.27 . . . . 15.0 111.293 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -132.97 85.79 44.99 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.308 -0.406 . . . . 15.0 110.983 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -72.84 1.74 6.11 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.062 2.508 . . . . 15.0 112.452 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -87.61 6.77 32.89 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.313 -0.403 . . . . 15.0 111.223 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -83.76 142.41 30.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.239 -0.437 . . . . 15.0 111.088 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 43.4 p -70.62 -172.56 0.64 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.161 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . 0.723 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -86.93 150.22 24.24 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.365 -0.38 . . . . 15.0 111.264 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . 0.903 ' O ' HD13 ' A' ' 467' ' ' LEU . 80.0 m-85 -59.14 -46.71 87.64 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.023 -0.535 . . . . 15.0 111.371 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -67.68 -16.44 67.84 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.921 -0.656 . . . . 15.0 113.225 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -90.23 -41.35 11.64 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.913 0.356 . . . . 15.0 111.705 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.903 HD13 ' O ' ' A' ' 464' ' ' PHE . 0.7 OUTLIER -76.53 -27.47 55.98 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.703 0.287 . . . . 15.0 110.842 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -128.16 112.2 14.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.203 -0.453 . . . . 15.0 110.362 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -67.02 -29.53 69.37 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.011 -0.54 . . . . 15.0 111.312 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.559 ' N ' HD21 ' A' ' 470' ' ' ASN . 0.9 OUTLIER -76.52 -13.66 60.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 15.0 111.144 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 60.65 28.05 17.76 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.199 -0.455 . . . . 15.0 111.285 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -71.42 -7.86 50.06 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.137 -0.483 . . . . 15.0 111.838 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.86 18.41 68.51 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.405 -0.902 . . . . 15.0 111.299 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' A' ' 445' ' ' HIS . 19.0 t -137.16 130.88 31.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.256 -0.472 . . . . 15.0 110.464 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.695 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 9.0 mm -93.92 120.19 42.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.959 0.409 . . . . 15.0 111.01 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' SER . . . . . 0.435 ' H ' ' HG3' ' A' ' 479' ' ' GLU . 52.9 m -103.38 173.4 6.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.819 -0.628 . . . . 15.0 110.686 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -53.74 -45.38 70.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.427 -0.351 . . . . 15.0 110.959 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' GLU . . . . . 0.552 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -62.38 -28.36 69.72 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.046 -0.524 . . . . 15.0 111.361 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 43.6 mm-40 -71.15 -50.05 37.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.41 0.147 . . . . 15.0 110.777 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 40.3 mtt -70.58 -46.66 63.03 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.797 -0.183 . . . . 15.0 110.958 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' VAL . . . . . 0.498 ' O ' HD12 ' A' ' 485' ' ' LEU . 84.1 t -59.84 -54.12 38.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.758 0.313 . . . . 15.0 110.693 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' SER . . . . . 0.933 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 38.6 m -56.63 -33.11 65.99 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 116.215 -0.448 . . . . 15.0 110.117 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' TYR . . . . . 0.555 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 8.5 t80 -69.27 -29.74 67.7 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.921 -0.581 . . . . 15.0 110.966 177.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' PHE . . . . . 0.59 ' CE2' HG21 ' A' ' 431' ' ' VAL . 0.1 OUTLIER -73.9 -41.93 61.42 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 110.215 -0.291 . . . . 15.0 110.215 179.259 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . 0.498 HD12 ' O ' ' A' ' 481' ' ' VAL . 5.5 mp -83.83 -17.78 39.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.308 -0.405 . . . . 15.0 110.556 177.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' ARG . . . . . 0.933 ' HB2' ' O ' ' A' ' 482' ' ' SER . 34.4 ttt180 -71.99 -48.26 46.1 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.323 -0.399 . . . . 15.0 110.812 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 53.3 m -80.58 19.65 0.79 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.872 -0.604 . . . . 15.0 111.502 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 54.6 m -80.7 124.68 29.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.374 -0.376 . . . . 15.0 110.926 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 52.9 m -104.53 -38.5 6.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.084 -0.507 . . . . 15.0 111.145 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 1.8 t -147.91 13.65 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.376 -0.375 . . . . 15.0 110.79 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.51 -40.15 15.55 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.242 -0.435 . . . . 15.0 111.068 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . 144.23 -158.77 27.57 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.879 -0.677 . . . . 15.0 112.546 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . -168.28 -123.73 0.68 Allowed Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.853 -0.689 . . . . 15.0 112.476 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -102.32 -41.54 6.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.628 0.251 . . . . 15.0 110.94 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 64.7 mtt -104.34 145.35 30.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.194 -0.457 . . . . 15.0 110.871 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . -146.58 -64.19 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.905 -0.664 . . . . 15.0 112.522 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.277 -0.868 . . . . 15.0 110.876 -179.994 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 93.3 mttt . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.788 0.327 . . . . 15.0 110.913 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 2.5 pp -153.26 132.92 13.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.108 -0.496 . . . . 15.0 110.681 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.605 ' O ' HG21 ' A' ' 423' ' ' VAL . 0.7 OUTLIER -149.48 124.55 10.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 15.0 111.238 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.713 ' O ' HG21 ' A' ' 424' ' ' VAL . 53.3 mt-30 -47.25 -55.68 8.18 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.819 -0.628 . . . . 15.0 111.879 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -63.14 -40.37 97.39 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.308 -0.405 . . . . 15.0 111.51 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 4.9 tp -57.46 -53.01 62.95 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.009 -0.541 . . . . 15.0 111.673 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.605 HG21 ' O ' ' A' ' 419' ' ' ASP . 1.5 t -79.95 -22.65 11.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.658 -0.701 . . . . 15.0 111.973 -177.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . 0.713 HG21 ' O ' ' A' ' 420' ' ' GLN . 9.9 t -63.43 -47.75 90.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 109.047 -0.723 . . . . 15.0 109.047 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -71.96 -34.17 68.76 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.33 -0.85 . . . . 15.0 110.577 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -70.78 -40.42 72.61 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.612 -0.267 . . . . 15.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . 0.496 ' O ' HG22 ' A' ' 431' ' ' VAL . 36.9 mt -66.48 -53.34 36.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.362 -0.381 . . . . 15.0 110.667 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -57.24 -42.27 81.12 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.151 0.5 . . . . 15.0 110.143 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -69.87 -25.34 63.67 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.528 -0.76 . . . . 15.0 110.549 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' MET . . . . . 0.632 ' O ' HG21 ' A' ' 434' ' ' VAL . 31.7 mmm -70.67 -47.73 58.44 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.425 -0.352 . . . . 15.0 110.935 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.588 HG23 ' CE2' ' A' ' 484' ' ' PHE . 0.8 OUTLIER -62.93 -40.3 88.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.014 0.435 . . . . 15.0 110.025 179.073 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -72.53 -33.31 66.79 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.733 -0.667 . . . . 15.0 110.978 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.784 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 3.6 m -66.33 -43.47 86.05 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.344 -0.389 . . . . 15.0 111.093 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.632 HG21 ' O ' ' A' ' 430' ' ' MET . 4.9 t -75.94 -38.84 36.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.212 -0.449 . . . . 15.0 110.779 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 431' ' ' VAL . 4.4 t80 -55.92 -42.87 76.73 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.068 -0.515 . . . . 15.0 110.821 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -89.16 -24.03 22.29 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.401 -0.363 . . . . 15.0 111.284 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . 0.784 ' HB2' ' O ' ' A' ' 433' ' ' SER . 4.2 t-20 -59.95 -34.7 73.6 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.987 0.422 . . . . 15.0 110.402 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . 0.436 ' O ' ' HB3' ' A' ' 450' ' ' GLU . 7.2 m-85 -71.79 -41.63 68.07 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.622 -0.717 . . . . 15.0 111.888 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . 0.707 ' HA ' ' OE2' ' A' ' 450' ' ' GLU . 5.1 p-10 -139.53 82.29 1.87 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.144 0.497 . . . . 15.0 111.91 -178.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.9 m -72.42 -8.57 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.925 -0.579 . . . . 15.0 111.248 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -66.84 -15.39 63.58 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.049 -0.523 . . . . 15.0 111.408 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 91.04 47.3 3.64 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.931 -0.652 . . . . 15.0 112.423 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -101.3 -19.53 15.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.674 0.273 . . . . 15.0 111.207 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 78.94 -13.69 17.7 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.039 -0.6 . . . . 15.0 113.0 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -144.48 168.37 20.29 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.889 0.376 . . . . 15.0 110.806 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' ILE . . . . . 0.562 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.2 mp -74.56 126.56 35.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.021 -0.536 . . . . 15.0 111.24 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 52.9 m -106.36 147.37 29.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.743 -0.662 . . . . 15.0 110.83 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -50.03 -45.59 52.18 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.193 -0.458 . . . . 15.0 111.677 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.72 -40.19 96.14 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.48 -0.327 . . . . 15.0 111.234 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . 0.707 ' OE2' ' HA ' ' A' ' 439' ' ' ASP . 5.5 mm-40 -63.33 -56.13 18.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.433 -0.349 . . . . 15.0 110.385 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.83 -28.99 67.96 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.165 -0.471 . . . . 15.0 110.93 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -61.82 -55.87 25.41 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 115.928 -0.578 . . . . 15.0 111.081 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 2.8 mt -70.86 -28.38 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.914 -0.585 . . . . 15.0 111.624 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 30.3 mt -67.24 -56.98 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.67 -0.241 . . . . 15.0 111.183 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -47.93 -36.17 11.93 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.478 -0.328 . . . . 15.0 111.877 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -63.79 -34.05 88.89 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.986 -0.626 . . . . 15.0 112.947 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -104.24 -2.43 25.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.537 0.208 . . . . 15.0 111.345 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -128.75 79.96 73.49 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.523 -0.308 . . . . 15.0 111.155 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -75.09 -3.66 14.25 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.075 2.517 . . . . 15.0 112.543 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -107.71 26.41 10.34 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.207 -0.451 . . . . 15.0 111.013 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 2.4 tp -91.62 151.36 20.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.176 -0.466 . . . . 15.0 111.118 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 49.2 m -67.73 176.7 2.36 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.104 -0.498 . . . . 15.0 111.362 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . 0.781 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -89.05 153.11 21.26 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.128 -0.487 . . . . 15.0 111.288 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . 0.872 ' O ' HD12 ' A' ' 467' ' ' LEU . 78.1 m-85 -57.41 -49.14 77.17 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.069 -0.514 . . . . 15.0 111.437 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -68.95 -15.48 69.37 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.992 -0.623 . . . . 15.0 113.57 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . 0.499 ' OD1' ' HB3' ' A' ' 463' ' ' ALA . 5.1 m-20 -89.83 -41.6 11.74 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.1 0.45 . . . . 15.0 111.712 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.872 HD12 ' O ' ' A' ' 464' ' ' PHE . 0.6 OUTLIER -78.0 -27.74 49.05 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.747 0.308 . . . . 15.0 110.714 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -129.83 111.38 12.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.073 -0.512 . . . . 15.0 110.336 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -66.0 -30.25 70.77 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.369 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.532 ' N ' HD21 ' A' ' 470' ' ' ASN . 1.0 OUTLIER -76.38 -13.52 60.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.343 -0.389 . . . . 15.0 111.262 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 59.9 28.09 17.55 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.25 -0.432 . . . . 15.0 111.287 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -74.37 -5.26 41.3 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.201 -0.454 . . . . 15.0 111.723 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.72 17.95 67.67 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.403 -0.904 . . . . 15.0 111.265 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' CYS . . . . . . . . . . . . . 15.8 t -136.31 130.96 33.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.226 -0.487 . . . . 15.0 110.496 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.562 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 14.1 mm -95.25 120.81 45.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.899 0.381 . . . . 15.0 110.977 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' SER . . . . . 0.444 ' H ' ' HG3' ' A' ' 479' ' ' GLU . 54.3 m -103.08 171.79 7.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 15.0 110.667 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -53.47 -44.59 69.09 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.417 -0.356 . . . . 15.0 110.931 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.8 mt-10 -62.91 -28.81 70.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.075 -0.511 . . . . 15.0 111.358 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . 0.587 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 63.5 mm-40 -70.5 -50.26 39.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.499 0.19 . . . . 15.0 110.875 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 33.7 mtt -70.85 -46.89 61.87 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.709 -0.223 . . . . 15.0 111.168 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 82.1 t -59.81 -53.13 52.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.626 0.251 . . . . 15.0 110.71 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' SER . . . . . 0.947 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 47.0 m -58.25 -32.66 68.57 Favored 'General case' 0 C--O 1.227 -0.104 0 CA-C-N 116.301 -0.408 . . . . 15.0 110.15 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' TYR . . . . . 0.587 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 7.4 t80 -69.62 -30.16 67.83 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.93 -0.577 . . . . 15.0 111.104 177.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' PHE . . . . . 0.588 ' CE2' HG23 ' A' ' 431' ' ' VAL . 0.1 OUTLIER -75.18 -40.51 59.36 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.762 0.315 . . . . 15.0 110.252 179.29 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.3 tt -83.98 -17.3 40.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 15.0 110.585 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' ARG . . . . . 0.947 ' HB2' ' O ' ' A' ' 482' ' ' SER . 25.1 ttt180 -74.14 -47.81 33.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.859 0.362 . . . . 15.0 110.918 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 13.9 t -82.89 19.92 1.28 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.901 -0.59 . . . . 15.0 111.554 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 88.1 p -82.97 121.86 27.54 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.792 0.329 . . . . 15.0 110.919 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 53.1 m -126.55 79.58 1.87 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.129 -0.487 . . . . 15.0 111.001 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . 0.496 ' O ' HD11 ' A' ' 491' ' ' LEU . 2.9 t -77.46 -60.64 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.091 -0.504 . . . . 15.0 110.906 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . 0.496 HD11 ' O ' ' A' ' 490' ' ' VAL . 1.9 mp -142.85 -43.82 0.31 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.22 -0.445 . . . . 15.0 110.918 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . 128.33 53.09 0.12 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.927 -0.654 . . . . 15.0 112.575 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . -158.2 -150.13 5.67 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.875 -0.679 . . . . 15.0 112.507 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -127.66 149.76 50.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.755 0.312 . . . . 15.0 110.944 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -102.35 145.92 28.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.119 -0.491 . . . . 15.0 110.874 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 122.19 78.98 0.48 Allowed Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.824 -0.703 . . . . 15.0 112.533 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 26.2 p90 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.199 -0.905 . . . . 15.0 110.942 -179.975 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 97.2 mttt . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.765 0.317 . . . . 15.0 110.899 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.7 mp -142.24 -44.22 0.33 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.125 -0.489 . . . . 15.0 110.843 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.616 ' O ' HG22 ' A' ' 423' ' ' VAL . 7.6 m-20 -94.21 18.91 10.06 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.238 -0.437 . . . . 15.0 111.098 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.693 ' O ' HG22 ' A' ' 424' ' ' VAL . 6.5 pt20 -46.42 -56.92 5.19 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.087 -0.506 . . . . 15.0 111.784 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -68.39 -37.64 80.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.404 -0.362 . . . . 15.0 111.279 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.522 HD12 ' OD2' ' A' ' 419' ' ' ASP . 1.2 tt -57.75 -53.72 55.06 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.882 -0.599 . . . . 15.0 111.701 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 419' ' ' ASP . 1.6 t -80.78 -23.8 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 CA-C-N 115.657 -0.701 . . . . 15.0 112.05 -177.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . 0.693 HG22 ' O ' ' A' ' 420' ' ' GLN . 7.2 t -62.9 -47.87 90.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.093 -0.706 . . . . 15.0 109.093 177.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -71.92 -34.16 68.86 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.486 -0.779 . . . . 15.0 110.561 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -70.72 -39.37 73.43 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.558 -0.292 . . . . 15.0 111.04 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . 0.54 ' O ' HG22 ' A' ' 431' ' ' VAL . 37.6 mt -67.84 -51.91 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.37 -0.377 . . . . 15.0 110.732 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -58.4 -42.19 86.61 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.192 0.52 . . . . 15.0 110.303 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 433' ' ' SER . 90.2 mttt -71.15 -25.14 62.43 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.521 -0.763 . . . . 15.0 110.707 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' MET . . . . . 0.656 ' O ' HG21 ' A' ' 434' ' ' VAL . 23.3 mmm -71.45 -46.97 58.6 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.448 -0.342 . . . . 15.0 110.908 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 427' ' ' ILE . 2.6 t -65.33 -39.15 84.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.879 0.371 . . . . 15.0 110.061 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -72.16 -31.14 65.68 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.859 -0.61 . . . . 15.0 110.73 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.853 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 14.2 t -70.86 -41.88 70.82 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.196 -0.456 . . . . 15.0 111.06 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.656 HG21 ' O ' ' A' ' 430' ' ' MET . 17.8 t -75.87 -41.29 39.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.249 -0.432 . . . . 15.0 110.956 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -60.58 -41.32 94.4 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.297 -0.41 . . . . 15.0 110.815 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -83.21 -28.62 29.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.504 -0.316 . . . . 15.0 110.681 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . 0.853 ' HB2' ' O ' ' A' ' 433' ' ' SER . 2.5 t30 -60.11 -44.54 94.77 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.085 -0.507 . . . . 15.0 111.247 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . 0.484 ' CE2' HG22 ' A' ' 454' ' ' ILE . 66.6 m-85 -93.94 0.53 56.14 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.841 -0.618 . . . . 15.0 111.448 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -127.48 53.1 1.77 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.979 0.418 . . . . 15.0 111.179 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.9 t -74.39 -14.24 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.078 -0.51 . . . . 15.0 111.065 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -90.2 -14.74 32.83 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.074 -0.512 . . . . 15.0 111.032 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 64.55 60.06 7.48 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.051 -0.595 . . . . 15.0 112.796 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.44 -10.81 11.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.705 0.288 . . . . 15.0 111.223 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 88.93 -13.55 62.75 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.811 -0.709 . . . . 15.0 112.227 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . 0.625 ' HB2' ' SG ' ' A' ' 474' ' ' CYS . 9.5 p80 -141.58 156.81 45.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.602 0.239 . . . . 15.0 110.415 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' ILE . . . . . 0.776 HG12 ' H ' ' A' ' 475' ' ' ILE . 0.9 OUTLIER -82.99 100.85 6.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.366 -0.379 . . . . 15.0 111.143 -179.166 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 7.6 t -67.71 152.12 46.13 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.282 -0.417 . . . . 15.0 110.918 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -51.59 -43.11 62.38 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.07 -0.514 . . . . 15.0 111.951 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . 0.524 ' O ' ' HB2' ' A' ' 452' ' ' GLN . 42.7 mt-10 -63.03 -40.09 96.7 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.552 -0.294 . . . . 15.0 111.322 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -58.24 -56.38 22.88 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.935 0.398 . . . . 15.0 110.412 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -66.85 -23.29 66.01 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.935 -0.575 . . . . 15.0 110.608 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' A' ' 449' ' ' GLU . 2.6 mm-40 -59.1 -54.84 42.48 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.838 -0.619 . . . . 15.0 111.008 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 8.7 mm -78.98 -31.82 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 115.649 -0.705 . . . . 15.0 111.694 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . 0.484 HG22 ' CE2' ' A' ' 438' ' ' PHE . 50.2 mt -61.22 -46.86 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.494 0.188 . . . . 15.0 111.273 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -55.74 -29.97 60.42 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.552 -0.295 . . . . 15.0 111.561 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -66.0 -31.8 80.58 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.963 -0.637 . . . . 15.0 112.759 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -103.64 -11.7 17.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.607 0.242 . . . . 15.0 111.365 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -136.23 78.98 44.52 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 116.465 -0.334 . . . . 15.0 110.985 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.08 2.4 6.71 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.166 2.577 . . . . 15.0 112.624 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -85.2 5.19 31.16 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.325 -0.398 . . . . 15.0 111.285 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -87.76 142.39 27.86 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.263 -0.426 . . . . 15.0 111.063 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' SER . . . . . 0.435 ' H ' ' HG ' ' A' ' 462' ' ' SER . 5.8 p -81.39 -157.35 0.17 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.066 -0.515 . . . . 15.0 110.975 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . 0.538 ' HB2' ' OD2' ' A' ' 466' ' ' ASP . . . -85.4 148.47 25.99 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.926 0.393 . . . . 15.0 111.655 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -51.24 -46.36 62.31 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.771 -0.649 . . . . 15.0 111.121 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -63.57 -19.38 62.5 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.907 -0.588 . . . . 15.0 113.005 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . 0.538 ' OD2' ' HB2' ' A' ' 463' ' ' ALA . 7.6 m-20 -87.87 -37.11 16.78 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.765 0.282 . . . . 15.0 110.977 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 463' ' ' ALA . 0.1 OUTLIER -68.99 -34.11 74.77 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.96 0.41 . . . . 15.0 110.154 178.34 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . 0.464 ' OD2' ' HB2' ' A' ' 470' ' ' ASN . 8.5 t70 -120.34 117.17 27.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.698 -0.683 . . . . 15.0 110.413 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -64.26 -27.68 69.21 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.083 -0.508 . . . . 15.0 111.577 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.464 ' HB2' ' OD2' ' A' ' 468' ' ' ASP . 5.0 m-80 -76.94 -9.01 58.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.371 -0.377 . . . . 15.0 111.442 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 54.4 36.01 24.46 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.365 -0.38 . . . . 15.0 111.4 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -88.43 0.78 55.87 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.194 -0.457 . . . . 15.0 111.47 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 65.67 14.08 59.88 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.427 -0.892 . . . . 15.0 111.314 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' CYS . . . . . 0.625 ' SG ' ' HB2' ' A' ' 445' ' ' HIS . 1.2 m -137.69 130.7 30.32 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.202 -0.499 . . . . 15.0 110.508 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.776 ' H ' HG12 ' A' ' 446' ' ' ILE . 2.7 mp -107.89 128.92 62.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.992 0.425 . . . . 15.0 111.246 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 48.8 m -104.33 -179.58 3.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.597 -0.728 . . . . 15.0 110.784 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -62.58 -47.51 83.5 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.364 -0.38 . . . . 15.0 111.214 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -60.45 -33.95 73.29 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.252 -0.431 . . . . 15.0 111.48 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 6.8 mm-40 -66.79 -45.21 79.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.562 0.22 . . . . 15.0 110.626 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 40.3 mtt -69.76 -47.58 62.47 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.608 -0.269 . . . . 15.0 110.893 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.14 -55.61 23.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.737 0.303 . . . . 15.0 110.937 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' SER . . . . . 0.941 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 75.0 m -54.51 -38.79 66.92 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 116.128 -0.487 . . . . 15.0 110.605 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' TYR . . . . . 0.496 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 2.6 m-85 -71.58 -24.43 61.91 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.036 -0.529 . . . . 15.0 111.555 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' PHE . . . . . 0.485 ' CD2' HG23 ' A' ' 431' ' ' VAL . 3.7 m-85 -75.28 -43.55 50.64 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 120.843 -0.343 . . . . 15.0 110.163 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . 0.438 ' HA ' ' OG ' ' A' ' 488' ' ' SER . 5.3 tt -84.16 -18.69 35.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 15.0 110.642 176.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' ARG . . . . . 0.941 ' HB2' ' O ' ' A' ' 482' ' ' SER . 24.2 ttt180 -70.97 -49.57 43.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.899 0.38 . . . . 15.0 110.791 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 14.5 t -83.43 19.68 1.5 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.831 -0.622 . . . . 15.0 111.339 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' SER . . . . . 0.438 ' OG ' ' HA ' ' A' ' 485' ' ' LEU . 74.0 m -80.71 133.72 35.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.335 -0.393 . . . . 15.0 111.001 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 54.0 m -97.69 -36.39 10.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 15.0 111.131 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 50.6 t -148.71 84.93 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.258 -0.428 . . . . 15.0 110.437 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 6.5 tt -124.79 -44.31 1.95 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.086 -0.507 . . . . 15.0 110.803 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . 125.21 161.07 10.92 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.847 -0.692 . . . . 15.0 112.466 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . -100.51 179.91 29.44 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.879 -0.677 . . . . 15.0 112.575 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -100.23 -41.69 6.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.72 0.295 . . . . 15.0 110.861 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 64.5 mtt -114.21 130.25 56.62 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.226 -0.443 . . . . 15.0 110.921 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 128.63 104.72 1.19 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.861 -0.685 . . . . 15.0 112.473 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.219 -0.896 . . . . 15.0 110.927 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 96.8 mttt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.749 0.309 . . . . 15.0 110.922 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 5.3 mp -109.65 -22.82 11.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.148 -0.478 . . . . 15.0 110.981 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.64 ' O ' HG23 ' A' ' 423' ' ' VAL . 8.4 m-20 58.92 28.58 17.76 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.143 -0.48 . . . . 15.0 111.335 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.689 ' O ' HG22 ' A' ' 424' ' ' VAL . 44.4 mt-30 -48.8 -58.05 5.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.089 -0.505 . . . . 15.0 111.864 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -68.09 -38.6 82.52 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.444 -0.344 . . . . 15.0 111.489 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.512 HD13 ' OD2' ' A' ' 419' ' ' ASP . 0.9 OUTLIER -57.36 -54.43 46.95 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.955 -0.566 . . . . 15.0 111.852 -179.241 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.7 t -81.1 -23.47 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-N 115.709 -0.678 . . . . 15.0 112.148 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 420' ' ' GLN . 7.2 t -63.28 -48.06 89.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.11 -0.7 . . . . 15.0 109.11 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -71.84 -34.0 68.92 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.488 -0.778 . . . . 15.0 110.607 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -70.57 -39.8 73.68 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.621 -0.263 . . . . 15.0 110.99 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . 0.55 ' O ' HG23 ' A' ' 431' ' ' VAL . 40.5 mt -67.61 -52.38 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 116.442 -0.345 . . . . 15.0 110.772 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -57.97 -42.04 84.21 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.096 0.474 . . . . 15.0 110.222 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.579 ' O ' ' HB2' ' A' ' 433' ' ' SER . 89.7 mttt -71.47 -24.86 62.08 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.521 -0.763 . . . . 15.0 110.737 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' MET . . . . . 0.61 ' O ' HG21 ' A' ' 434' ' ' VAL . 26.2 mtp -71.17 -47.68 56.23 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.467 -0.333 . . . . 15.0 110.937 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 427' ' ' ILE . 1.8 t -65.77 -39.03 83.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.913 0.387 . . . . 15.0 110.079 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -72.19 -30.01 64.54 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.842 -0.617 . . . . 15.0 110.681 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.767 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 13.4 t -70.25 -42.66 71.89 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.261 -0.427 . . . . 15.0 110.936 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.61 HG21 ' O ' ' A' ' 430' ' ' MET . 14.4 t -76.09 -40.37 37.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.207 -0.452 . . . . 15.0 110.77 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -58.7 -43.39 90.01 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.191 -0.458 . . . . 15.0 110.579 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -83.52 -25.3 31.15 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.451 -0.34 . . . . 15.0 110.961 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . 0.767 ' HB2' ' O ' ' A' ' 433' ' ' SER . 4.9 t-20 -60.11 -38.75 83.95 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.383 -0.372 . . . . 15.0 110.477 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . 0.488 ' CE2' HG22 ' A' ' 454' ' ' ILE . 32.6 m-85 -95.36 -12.15 26.53 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.763 -0.653 . . . . 15.0 111.581 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -106.33 54.09 0.69 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.88 0.371 . . . . 15.0 111.375 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.18 -6.46 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.194 -0.457 . . . . 15.0 111.403 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -94.0 -15.04 25.23 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.3 -0.409 . . . . 15.0 111.214 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 68.3 48.07 54.36 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.018 -0.611 . . . . 15.0 112.681 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -110.85 -18.05 13.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.649 0.261 . . . . 15.0 111.168 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 91.27 -5.2 81.06 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.921 -0.657 . . . . 15.0 112.378 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -143.29 156.92 44.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.816 0.341 . . . . 15.0 110.742 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' ILE . . . . . 0.645 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.7 mp -81.77 136.47 22.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.285 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 5.4 m -105.17 149.15 26.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.663 -0.699 . . . . 15.0 110.72 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -47.73 -46.93 30.35 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.176 -0.465 . . . . 15.0 111.776 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -64.69 -38.7 91.88 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.512 -0.313 . . . . 15.0 111.208 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -59.49 -59.07 6.04 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.275 -0.42 . . . . 15.0 110.427 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -63.18 -26.52 68.84 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.797 -0.638 . . . . 15.0 110.83 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -59.25 -56.94 15.75 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.902 -0.59 . . . . 15.0 111.288 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -78.29 -29.96 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.879 -0.601 . . . . 15.0 111.795 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . 0.488 HG22 ' CE2' ' A' ' 438' ' ' PHE . 46.6 mt -63.37 -46.14 96.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 120.397 0.141 . . . . 15.0 111.319 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -52.5 -29.22 23.96 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.802 0.297 . . . . 15.0 111.802 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -74.78 -24.65 71.69 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.833 -0.698 . . . . 15.0 112.676 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -71.6 -56.91 4.95 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.478 0.18 . . . . 15.0 111.402 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -144.59 98.71 4.9 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-O 120.628 0.251 . . . . 15.0 111.117 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.43 4.16 4.68 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.118 2.545 . . . . 15.0 112.594 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -112.29 -24.82 9.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.384 -0.371 . . . . 15.0 111.374 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.4 tp -56.77 -56.24 24.07 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.283 -0.417 . . . . 15.0 111.652 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' SER . . . . . 0.413 ' C ' HD23 ' A' ' 467' ' ' LEU . 5.7 m -135.44 109.01 7.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.766 0.317 . . . . 15.0 111.019 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . 0.657 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -77.89 106.4 9.71 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.238 -0.437 . . . . 15.0 110.944 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . 0.433 ' CE1' ' HA2' ' A' ' 473' ' ' GLY . 29.3 t80 -40.37 -42.28 1.54 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.905 -0.588 . . . . 15.0 111.99 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -59.82 -36.92 91.59 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.03 -0.605 . . . . 15.0 113.27 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 483' ' ' TYR . 6.3 m-20 -90.48 -21.41 21.88 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.569 0.581 . . . . 15.0 112.569 -178.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 463' ' ' ALA . 0.1 OUTLIER -85.83 -43.24 13.45 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.791 -0.364 . . . . 15.0 110.518 179.383 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . 0.427 ' HB2' ' CD1' ' A' ' 475' ' ' ILE . 24.0 t0 -130.07 110.9 11.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.001 -0.545 . . . . 15.0 111.231 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -85.67 -16.84 37.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.087 -0.506 . . . . 15.0 110.772 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . 0.541 ' N ' HD21 ' A' ' 470' ' ' ASN . 0.8 OUTLIER -78.6 -13.83 59.63 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.112 -0.495 . . . . 15.0 111.195 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 60.91 24.18 14.21 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.182 -0.463 . . . . 15.0 111.629 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -75.05 -3.42 32.4 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.41 -0.359 . . . . 15.0 111.645 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . 0.433 ' HA2' ' CE1' ' A' ' 464' ' ' PHE . . . 66.57 13.83 61.48 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.634 -0.793 . . . . 15.0 111.431 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' CYS . . . . . . . . . . . . . 14.8 t -133.13 130.81 39.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.374 -0.413 . . . . 15.0 110.609 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.645 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 10.8 mm -103.6 124.25 57.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 120.778 0.323 . . . . 15.0 110.99 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 53.4 m -102.44 167.47 9.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 15.0 110.812 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -53.31 -43.3 67.48 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.245 -0.434 . . . . 15.0 111.127 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' GLU . . . . . 0.689 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -60.4 -32.7 71.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.189 -0.459 . . . . 15.0 111.547 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . 0.562 ' OE1' ' HA ' ' A' ' 475' ' ' ILE . 47.6 mt-10 -67.08 -54.26 23.13 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.424 0.154 . . . . 15.0 111.095 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 58.5 mtt -70.07 -49.59 49.58 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.755 -0.202 . . . . 15.0 111.265 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 71.6 t -58.91 -56.78 14.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.57 0.224 . . . . 15.0 111.169 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' SER . . . . . 1.01 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 58.1 m -55.22 -36.59 66.16 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 116.457 -0.338 . . . . 15.0 110.511 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' TYR . . . . . 0.527 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 20.5 t80 -69.37 -26.89 64.88 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.135 -0.484 . . . . 15.0 111.253 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' PHE . . . . . 0.523 ' CD2' HG21 ' A' ' 431' ' ' VAL . 5.1 m-85 -76.15 -44.15 39.56 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 120.902 -0.319 . . . . 15.0 110.533 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.3 tt -83.52 -16.67 44.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.473 -0.33 . . . . 15.0 110.706 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' ARG . . . . . 1.01 ' HB2' ' O ' ' A' ' 482' ' ' SER . 30.7 ttt180 -75.91 -50.28 15.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.525 -0.307 . . . . 15.0 111.284 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 52.3 m -86.25 -51.1 6.48 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.183 -0.462 . . . . 15.0 111.916 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' SER . . . . . 0.495 ' HB3' ' O ' ' A' ' 484' ' ' PHE . 12.5 t -67.23 152.72 45.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.939 0.4 . . . . 15.0 111.448 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 51.9 m -97.2 69.53 2.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.797 -0.638 . . . . 15.0 110.975 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 3.8 t -60.17 -62.09 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.3 -0.409 . . . . 15.0 111.347 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 9.1 mt -142.18 -45.08 0.33 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.292 -0.413 . . . . 15.0 111.067 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -110.45 151.81 17.48 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.867 -0.682 . . . . 15.0 112.564 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . -121.53 -46.19 0.33 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.889 -0.672 . . . . 15.0 112.557 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -99.12 -41.57 7.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.662 0.268 . . . . 15.0 110.954 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 87.4 mtp -102.35 149.66 24.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.229 -0.441 . . . . 15.0 110.919 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 165.56 105.6 0.19 Allowed Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.945 -0.645 . . . . 15.0 112.525 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.2 -0.905 . . . . 15.0 110.937 179.996 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 58.5 mttp . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.759 0.314 . . . . 15.0 110.916 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 9.7 mt -129.81 136.67 49.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.139 -0.482 . . . . 15.0 110.89 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' ASP . . . . . 0.601 ' O ' HG23 ' A' ' 423' ' ' VAL . 8.7 m-20 -96.03 15.34 20.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.074 -0.512 . . . . 15.0 110.926 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' GLN . . . . . 0.696 ' O ' HG21 ' A' ' 424' ' ' VAL . 9.6 tt0 -46.25 -57.64 4.38 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.088 -0.505 . . . . 15.0 111.578 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -68.3 -37.28 80.46 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.306 -0.406 . . . . 15.0 111.238 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' LEU . . . . . 0.408 HD13 ' OD1' ' A' ' 419' ' ' ASP . 1.4 tt -57.39 -54.56 45.39 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.791 -0.641 . . . . 15.0 111.688 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.4 t -81.29 -23.74 10.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.724 -0.671 . . . . 15.0 112.097 -177.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . 0.696 HG21 ' O ' ' A' ' 420' ' ' GLN . 7.0 t -62.64 -48.43 88.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 109.044 -0.724 . . . . 15.0 109.044 178.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -72.2 -33.96 68.03 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.428 -0.806 . . . . 15.0 110.6 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . 0.4 ' HB2' ' O ' ' A' ' 422' ' ' LEU . 2.5 t60 -70.83 -39.11 73.21 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 120.716 0.293 . . . . 15.0 110.995 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' ' 431' ' ' VAL . 36.4 mt -67.63 -54.0 26.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.328 -0.396 . . . . 15.0 110.658 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -56.93 -42.32 79.8 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.132 0.491 . . . . 15.0 110.153 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . 0.619 ' O ' ' HB2' ' A' ' 433' ' ' SER . 88.1 mttt -70.54 -25.13 62.97 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 115.545 -0.752 . . . . 15.0 110.762 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' MET . . . . . 0.603 ' O ' HG22 ' A' ' 434' ' ' VAL . 18.3 mtm -71.44 -46.54 59.79 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.546 -0.297 . . . . 15.0 110.948 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.6 HG21 ' CE2' ' A' ' 484' ' ' PHE . 0.8 OUTLIER -63.87 -41.87 93.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 121.041 0.448 . . . . 15.0 109.978 178.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -72.45 -29.6 63.83 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.642 -0.708 . . . . 15.0 110.952 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' SER . . . . . 0.844 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 13.3 t -69.43 -43.7 72.84 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.304 -0.407 . . . . 15.0 111.02 -179.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 430' ' ' MET . 12.1 t -75.16 -42.9 44.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.281 -0.418 . . . . 15.0 110.869 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' PHE . . . . . 0.47 ' CZ ' ' HG3' ' A' ' 477' ' ' ARG . 7.7 t80 -56.69 -43.64 80.7 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.113 -0.494 . . . . 15.0 110.902 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -85.55 -23.94 27.45 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.464 -0.335 . . . . 15.0 111.205 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' ASN . . . . . 0.844 ' HB2' ' O ' ' A' ' 433' ' ' SER . 4.4 t-20 -59.84 -40.24 87.85 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.429 -0.351 . . . . 15.0 110.637 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -95.71 -13.83 23.89 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.931 -0.577 . . . . 15.0 111.807 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -105.31 54.33 0.71 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.924 0.392 . . . . 15.0 111.239 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 11.1 p -71.95 -16.1 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.13 -0.487 . . . . 15.0 111.338 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 40.2 p30 -79.92 -14.26 58.75 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.144 -0.48 . . . . 15.0 111.341 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 71.29 47.14 37.83 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.869 -0.682 . . . . 15.0 112.386 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -106.5 -18.46 13.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.676 0.274 . . . . 15.0 111.192 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 89.93 -9.32 77.67 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.956 -0.64 . . . . 15.0 112.494 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -146.01 162.53 37.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.774 0.321 . . . . 15.0 110.709 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' ILE . . . . . 0.608 ' N ' HD12 ' A' ' 446' ' ' ILE . 1.7 mp -77.84 135.13 26.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.225 -0.443 . . . . 15.0 111.179 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.0 m -106.14 148.72 27.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.669 -0.696 . . . . 15.0 110.584 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -48.32 -47.46 36.8 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.257 -0.429 . . . . 15.0 111.697 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' GLU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.4 mt-10 -64.46 -38.22 90.27 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.423 -0.353 . . . . 15.0 111.329 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -58.37 -61.53 2.51 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.883 0.373 . . . . 15.0 110.605 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.7 -22.69 66.64 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.923 -0.581 . . . . 15.0 110.932 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' GLN . . . . . 0.416 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 0.9 OUTLIER -60.49 -57.55 12.27 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.938 -0.574 . . . . 15.0 111.281 179.49 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -76.87 -33.76 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 115.771 -0.65 . . . . 15.0 111.855 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 61.0 mt -62.49 -49.97 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 120.489 0.185 . . . . 15.0 111.284 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' ARG . . . . . 0.444 ' NH2' ' H ' ' A' ' 461' ' ' LEU . 0.1 OUTLIER -57.94 -30.6 66.09 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.524 -0.307 . . . . 15.0 111.521 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -70.57 -33.73 67.44 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.918 -0.658 . . . . 15.0 112.775 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' ASN . . . . . 0.428 ' O ' ' HD3' ' A' ' 459' ' ' PRO . 40.9 m-80 -90.4 -22.21 21.57 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.637 0.256 . . . . 15.0 111.189 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -115.97 84.39 13.34 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.432 -0.349 . . . . 15.0 111.034 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 457' ' ' ASN . 13.0 Cg_exo -70.83 -10.55 27.93 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.947 2.431 . . . . 15.0 112.545 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -96.84 25.55 5.2 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.318 -0.401 . . . . 15.0 110.974 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' LEU . . . . . 0.444 ' H ' ' NH2' ' A' ' 455' ' ' ARG . 0.7 OUTLIER -98.01 152.07 19.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.218 -0.447 . . . . 15.0 111.061 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 43.1 p -63.63 175.73 1.02 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.072 -0.513 . . . . 15.0 111.328 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' ALA . . . . . 0.738 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -87.76 148.42 24.73 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.184 -0.462 . . . . 15.0 111.242 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' PHE . . . . . 0.865 ' O ' HD12 ' A' ' 467' ' ' LEU . 46.0 m-85 -54.44 -48.07 72.13 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.937 -0.574 . . . . 15.0 111.477 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -70.4 -15.62 72.91 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.014 -0.613 . . . . 15.0 113.519 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' ASP . . . . . 0.482 ' OD1' ' HB3' ' A' ' 463' ' ' ALA . 4.1 m-20 -90.26 -36.67 14.59 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 117.089 0.445 . . . . 15.0 111.796 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.865 HD12 ' O ' ' A' ' 464' ' ' PHE . 0.5 OUTLIER -82.08 -30.88 31.07 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.9 0.381 . . . . 15.0 110.571 179.193 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -126.47 108.75 11.46 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.976 -0.556 . . . . 15.0 110.273 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -69.22 -22.11 63.89 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.112 -0.494 . . . . 15.0 111.489 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -76.51 -14.11 60.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.226 -0.443 . . . . 15.0 111.326 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 57.38 26.61 12.7 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.224 -0.444 . . . . 15.0 111.413 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -81.23 0.05 38.44 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.257 -0.429 . . . . 15.0 111.551 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 65.89 16.04 63.34 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.469 -0.872 . . . . 15.0 111.227 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' CYS . . . . . . . . . . . . . 13.8 t -137.94 131.12 30.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.142 -0.529 . . . . 15.0 110.431 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.566 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 94.9 mt -106.84 127.24 62.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.912 0.387 . . . . 15.0 111.023 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 64.7 m -103.61 177.22 4.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.739 -0.664 . . . . 15.0 111.077 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' ARG . . . . . 0.47 ' HG3' ' CZ ' ' A' ' 435' ' ' PHE . 68.7 mtp180 -58.81 -46.96 86.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.21 -0.45 . . . . 15.0 111.221 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' GLU . . . . . 0.619 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -60.21 -32.42 71.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.215 -0.448 . . . . 15.0 111.423 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . 0.42 ' O ' ' HD1' ' A' ' 483' ' ' TYR . 5.5 mm-40 -66.42 -50.22 64.16 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.497 0.189 . . . . 15.0 110.778 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 60.0 mtt -69.86 -47.0 64.32 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.684 -0.234 . . . . 15.0 110.923 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 89.8 t -61.56 -54.01 40.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.702 0.287 . . . . 15.0 110.842 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' SER . . . . . 0.877 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 10.3 m -50.55 -47.17 57.78 Favored 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 116.034 -0.53 . . . . 15.0 110.382 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' TYR . . . . . 0.42 ' HD1' ' O ' ' A' ' 479' ' ' GLU . 8.0 m-85 -69.22 -22.42 63.87 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.423 -0.808 . . . . 15.0 111.856 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' PHE . . . . . 0.779 ' O ' ' HB2' ' A' ' 488' ' ' SER . 0.1 OUTLIER -74.03 -45.94 46.52 Favored 'General case' 0 CA--C 1.527 0.091 0 C-N-CA 120.779 -0.369 . . . . 15.0 110.1 179.05 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . 0.606 HD11 ' O ' ' A' ' 485' ' ' LEU . 1.5 tm? -84.43 -16.62 42.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.425 -0.352 . . . . 15.0 110.664 177.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' ARG . . . . . 0.877 ' HB2' ' O ' ' A' ' 482' ' ' SER . 21.3 ttt180 -74.36 -53.32 9.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.451 -0.34 . . . . 15.0 111.578 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' SER . . . . . 0.592 ' HG ' ' H ' ' A' ' 488' ' ' SER . 79.7 p -92.58 -54.49 3.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.314 -0.403 . . . . 15.0 112.058 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' SER . . . . . 0.779 ' HB2' ' O ' ' A' ' 484' ' ' PHE . 54.7 m -59.94 150.07 29.92 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.871 0.367 . . . . 15.0 111.492 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 13.8 t -97.8 64.04 1.73 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.886 -0.597 . . . . 15.0 111.106 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 10.3 t -60.74 -55.04 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.327 -0.397 . . . . 15.0 111.152 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 8.9 mt -139.77 -43.43 0.44 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.219 -0.446 . . . . 15.0 110.893 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . 102.25 54.5 0.9 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.884 -0.674 . . . . 15.0 112.539 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . -151.0 -135.04 2.28 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.94 -0.647 . . . . 15.0 112.532 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -126.71 146.89 50.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.737 0.304 . . . . 15.0 110.926 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 8.0 ttt -109.41 -42.12 4.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 15.0 110.932 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . -152.24 -100.91 0.2 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.875 -0.679 . . . . 15.0 112.524 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.305 -0.855 . . . . 15.0 110.885 179.974 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.656 ' O ' HG23 ' A' ' 423' ' ' VAL . 8.9 m-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.747 0.308 . . . . 15.0 111.037 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.732 ' O ' HG23 ' A' ' 424' ' ' VAL . 53.6 mt-30 -44.81 -57.25 3.86 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.053 -0.522 . . . . 15.0 111.607 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -68.48 -36.83 79.51 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.308 -0.406 . . . . 15.0 111.136 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 1.6 tt -57.75 -54.55 45.65 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.826 -0.625 . . . . 15.0 111.668 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.1 t -81.32 -23.48 10.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.665 -0.698 . . . . 15.0 112.039 -177.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 424' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 420' ' ' GLN . 6.8 t -62.78 -47.46 92.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 109.047 -0.723 . . . . 15.0 109.047 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -72.97 -33.94 66.18 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.435 -0.802 . . . . 15.0 110.583 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' HIS . . . . . 0.576 ' O ' ' HB2' ' A' ' 430' ' ' MET . 2.4 t-80 -70.85 -39.38 72.99 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.678 0.275 . . . . 15.0 110.975 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 427' ' ' ILE . . . . . 0.58 ' O ' HG23 ' A' ' 431' ' ' VAL . 40.1 mt -68.88 -52.0 39.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.372 -0.376 . . . . 15.0 110.715 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -57.32 -43.0 82.95 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.132 0.492 . . . . 15.0 110.197 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -71.83 -24.27 61.68 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 115.559 -0.746 . . . . 15.0 110.542 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 430' ' ' MET . . . . . 0.672 ' O ' HG23 ' A' ' 434' ' ' VAL . 8.5 ttm -70.32 -49.82 45.52 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.36 -0.382 . . . . 15.0 110.853 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 427' ' ' ILE . 1.5 t -64.56 -37.34 79.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.918 0.39 . . . . 15.0 110.033 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -71.57 -32.93 68.62 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.826 -0.625 . . . . 15.0 110.692 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.917 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 4.0 m -69.61 -41.11 76.12 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.181 -0.463 . . . . 15.0 111.09 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 430' ' ' MET . 16.4 t -75.36 -42.2 43.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.2 -0.455 . . . . 15.0 110.786 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 435' ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 9.8 t80 -58.32 -41.71 85.11 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.965 -0.561 . . . . 15.0 111.013 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -86.37 -26.91 24.55 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.436 -0.347 . . . . 15.0 110.933 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 437' ' ' ASN . . . . . 0.917 ' HB2' ' O ' ' A' ' 433' ' ' SER . 2.6 t-20 -59.73 -45.27 92.71 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.227 -0.442 . . . . 15.0 111.455 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 438' ' ' PHE . . . . . 0.483 ' CE2' HG21 ' A' ' 454' ' ' ILE . 54.8 m-85 -94.33 -2.09 52.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.119 -0.491 . . . . 15.0 111.494 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 439' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 1.1 t0 -120.08 54.49 1.03 Allowed 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.918 0.39 . . . . 15.0 111.16 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.26 -9.42 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.054 -0.521 . . . . 15.0 111.32 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -92.35 -3.96 54.57 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.257 -0.429 . . . . 15.0 111.219 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 61.06 51.01 61.18 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.051 -0.595 . . . . 15.0 112.664 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -103.19 -18.09 15.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.645 0.259 . . . . 15.0 111.231 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 87.8 -13.85 59.93 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.933 -0.651 . . . . 15.0 112.302 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 445' ' ' HIS . . . . . 0.469 ' HB2' ' SG ' ' A' ' 474' ' ' CYS . 14.4 p80 -137.77 154.37 49.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.622 0.248 . . . . 15.0 110.408 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 446' ' ' ILE . . . . . 0.624 ' O ' ' HA ' ' A' ' 474' ' ' CYS . 1.6 mp -85.6 98.95 6.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.072 0.463 . . . . 15.0 111.023 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 52.8 m -63.7 150.89 43.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.705 -0.68 . . . . 15.0 111.072 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -55.33 -37.91 68.05 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.069 -0.514 . . . . 15.0 111.802 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 449' ' ' GLU . . . . . 0.463 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -63.23 -40.25 96.92 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.522 -0.308 . . . . 15.0 111.38 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -58.55 -60.51 3.7 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.947 0.403 . . . . 15.0 110.507 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -64.61 -24.1 67.48 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.822 -0.627 . . . . 15.0 110.614 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 452' ' ' GLN . . . . . 0.463 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 0.2 OUTLIER -58.9 -57.05 14.76 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.724 -0.671 . . . . 15.0 111.588 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -81.05 -33.61 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.682 -0.69 . . . . 15.0 111.927 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 454' ' ' ILE . . . . . 0.483 HG21 ' CE2' ' A' ' 438' ' ' PHE . 56.0 mt -63.9 -38.17 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.444 0.164 . . . . 15.0 111.438 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -62.65 -21.74 65.92 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.687 0.28 . . . . 15.0 111.468 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -66.36 -23.94 71.98 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.014 -0.613 . . . . 15.0 112.7 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -116.03 -10.7 11.53 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.676 0.274 . . . . 15.0 111.208 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -127.67 74.7 78.18 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.385 -0.37 . . . . 15.0 111.007 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.04 1.93 8.15 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.189 2.593 . . . . 15.0 112.612 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -81.32 2.5 27.94 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.328 -0.396 . . . . 15.0 111.449 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.4 mp -102.16 152.3 21.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.379 -0.373 . . . . 15.0 111.041 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 50.9 m -74.67 -174.83 2.24 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.079 -0.51 . . . . 15.0 111.288 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 463' ' ' ALA . . . . . 0.575 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -87.79 156.93 19.17 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.22 -0.446 . . . . 15.0 111.793 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -50.08 -41.67 48.56 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.74 -0.663 . . . . 15.0 111.348 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -62.19 -26.72 68.02 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.944 -0.571 . . . . 15.0 113.35 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -88.44 -33.24 17.93 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.858 0.329 . . . . 15.0 111.433 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 463' ' ' ALA . 0.1 OUTLIER -77.65 -36.32 51.57 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.863 0.363 . . . . 15.0 110.403 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 468' ' ' ASP . . . . . 0.539 ' HA ' ' OE2' ' A' ' 479' ' ' GLU . 10.4 t70 -123.77 114.62 20.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.876 -0.602 . . . . 15.0 110.47 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -67.28 -33.74 75.94 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.052 -0.522 . . . . 15.0 111.542 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -79.27 -9.44 59.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.397 -0.365 . . . . 15.0 111.413 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 55.86 39.08 30.68 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.27 -0.423 . . . . 15.0 111.382 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -78.56 -0.72 30.79 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.178 -0.464 . . . . 15.0 111.593 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.47 15.09 63.3 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.494 -0.86 . . . . 15.0 111.255 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 474' ' ' CYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 446' ' ' ILE . 1.0 OUTLIER -136.09 131.16 34.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.235 -0.483 . . . . 15.0 110.455 -178.724 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.572 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 16.7 mm -102.74 124.9 57.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.938 0.399 . . . . 15.0 111.136 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 12.3 t -103.59 175.71 5.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.729 -0.669 . . . . 15.0 110.823 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 477' ' ' ARG . . . . . 0.44 ' O ' HG23 ' A' ' 481' ' ' VAL . 24.7 ptt180 -58.08 -44.48 87.6 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.328 -0.396 . . . . 15.0 111.149 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 478' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.6 mt-10 -62.11 -29.62 70.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.437 . . . . 15.0 111.458 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 479' ' ' GLU . . . . . 0.539 ' OE2' ' HA ' ' A' ' 468' ' ' ASP . 5.3 mm-40 -71.69 -47.99 50.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.496 0.188 . . . . 15.0 110.862 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 60.5 mtt -70.45 -46.2 64.33 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.687 -0.233 . . . . 15.0 110.963 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 481' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 477' ' ' ARG . 79.1 t -60.26 -52.7 58.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 120.738 0.304 . . . . 15.0 110.659 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 482' ' ' SER . . . . . 0.918 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 39.5 m -57.77 -32.96 68.01 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 116.162 -0.472 . . . . 15.0 110.183 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 483' ' ' TYR . . . . . 0.538 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 9.1 t80 -69.02 -30.01 68.31 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.904 -0.589 . . . . 15.0 111.013 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 484' ' ' PHE . . . . . 0.57 ' CD2' HG22 ' A' ' 431' ' ' VAL . 1.9 m-85 -75.16 -40.18 59.77 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.708 0.289 . . . . 15.0 110.332 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.2 tt -83.82 -18.74 36.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 15.0 110.558 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 486' ' ' ARG . . . . . 0.918 ' HB2' ' O ' ' A' ' 482' ' ' SER . 31.0 ttt180 -72.61 -52.98 13.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.433 -0.349 . . . . 15.0 110.882 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 53.4 m -89.26 19.37 4.39 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.979 -0.555 . . . . 15.0 111.354 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 488' ' ' SER . . . . . 0.559 ' HB2' ' O ' ' A' ' 484' ' ' PHE . 22.6 t . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.345 -0.389 . . . . 15.0 110.933 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.637 ' O ' HG23 ' A' ' 423' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.85 0.357 . . . . 15.0 111.114 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.724 ' O ' HG23 ' A' ' 424' ' ' VAL . 4.3 tt0 -47.96 -56.35 7.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.784 -0.643 . . . . 15.0 111.862 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.42 95.96 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.328 -0.397 . . . . 15.0 111.62 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 3.2 tt -57.49 -53.34 59.31 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.077 -0.51 . . . . 15.0 111.743 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.6 t -80.9 -22.54 10.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.736 -0.665 . . . . 15.0 111.966 -176.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 424' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 420' ' ' GLN . 9.3 t -64.07 -47.68 89.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 109.056 -0.72 . . . . 15.0 109.056 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -72.61 -33.29 66.57 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.426 -0.807 . . . . 15.0 110.584 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' HIS . . . . . 0.629 ' O ' ' HB2' ' A' ' 430' ' ' MET . 4.6 t-80 -71.02 -39.29 72.43 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.568 -0.287 . . . . 15.0 111.05 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 427' ' ' ILE . . . . . 0.555 ' O ' HG23 ' A' ' 431' ' ' VAL . 40.7 mt -68.88 -52.29 36.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 116.352 -0.386 . . . . 15.0 110.77 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -57.7 -43.55 85.25 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.154 0.502 . . . . 15.0 110.169 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -72.04 -22.73 61.35 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.506 -0.77 . . . . 15.0 110.548 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' MET . . . . . 0.629 ' HB2' ' O ' ' A' ' 426' ' ' HIS . 0.0 OUTLIER -70.28 -51.37 30.99 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.405 -0.361 . . . . 15.0 110.88 179.077 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.557 HG22 ' CE2' ' A' ' 484' ' ' PHE . 1.0 OUTLIER -63.87 -38.69 83.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.317 -0.402 . . . . 15.0 110.046 179.128 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -71.89 -31.69 66.68 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.823 -0.626 . . . . 15.0 110.878 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.817 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 2.6 m -68.54 -42.68 78.1 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.244 -0.435 . . . . 15.0 111.028 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 430' ' ' MET . 10.2 t -75.32 -41.91 43.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.271 -0.422 . . . . 15.0 110.869 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 435' ' ' PHE . . . . . 0.61 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 4.1 t80 -56.75 -42.67 79.74 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.037 -0.529 . . . . 15.0 110.749 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 -87.02 -23.55 24.95 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.441 -0.345 . . . . 15.0 111.229 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 437' ' ' ASN . . . . . 0.817 ' HB2' ' O ' ' A' ' 433' ' ' SER . 5.1 t-20 -59.97 -39.62 86.28 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.863 0.363 . . . . 15.0 110.568 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 438' ' ' PHE . . . . . 0.493 ' CE2' HG21 ' A' ' 454' ' ' ILE . 35.6 m-85 -94.15 -16.51 23.66 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.854 -0.612 . . . . 15.0 111.635 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 439' ' ' ASP . . . . . 0.61 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 0.3 OUTLIER -99.18 54.03 0.97 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.864 0.364 . . . . 15.0 111.429 -179.525 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.3 -12.85 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.327 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -88.59 -14.82 36.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.119 -0.491 . . . . 15.0 111.171 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 73.7 39.44 48.51 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.004 -0.617 . . . . 15.0 112.508 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -95.79 -17.34 21.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.623 0.249 . . . . 15.0 111.162 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 87.22 -7.73 79.51 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.911 -0.662 . . . . 15.0 112.37 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -144.92 162.18 37.51 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.717 0.294 . . . . 15.0 110.658 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 446' ' ' ILE . . . . . 0.881 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.6 mp -77.78 136.36 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.113 0.483 . . . . 15.0 111.265 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 48.5 m -105.76 147.8 28.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.474 -0.784 . . . . 15.0 110.711 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -50.71 -46.85 59.11 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.169 -0.469 . . . . 15.0 111.606 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 449' ' ' GLU . . . . . 0.422 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -65.31 -36.91 85.52 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.479 -0.328 . . . . 15.0 111.168 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -60.58 -58.71 7.34 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.295 -0.411 . . . . 15.0 110.543 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.45 -23.73 67.0 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.767 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 452' ' ' GLN . . . . . 0.422 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 1.5 mm-40 -61.07 -56.93 15.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.88 -0.6 . . . . 15.0 111.302 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -76.73 -32.89 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 115.804 -0.635 . . . . 15.0 111.913 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 454' ' ' ILE . . . . . 0.493 HG21 ' CE2' ' A' ' 438' ' ' PHE . 46.3 mt -64.71 -51.96 60.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.501 0.191 . . . . 15.0 111.244 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -55.32 -33.19 63.09 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.694 0.283 . . . . 15.0 111.46 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -66.84 -30.78 76.66 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.908 -0.663 . . . . 15.0 112.629 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 457' ' ' ASN . . . . . 0.468 ' O ' ' HD3' ' A' ' 459' ' ' PRO . 42.0 m-80 -94.28 -18.99 21.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.687 0.279 . . . . 15.0 111.246 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -115.8 83.29 11.47 Favored Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 116.375 -0.375 . . . . 15.0 110.936 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 459' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 457' ' ' ASN . 12.6 Cg_exo -70.78 -10.08 27.03 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.046 2.497 . . . . 15.0 112.631 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -96.53 25.25 5.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.26 -0.427 . . . . 15.0 111.034 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 2.3 tp -100.39 152.55 20.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.16 -0.473 . . . . 15.0 110.975 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 52.5 m -65.54 176.41 1.48 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.115 -0.493 . . . . 15.0 111.378 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 463' ' ' ALA . . . . . 0.76 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -86.84 150.49 24.09 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.239 -0.437 . . . . 15.0 111.243 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 464' ' ' PHE . . . . . 0.749 ' HA ' HD11 ' A' ' 467' ' ' LEU . 68.1 m-85 -56.62 -48.76 76.79 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.999 -0.546 . . . . 15.0 111.506 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -68.15 -16.33 68.68 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.962 -0.637 . . . . 15.0 113.459 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -90.13 -39.33 12.93 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.101 0.45 . . . . 15.0 111.776 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.985 HD13 HD11 ' A' ' 475' ' ' ILE . 0.6 OUTLIER -79.06 -28.76 43.18 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.762 0.315 . . . . 15.0 110.755 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 468' ' ' ASP . . . . . 0.602 ' N ' HD12 ' A' ' 467' ' ' LEU . 12.4 t70 -130.87 110.49 11.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.039 -0.528 . . . . 15.0 110.286 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -66.06 -28.77 69.09 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.008 -0.542 . . . . 15.0 111.454 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -76.54 -14.11 60.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.249 -0.432 . . . . 15.0 111.214 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 58.67 29.36 18.46 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.238 -0.437 . . . . 15.0 111.306 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -74.35 -4.8 38.58 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.147 -0.479 . . . . 15.0 111.767 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.52 17.57 66.81 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.464 -0.875 . . . . 15.0 111.197 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 474' ' ' CYS . . . . . . . . . . . . . 18.5 t -135.78 131.7 35.81 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.268 -0.466 . . . . 15.0 110.492 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.985 HD11 HD13 ' A' ' 467' ' ' LEU . 11.1 mm -98.79 122.24 50.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 15.0 110.938 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 476' ' ' SER . . . . . 0.508 ' H ' ' HG3' ' A' ' 479' ' ' GLU . 15.4 t -102.89 171.12 7.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.918 -0.583 . . . . 15.0 110.672 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -52.86 -45.51 67.44 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.338 -0.392 . . . . 15.0 110.915 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 478' ' ' GLU . . . . . 0.563 ' O ' ' HB2' ' A' ' 482' ' ' SER . 9.4 tt0 -62.51 -28.39 69.81 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.049 -0.523 . . . . 15.0 111.254 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 479' ' ' GLU . . . . . 0.599 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 52.1 mm-40 -70.35 -51.36 30.57 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.505 0.193 . . . . 15.0 110.84 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 44.2 mtt -70.06 -47.18 63.03 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.653 -0.249 . . . . 15.0 111.081 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 82.1 t -59.94 -53.49 47.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.68 0.276 . . . . 15.0 110.85 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 482' ' ' SER . . . . . 0.941 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 43.0 m -57.96 -32.46 67.85 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 116.267 -0.424 . . . . 15.0 110.208 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 483' ' ' TYR . . . . . 0.599 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 8.3 t80 -69.3 -31.05 69.28 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.954 -0.566 . . . . 15.0 111.199 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 484' ' ' PHE . . . . . 0.585 ' HZ ' ' SD ' ' A' ' 430' ' ' MET . 1.6 m-85 -75.9 -39.03 57.12 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.926 -0.31 . . . . 15.0 110.387 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.1 tt -83.74 -19.65 34.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 15.0 110.49 176.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 486' ' ' ARG . . . . . 0.941 ' HB2' ' O ' ' A' ' 482' ' ' SER . 32.1 ttt180 -72.08 -48.55 43.3 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.845 0.355 . . . . 15.0 110.751 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 49.5 p -82.77 19.58 1.31 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.907 -0.588 . . . . 15.0 111.439 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 67.9 m . . . . . 0 C--N 1.332 -0.187 0 CA-C-N 116.279 -0.418 . . . . 15.0 110.961 179.856 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.637 ' O ' HG23 ' A' ' 423' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.775 0.321 . . . . 15.0 110.89 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.736 ' O ' HG23 ' A' ' 424' ' ' VAL . 45.9 mt-30 -48.99 -56.66 8.23 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.878 -0.601 . . . . 15.0 111.731 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -65.91 -38.47 88.8 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.905 0.383 . . . . 15.0 111.43 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 3.4 tt -57.97 -53.09 62.11 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.862 -0.608 . . . . 15.0 111.572 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 419' ' ' ASP . 2.1 t -80.81 -22.7 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 CA-C-N 115.665 -0.698 . . . . 15.0 111.978 -177.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 424' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 420' ' ' GLN . 9.6 t -63.83 -48.02 88.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 109.023 -0.732 . . . . 15.0 109.023 177.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -71.7 -33.55 68.88 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.335 -0.848 . . . . 15.0 110.46 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -70.71 -39.8 73.22 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.53 -0.305 . . . . 15.0 110.915 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 427' ' ' ILE . . . . . 0.574 ' O ' HG23 ' A' ' 431' ' ' VAL . 38.6 mt -67.33 -52.35 43.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.358 -0.383 . . . . 15.0 110.712 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -58.37 -41.99 86.01 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.156 0.503 . . . . 15.0 110.287 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.618 ' O ' ' HB2' ' A' ' 433' ' ' SER . 89.6 mttt -71.29 -24.19 62.1 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 115.473 -0.785 . . . . 15.0 110.74 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 430' ' ' MET . . . . . 0.653 ' O ' HG23 ' A' ' 434' ' ' VAL . 25.2 mmm -71.63 -47.53 53.88 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.428 -0.351 . . . . 15.0 110.923 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.588 HG22 ' CD2' ' A' ' 484' ' ' PHE . 2.0 t -65.36 -39.22 84.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.325 -0.398 . . . . 15.0 110.0 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -72.62 -30.45 64.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.916 -0.584 . . . . 15.0 110.756 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.843 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 13.2 t -68.86 -43.11 76.09 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.202 -0.453 . . . . 15.0 110.91 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 430' ' ' MET . 10.6 t -76.53 -40.82 34.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.784 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 435' ' ' PHE . . . . . 0.551 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 2.9 t80 -56.99 -42.9 81.11 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.065 -0.516 . . . . 15.0 110.673 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -87.41 -23.6 24.47 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.361 -0.382 . . . . 15.0 111.18 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 437' ' ' ASN . . . . . 0.843 ' HB2' ' O ' ' A' ' 433' ' ' SER . 3.3 t30 -60.0 -38.93 84.07 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.934 0.397 . . . . 15.0 110.515 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 438' ' ' PHE . . . . . 0.459 ' CD2' HD13 ' A' ' 454' ' ' ILE . 33.1 m-85 -94.41 -16.65 23.24 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.802 -0.636 . . . . 15.0 111.55 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 439' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 0.6 OUTLIER -99.92 53.44 0.92 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.892 0.377 . . . . 15.0 111.589 -179.323 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.8 t -70.37 -12.49 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.132 -0.485 . . . . 15.0 111.0 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -90.85 -14.96 30.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.079 -0.51 . . . . 15.0 111.048 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 76.56 41.62 24.2 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.971 -0.633 . . . . 15.0 112.509 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -97.64 -18.64 18.78 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.671 0.272 . . . . 15.0 111.149 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 86.2 -4.48 85.97 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.899 -0.667 . . . . 15.0 112.468 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 445' ' ' HIS . . . . . 0.684 ' HB2' ' SG ' ' A' ' 474' ' ' CYS . 11.1 p-80 -146.18 164.3 32.68 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.757 0.313 . . . . 15.0 110.807 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 446' ' ' ILE . . . . . 0.841 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.2 mp -76.98 135.76 25.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.215 -0.448 . . . . 15.0 110.999 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 9.9 t -106.33 147.53 29.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.823 -0.626 . . . . 15.0 110.789 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -52.42 -47.93 66.03 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.167 -0.469 . . . . 15.0 111.541 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 449' ' ' GLU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -64.72 -36.85 85.63 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.444 -0.343 . . . . 15.0 111.047 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 450' ' ' GLU . . . . . 0.419 ' O ' HD12 ' A' ' 454' ' ' ILE . 5.0 mm-40 -61.16 -56.56 19.36 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.317 -0.401 . . . . 15.0 110.279 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 451' ' ' PHE . . . . . 0.522 ' CE2' HD23 ' A' ' 461' ' ' LEU . 0.7 OUTLIER -64.99 -25.07 67.71 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.911 -0.586 . . . . 15.0 110.529 178.783 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 452' ' ' GLN . . . . . 0.415 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 2.5 mm-40 -60.66 -57.92 10.66 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.76 -0.654 . . . . 15.0 111.389 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 8.8 mm -76.0 -33.04 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.86 -0.609 . . . . 15.0 111.842 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 454' ' ' ILE . . . . . 0.459 HD13 ' CD2' ' A' ' 438' ' ' PHE . 28.3 mt -63.2 -47.52 91.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 120.489 0.185 . . . . 15.0 111.272 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 455' ' ' ARG . . . . . 0.647 ' NH2' ' HA ' ' A' ' 463' ' ' ALA . 8.1 mtt180 -54.87 -33.68 62.14 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.539 -0.3 . . . . 15.0 111.507 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -64.08 -29.3 74.52 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 121.033 -0.603 . . . . 15.0 112.612 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -97.37 -15.04 20.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.556 0.217 . . . . 15.0 111.162 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 458' ' ' PHE . . . . . 0.506 ' HB3' HD13 ' A' ' 461' ' ' LEU . 86.0 m-85 -125.47 86.66 56.88 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.39 -0.368 . . . . 15.0 111.044 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -72.53 -2.71 12.2 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.989 2.459 . . . . 15.0 112.589 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -103.35 23.54 12.35 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.319 -0.401 . . . . 15.0 110.998 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.522 HD23 ' CE2' ' A' ' 451' ' ' PHE . 1.0 OUTLIER -89.32 147.77 23.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 15.0 111.084 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 58.2 m -66.78 175.37 2.44 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.044 -0.525 . . . . 15.0 111.329 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 463' ' ' ALA . . . . . 0.74 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -87.88 149.11 24.3 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.114 -0.494 . . . . 15.0 111.271 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 464' ' ' PHE . . . . . 0.743 ' HA ' HD11 ' A' ' 467' ' ' LEU . 90.1 m-85 -56.71 -47.6 79.58 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.932 -0.577 . . . . 15.0 111.47 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -69.06 -16.06 70.28 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 121.034 -0.603 . . . . 15.0 113.449 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -89.92 -38.97 13.31 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.202 0.501 . . . . 15.0 111.678 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.912 HD13 HD11 ' A' ' 475' ' ' ILE . 0.6 OUTLIER -80.9 -28.56 35.83 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.815 0.341 . . . . 15.0 110.586 179.57 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 468' ' ' ASP . . . . . 0.595 ' N ' HD12 ' A' ' 467' ' ' LEU . 12.4 t70 -131.65 111.93 12.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.049 -0.523 . . . . 15.0 110.213 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -62.07 -35.74 79.57 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.029 -0.532 . . . . 15.0 111.788 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -77.88 -10.58 59.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.417 -0.356 . . . . 15.0 111.456 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 57.66 34.13 24.11 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.943 0.402 . . . . 15.0 111.303 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -73.88 -4.44 34.99 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.113 -0.494 . . . . 15.0 111.716 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.72 18.04 67.78 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.489 -0.863 . . . . 15.0 111.277 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 474' ' ' CYS . . . . . 0.684 ' SG ' ' HB2' ' A' ' 445' ' ' HIS . 3.7 t -135.19 130.93 36.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.248 -0.476 . . . . 15.0 110.52 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.912 HD11 HD13 ' A' ' 467' ' ' LEU . 21.1 mm -98.78 123.67 51.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.892 0.377 . . . . 15.0 110.93 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 476' ' ' SER . . . . . 0.404 ' H ' ' HG3' ' A' ' 479' ' ' GLU . 14.5 t -101.84 166.96 10.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.931 -0.577 . . . . 15.0 110.577 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -50.49 -46.98 57.38 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.34 -0.391 . . . . 15.0 110.915 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 478' ' ' GLU . . . . . 0.726 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -62.21 -30.84 71.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.031 -0.531 . . . . 15.0 111.473 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 479' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 5.7 mm-40 -69.83 -55.06 10.81 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 121.285 -0.166 . . . . 15.0 110.956 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 6.6 tpp -68.65 -48.46 63.96 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.752 -0.204 . . . . 15.0 111.228 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 76.0 t -60.51 -54.56 33.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 121.148 -0.221 . . . . 15.0 111.128 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 482' ' ' SER . . . . . 0.98 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 36.8 m -56.51 -33.61 66.18 Favored 'General case' 0 C--O 1.227 -0.088 0 CA-C-N 116.515 -0.311 . . . . 15.0 110.462 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 483' ' ' TYR . . . . . 0.573 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 8.5 t80 -70.24 -30.76 67.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.116 -0.493 . . . . 15.0 111.167 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 484' ' ' PHE . . . . . 0.588 ' CD2' HG22 ' A' ' 431' ' ' VAL . 6.0 m-85 -74.16 -41.84 60.86 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 120.888 -0.325 . . . . 15.0 110.372 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.5 tt -83.95 -16.98 42.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.396 . . . . 15.0 110.492 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 486' ' ' ARG . . . . . 0.98 ' HB2' ' O ' ' A' ' 482' ' ' SER . 5.8 tpt180 -71.59 -51.5 23.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.892 0.377 . . . . 15.0 110.844 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 52.5 m -87.55 19.37 3.38 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.961 -0.563 . . . . 15.0 111.55 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 488' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 484' ' ' PHE . 9.3 t . . . . . 0 C--N 1.332 -0.177 0 CA-C-N 116.374 -0.376 . . . . 15.0 111.042 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.661 ' O ' HG23 ' A' ' 423' ' ' VAL . 7.6 m-20 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.826 0.346 . . . . 15.0 111.115 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.739 ' O ' HG23 ' A' ' 424' ' ' VAL . 4.0 tt0 -46.85 -57.42 4.93 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.097 -0.501 . . . . 15.0 111.624 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.82 81.78 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.345 -0.388 . . . . 15.0 111.294 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.543 HD13 ' OD2' ' A' ' 419' ' ' ASP . 1.2 tt -57.82 -53.77 54.4 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.872 -0.604 . . . . 15.0 111.618 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.7 t -80.69 -23.98 11.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.636 -0.711 . . . . 15.0 112.02 -177.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 424' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 420' ' ' GLN . 7.3 t -62.74 -47.82 91.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 109.076 -0.713 . . . . 15.0 109.076 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -71.53 -34.53 70.12 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.468 -0.787 . . . . 15.0 110.539 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -70.4 -40.07 74.11 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.569 -0.287 . . . . 15.0 110.936 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 427' ' ' ILE . . . . . 0.567 HG13 HG12 ' A' ' 423' ' ' VAL . 37.2 mt -66.58 -53.61 33.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.329 -0.396 . . . . 15.0 110.676 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -57.35 -41.97 81.09 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.105 0.479 . . . . 15.0 110.275 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.613 ' O ' ' HB2' ' A' ' 433' ' ' SER . 89.0 mttt -70.24 -24.98 63.17 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.516 -0.765 . . . . 15.0 110.592 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 430' ' ' MET . . . . . 0.65 ' O ' HG23 ' A' ' 434' ' ' VAL . 33.7 mmm -71.81 -46.09 59.34 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.469 -0.332 . . . . 15.0 110.898 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.607 HG22 ' CE2' ' A' ' 484' ' ' PHE . 1.0 OUTLIER -64.14 -41.19 91.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.979 0.419 . . . . 15.0 109.974 178.823 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -72.75 -29.75 63.58 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.708 -0.678 . . . . 15.0 110.992 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.781 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 13.3 t -69.64 -43.39 72.74 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.269 -0.423 . . . . 15.0 110.996 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 430' ' ' MET . 12.7 t -75.77 -41.86 40.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.201 -0.454 . . . . 15.0 110.811 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -57.89 -42.57 84.92 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.222 -0.444 . . . . 15.0 110.706 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -84.52 -25.19 28.97 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.506 -0.315 . . . . 15.0 111.033 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 437' ' ' ASN . . . . . 0.781 ' HB2' ' O ' ' A' ' 433' ' ' SER . 3.1 t30 -60.38 -38.96 85.55 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.851 0.358 . . . . 15.0 110.498 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -96.81 -10.47 26.56 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.911 -0.586 . . . . 15.0 111.734 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -108.83 53.6 0.68 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.896 0.379 . . . . 15.0 111.481 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 440' ' ' VAL . . . . . 0.413 HG12 ' OE1' ' A' ' 450' ' ' GLU . 8.6 p -74.91 -0.13 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.132 -0.486 . . . . 15.0 110.866 178.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -86.39 -15.13 41.33 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.843 -0.617 . . . . 15.0 111.102 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 67.85 40.9 89.31 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 121.019 -0.61 . . . . 15.0 112.605 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -115.65 -15.56 11.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.651 0.262 . . . . 15.0 111.238 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 89.46 -4.93 84.18 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.876 -0.678 . . . . 15.0 112.487 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -142.64 156.72 45.1 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.793 0.33 . . . . 15.0 110.722 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 446' ' ' ILE . . . . . 0.654 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.7 mp -78.67 134.99 26.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 15.0 111.282 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 447' ' ' SER . . . . . 0.697 ' OG ' ' HG3' ' A' ' 450' ' ' GLU . 90.5 p -107.05 149.02 28.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.623 -0.717 . . . . 15.0 110.617 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -48.49 -43.54 35.01 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.182 -0.463 . . . . 15.0 111.852 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.89 -40.68 98.27 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.534 -0.303 . . . . 15.0 111.436 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 450' ' ' GLU . . . . . 0.697 ' HG3' ' OG ' ' A' ' 447' ' ' SER . 25.9 mt-10 -61.08 -57.72 11.38 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.399 -0.364 . . . . 15.0 110.558 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 451' ' ' PHE . . . . . 0.502 ' O ' ' HG2' ' A' ' 455' ' ' ARG . 3.9 t80 -61.5 -27.16 68.39 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.992 -0.549 . . . . 15.0 110.967 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 452' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -61.44 -56.65 17.8 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.029 -0.532 . . . . 15.0 111.197 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 2.1 mt -72.6 -30.14 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.908 -0.587 . . . . 15.0 111.828 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 454' ' ' ILE . . . . . 0.405 HG23 ' CD1' ' A' ' 458' ' ' PHE . 45.9 mt -66.39 -56.32 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.752 -0.203 . . . . 15.0 111.462 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 455' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 451' ' ' PHE . 28.4 ptt180 -51.88 -33.04 34.92 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.931 0.345 . . . . 15.0 111.931 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -69.88 -34.81 71.84 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.901 -0.666 . . . . 15.0 112.83 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 457' ' ' ASN . . . . . 0.411 ' O ' ' HD3' ' A' ' 459' ' ' PRO . 42.0 m-80 -92.93 -13.77 28.44 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.589 0.233 . . . . 15.0 111.39 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 458' ' ' PHE . . . . . 0.405 ' CD1' HG23 ' A' ' 454' ' ' ILE . 81.2 m-85 -116.69 85.59 17.26 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.484 -0.325 . . . . 15.0 111.036 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 459' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 457' ' ' ASN . 12.3 Cg_exo -71.37 -11.75 28.88 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.965 2.443 . . . . 15.0 112.507 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -99.51 26.24 6.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.249 -0.432 . . . . 15.0 110.926 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.7 tp -91.09 146.31 23.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.093 -0.503 . . . . 15.0 111.104 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 66.7 m -69.2 -172.55 0.44 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.08 -0.509 . . . . 15.0 111.245 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 463' ' ' ALA . . . . . 0.683 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -85.06 150.68 24.7 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.227 -0.442 . . . . 15.0 111.461 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 464' ' ' PHE . . . . . 0.686 ' HA ' HD11 ' A' ' 467' ' ' LEU . 66.0 m-85 -55.46 -51.6 66.39 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.76 -0.655 . . . . 15.0 111.226 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -68.78 -11.97 63.8 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.111 -0.566 . . . . 15.0 113.276 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -88.79 -36.17 16.23 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.078 0.439 . . . . 15.0 111.145 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.686 HD11 ' HA ' ' A' ' 464' ' ' PHE . 0.1 OUTLIER -85.14 -23.99 28.18 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.024 0.44 . . . . 15.0 110.055 178.351 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -135.23 111.06 9.35 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.77 -0.65 . . . . 15.0 110.008 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -61.48 -36.42 80.41 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.053 -0.521 . . . . 15.0 112.041 -178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -77.63 -9.08 58.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.532 -0.304 . . . . 15.0 111.681 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 55.45 34.1 22.3 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.442 -0.344 . . . . 15.0 111.438 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -82.09 1.99 33.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.163 -0.471 . . . . 15.0 111.511 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.22 15.28 63.0 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.457 -0.878 . . . . 15.0 110.981 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 474' ' ' CYS . . . . . . . . . . . . . 13.5 t -136.61 130.56 32.47 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.127 -0.536 . . . . 15.0 110.374 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.654 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 1.4 mp -103.4 127.53 57.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.964 0.411 . . . . 15.0 111.253 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 12.7 t -103.94 175.16 5.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.695 -0.684 . . . . 15.0 110.811 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 477' ' ' ARG . . . . . 0.426 ' O ' HG23 ' A' ' 481' ' ' VAL . 99.0 mtt180 -56.98 -45.3 83.03 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.324 -0.398 . . . . 15.0 111.108 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 478' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.6 mt-10 -61.15 -29.57 69.87 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.179 -0.464 . . . . 15.0 111.524 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 479' ' ' GLU . . . . . 0.55 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 5.5 mm-40 -70.7 -49.03 51.42 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.401 0.143 . . . . 15.0 110.871 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 33.4 mtt -70.4 -46.22 64.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.72 -0.218 . . . . 15.0 111.02 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 481' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 477' ' ' ARG . 88.8 t -60.24 -52.72 58.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.689 0.28 . . . . 15.0 110.607 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 482' ' ' SER . . . . . 0.901 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 40.3 m -57.73 -32.7 67.7 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 116.171 -0.468 . . . . 15.0 110.061 178.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 483' ' ' TYR . . . . . 0.55 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 8.8 t80 -69.04 -30.9 69.36 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.872 -0.604 . . . . 15.0 110.913 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 484' ' ' PHE . . . . . 0.607 ' CE2' HG22 ' A' ' 431' ' ' VAL . 0.1 OUTLIER -74.17 -40.54 62.47 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 110.243 -0.281 . . . . 15.0 110.243 179.279 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.2 tt -83.44 -18.9 37.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 15.0 110.531 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 486' ' ' ARG . . . . . 0.901 ' HB2' ' O ' ' A' ' 482' ' ' SER . 32.9 ttt180 -71.49 -52.22 19.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.345 . . . . 15.0 110.843 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 14.0 t -90.13 19.46 5.0 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.977 -0.556 . . . . 15.0 111.244 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 488' ' ' SER . . . . . 0.56 ' HB2' ' O ' ' A' ' 484' ' ' PHE . 22.8 t . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.31 -0.405 . . . . 15.0 111.004 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.68 ' O ' HG23 ' A' ' 423' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.811 0.338 . . . . 15.0 111.091 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.754 ' O ' HG23 ' A' ' 424' ' ' VAL . 4.3 tt0 -46.72 -56.52 6.04 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.781 -0.645 . . . . 15.0 111.961 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -63.51 -39.83 95.46 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.438 -0.347 . . . . 15.0 111.485 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 5.2 tp -57.33 -51.75 68.13 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.902 -0.59 . . . . 15.0 111.603 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.1 t -81.18 -21.68 10.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 115.67 -0.696 . . . . 15.0 111.929 -177.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 424' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 420' ' ' GLN . 12.0 t -64.05 -48.22 86.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.95 -0.759 . . . . 15.0 108.95 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -72.91 -33.04 65.73 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.37 -0.832 . . . . 15.0 110.629 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' HIS . . . . . 0.644 ' O ' ' HB2' ' A' ' 430' ' ' MET . 2.2 t60 -71.26 -39.32 71.67 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.579 -0.282 . . . . 15.0 110.984 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 427' ' ' ILE . . . . . 0.565 HG13 HG12 ' A' ' 423' ' ' VAL . 41.4 mt -69.29 -50.68 49.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.407 -0.361 . . . . 15.0 110.809 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -58.95 -43.27 91.22 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.088 0.471 . . . . 15.0 110.141 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.611 ' O ' ' HB2' ' A' ' 433' ' ' SER . 92.0 mttt -72.49 -23.04 60.97 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.513 -0.767 . . . . 15.0 110.516 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 430' ' ' MET . . . . . 0.666 ' O ' HG23 ' A' ' 434' ' ' VAL . 4.0 ttt -70.69 -49.55 45.98 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.456 -0.338 . . . . 15.0 110.8 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 427' ' ' ILE . 2.7 t -65.02 -39.07 84.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.269 -0.423 . . . . 15.0 110.008 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -71.38 -31.26 67.1 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.879 -0.601 . . . . 15.0 110.564 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.949 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 12.7 t -70.67 -41.22 72.38 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 116.217 -0.447 . . . . 15.0 111.041 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 430' ' ' MET . 19.4 t -75.1 -42.68 45.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.26 -0.427 . . . . 15.0 110.969 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 435' ' ' PHE . . . . . 0.633 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 14.3 t80 -59.28 -42.08 90.39 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.12 -0.491 . . . . 15.0 111.02 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -84.95 -27.95 26.18 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.548 -0.296 . . . . 15.0 110.953 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 437' ' ' ASN . . . . . 0.949 ' HB2' ' O ' ' A' ' 433' ' ' SER . 2.2 t30 -60.12 -44.89 94.54 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.203 -0.453 . . . . 15.0 111.393 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 438' ' ' PHE . . . . . 0.426 ' CZ ' HD21 ' A' ' 461' ' ' LEU . 45.3 m-85 -94.78 4.84 53.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.372 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 439' ' ' ASP . . . . . 0.633 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 0.3 OUTLIER -126.84 55.2 1.56 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.899 0.38 . . . . 15.0 111.352 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 440' ' ' VAL . . . . . 0.401 ' H ' HG23 ' A' ' 440' ' ' VAL . 2.5 t -68.64 -8.42 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.129 -0.487 . . . . 15.0 111.325 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -87.97 -6.47 57.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.233 -0.44 . . . . 15.0 111.16 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 62.04 30.19 74.83 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.843 -0.694 . . . . 15.0 111.979 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -90.51 -18.91 24.47 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 122.307 0.243 . . . . 15.0 111.291 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 83.21 -7.33 67.87 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.91 -0.662 . . . . 15.0 112.576 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 445' ' ' HIS . . . . . 0.606 ' HB3' ' SG ' ' A' ' 474' ' ' CYS . 73.3 m-70 -131.84 140.21 49.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.809 0.338 . . . . 15.0 110.602 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 446' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 474' ' ' CYS . 1.5 mp -84.98 98.57 6.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.157 -0.474 . . . . 15.0 111.013 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 29.8 m -68.29 155.33 39.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.82 -0.627 . . . . 15.0 111.016 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -53.67 -40.62 66.09 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.153 -0.476 . . . . 15.0 111.825 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 449' ' ' GLU . . . . . 0.567 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -62.81 -39.42 94.21 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.496 -0.32 . . . . 15.0 111.424 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 450' ' ' GLU . . . . . 0.445 ' OE1' ' HA ' ' A' ' 446' ' ' ILE . 49.7 mt-10 -57.13 -58.83 6.47 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.048 0.451 . . . . 15.0 110.448 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 451' ' ' PHE . . . . . 0.614 ' CZ ' HD23 ' A' ' 461' ' ' LEU . 6.9 t80 -69.05 -20.43 64.11 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.771 -0.649 . . . . 15.0 110.609 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 452' ' ' GLN . . . . . 0.567 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 0.4 OUTLIER -59.31 -54.91 41.39 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.877 -0.601 . . . . 15.0 111.113 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -84.32 -32.5 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.733 -0.667 . . . . 15.0 111.843 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 57.7 mt -64.57 -40.07 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 111.664 0.246 . . . . 15.0 111.664 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 455' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 452' ' ' GLN . 32.0 ptt180 -59.67 -19.09 47.2 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.631 0.253 . . . . 15.0 111.597 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -79.32 -23.55 62.86 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.899 -0.667 . . . . 15.0 112.506 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -88.09 -27.25 22.06 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.642 0.258 . . . . 15.0 111.196 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -121.67 87.77 46.27 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.335 -0.393 . . . . 15.0 110.817 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.41 -3.89 13.36 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.963 2.442 . . . . 15.0 112.67 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -103.54 23.66 12.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.369 -0.378 . . . . 15.0 111.011 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.614 HD23 ' CZ ' ' A' ' 451' ' ' PHE . 2.9 tp -102.29 155.29 18.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.088 -0.505 . . . . 15.0 111.08 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 55.2 m -71.98 172.84 9.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.072 -0.513 . . . . 15.0 111.333 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 463' ' ' ALA . . . . . 0.46 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -91.54 156.64 17.52 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.115 -0.493 . . . . 15.0 111.77 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -45.83 -48.74 15.73 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.695 -0.684 . . . . 15.0 111.568 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -62.37 -23.84 64.97 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.89 -0.596 . . . . 15.0 113.637 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -88.43 -28.95 20.56 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 117.063 0.431 . . . . 15.0 111.592 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 463' ' ' ALA . 0.0 OUTLIER -77.43 -34.91 54.51 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.849 0.356 . . . . 15.0 110.252 178.524 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 468' ' ' ASP . . . . . 0.44 ' OD1' ' HB2' ' A' ' 470' ' ' ASN . 9.1 t70 -130.39 119.77 23.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.893 -0.594 . . . . 15.0 110.496 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -68.19 -28.05 66.93 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.104 -0.498 . . . . 15.0 111.525 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.44 ' HB2' ' OD1' ' A' ' 468' ' ' ASP . 8.6 m120 -76.88 -10.69 59.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.252 -0.431 . . . . 15.0 111.357 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 56.24 34.03 23.25 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.289 -0.414 . . . . 15.0 111.414 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -82.42 -1.89 51.48 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.199 -0.455 . . . . 15.0 111.514 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 65.59 14.95 61.09 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.585 -0.817 . . . . 15.0 111.436 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 474' ' ' CYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 446' ' ' ILE . 4.2 t -135.09 130.92 36.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.248 -0.476 . . . . 15.0 110.403 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.459 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 9.5 mm -105.04 124.88 60.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.982 0.42 . . . . 15.0 111.212 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 50.5 m -103.28 174.79 5.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.707 -0.679 . . . . 15.0 110.615 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -56.02 -49.07 74.7 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.418 -0.356 . . . . 15.0 111.018 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 478' ' ' GLU . . . . . 0.668 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -61.76 -33.44 74.09 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.124 -0.489 . . . . 15.0 111.763 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 479' ' ' GLU . . . . . 0.539 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 5.4 mm-40 -69.5 -53.23 20.15 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 121.228 -0.189 . . . . 15.0 110.983 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 480' ' ' MET . . . . . 0.407 ' SD ' ' HB ' ' A' ' 434' ' ' VAL . 9.9 ttm -69.21 -48.56 61.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.754 -0.203 . . . . 15.0 111.313 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 481' ' ' VAL . . . . . 0.553 HG22 HG11 ' A' ' 431' ' ' VAL . 79.4 t -60.92 -55.77 22.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.575 0.226 . . . . 15.0 111.217 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 482' ' ' SER . . . . . 0.958 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 44.5 m -54.89 -36.96 65.7 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.382 -0.372 . . . . 15.0 110.548 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 483' ' ' TYR . . . . . 0.539 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 1.9 m-85 -71.23 -26.04 62.75 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.236 -0.438 . . . . 15.0 111.321 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 484' ' ' PHE . . . . . 0.519 ' CD2' HG22 ' A' ' 431' ' ' VAL . 1.9 m-85 -73.37 -44.55 58.42 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 110.129 -0.323 . . . . 15.0 110.129 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.4 tt -84.24 -17.61 39.19 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.135 -0.484 . . . . 15.0 110.672 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 486' ' ' ARG . . . . . 0.958 ' HB2' ' O ' ' A' ' 482' ' ' SER . 30.8 ttt180 -70.97 -48.8 51.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.887 0.375 . . . . 15.0 110.758 177.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 52.2 m -82.7 19.26 1.35 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.89 -0.596 . . . . 15.0 111.469 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 C--O 1.232 0.166 0 CA-C-N 116.358 -0.383 . . . . 15.0 111.0 179.826 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.637 ' O ' HG23 ' A' ' 423' ' ' VAL . 1.1 m-20 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.857 0.36 . . . . 15.0 111.107 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.731 ' O ' HG23 ' A' ' 424' ' ' VAL . 45.4 mt-30 -47.62 -56.15 7.81 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.77 -0.65 . . . . 15.0 111.994 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -64.13 -40.94 97.25 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.384 -0.371 . . . . 15.0 111.67 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 5.0 tp -57.4 -53.3 59.65 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.041 -0.527 . . . . 15.0 111.726 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.7 t -80.13 -23.36 11.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.674 -0.694 . . . . 15.0 112.004 -177.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 424' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 420' ' ' GLN . 8.4 t -63.22 -47.66 91.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.02 -0.733 . . . . 15.0 109.02 177.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -71.77 -34.38 69.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.422 -0.808 . . . . 15.0 110.504 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -70.53 -40.39 73.46 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.534 -0.303 . . . . 15.0 110.946 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 427' ' ' ILE . . . . . 0.553 HG13 HG12 ' A' ' 423' ' ' VAL . 35.9 mt -66.36 -53.68 33.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.355 -0.384 . . . . 15.0 110.771 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -57.15 -41.83 79.89 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.105 0.479 . . . . 15.0 110.326 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.632 ' O ' ' HB2' ' A' ' 433' ' ' SER . 89.2 mttt -70.86 -24.7 62.56 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.538 -0.756 . . . . 15.0 110.749 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 430' ' ' MET . . . . . 0.664 ' O ' HG23 ' A' ' 434' ' ' VAL . 33.9 mtp -71.99 -47.49 51.69 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.405 -0.362 . . . . 15.0 110.891 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.588 HG22 ' CE2' ' A' ' 484' ' ' PHE . 0.8 OUTLIER -63.62 -40.98 91.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.065 0.459 . . . . 15.0 109.939 178.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -72.24 -30.35 64.8 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.666 -0.697 . . . . 15.0 110.826 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.837 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 12.2 t -68.75 -43.48 75.76 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.307 -0.406 . . . . 15.0 111.085 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 430' ' ' MET . 7.7 t -75.27 -41.97 43.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.32 -0.4 . . . . 15.0 110.848 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 435' ' ' PHE . . . . . 0.637 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 3.8 t80 -58.39 -41.57 85.16 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.09 -0.504 . . . . 15.0 110.967 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -85.11 -27.17 26.43 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.371 -0.377 . . . . 15.0 110.889 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 437' ' ' ASN . . . . . 0.837 ' HB2' ' O ' ' A' ' 433' ' ' SER . 2.7 t30 -59.36 -44.54 92.68 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.272 -0.422 . . . . 15.0 111.194 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 438' ' ' PHE . . . . . 0.516 ' CE2' HG21 ' A' ' 454' ' ' ILE . 33.1 m-85 -90.2 -5.91 55.87 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.019 -0.537 . . . . 15.0 111.212 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 439' ' ' ASP . . . . . 0.637 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 0.2 OUTLIER -109.82 53.94 0.68 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.838 0.351 . . . . 15.0 111.405 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 3.3 m -70.6 -9.22 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.21 -0.45 . . . . 15.0 111.617 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -88.92 -15.14 35.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.235 -0.439 . . . . 15.0 111.144 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 73.12 37.77 55.36 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.922 -0.656 . . . . 15.0 112.538 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -97.31 -16.39 20.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.653 0.264 . . . . 15.0 111.195 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 86.8 -7.69 78.88 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.825 -0.702 . . . . 15.0 112.374 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 445' ' ' HIS . . . . . 0.49 ' HB2' ' SG ' ' A' ' 474' ' ' CYS . 15.0 p80 -142.39 158.36 43.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.759 0.314 . . . . 15.0 110.712 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 446' ' ' ILE . . . . . 0.766 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.6 mp -77.71 135.99 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 15.0 111.165 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 14.4 t -106.19 148.11 28.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.585 -0.734 . . . . 15.0 110.767 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -50.18 -46.39 54.22 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.214 -0.448 . . . . 15.0 111.507 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 449' ' ' GLU . . . . . 0.469 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -65.42 -35.24 80.33 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.426 -0.352 . . . . 15.0 110.89 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -60.06 -59.56 5.23 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.241 -0.436 . . . . 15.0 110.483 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.36 -23.56 67.01 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.984 -0.553 . . . . 15.0 110.629 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 452' ' ' GLN . . . . . 0.469 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 8.1 mt-30 -60.14 -57.57 12.27 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.802 -0.635 . . . . 15.0 111.234 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 8.7 mm -76.6 -33.05 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.782 -0.645 . . . . 15.0 111.831 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 454' ' ' ILE . . . . . 0.516 HG21 ' CE2' ' A' ' 438' ' ' PHE . 48.5 mt -62.71 -46.98 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.803 -0.18 . . . . 15.0 111.133 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 455' ' ' ARG . . . . . 0.626 ' NH2' ' HA ' ' A' ' 463' ' ' ALA . 10.5 mtt180 -54.79 -34.33 62.56 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.718 0.294 . . . . 15.0 111.551 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -66.05 -30.84 77.74 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.994 -0.622 . . . . 15.0 112.896 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -96.95 -16.32 20.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.667 0.27 . . . . 15.0 111.293 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -132.97 85.79 44.99 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.308 -0.406 . . . . 15.0 110.983 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -72.84 1.74 6.11 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.062 2.508 . . . . 15.0 112.452 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -87.61 6.77 32.89 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.313 -0.403 . . . . 15.0 111.223 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -83.76 142.41 30.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.239 -0.437 . . . . 15.0 111.088 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 43.4 p -70.62 -172.56 0.64 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.161 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 463' ' ' ALA . . . . . 0.73 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -86.93 150.22 24.24 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.365 -0.38 . . . . 15.0 111.264 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 464' ' ' PHE . . . . . 0.731 ' HA ' HD11 ' A' ' 467' ' ' LEU . 80.0 m-85 -59.14 -46.71 87.64 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.023 -0.535 . . . . 15.0 111.371 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -67.68 -16.44 67.84 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.921 -0.656 . . . . 15.0 113.225 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -90.23 -41.35 11.64 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.913 0.356 . . . . 15.0 111.705 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.81 HD13 HD11 ' A' ' 475' ' ' ILE . 0.7 OUTLIER -76.53 -27.47 55.98 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.703 0.287 . . . . 15.0 110.842 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 468' ' ' ASP . . . . . 0.621 ' N ' HD12 ' A' ' 467' ' ' LEU . 10.9 t70 -128.16 112.2 14.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.203 -0.453 . . . . 15.0 110.362 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -67.02 -29.53 69.37 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.011 -0.54 . . . . 15.0 111.312 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -76.52 -13.66 60.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 15.0 111.144 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 60.65 28.05 17.76 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.199 -0.455 . . . . 15.0 111.285 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -71.42 -7.86 50.06 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.137 -0.483 . . . . 15.0 111.838 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.86 18.41 68.51 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.405 -0.902 . . . . 15.0 111.299 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 474' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 445' ' ' HIS . 19.0 t -137.16 130.88 31.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.256 -0.472 . . . . 15.0 110.464 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.81 HD11 HD13 ' A' ' 467' ' ' LEU . 9.0 mm -93.92 120.19 42.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.959 0.409 . . . . 15.0 111.01 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 476' ' ' SER . . . . . 0.464 ' H ' ' HG3' ' A' ' 479' ' ' GLU . 52.9 m -103.38 173.4 6.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.819 -0.628 . . . . 15.0 110.686 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 477' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 481' ' ' VAL . 98.8 mtt180 -53.74 -45.38 70.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.427 -0.351 . . . . 15.0 110.959 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 478' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -62.38 -28.36 69.72 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.046 -0.524 . . . . 15.0 111.361 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 479' ' ' GLU . . . . . 0.576 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 43.6 mm-40 -71.15 -50.05 37.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.41 0.147 . . . . 15.0 110.777 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 40.3 mtt -70.58 -46.66 63.03 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.797 -0.183 . . . . 15.0 110.958 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 481' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 477' ' ' ARG . 84.1 t -59.84 -54.12 38.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.758 0.313 . . . . 15.0 110.693 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 482' ' ' SER . . . . . 0.942 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 38.6 m -56.63 -33.11 65.99 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 116.215 -0.448 . . . . 15.0 110.117 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 483' ' ' TYR . . . . . 0.576 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 8.5 t80 -69.27 -29.74 67.7 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.921 -0.581 . . . . 15.0 110.966 177.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 484' ' ' PHE . . . . . 0.588 ' CE2' HG22 ' A' ' 431' ' ' VAL . 0.1 OUTLIER -73.9 -41.93 61.42 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 110.215 -0.291 . . . . 15.0 110.215 179.259 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.5 mp -83.83 -17.78 39.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.308 -0.405 . . . . 15.0 110.556 177.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 486' ' ' ARG . . . . . 0.942 ' HB2' ' O ' ' A' ' 482' ' ' SER . 34.4 ttt180 -71.99 -48.26 46.1 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.323 -0.399 . . . . 15.0 110.812 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 53.3 m -80.58 19.65 0.79 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.872 -0.604 . . . . 15.0 111.502 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 54.6 m . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 116.374 -0.376 . . . . 15.0 110.926 179.834 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.616 ' O ' HG23 ' A' ' 423' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.83 0.348 . . . . 15.0 111.238 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.732 ' O ' HG23 ' A' ' 424' ' ' VAL . 53.3 mt-30 -47.25 -55.68 8.18 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.819 -0.628 . . . . 15.0 111.879 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -63.14 -40.37 97.39 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.308 -0.405 . . . . 15.0 111.51 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 4.9 tp -57.46 -53.01 62.95 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.009 -0.541 . . . . 15.0 111.673 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.5 t -79.95 -22.65 11.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.658 -0.701 . . . . 15.0 111.973 -177.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 424' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 420' ' ' GLN . 9.9 t -63.43 -47.75 90.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 109.047 -0.723 . . . . 15.0 109.047 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -71.96 -34.17 68.76 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.33 -0.85 . . . . 15.0 110.577 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -70.78 -40.42 72.61 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.612 -0.267 . . . . 15.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 427' ' ' ILE . . . . . 0.561 HG13 HG12 ' A' ' 423' ' ' VAL . 36.9 mt -66.48 -53.34 36.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.362 -0.381 . . . . 15.0 110.667 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -57.24 -42.27 81.12 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.151 0.5 . . . . 15.0 110.143 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -69.87 -25.34 63.67 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.528 -0.76 . . . . 15.0 110.549 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 430' ' ' MET . . . . . 0.681 ' O ' HG23 ' A' ' 434' ' ' VAL . 31.7 mmm -70.67 -47.73 58.44 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.425 -0.352 . . . . 15.0 110.935 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.584 HG22 ' CE2' ' A' ' 484' ' ' PHE . 0.8 OUTLIER -62.93 -40.3 88.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.014 0.435 . . . . 15.0 110.025 179.073 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -72.53 -33.31 66.79 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.733 -0.667 . . . . 15.0 110.978 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.796 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 3.6 m -66.33 -43.47 86.05 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.344 -0.389 . . . . 15.0 111.093 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 430' ' ' MET . 4.9 t -75.94 -38.84 36.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.212 -0.449 . . . . 15.0 110.779 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 435' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 431' ' ' VAL . 4.4 t80 -55.92 -42.87 76.73 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.068 -0.515 . . . . 15.0 110.821 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -89.16 -24.03 22.29 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.401 -0.363 . . . . 15.0 111.284 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 437' ' ' ASN . . . . . 0.796 ' HB2' ' O ' ' A' ' 433' ' ' SER . 4.2 t-20 -59.95 -34.7 73.6 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.987 0.422 . . . . 15.0 110.402 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 438' ' ' PHE . . . . . 0.439 ' O ' ' HB3' ' A' ' 450' ' ' GLU . 7.2 m-85 -71.79 -41.63 68.07 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.622 -0.717 . . . . 15.0 111.888 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 439' ' ' ASP . . . . . 0.722 ' HA ' ' OE2' ' A' ' 450' ' ' GLU . 5.1 p-10 -139.53 82.29 1.87 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.144 0.497 . . . . 15.0 111.91 -178.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.9 m -72.42 -8.57 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.925 -0.579 . . . . 15.0 111.248 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -66.84 -15.39 63.58 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.049 -0.523 . . . . 15.0 111.408 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 91.04 47.3 3.64 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.931 -0.652 . . . . 15.0 112.423 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -101.3 -19.53 15.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.674 0.273 . . . . 15.0 111.207 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 78.94 -13.69 17.7 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.039 -0.6 . . . . 15.0 113.0 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -144.48 168.37 20.29 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.889 0.376 . . . . 15.0 110.806 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 446' ' ' ILE . . . . . 0.594 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.2 mp -74.56 126.56 35.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.021 -0.536 . . . . 15.0 111.24 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 52.9 m -106.36 147.37 29.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.743 -0.662 . . . . 15.0 110.83 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -50.03 -45.59 52.18 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.193 -0.458 . . . . 15.0 111.677 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.72 -40.19 96.14 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.48 -0.327 . . . . 15.0 111.234 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 450' ' ' GLU . . . . . 0.722 ' OE2' ' HA ' ' A' ' 439' ' ' ASP . 5.5 mm-40 -63.33 -56.13 18.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.433 -0.349 . . . . 15.0 110.385 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.83 -28.99 67.96 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.165 -0.471 . . . . 15.0 110.93 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 452' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -61.82 -55.87 25.41 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 115.928 -0.578 . . . . 15.0 111.081 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 2.8 mt -70.86 -28.38 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.914 -0.585 . . . . 15.0 111.624 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 454' ' ' ILE . . . . . 0.453 HG23 ' CD1' ' A' ' 458' ' ' PHE . 30.3 mt -67.24 -56.98 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.67 -0.241 . . . . 15.0 111.183 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -47.93 -36.17 11.93 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.478 -0.328 . . . . 15.0 111.877 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -63.79 -34.05 88.89 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.986 -0.626 . . . . 15.0 112.947 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -104.24 -2.43 25.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.537 0.208 . . . . 15.0 111.345 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 458' ' ' PHE . . . . . 0.453 ' CD1' HG23 ' A' ' 454' ' ' ILE . 81.4 m-85 -128.75 79.96 73.49 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.523 -0.308 . . . . 15.0 111.155 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -75.09 -3.66 14.25 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.075 2.517 . . . . 15.0 112.543 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -107.71 26.41 10.34 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.207 -0.451 . . . . 15.0 111.013 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 2.4 tp -91.62 151.36 20.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.176 -0.466 . . . . 15.0 111.118 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 49.2 m -67.73 176.7 2.36 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.104 -0.498 . . . . 15.0 111.362 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 463' ' ' ALA . . . . . 0.786 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -89.05 153.11 21.26 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.128 -0.487 . . . . 15.0 111.288 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 464' ' ' PHE . . . . . 0.698 ' HA ' HD11 ' A' ' 467' ' ' LEU . 78.1 m-85 -57.41 -49.14 77.17 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.069 -0.514 . . . . 15.0 111.437 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -68.95 -15.48 69.37 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.992 -0.623 . . . . 15.0 113.57 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 466' ' ' ASP . . . . . 0.507 ' OD1' ' HB3' ' A' ' 463' ' ' ALA . 5.1 m-20 -89.83 -41.6 11.74 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.1 0.45 . . . . 15.0 111.712 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.887 HD13 HD11 ' A' ' 475' ' ' ILE . 0.6 OUTLIER -78.0 -27.74 49.05 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.747 0.308 . . . . 15.0 110.714 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 468' ' ' ASP . . . . . 0.589 ' N ' HD12 ' A' ' 467' ' ' LEU . 13.7 t70 -129.83 111.38 12.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.073 -0.512 . . . . 15.0 110.336 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -66.0 -30.25 70.77 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.369 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -76.38 -13.52 60.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.343 -0.389 . . . . 15.0 111.262 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 59.9 28.09 17.55 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.25 -0.432 . . . . 15.0 111.287 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -74.37 -5.26 41.3 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.201 -0.454 . . . . 15.0 111.723 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.72 17.95 67.67 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.403 -0.904 . . . . 15.0 111.265 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 474' ' ' CYS . . . . . . . . . . . . . 15.8 t -136.31 130.96 33.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.226 -0.487 . . . . 15.0 110.496 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.887 HD11 HD13 ' A' ' 467' ' ' LEU . 14.1 mm -95.25 120.81 45.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.899 0.381 . . . . 15.0 110.977 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 476' ' ' SER . . . . . 0.471 ' H ' ' HG3' ' A' ' 479' ' ' GLU . 54.3 m -103.08 171.79 7.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 15.0 110.667 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 477' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 481' ' ' VAL . 81.0 mtm180 -53.47 -44.59 69.09 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.417 -0.356 . . . . 15.0 110.931 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 478' ' ' GLU . . . . . 0.523 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.8 mt-10 -62.91 -28.81 70.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.075 -0.511 . . . . 15.0 111.358 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 479' ' ' GLU . . . . . 0.607 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 63.5 mm-40 -70.5 -50.26 39.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.499 0.19 . . . . 15.0 110.875 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 33.7 mtt -70.85 -46.89 61.87 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.709 -0.223 . . . . 15.0 111.168 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 481' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 477' ' ' ARG . 82.1 t -59.81 -53.13 52.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.626 0.251 . . . . 15.0 110.71 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 482' ' ' SER . . . . . 0.955 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 47.0 m -58.25 -32.66 68.57 Favored 'General case' 0 C--O 1.227 -0.104 0 CA-C-N 116.301 -0.408 . . . . 15.0 110.15 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 483' ' ' TYR . . . . . 0.607 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 7.4 t80 -69.62 -30.16 67.83 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.93 -0.577 . . . . 15.0 111.104 177.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 484' ' ' PHE . . . . . 0.584 ' CE2' HG22 ' A' ' 431' ' ' VAL . 0.1 OUTLIER -75.18 -40.51 59.36 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.762 0.315 . . . . 15.0 110.252 179.29 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.3 tt -83.98 -17.3 40.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 15.0 110.585 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 486' ' ' ARG . . . . . 0.955 ' HB2' ' O ' ' A' ' 482' ' ' SER . 25.1 ttt180 -74.14 -47.81 33.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.859 0.362 . . . . 15.0 110.918 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 13.9 t -82.89 19.92 1.28 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.901 -0.59 . . . . 15.0 111.554 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 88.1 p . . . . . 0 C--N 1.332 -0.169 0 CA-C-O 120.792 0.329 . . . . 15.0 110.919 179.744 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.669 ' O ' HG23 ' A' ' 423' ' ' VAL . 7.6 m-20 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.787 0.327 . . . . 15.0 111.098 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.725 ' O ' HG23 ' A' ' 424' ' ' VAL . 6.5 pt20 -46.42 -56.92 5.19 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.087 -0.506 . . . . 15.0 111.784 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 421' ' ' ALA . . . . . 0.418 ' H ' ' HG3' ' A' ' 420' ' ' GLN . . . -68.39 -37.64 80.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.404 -0.362 . . . . 15.0 111.279 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.527 HD13 ' OD2' ' A' ' 419' ' ' ASP . 1.2 tt -57.75 -53.72 55.06 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.882 -0.599 . . . . 15.0 111.701 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.6 t -80.78 -23.8 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 CA-C-N 115.657 -0.701 . . . . 15.0 112.05 -177.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 424' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 420' ' ' GLN . 7.2 t -62.9 -47.87 90.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.093 -0.706 . . . . 15.0 109.093 177.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -71.92 -34.16 68.86 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.486 -0.779 . . . . 15.0 110.561 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -70.72 -39.37 73.43 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.558 -0.292 . . . . 15.0 111.04 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' ILE . . . . . 0.572 ' O ' HG23 ' A' ' 431' ' ' VAL . 37.6 mt -67.84 -51.91 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.37 -0.377 . . . . 15.0 110.732 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -58.4 -42.19 86.61 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.192 0.52 . . . . 15.0 110.303 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.555 ' O ' ' HB2' ' A' ' 433' ' ' SER . 90.2 mttt -71.15 -25.14 62.43 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.521 -0.763 . . . . 15.0 110.707 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 430' ' ' MET . . . . . 0.683 ' O ' HG23 ' A' ' 434' ' ' VAL . 23.3 mmm -71.45 -46.97 58.6 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.448 -0.342 . . . . 15.0 110.908 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 427' ' ' ILE . 2.6 t -65.33 -39.15 84.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.879 0.371 . . . . 15.0 110.061 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -72.16 -31.14 65.68 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.859 -0.61 . . . . 15.0 110.73 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.869 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 14.2 t -70.86 -41.88 70.82 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.196 -0.456 . . . . 15.0 111.06 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 430' ' ' MET . 17.8 t -75.87 -41.29 39.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.249 -0.432 . . . . 15.0 110.956 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -60.58 -41.32 94.4 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.297 -0.41 . . . . 15.0 110.815 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -83.21 -28.62 29.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.504 -0.316 . . . . 15.0 110.681 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 437' ' ' ASN . . . . . 0.869 ' HB2' ' O ' ' A' ' 433' ' ' SER . 2.5 t30 -60.11 -44.54 94.77 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.085 -0.507 . . . . 15.0 111.247 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 438' ' ' PHE . . . . . 0.522 ' CE2' HG21 ' A' ' 454' ' ' ILE . 66.6 m-85 -93.94 0.53 56.14 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.841 -0.618 . . . . 15.0 111.448 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -127.48 53.1 1.77 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.979 0.418 . . . . 15.0 111.179 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.9 t -74.39 -14.24 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.078 -0.51 . . . . 15.0 111.065 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -90.2 -14.74 32.83 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.074 -0.512 . . . . 15.0 111.032 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 64.55 60.06 7.48 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.051 -0.595 . . . . 15.0 112.796 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.44 -10.81 11.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.705 0.288 . . . . 15.0 111.223 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 88.93 -13.55 62.75 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.811 -0.709 . . . . 15.0 112.227 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 445' ' ' HIS . . . . . 0.631 ' HB2' ' SG ' ' A' ' 474' ' ' CYS . 9.5 p80 -141.58 156.81 45.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.602 0.239 . . . . 15.0 110.415 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 446' ' ' ILE . . . . . 0.875 HG12 ' H ' ' A' ' 475' ' ' ILE . 0.9 OUTLIER -82.99 100.85 6.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.366 -0.379 . . . . 15.0 111.143 -179.166 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 7.6 t -67.71 152.12 46.13 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.282 -0.417 . . . . 15.0 110.918 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -51.59 -43.11 62.38 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.07 -0.514 . . . . 15.0 111.951 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 449' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 452' ' ' GLN . 42.7 mt-10 -63.03 -40.09 96.7 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.552 -0.294 . . . . 15.0 111.322 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -58.24 -56.38 22.88 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.935 0.398 . . . . 15.0 110.412 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -66.85 -23.29 66.01 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.935 -0.575 . . . . 15.0 110.608 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 452' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 449' ' ' GLU . 2.6 mm-40 -59.1 -54.84 42.48 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.838 -0.619 . . . . 15.0 111.008 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 8.7 mm -78.98 -31.82 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 115.649 -0.705 . . . . 15.0 111.694 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 454' ' ' ILE . . . . . 0.522 HG21 ' CE2' ' A' ' 438' ' ' PHE . 50.2 mt -61.22 -46.86 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.494 0.188 . . . . 15.0 111.273 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -55.74 -29.97 60.42 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.552 -0.295 . . . . 15.0 111.561 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -66.0 -31.8 80.58 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.963 -0.637 . . . . 15.0 112.759 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -103.64 -11.7 17.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.607 0.242 . . . . 15.0 111.365 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -136.23 78.98 44.52 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 116.465 -0.334 . . . . 15.0 110.985 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.08 2.4 6.71 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.166 2.577 . . . . 15.0 112.624 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -85.2 5.19 31.16 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.325 -0.398 . . . . 15.0 111.285 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -87.76 142.39 27.86 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.263 -0.426 . . . . 15.0 111.063 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 462' ' ' SER . . . . . 0.406 ' HB2' ' H ' ' A' ' 463' ' ' ALA . 5.8 p -81.39 -157.35 0.17 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.066 -0.515 . . . . 15.0 110.975 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 463' ' ' ALA . . . . . 0.555 ' HB3' ' OD2' ' A' ' 466' ' ' ASP . . . -85.4 148.47 25.99 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.926 0.393 . . . . 15.0 111.655 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -51.24 -46.36 62.31 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.771 -0.649 . . . . 15.0 111.121 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -63.57 -19.38 62.5 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.907 -0.588 . . . . 15.0 113.005 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 466' ' ' ASP . . . . . 0.555 ' OD2' ' HB3' ' A' ' 463' ' ' ALA . 7.6 m-20 -87.87 -37.11 16.78 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.765 0.282 . . . . 15.0 110.977 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.442 ' H ' ' HG ' ' A' ' 467' ' ' LEU . 0.1 OUTLIER -68.99 -34.11 74.77 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.96 0.41 . . . . 15.0 110.154 178.34 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 468' ' ' ASP . . . . . 0.467 ' OD2' ' HB2' ' A' ' 470' ' ' ASN . 8.5 t70 -120.34 117.17 27.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.698 -0.683 . . . . 15.0 110.413 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -64.26 -27.68 69.21 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.083 -0.508 . . . . 15.0 111.577 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 470' ' ' ASN . . . . . 0.467 ' HB2' ' OD2' ' A' ' 468' ' ' ASP . 5.0 m-80 -76.94 -9.01 58.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.371 -0.377 . . . . 15.0 111.442 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 54.4 36.01 24.46 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.365 -0.38 . . . . 15.0 111.4 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -88.43 0.78 55.87 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.194 -0.457 . . . . 15.0 111.47 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 65.67 14.08 59.88 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.427 -0.892 . . . . 15.0 111.314 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 474' ' ' CYS . . . . . 0.631 ' SG ' ' HB2' ' A' ' 445' ' ' HIS . 1.2 m -137.69 130.7 30.32 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.202 -0.499 . . . . 15.0 110.508 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.875 ' H ' HG12 ' A' ' 446' ' ' ILE . 2.7 mp -107.89 128.92 62.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.992 0.425 . . . . 15.0 111.246 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 48.8 m -104.33 -179.58 3.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.597 -0.728 . . . . 15.0 110.784 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 477' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 481' ' ' VAL . 24.6 ptt180 -62.58 -47.51 83.5 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.364 -0.38 . . . . 15.0 111.214 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 478' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -60.45 -33.95 73.29 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.252 -0.431 . . . . 15.0 111.48 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 479' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 6.8 mm-40 -66.79 -45.21 79.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.562 0.22 . . . . 15.0 110.626 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 40.3 mtt -69.76 -47.58 62.47 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.608 -0.269 . . . . 15.0 110.893 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 481' ' ' VAL . . . . . 0.568 HG22 HG11 ' A' ' 431' ' ' VAL . 89.9 t -60.14 -55.61 23.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.737 0.303 . . . . 15.0 110.937 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 482' ' ' SER . . . . . 0.952 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 75.0 m -54.51 -38.79 66.92 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 116.128 -0.487 . . . . 15.0 110.605 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 483' ' ' TYR . . . . . 0.489 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 2.6 m-85 -71.58 -24.43 61.91 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.036 -0.529 . . . . 15.0 111.555 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 484' ' ' PHE . . . . . 0.533 ' CD2' HG22 ' A' ' 431' ' ' VAL . 3.7 m-85 -75.28 -43.55 50.64 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 120.843 -0.343 . . . . 15.0 110.163 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 485' ' ' LEU . . . . . 0.434 ' HA ' ' OG ' ' A' ' 488' ' ' SER . 5.3 tt -84.16 -18.69 35.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 15.0 110.642 176.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 486' ' ' ARG . . . . . 0.952 ' HB2' ' O ' ' A' ' 482' ' ' SER . 24.2 ttt180 -70.97 -49.57 43.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.899 0.38 . . . . 15.0 110.791 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 14.5 t -83.43 19.68 1.5 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.831 -0.622 . . . . 15.0 111.339 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 488' ' ' SER . . . . . 0.434 ' OG ' ' HA ' ' A' ' 485' ' ' LEU . 74.0 m . . . . . 0 C--N 1.331 -0.208 0 CA-C-N 116.335 -0.393 . . . . 15.0 111.001 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.678 ' O ' HG23 ' A' ' 423' ' ' VAL . 8.4 m-20 . . . . . 0 N--CA 1.466 0.366 0 CA-C-O 120.856 0.36 . . . . 15.0 111.335 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.724 ' O ' HG23 ' A' ' 424' ' ' VAL . 44.4 mt-30 -48.8 -58.05 5.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.089 -0.505 . . . . 15.0 111.864 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -68.09 -38.6 82.52 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.444 -0.344 . . . . 15.0 111.489 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.511 HD13 ' OD2' ' A' ' 419' ' ' ASP . 0.9 OUTLIER -57.36 -54.43 46.95 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.955 -0.566 . . . . 15.0 111.852 -179.241 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.7 t -81.1 -23.47 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-N 115.709 -0.678 . . . . 15.0 112.148 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 424' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 420' ' ' GLN . 7.2 t -63.28 -48.06 89.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.11 -0.7 . . . . 15.0 109.11 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -71.84 -34.0 68.92 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.488 -0.778 . . . . 15.0 110.607 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -70.57 -39.8 73.68 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.621 -0.263 . . . . 15.0 110.99 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 427' ' ' ILE . . . . . 0.583 ' O ' HG23 ' A' ' 431' ' ' VAL . 40.5 mt -67.61 -52.38 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 116.442 -0.345 . . . . 15.0 110.772 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -57.97 -42.04 84.21 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.096 0.474 . . . . 15.0 110.222 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 433' ' ' SER . 89.7 mttt -71.47 -24.86 62.08 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.521 -0.763 . . . . 15.0 110.737 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 430' ' ' MET . . . . . 0.634 ' O ' HG23 ' A' ' 434' ' ' VAL . 26.2 mtp -71.17 -47.68 56.23 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.467 -0.333 . . . . 15.0 110.937 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 427' ' ' ILE . 1.8 t -65.77 -39.03 83.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.913 0.387 . . . . 15.0 110.079 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -72.19 -30.01 64.54 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.842 -0.617 . . . . 15.0 110.681 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.782 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 13.4 t -70.25 -42.66 71.89 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.261 -0.427 . . . . 15.0 110.936 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 430' ' ' MET . 14.4 t -76.09 -40.37 37.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.207 -0.452 . . . . 15.0 110.77 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -58.7 -43.39 90.01 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.191 -0.458 . . . . 15.0 110.579 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -83.52 -25.3 31.15 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.451 -0.34 . . . . 15.0 110.961 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 437' ' ' ASN . . . . . 0.782 ' HB2' ' O ' ' A' ' 433' ' ' SER . 4.9 t-20 -60.11 -38.75 83.95 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.383 -0.372 . . . . 15.0 110.477 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 438' ' ' PHE . . . . . 0.539 ' CE2' HG21 ' A' ' 454' ' ' ILE . 32.6 m-85 -95.36 -12.15 26.53 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.763 -0.653 . . . . 15.0 111.581 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -106.33 54.09 0.69 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.88 0.371 . . . . 15.0 111.375 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.18 -6.46 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.194 -0.457 . . . . 15.0 111.403 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -94.0 -15.04 25.23 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.3 -0.409 . . . . 15.0 111.214 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 68.3 48.07 54.36 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.018 -0.611 . . . . 15.0 112.681 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -110.85 -18.05 13.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.649 0.261 . . . . 15.0 111.168 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 91.27 -5.2 81.06 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.921 -0.657 . . . . 15.0 112.378 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -143.29 156.92 44.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.816 0.341 . . . . 15.0 110.742 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 446' ' ' ILE . . . . . 0.684 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.7 mp -81.77 136.47 22.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.285 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 5.4 m -105.17 149.15 26.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.663 -0.699 . . . . 15.0 110.72 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -47.73 -46.93 30.35 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.176 -0.465 . . . . 15.0 111.776 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -64.69 -38.7 91.88 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.512 -0.313 . . . . 15.0 111.208 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -59.49 -59.07 6.04 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.275 -0.42 . . . . 15.0 110.427 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -63.18 -26.52 68.84 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.797 -0.638 . . . . 15.0 110.83 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 452' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -59.25 -56.94 15.75 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.902 -0.59 . . . . 15.0 111.288 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -78.29 -29.96 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.879 -0.601 . . . . 15.0 111.795 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 454' ' ' ILE . . . . . 0.539 HG21 ' CE2' ' A' ' 438' ' ' PHE . 46.6 mt -63.37 -46.14 96.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 120.397 0.141 . . . . 15.0 111.319 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -52.5 -29.22 23.96 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.802 0.297 . . . . 15.0 111.802 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -74.78 -24.65 71.69 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.833 -0.698 . . . . 15.0 112.676 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -71.6 -56.91 4.95 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.478 0.18 . . . . 15.0 111.402 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -144.59 98.71 4.9 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-O 120.628 0.251 . . . . 15.0 111.117 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.43 4.16 4.68 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.118 2.545 . . . . 15.0 112.594 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -112.29 -24.82 9.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.384 -0.371 . . . . 15.0 111.374 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.4 tp -56.77 -56.24 24.07 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.283 -0.417 . . . . 15.0 111.652 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 5.7 m -135.44 109.01 7.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.766 0.317 . . . . 15.0 111.019 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 463' ' ' ALA . . . . . 0.661 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -77.89 106.4 9.71 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.238 -0.437 . . . . 15.0 110.944 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 464' ' ' PHE . . . . . 0.475 ' HZ ' ' H ' ' A' ' 473' ' ' GLY . 29.3 t80 -40.37 -42.28 1.54 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.905 -0.588 . . . . 15.0 111.99 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -59.82 -36.92 91.59 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.03 -0.605 . . . . 15.0 113.27 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 466' ' ' ASP . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 483' ' ' TYR . 6.3 m-20 -90.48 -21.41 21.88 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.569 0.581 . . . . 15.0 112.569 -178.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 463' ' ' ALA . 0.1 OUTLIER -85.83 -43.24 13.45 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.791 -0.364 . . . . 15.0 110.518 179.383 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 468' ' ' ASP . . . . . 0.478 ' HB2' HD13 ' A' ' 475' ' ' ILE . 24.0 t0 -130.07 110.9 11.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.001 -0.545 . . . . 15.0 111.231 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -85.67 -16.84 37.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.087 -0.506 . . . . 15.0 110.772 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -78.6 -13.83 59.63 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.112 -0.495 . . . . 15.0 111.195 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 60.91 24.18 14.21 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.182 -0.463 . . . . 15.0 111.629 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -75.05 -3.42 32.4 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.41 -0.359 . . . . 15.0 111.645 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 473' ' ' GLY . . . . . 0.475 ' H ' ' HZ ' ' A' ' 464' ' ' PHE . . . 66.57 13.83 61.48 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.634 -0.793 . . . . 15.0 111.431 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 474' ' ' CYS . . . . . . . . . . . . . 14.8 t -133.13 130.81 39.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.374 -0.413 . . . . 15.0 110.609 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.684 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 10.8 mm -103.6 124.25 57.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 120.778 0.323 . . . . 15.0 110.99 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 53.4 m -102.44 167.47 9.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 15.0 110.812 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -53.31 -43.3 67.48 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.245 -0.434 . . . . 15.0 111.127 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 478' ' ' GLU . . . . . 0.67 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -60.4 -32.7 71.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.189 -0.459 . . . . 15.0 111.547 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 479' ' ' GLU . . . . . 0.565 ' OE1' ' HA ' ' A' ' 475' ' ' ILE . 47.6 mt-10 -67.08 -54.26 23.13 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.424 0.154 . . . . 15.0 111.095 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 58.5 mtt -70.07 -49.59 49.58 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.755 -0.202 . . . . 15.0 111.265 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 71.6 t -58.91 -56.78 14.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.57 0.224 . . . . 15.0 111.169 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 482' ' ' SER . . . . . 1.02 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 58.1 m -55.22 -36.59 66.16 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 116.457 -0.338 . . . . 15.0 110.511 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 483' ' ' TYR . . . . . 0.552 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 20.5 t80 -69.37 -26.89 64.88 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.135 -0.484 . . . . 15.0 111.253 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 484' ' ' PHE . . . . . 0.558 ' CD2' HG22 ' A' ' 431' ' ' VAL . 5.1 m-85 -76.15 -44.15 39.56 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 120.902 -0.319 . . . . 15.0 110.533 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.3 tt -83.52 -16.67 44.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.473 -0.33 . . . . 15.0 110.706 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 486' ' ' ARG . . . . . 1.02 ' HB2' ' O ' ' A' ' 482' ' ' SER . 30.7 ttt180 -75.91 -50.28 15.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.525 -0.307 . . . . 15.0 111.284 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 52.3 m -86.25 -51.1 6.48 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.183 -0.462 . . . . 15.0 111.916 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 488' ' ' SER . . . . . 0.52 ' HB3' ' O ' ' A' ' 484' ' ' PHE . 12.5 t . . . . . 0 N--CA 1.463 0.224 0 CA-C-O 120.939 0.4 . . . . 15.0 111.448 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 419' ' ' ASP . . . . . 0.662 ' O ' HG23 ' A' ' 423' ' ' VAL . 8.7 m-20 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.754 0.311 . . . . 15.0 110.926 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' GLN . . . . . 0.726 ' O ' HG23 ' A' ' 424' ' ' VAL . 9.6 tt0 -46.25 -57.64 4.38 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.088 -0.505 . . . . 15.0 111.578 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -68.3 -37.28 80.46 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.306 -0.406 . . . . 15.0 111.238 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 422' ' ' LEU . . . . . 0.414 HD13 ' OD1' ' A' ' 419' ' ' ASP . 1.4 tt -57.39 -54.56 45.39 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.791 -0.641 . . . . 15.0 111.688 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 423' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.4 t -81.29 -23.74 10.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.724 -0.671 . . . . 15.0 112.097 -177.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 424' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 420' ' ' GLN . 7.0 t -62.64 -48.43 88.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 109.044 -0.724 . . . . 15.0 109.044 178.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -72.2 -33.96 68.03 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.428 -0.806 . . . . 15.0 110.6 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' HIS . . . . . 0.414 ' HB2' ' O ' ' A' ' 422' ' ' LEU . 2.5 t60 -70.83 -39.11 73.21 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 120.716 0.293 . . . . 15.0 110.995 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 427' ' ' ILE . . . . . 0.579 HG13 HG12 ' A' ' 423' ' ' VAL . 36.4 mt -67.63 -54.0 26.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.328 -0.396 . . . . 15.0 110.658 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -56.93 -42.32 79.8 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.132 0.491 . . . . 15.0 110.153 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.641 ' O ' ' HB2' ' A' ' 433' ' ' SER . 88.1 mttt -70.54 -25.13 62.97 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 115.545 -0.752 . . . . 15.0 110.762 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 430' ' ' MET . . . . . 0.645 ' O ' HG23 ' A' ' 434' ' ' VAL . 18.3 mtm -71.44 -46.54 59.79 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.546 -0.297 . . . . 15.0 110.948 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.611 HG22 ' CD2' ' A' ' 484' ' ' PHE . 0.8 OUTLIER -63.87 -41.87 93.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 121.041 0.448 . . . . 15.0 109.978 178.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -72.45 -29.6 63.83 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.642 -0.708 . . . . 15.0 110.952 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 433' ' ' SER . . . . . 0.853 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 13.3 t -69.43 -43.7 72.84 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.304 -0.407 . . . . 15.0 111.02 -179.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 434' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 430' ' ' MET . 12.1 t -75.16 -42.9 44.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.281 -0.418 . . . . 15.0 110.869 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 435' ' ' PHE . . . . . 0.492 ' CZ ' ' HG3' ' A' ' 477' ' ' ARG . 7.7 t80 -56.69 -43.64 80.7 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.113 -0.494 . . . . 15.0 110.902 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -85.55 -23.94 27.45 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.464 -0.335 . . . . 15.0 111.205 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 437' ' ' ASN . . . . . 0.853 ' HB2' ' O ' ' A' ' 433' ' ' SER . 4.4 t-20 -59.84 -40.24 87.85 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.429 -0.351 . . . . 15.0 110.637 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 438' ' ' PHE . . . . . 0.524 ' CE2' HG21 ' A' ' 454' ' ' ILE . 54.8 m-85 -95.71 -13.83 23.89 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.931 -0.577 . . . . 15.0 111.807 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -105.31 54.33 0.71 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.924 0.392 . . . . 15.0 111.239 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 11.1 p -71.95 -16.1 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.13 -0.487 . . . . 15.0 111.338 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 40.2 p30 -79.92 -14.26 58.75 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.144 -0.48 . . . . 15.0 111.341 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 71.29 47.14 37.83 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.869 -0.682 . . . . 15.0 112.386 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -106.5 -18.46 13.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.676 0.274 . . . . 15.0 111.192 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 89.93 -9.32 77.67 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.956 -0.64 . . . . 15.0 112.494 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 445' ' ' HIS . . . . . 0.403 ' HB3' ' SG ' ' A' ' 474' ' ' CYS . 88.8 m-70 -146.01 162.53 37.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.774 0.321 . . . . 15.0 110.709 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 446' ' ' ILE . . . . . 0.598 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.7 mp -77.84 135.13 26.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.225 -0.443 . . . . 15.0 111.179 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.0 m -106.14 148.72 27.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.669 -0.696 . . . . 15.0 110.584 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -48.32 -47.46 36.8 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.257 -0.429 . . . . 15.0 111.697 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 449' ' ' GLU . . . . . 0.435 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.4 mt-10 -64.46 -38.22 90.27 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.423 -0.353 . . . . 15.0 111.329 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -58.37 -61.53 2.51 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.883 0.373 . . . . 15.0 110.605 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.7 -22.69 66.64 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.923 -0.581 . . . . 15.0 110.932 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 452' ' ' GLN . . . . . 0.435 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 0.9 OUTLIER -60.49 -57.55 12.27 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.938 -0.574 . . . . 15.0 111.281 179.49 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -76.87 -33.76 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 115.771 -0.65 . . . . 15.0 111.855 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 454' ' ' ILE . . . . . 0.524 HG21 ' CE2' ' A' ' 438' ' ' PHE . 61.0 mt -62.49 -49.97 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 120.489 0.185 . . . . 15.0 111.284 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 455' ' ' ARG . . . . . 0.515 ' NH2' ' H ' ' A' ' 461' ' ' LEU . 0.1 OUTLIER -57.94 -30.6 66.09 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.524 -0.307 . . . . 15.0 111.521 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -70.57 -33.73 67.44 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.918 -0.658 . . . . 15.0 112.775 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 457' ' ' ASN . . . . . 0.452 ' O ' ' HD3' ' A' ' 459' ' ' PRO . 40.9 m-80 -90.4 -22.21 21.57 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.637 0.256 . . . . 15.0 111.189 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -115.97 84.39 13.34 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.432 -0.349 . . . . 15.0 111.034 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 459' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 457' ' ' ASN . 13.0 Cg_exo -70.83 -10.55 27.93 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.947 2.431 . . . . 15.0 112.545 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -96.84 25.55 5.2 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.318 -0.401 . . . . 15.0 110.974 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 461' ' ' LEU . . . . . 0.515 ' H ' ' NH2' ' A' ' 455' ' ' ARG . 0.7 OUTLIER -98.01 152.07 19.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.218 -0.447 . . . . 15.0 111.061 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 462' ' ' SER . . . . . 0.494 ' OG ' HD23 ' A' ' 467' ' ' LEU . 43.1 p -63.63 175.73 1.02 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.072 -0.513 . . . . 15.0 111.328 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 463' ' ' ALA . . . . . 0.745 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -87.76 148.42 24.73 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.184 -0.462 . . . . 15.0 111.242 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 464' ' ' PHE . . . . . 0.714 ' HA ' HD11 ' A' ' 467' ' ' LEU . 46.0 m-85 -54.44 -48.07 72.13 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.937 -0.574 . . . . 15.0 111.477 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -70.4 -15.62 72.91 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.014 -0.613 . . . . 15.0 113.519 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 466' ' ' ASP . . . . . 0.489 ' OD1' ' HB3' ' A' ' 463' ' ' ALA . 4.1 m-20 -90.26 -36.67 14.59 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 117.089 0.445 . . . . 15.0 111.796 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 467' ' ' LEU . . . . . 0.855 HD13 HD11 ' A' ' 475' ' ' ILE . 0.5 OUTLIER -82.08 -30.88 31.07 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.9 0.381 . . . . 15.0 110.571 179.193 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 468' ' ' ASP . . . . . 0.595 ' N ' HD12 ' A' ' 467' ' ' LEU . 20.7 t70 -126.47 108.75 11.46 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.976 -0.556 . . . . 15.0 110.273 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -69.22 -22.11 63.89 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.112 -0.494 . . . . 15.0 111.489 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -76.51 -14.11 60.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.226 -0.443 . . . . 15.0 111.326 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 57.38 26.61 12.7 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.224 -0.444 . . . . 15.0 111.413 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -81.23 0.05 38.44 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.257 -0.429 . . . . 15.0 111.551 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 65.89 16.04 63.34 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.469 -0.872 . . . . 15.0 111.227 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 474' ' ' CYS . . . . . 0.403 ' SG ' ' HB3' ' A' ' 445' ' ' HIS . 13.8 t -137.94 131.12 30.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.142 -0.529 . . . . 15.0 110.431 -178.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.855 HD11 HD13 ' A' ' 467' ' ' LEU . 94.9 mt -106.84 127.24 62.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.912 0.387 . . . . 15.0 111.023 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 64.7 m -103.61 177.22 4.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.739 -0.664 . . . . 15.0 111.077 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 477' ' ' ARG . . . . . 0.492 ' HG3' ' CZ ' ' A' ' 435' ' ' PHE . 68.7 mtp180 -58.81 -46.96 86.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.21 -0.45 . . . . 15.0 111.221 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 478' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -60.21 -32.42 71.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.215 -0.448 . . . . 15.0 111.423 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 479' ' ' GLU . . . . . 0.45 ' HB2' HG23 ' A' ' 475' ' ' ILE . 5.5 mm-40 -66.42 -50.22 64.16 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.497 0.189 . . . . 15.0 110.778 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 60.0 mtt -69.86 -47.0 64.32 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.684 -0.234 . . . . 15.0 110.923 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 481' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 477' ' ' ARG . 89.8 t -61.56 -54.01 40.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.702 0.287 . . . . 15.0 110.842 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 482' ' ' SER . . . . . 0.89 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 10.3 m -50.55 -47.17 57.78 Favored 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 116.034 -0.53 . . . . 15.0 110.382 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 483' ' ' TYR . . . . . 0.418 ' HD1' ' O ' ' A' ' 479' ' ' GLU . 8.0 m-85 -69.22 -22.42 63.87 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.423 -0.808 . . . . 15.0 111.856 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 484' ' ' PHE . . . . . 0.778 ' O ' ' HB2' ' A' ' 488' ' ' SER . 0.1 OUTLIER -74.03 -45.94 46.52 Favored 'General case' 0 CA--C 1.527 0.091 0 C-N-CA 120.779 -0.369 . . . . 15.0 110.1 179.05 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 485' ' ' LEU . . . . . 0.612 HD13 ' O ' ' A' ' 485' ' ' LEU . 1.5 tm? -84.43 -16.62 42.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.425 -0.352 . . . . 15.0 110.664 177.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 486' ' ' ARG . . . . . 0.89 ' HB2' ' O ' ' A' ' 482' ' ' SER . 21.3 ttt180 -74.36 -53.32 9.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.451 -0.34 . . . . 15.0 111.578 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 79.7 p -92.58 -54.49 3.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.314 -0.403 . . . . 15.0 112.058 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 488' ' ' SER . . . . . 0.778 ' HB2' ' O ' ' A' ' 484' ' ' PHE . 54.7 m . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.871 0.367 . . . . 15.0 111.492 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 50.3 pttt . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.761 0.315 . . . . 15.0 110.931 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 9.1 mt -102.57 139.07 38.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.085 -0.507 . . . . 15.0 110.889 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.656 ' O ' HG23 ' A' ' 423' ' ' VAL . 8.9 m-20 -97.52 8.95 43.68 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.048 -0.524 . . . . 15.0 111.037 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.732 ' O ' HG23 ' A' ' 424' ' ' VAL . 53.6 mt-30 -44.81 -57.25 3.86 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.053 -0.522 . . . . 15.0 111.607 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -68.48 -36.83 79.51 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.308 -0.406 . . . . 15.0 111.136 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 1.6 tt -57.75 -54.55 45.65 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.826 -0.625 . . . . 15.0 111.668 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.1 t -81.32 -23.48 10.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.665 -0.698 . . . . 15.0 112.039 -177.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 424' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 420' ' ' GLN . 6.8 t -62.78 -47.46 92.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 109.047 -0.723 . . . . 15.0 109.047 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -72.97 -33.94 66.18 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.435 -0.802 . . . . 15.0 110.583 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' HIS . . . . . 0.576 ' O ' ' HB2' ' A' ' 430' ' ' MET . 2.4 t-80 -70.85 -39.38 72.99 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.678 0.275 . . . . 15.0 110.975 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 427' ' ' ILE . . . . . 0.58 ' O ' HG23 ' A' ' 431' ' ' VAL . 40.1 mt -68.88 -52.0 39.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.372 -0.376 . . . . 15.0 110.715 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -57.32 -43.0 82.95 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.132 0.492 . . . . 15.0 110.197 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -71.83 -24.27 61.68 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 115.559 -0.746 . . . . 15.0 110.542 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' MET . . . . . 0.672 ' O ' HG23 ' A' ' 434' ' ' VAL . 8.5 ttm -70.32 -49.82 45.52 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.36 -0.382 . . . . 15.0 110.853 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 427' ' ' ILE . 1.5 t -64.56 -37.34 79.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.918 0.39 . . . . 15.0 110.033 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -71.57 -32.93 68.62 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.826 -0.625 . . . . 15.0 110.692 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.917 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 4.0 m -69.61 -41.11 76.12 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.181 -0.463 . . . . 15.0 111.09 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 430' ' ' MET . 16.4 t -75.36 -42.2 43.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.2 -0.455 . . . . 15.0 110.786 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 435' ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 9.8 t80 -58.32 -41.71 85.11 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.965 -0.561 . . . . 15.0 111.013 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -86.37 -26.91 24.55 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.436 -0.347 . . . . 15.0 110.933 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' ASN . . . . . 0.917 ' HB2' ' O ' ' A' ' 433' ' ' SER . 2.6 t-20 -59.73 -45.27 92.71 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.227 -0.442 . . . . 15.0 111.455 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 438' ' ' PHE . . . . . 0.483 ' CE2' HG21 ' A' ' 454' ' ' ILE . 54.8 m-85 -94.33 -2.09 52.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.119 -0.491 . . . . 15.0 111.494 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 439' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 1.1 t0 -120.08 54.49 1.03 Allowed 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.918 0.39 . . . . 15.0 111.16 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.26 -9.42 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.054 -0.521 . . . . 15.0 111.32 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -92.35 -3.96 54.57 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.257 -0.429 . . . . 15.0 111.219 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 61.06 51.01 61.18 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.051 -0.595 . . . . 15.0 112.664 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -103.19 -18.09 15.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.645 0.259 . . . . 15.0 111.231 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 87.8 -13.85 59.93 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.933 -0.651 . . . . 15.0 112.302 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 445' ' ' HIS . . . . . 0.469 ' HB2' ' SG ' ' A' ' 474' ' ' CYS . 14.4 p80 -137.77 154.37 49.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.622 0.248 . . . . 15.0 110.408 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 446' ' ' ILE . . . . . 0.624 ' O ' ' HA ' ' A' ' 474' ' ' CYS . 1.6 mp -85.6 98.95 6.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.072 0.463 . . . . 15.0 111.023 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 52.8 m -63.7 150.89 43.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.705 -0.68 . . . . 15.0 111.072 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -55.33 -37.91 68.05 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.069 -0.514 . . . . 15.0 111.802 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 449' ' ' GLU . . . . . 0.463 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -63.23 -40.25 96.92 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.522 -0.308 . . . . 15.0 111.38 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -58.55 -60.51 3.7 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.947 0.403 . . . . 15.0 110.507 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -64.61 -24.1 67.48 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.822 -0.627 . . . . 15.0 110.614 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 452' ' ' GLN . . . . . 0.463 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 0.2 OUTLIER -58.9 -57.05 14.76 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.724 -0.671 . . . . 15.0 111.588 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -81.05 -33.61 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.682 -0.69 . . . . 15.0 111.927 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 454' ' ' ILE . . . . . 0.483 HG21 ' CE2' ' A' ' 438' ' ' PHE . 56.0 mt -63.9 -38.17 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.444 0.164 . . . . 15.0 111.438 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -62.65 -21.74 65.92 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.687 0.28 . . . . 15.0 111.468 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -66.36 -23.94 71.98 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.014 -0.613 . . . . 15.0 112.7 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -116.03 -10.7 11.53 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.676 0.274 . . . . 15.0 111.208 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -127.67 74.7 78.18 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.385 -0.37 . . . . 15.0 111.007 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.04 1.93 8.15 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.189 2.593 . . . . 15.0 112.612 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -81.32 2.5 27.94 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.328 -0.396 . . . . 15.0 111.449 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.4 mp -102.16 152.3 21.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.379 -0.373 . . . . 15.0 111.041 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 50.9 m -74.67 -174.83 2.24 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.079 -0.51 . . . . 15.0 111.288 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 463' ' ' ALA . . . . . 0.575 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -87.79 156.93 19.17 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.22 -0.446 . . . . 15.0 111.793 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -50.08 -41.67 48.56 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.74 -0.663 . . . . 15.0 111.348 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -62.19 -26.72 68.02 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.944 -0.571 . . . . 15.0 113.35 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -88.44 -33.24 17.93 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.858 0.329 . . . . 15.0 111.433 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 463' ' ' ALA . 0.1 OUTLIER -77.65 -36.32 51.57 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.863 0.363 . . . . 15.0 110.403 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 468' ' ' ASP . . . . . 0.539 ' HA ' ' OE2' ' A' ' 479' ' ' GLU . 10.4 t70 -123.77 114.62 20.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.876 -0.602 . . . . 15.0 110.47 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -67.28 -33.74 75.94 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.052 -0.522 . . . . 15.0 111.542 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -79.27 -9.44 59.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.397 -0.365 . . . . 15.0 111.413 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 55.86 39.08 30.68 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.27 -0.423 . . . . 15.0 111.382 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -78.56 -0.72 30.79 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.178 -0.464 . . . . 15.0 111.593 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.47 15.09 63.3 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.494 -0.86 . . . . 15.0 111.255 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 474' ' ' CYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 446' ' ' ILE . 1.0 OUTLIER -136.09 131.16 34.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.235 -0.483 . . . . 15.0 110.455 -178.724 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.572 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 16.7 mm -102.74 124.9 57.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.938 0.399 . . . . 15.0 111.136 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 12.3 t -103.59 175.71 5.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.729 -0.669 . . . . 15.0 110.823 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.44 ' O ' HG23 ' A' ' 481' ' ' VAL . 24.7 ptt180 -58.08 -44.48 87.6 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.328 -0.396 . . . . 15.0 111.149 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 478' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.6 mt-10 -62.11 -29.62 70.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.437 . . . . 15.0 111.458 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 479' ' ' GLU . . . . . 0.539 ' OE2' ' HA ' ' A' ' 468' ' ' ASP . 5.3 mm-40 -71.69 -47.99 50.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.496 0.188 . . . . 15.0 110.862 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 60.5 mtt -70.45 -46.2 64.33 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.687 -0.233 . . . . 15.0 110.963 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 481' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 477' ' ' ARG . 79.1 t -60.26 -52.7 58.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 120.738 0.304 . . . . 15.0 110.659 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 482' ' ' SER . . . . . 0.918 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 39.5 m -57.77 -32.96 68.01 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 116.162 -0.472 . . . . 15.0 110.183 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 483' ' ' TYR . . . . . 0.538 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 9.1 t80 -69.02 -30.01 68.31 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.904 -0.589 . . . . 15.0 111.013 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 484' ' ' PHE . . . . . 0.57 ' CD2' HG22 ' A' ' 431' ' ' VAL . 1.9 m-85 -75.16 -40.18 59.77 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.708 0.289 . . . . 15.0 110.332 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.2 tt -83.82 -18.74 36.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 15.0 110.558 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 486' ' ' ARG . . . . . 0.918 ' HB2' ' O ' ' A' ' 482' ' ' SER . 31.0 ttt180 -72.61 -52.98 13.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.433 -0.349 . . . . 15.0 110.882 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 53.4 m -89.26 19.37 4.39 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.979 -0.555 . . . . 15.0 111.354 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 488' ' ' SER . . . . . 0.559 ' HB2' ' O ' ' A' ' 484' ' ' PHE . 22.6 t -87.69 130.16 34.9 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.345 -0.389 . . . . 15.0 110.933 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 51.8 m -95.65 -129.45 0.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.114 -0.493 . . . . 15.0 110.842 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 5.1 t -65.93 -51.65 58.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 116.515 -0.311 . . . . 15.0 111.073 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 1.5 mp -131.47 -42.16 1.06 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.918 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -110.43 -103.75 2.78 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.961 -0.638 . . . . 15.0 112.499 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 164.91 57.63 0.02 OUTLIER Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.824 -0.703 . . . . 15.0 112.512 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -127.94 147.22 50.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.73 0.3 . . . . 15.0 110.913 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 64.1 mtt -122.56 -42.77 2.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.464 . . . . 15.0 110.979 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 126.06 64.28 0.16 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.847 -0.692 . . . . 15.0 112.482 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.295 -0.859 . . . . 15.0 110.904 179.975 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 66.1 mttm . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.723 0.297 . . . . 15.0 111.023 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 11.2 mt -140.18 110.79 6.76 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.199 -0.455 . . . . 15.0 110.814 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.637 ' O ' HG23 ' A' ' 423' ' ' VAL . 0.8 OUTLIER -153.57 126.58 8.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.144 -0.48 . . . . 15.0 111.114 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.724 ' O ' HG23 ' A' ' 424' ' ' VAL . 4.3 tt0 -47.96 -56.35 7.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.784 -0.643 . . . . 15.0 111.862 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.42 95.96 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.328 -0.397 . . . . 15.0 111.62 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 3.2 tt -57.49 -53.34 59.31 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.077 -0.51 . . . . 15.0 111.743 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.6 t -80.9 -22.54 10.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.736 -0.665 . . . . 15.0 111.966 -176.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 424' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 420' ' ' GLN . 9.3 t -64.07 -47.68 89.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 109.056 -0.72 . . . . 15.0 109.056 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -72.61 -33.29 66.57 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.426 -0.807 . . . . 15.0 110.584 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' HIS . . . . . 0.629 ' O ' ' HB2' ' A' ' 430' ' ' MET . 4.6 t-80 -71.02 -39.29 72.43 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.568 -0.287 . . . . 15.0 111.05 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 427' ' ' ILE . . . . . 0.555 ' O ' HG23 ' A' ' 431' ' ' VAL . 40.7 mt -68.88 -52.29 36.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 116.352 -0.386 . . . . 15.0 110.77 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -57.7 -43.55 85.25 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.154 0.502 . . . . 15.0 110.169 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -72.04 -22.73 61.35 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.506 -0.77 . . . . 15.0 110.548 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' MET . . . . . 0.629 ' HB2' ' O ' ' A' ' 426' ' ' HIS . 0.0 OUTLIER -70.28 -51.37 30.99 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.405 -0.361 . . . . 15.0 110.88 179.077 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.557 HG22 ' CE2' ' A' ' 484' ' ' PHE . 1.0 OUTLIER -63.87 -38.69 83.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.317 -0.402 . . . . 15.0 110.046 179.128 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -71.89 -31.69 66.68 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.823 -0.626 . . . . 15.0 110.878 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.817 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 2.6 m -68.54 -42.68 78.1 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.244 -0.435 . . . . 15.0 111.028 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 430' ' ' MET . 10.2 t -75.32 -41.91 43.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.271 -0.422 . . . . 15.0 110.869 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 435' ' ' PHE . . . . . 0.61 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 4.1 t80 -56.75 -42.67 79.74 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.037 -0.529 . . . . 15.0 110.749 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 -87.02 -23.55 24.95 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.441 -0.345 . . . . 15.0 111.229 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 437' ' ' ASN . . . . . 0.817 ' HB2' ' O ' ' A' ' 433' ' ' SER . 5.1 t-20 -59.97 -39.62 86.28 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.863 0.363 . . . . 15.0 110.568 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 438' ' ' PHE . . . . . 0.493 ' CE2' HG21 ' A' ' 454' ' ' ILE . 35.6 m-85 -94.15 -16.51 23.66 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.854 -0.612 . . . . 15.0 111.635 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 439' ' ' ASP . . . . . 0.61 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 0.3 OUTLIER -99.18 54.03 0.97 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.864 0.364 . . . . 15.0 111.429 -179.525 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.3 -12.85 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.327 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -88.59 -14.82 36.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.119 -0.491 . . . . 15.0 111.171 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 73.7 39.44 48.51 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.004 -0.617 . . . . 15.0 112.508 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -95.79 -17.34 21.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.623 0.249 . . . . 15.0 111.162 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 87.22 -7.73 79.51 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.911 -0.662 . . . . 15.0 112.37 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -144.92 162.18 37.51 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.717 0.294 . . . . 15.0 110.658 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 446' ' ' ILE . . . . . 0.881 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.6 mp -77.78 136.36 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.113 0.483 . . . . 15.0 111.265 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 48.5 m -105.76 147.8 28.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.474 -0.784 . . . . 15.0 110.711 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -50.71 -46.85 59.11 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.169 -0.469 . . . . 15.0 111.606 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 449' ' ' GLU . . . . . 0.422 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -65.31 -36.91 85.52 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.479 -0.328 . . . . 15.0 111.168 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -60.58 -58.71 7.34 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.295 -0.411 . . . . 15.0 110.543 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.45 -23.73 67.0 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.767 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 452' ' ' GLN . . . . . 0.422 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 1.5 mm-40 -61.07 -56.93 15.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.88 -0.6 . . . . 15.0 111.302 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -76.73 -32.89 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 115.804 -0.635 . . . . 15.0 111.913 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 454' ' ' ILE . . . . . 0.493 HG21 ' CE2' ' A' ' 438' ' ' PHE . 46.3 mt -64.71 -51.96 60.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.501 0.191 . . . . 15.0 111.244 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -55.32 -33.19 63.09 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.694 0.283 . . . . 15.0 111.46 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -66.84 -30.78 76.66 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.908 -0.663 . . . . 15.0 112.629 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 457' ' ' ASN . . . . . 0.468 ' O ' ' HD3' ' A' ' 459' ' ' PRO . 42.0 m-80 -94.28 -18.99 21.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.687 0.279 . . . . 15.0 111.246 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -115.8 83.29 11.47 Favored Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 116.375 -0.375 . . . . 15.0 110.936 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 459' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 457' ' ' ASN . 12.6 Cg_exo -70.78 -10.08 27.03 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.046 2.497 . . . . 15.0 112.631 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -96.53 25.25 5.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.26 -0.427 . . . . 15.0 111.034 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 2.3 tp -100.39 152.55 20.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.16 -0.473 . . . . 15.0 110.975 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 52.5 m -65.54 176.41 1.48 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.115 -0.493 . . . . 15.0 111.378 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 463' ' ' ALA . . . . . 0.76 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -86.84 150.49 24.09 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.239 -0.437 . . . . 15.0 111.243 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 464' ' ' PHE . . . . . 0.749 ' HA ' HD11 ' A' ' 467' ' ' LEU . 68.1 m-85 -56.62 -48.76 76.79 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.999 -0.546 . . . . 15.0 111.506 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -68.15 -16.33 68.68 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.962 -0.637 . . . . 15.0 113.459 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -90.13 -39.33 12.93 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.101 0.45 . . . . 15.0 111.776 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.985 HD13 HD11 ' A' ' 475' ' ' ILE . 0.6 OUTLIER -79.06 -28.76 43.18 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.762 0.315 . . . . 15.0 110.755 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 468' ' ' ASP . . . . . 0.602 ' N ' HD12 ' A' ' 467' ' ' LEU . 12.4 t70 -130.87 110.49 11.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.039 -0.528 . . . . 15.0 110.286 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -66.06 -28.77 69.09 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.008 -0.542 . . . . 15.0 111.454 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -76.54 -14.11 60.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.249 -0.432 . . . . 15.0 111.214 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 58.67 29.36 18.46 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.238 -0.437 . . . . 15.0 111.306 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -74.35 -4.8 38.58 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.147 -0.479 . . . . 15.0 111.767 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.52 17.57 66.81 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.464 -0.875 . . . . 15.0 111.197 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 474' ' ' CYS . . . . . . . . . . . . . 18.5 t -135.78 131.7 35.81 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.268 -0.466 . . . . 15.0 110.492 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.985 HD11 HD13 ' A' ' 467' ' ' LEU . 11.1 mm -98.79 122.24 50.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 15.0 110.938 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 476' ' ' SER . . . . . 0.508 ' H ' ' HG3' ' A' ' 479' ' ' GLU . 15.4 t -102.89 171.12 7.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.918 -0.583 . . . . 15.0 110.672 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -52.86 -45.51 67.44 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.338 -0.392 . . . . 15.0 110.915 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 478' ' ' GLU . . . . . 0.563 ' O ' ' HB2' ' A' ' 482' ' ' SER . 9.4 tt0 -62.51 -28.39 69.81 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.049 -0.523 . . . . 15.0 111.254 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 479' ' ' GLU . . . . . 0.599 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 52.1 mm-40 -70.35 -51.36 30.57 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.505 0.193 . . . . 15.0 110.84 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 44.2 mtt -70.06 -47.18 63.03 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.653 -0.249 . . . . 15.0 111.081 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 82.1 t -59.94 -53.49 47.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.68 0.276 . . . . 15.0 110.85 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 482' ' ' SER . . . . . 0.941 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 43.0 m -57.96 -32.46 67.85 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 116.267 -0.424 . . . . 15.0 110.208 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 483' ' ' TYR . . . . . 0.599 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 8.3 t80 -69.3 -31.05 69.28 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.954 -0.566 . . . . 15.0 111.199 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 484' ' ' PHE . . . . . 0.585 ' HZ ' ' SD ' ' A' ' 430' ' ' MET . 1.6 m-85 -75.9 -39.03 57.12 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.926 -0.31 . . . . 15.0 110.387 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.1 tt -83.74 -19.65 34.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 15.0 110.49 176.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 486' ' ' ARG . . . . . 0.941 ' HB2' ' O ' ' A' ' 482' ' ' SER . 32.1 ttt180 -72.08 -48.55 43.3 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.845 0.355 . . . . 15.0 110.751 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 49.5 p -82.77 19.58 1.31 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.907 -0.588 . . . . 15.0 111.439 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 67.9 m -77.25 123.5 26.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.279 -0.418 . . . . 15.0 110.961 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 41.2 p -107.79 -43.68 4.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.106 -0.497 . . . . 15.0 111.16 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 58.1 t -148.44 89.0 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.374 -0.375 . . . . 15.0 110.567 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 4.8 mp -136.1 -40.21 0.67 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.098 -0.501 . . . . 15.0 111.032 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . 142.69 -81.35 0.23 Allowed Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.915 -0.659 . . . . 15.0 112.462 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 102.44 55.37 0.85 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.871 -0.68 . . . . 15.0 112.412 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 494' ' ' ARG . . . . . 0.416 ' O ' ' HE2' ' A' ' 497' ' ' PHE . 99.6 mtt180 -100.78 -41.05 7.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.688 0.28 . . . . 15.0 110.991 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -105.91 130.15 53.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.25 -0.432 . . . . 15.0 110.893 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 129.75 74.23 0.14 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.938 -0.648 . . . . 15.0 112.51 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 497' ' ' PHE . . . . . 0.416 ' HE2' ' O ' ' A' ' 494' ' ' ARG . 84.0 m-85 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.286 -0.864 . . . . 15.0 110.933 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 97.1 mttt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.731 0.301 . . . . 15.0 110.923 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.3 mp -143.66 -70.14 0.31 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.131 -0.486 . . . . 15.0 110.902 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.637 ' O ' HG23 ' A' ' 423' ' ' VAL . 0.2 OUTLIER -172.53 140.66 1.07 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.343 -0.389 . . . . 15.0 110.89 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.736 ' O ' HG23 ' A' ' 424' ' ' VAL . 45.9 mt-30 -48.99 -56.66 8.23 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.878 -0.601 . . . . 15.0 111.731 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -65.91 -38.47 88.8 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.905 0.383 . . . . 15.0 111.43 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 3.4 tt -57.97 -53.09 62.11 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.862 -0.608 . . . . 15.0 111.572 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 419' ' ' ASP . 2.1 t -80.81 -22.7 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 CA-C-N 115.665 -0.698 . . . . 15.0 111.978 -177.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 424' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 420' ' ' GLN . 9.6 t -63.83 -48.02 88.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 109.023 -0.732 . . . . 15.0 109.023 177.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -71.7 -33.55 68.88 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.335 -0.848 . . . . 15.0 110.46 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -70.71 -39.8 73.22 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.53 -0.305 . . . . 15.0 110.915 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' ILE . . . . . 0.574 ' O ' HG23 ' A' ' 431' ' ' VAL . 38.6 mt -67.33 -52.35 43.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.358 -0.383 . . . . 15.0 110.712 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -58.37 -41.99 86.01 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.156 0.503 . . . . 15.0 110.287 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.618 ' O ' ' HB2' ' A' ' 433' ' ' SER . 89.6 mttt -71.29 -24.19 62.1 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 115.473 -0.785 . . . . 15.0 110.74 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 430' ' ' MET . . . . . 0.653 ' O ' HG23 ' A' ' 434' ' ' VAL . 25.2 mmm -71.63 -47.53 53.88 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.428 -0.351 . . . . 15.0 110.923 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.588 HG22 ' CD2' ' A' ' 484' ' ' PHE . 2.0 t -65.36 -39.22 84.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.325 -0.398 . . . . 15.0 110.0 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -72.62 -30.45 64.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.916 -0.584 . . . . 15.0 110.756 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.843 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 13.2 t -68.86 -43.11 76.09 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.202 -0.453 . . . . 15.0 110.91 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 430' ' ' MET . 10.6 t -76.53 -40.82 34.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.784 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 435' ' ' PHE . . . . . 0.551 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 2.9 t80 -56.99 -42.9 81.11 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.065 -0.516 . . . . 15.0 110.673 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -87.41 -23.6 24.47 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.361 -0.382 . . . . 15.0 111.18 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' ASN . . . . . 0.843 ' HB2' ' O ' ' A' ' 433' ' ' SER . 3.3 t30 -60.0 -38.93 84.07 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.934 0.397 . . . . 15.0 110.515 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 438' ' ' PHE . . . . . 0.459 ' CD2' HD13 ' A' ' 454' ' ' ILE . 33.1 m-85 -94.41 -16.65 23.24 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.802 -0.636 . . . . 15.0 111.55 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 439' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 0.6 OUTLIER -99.92 53.44 0.92 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.892 0.377 . . . . 15.0 111.589 -179.323 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.8 t -70.37 -12.49 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.132 -0.485 . . . . 15.0 111.0 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -90.85 -14.96 30.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.079 -0.51 . . . . 15.0 111.048 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 76.56 41.62 24.2 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.971 -0.633 . . . . 15.0 112.509 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -97.64 -18.64 18.78 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.671 0.272 . . . . 15.0 111.149 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 86.2 -4.48 85.97 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.899 -0.667 . . . . 15.0 112.468 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 445' ' ' HIS . . . . . 0.684 ' HB2' ' SG ' ' A' ' 474' ' ' CYS . 11.1 p-80 -146.18 164.3 32.68 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.757 0.313 . . . . 15.0 110.807 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 446' ' ' ILE . . . . . 0.841 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.2 mp -76.98 135.76 25.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.215 -0.448 . . . . 15.0 110.999 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 9.9 t -106.33 147.53 29.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.823 -0.626 . . . . 15.0 110.789 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -52.42 -47.93 66.03 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.167 -0.469 . . . . 15.0 111.541 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 449' ' ' GLU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -64.72 -36.85 85.63 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.444 -0.343 . . . . 15.0 111.047 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 450' ' ' GLU . . . . . 0.419 ' O ' HD12 ' A' ' 454' ' ' ILE . 5.0 mm-40 -61.16 -56.56 19.36 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.317 -0.401 . . . . 15.0 110.279 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 451' ' ' PHE . . . . . 0.522 ' CE2' HD23 ' A' ' 461' ' ' LEU . 0.7 OUTLIER -64.99 -25.07 67.71 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.911 -0.586 . . . . 15.0 110.529 178.783 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 452' ' ' GLN . . . . . 0.415 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 2.5 mm-40 -60.66 -57.92 10.66 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.76 -0.654 . . . . 15.0 111.389 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 8.8 mm -76.0 -33.04 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.86 -0.609 . . . . 15.0 111.842 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 454' ' ' ILE . . . . . 0.459 HD13 ' CD2' ' A' ' 438' ' ' PHE . 28.3 mt -63.2 -47.52 91.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 120.489 0.185 . . . . 15.0 111.272 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 455' ' ' ARG . . . . . 0.647 ' NH2' ' HA ' ' A' ' 463' ' ' ALA . 8.1 mtt180 -54.87 -33.68 62.14 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.539 -0.3 . . . . 15.0 111.507 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -64.08 -29.3 74.52 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 121.033 -0.603 . . . . 15.0 112.612 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -97.37 -15.04 20.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.556 0.217 . . . . 15.0 111.162 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 458' ' ' PHE . . . . . 0.506 ' HB3' HD13 ' A' ' 461' ' ' LEU . 86.0 m-85 -125.47 86.66 56.88 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.39 -0.368 . . . . 15.0 111.044 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -72.53 -2.71 12.2 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.989 2.459 . . . . 15.0 112.589 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -103.35 23.54 12.35 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.319 -0.401 . . . . 15.0 110.998 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.522 HD23 ' CE2' ' A' ' 451' ' ' PHE . 1.0 OUTLIER -89.32 147.77 23.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 15.0 111.084 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 58.2 m -66.78 175.37 2.44 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.044 -0.525 . . . . 15.0 111.329 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 463' ' ' ALA . . . . . 0.74 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -87.88 149.11 24.3 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.114 -0.494 . . . . 15.0 111.271 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 464' ' ' PHE . . . . . 0.743 ' HA ' HD11 ' A' ' 467' ' ' LEU . 90.1 m-85 -56.71 -47.6 79.58 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.932 -0.577 . . . . 15.0 111.47 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -69.06 -16.06 70.28 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 121.034 -0.603 . . . . 15.0 113.449 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -89.92 -38.97 13.31 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.202 0.501 . . . . 15.0 111.678 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.912 HD13 HD11 ' A' ' 475' ' ' ILE . 0.6 OUTLIER -80.9 -28.56 35.83 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.815 0.341 . . . . 15.0 110.586 179.57 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 468' ' ' ASP . . . . . 0.595 ' N ' HD12 ' A' ' 467' ' ' LEU . 12.4 t70 -131.65 111.93 12.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.049 -0.523 . . . . 15.0 110.213 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -62.07 -35.74 79.57 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.029 -0.532 . . . . 15.0 111.788 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -77.88 -10.58 59.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.417 -0.356 . . . . 15.0 111.456 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 57.66 34.13 24.11 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.943 0.402 . . . . 15.0 111.303 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -73.88 -4.44 34.99 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.113 -0.494 . . . . 15.0 111.716 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.72 18.04 67.78 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.489 -0.863 . . . . 15.0 111.277 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 474' ' ' CYS . . . . . 0.684 ' SG ' ' HB2' ' A' ' 445' ' ' HIS . 3.7 t -135.19 130.93 36.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.248 -0.476 . . . . 15.0 110.52 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.912 HD11 HD13 ' A' ' 467' ' ' LEU . 21.1 mm -98.78 123.67 51.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.892 0.377 . . . . 15.0 110.93 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 476' ' ' SER . . . . . 0.404 ' H ' ' HG3' ' A' ' 479' ' ' GLU . 14.5 t -101.84 166.96 10.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.931 -0.577 . . . . 15.0 110.577 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -50.49 -46.98 57.38 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.34 -0.391 . . . . 15.0 110.915 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 478' ' ' GLU . . . . . 0.726 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -62.21 -30.84 71.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.031 -0.531 . . . . 15.0 111.473 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 479' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 5.7 mm-40 -69.83 -55.06 10.81 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 121.285 -0.166 . . . . 15.0 110.956 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 6.6 tpp -68.65 -48.46 63.96 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.752 -0.204 . . . . 15.0 111.228 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 76.0 t -60.51 -54.56 33.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 121.148 -0.221 . . . . 15.0 111.128 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 482' ' ' SER . . . . . 0.98 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 36.8 m -56.51 -33.61 66.18 Favored 'General case' 0 C--O 1.227 -0.088 0 CA-C-N 116.515 -0.311 . . . . 15.0 110.462 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 483' ' ' TYR . . . . . 0.573 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 8.5 t80 -70.24 -30.76 67.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.116 -0.493 . . . . 15.0 111.167 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 484' ' ' PHE . . . . . 0.588 ' CD2' HG22 ' A' ' 431' ' ' VAL . 6.0 m-85 -74.16 -41.84 60.86 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 120.888 -0.325 . . . . 15.0 110.372 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.5 tt -83.95 -16.98 42.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.396 . . . . 15.0 110.492 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 486' ' ' ARG . . . . . 0.98 ' HB2' ' O ' ' A' ' 482' ' ' SER . 5.8 tpt180 -71.59 -51.5 23.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.892 0.377 . . . . 15.0 110.844 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 52.5 m -87.55 19.37 3.38 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.961 -0.563 . . . . 15.0 111.55 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 488' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 484' ' ' PHE . 9.3 t -121.55 157.27 31.08 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.374 -0.376 . . . . 15.0 111.042 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 52.9 m -94.56 161.0 14.38 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.046 -0.525 . . . . 15.0 110.915 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 60.1 t -148.9 90.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.2 -0.454 . . . . 15.0 110.516 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 2.4 tp -97.69 -42.04 7.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.015 -0.539 . . . . 15.0 111.032 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -118.73 -101.98 2.05 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.877 -0.678 . . . . 15.0 112.527 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 102.57 88.58 2.05 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.85 -0.69 . . . . 15.0 112.465 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -102.64 135.03 45.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.775 0.322 . . . . 15.0 110.933 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 64.8 mtt -102.13 -42.12 6.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.148 -0.478 . . . . 15.0 110.998 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 128.62 91.64 0.68 Allowed Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.849 -0.691 . . . . 15.0 112.512 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.315 -0.85 . . . . 15.0 110.862 -179.987 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 417' ' ' LYS . . . . . 0.584 ' HD3' ' OE1' ' A' ' 420' ' ' GLN . 97.6 mttt . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.792 0.329 . . . . 15.0 110.86 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 2.7 tp -144.49 -47.4 0.25 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.123 -0.49 . . . . 15.0 110.871 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.661 ' O ' HG23 ' A' ' 423' ' ' VAL . 7.6 m-20 -92.0 20.63 5.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.136 -0.484 . . . . 15.0 111.115 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.739 ' O ' HG23 ' A' ' 424' ' ' VAL . 4.0 tt0 -46.85 -57.42 4.93 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.097 -0.501 . . . . 15.0 111.624 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.82 81.78 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.345 -0.388 . . . . 15.0 111.294 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.543 HD13 ' OD2' ' A' ' 419' ' ' ASP . 1.2 tt -57.82 -53.77 54.4 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.872 -0.604 . . . . 15.0 111.618 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.7 t -80.69 -23.98 11.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.636 -0.711 . . . . 15.0 112.02 -177.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 424' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 420' ' ' GLN . 7.3 t -62.74 -47.82 91.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 109.076 -0.713 . . . . 15.0 109.076 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -71.53 -34.53 70.12 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.468 -0.787 . . . . 15.0 110.539 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -70.4 -40.07 74.11 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.569 -0.287 . . . . 15.0 110.936 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' ILE . . . . . 0.567 HG13 HG12 ' A' ' 423' ' ' VAL . 37.2 mt -66.58 -53.61 33.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.329 -0.396 . . . . 15.0 110.676 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -57.35 -41.97 81.09 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.105 0.479 . . . . 15.0 110.275 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.613 ' O ' ' HB2' ' A' ' 433' ' ' SER . 89.0 mttt -70.24 -24.98 63.17 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.516 -0.765 . . . . 15.0 110.592 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 430' ' ' MET . . . . . 0.65 ' O ' HG23 ' A' ' 434' ' ' VAL . 33.7 mmm -71.81 -46.09 59.34 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.469 -0.332 . . . . 15.0 110.898 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.607 HG22 ' CE2' ' A' ' 484' ' ' PHE . 1.0 OUTLIER -64.14 -41.19 91.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.979 0.419 . . . . 15.0 109.974 178.823 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -72.75 -29.75 63.58 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.708 -0.678 . . . . 15.0 110.992 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.781 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 13.3 t -69.64 -43.39 72.74 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.269 -0.423 . . . . 15.0 110.996 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 430' ' ' MET . 12.7 t -75.77 -41.86 40.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.201 -0.454 . . . . 15.0 110.811 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -57.89 -42.57 84.92 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.222 -0.444 . . . . 15.0 110.706 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -84.52 -25.19 28.97 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.506 -0.315 . . . . 15.0 111.033 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 437' ' ' ASN . . . . . 0.781 ' HB2' ' O ' ' A' ' 433' ' ' SER . 3.1 t30 -60.38 -38.96 85.55 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.851 0.358 . . . . 15.0 110.498 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -96.81 -10.47 26.56 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.911 -0.586 . . . . 15.0 111.734 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -108.83 53.6 0.68 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.896 0.379 . . . . 15.0 111.481 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.413 HG12 ' OE1' ' A' ' 450' ' ' GLU . 8.6 p -74.91 -0.13 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.132 -0.486 . . . . 15.0 110.866 178.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -86.39 -15.13 41.33 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.843 -0.617 . . . . 15.0 111.102 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 67.85 40.9 89.31 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 121.019 -0.61 . . . . 15.0 112.605 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -115.65 -15.56 11.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.651 0.262 . . . . 15.0 111.238 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 89.46 -4.93 84.18 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.876 -0.678 . . . . 15.0 112.487 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -142.64 156.72 45.1 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.793 0.33 . . . . 15.0 110.722 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 446' ' ' ILE . . . . . 0.654 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.7 mp -78.67 134.99 26.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 15.0 111.282 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 447' ' ' SER . . . . . 0.697 ' OG ' ' HG3' ' A' ' 450' ' ' GLU . 90.5 p -107.05 149.02 28.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.623 -0.717 . . . . 15.0 110.617 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -48.49 -43.54 35.01 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.182 -0.463 . . . . 15.0 111.852 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.89 -40.68 98.27 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.534 -0.303 . . . . 15.0 111.436 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 450' ' ' GLU . . . . . 0.697 ' HG3' ' OG ' ' A' ' 447' ' ' SER . 25.9 mt-10 -61.08 -57.72 11.38 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.399 -0.364 . . . . 15.0 110.558 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 451' ' ' PHE . . . . . 0.502 ' O ' ' HG2' ' A' ' 455' ' ' ARG . 3.9 t80 -61.5 -27.16 68.39 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.992 -0.549 . . . . 15.0 110.967 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 452' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -61.44 -56.65 17.8 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.029 -0.532 . . . . 15.0 111.197 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 2.1 mt -72.6 -30.14 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.908 -0.587 . . . . 15.0 111.828 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 454' ' ' ILE . . . . . 0.405 HG23 ' CD1' ' A' ' 458' ' ' PHE . 45.9 mt -66.39 -56.32 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.752 -0.203 . . . . 15.0 111.462 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 455' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 451' ' ' PHE . 28.4 ptt180 -51.88 -33.04 34.92 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.931 0.345 . . . . 15.0 111.931 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -69.88 -34.81 71.84 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.901 -0.666 . . . . 15.0 112.83 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 457' ' ' ASN . . . . . 0.411 ' O ' ' HD3' ' A' ' 459' ' ' PRO . 42.0 m-80 -92.93 -13.77 28.44 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.589 0.233 . . . . 15.0 111.39 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 458' ' ' PHE . . . . . 0.405 ' CD1' HG23 ' A' ' 454' ' ' ILE . 81.2 m-85 -116.69 85.59 17.26 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.484 -0.325 . . . . 15.0 111.036 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 459' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 457' ' ' ASN . 12.3 Cg_exo -71.37 -11.75 28.88 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.965 2.443 . . . . 15.0 112.507 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -99.51 26.24 6.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.249 -0.432 . . . . 15.0 110.926 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.7 tp -91.09 146.31 23.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.093 -0.503 . . . . 15.0 111.104 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 66.7 m -69.2 -172.55 0.44 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.08 -0.509 . . . . 15.0 111.245 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 463' ' ' ALA . . . . . 0.683 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -85.06 150.68 24.7 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.227 -0.442 . . . . 15.0 111.461 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 464' ' ' PHE . . . . . 0.686 ' HA ' HD11 ' A' ' 467' ' ' LEU . 66.0 m-85 -55.46 -51.6 66.39 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.76 -0.655 . . . . 15.0 111.226 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -68.78 -11.97 63.8 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.111 -0.566 . . . . 15.0 113.276 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -88.79 -36.17 16.23 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.078 0.439 . . . . 15.0 111.145 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.686 HD11 ' HA ' ' A' ' 464' ' ' PHE . 0.1 OUTLIER -85.14 -23.99 28.18 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.024 0.44 . . . . 15.0 110.055 178.351 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -135.23 111.06 9.35 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.77 -0.65 . . . . 15.0 110.008 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -61.48 -36.42 80.41 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.053 -0.521 . . . . 15.0 112.041 -178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -77.63 -9.08 58.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.532 -0.304 . . . . 15.0 111.681 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 55.45 34.1 22.3 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.442 -0.344 . . . . 15.0 111.438 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -82.09 1.99 33.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.163 -0.471 . . . . 15.0 111.511 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.22 15.28 63.0 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.457 -0.878 . . . . 15.0 110.981 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 474' ' ' CYS . . . . . . . . . . . . . 13.5 t -136.61 130.56 32.47 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.127 -0.536 . . . . 15.0 110.374 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.654 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 1.4 mp -103.4 127.53 57.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.964 0.411 . . . . 15.0 111.253 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 12.7 t -103.94 175.16 5.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.695 -0.684 . . . . 15.0 110.811 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.426 ' O ' HG23 ' A' ' 481' ' ' VAL . 99.0 mtt180 -56.98 -45.3 83.03 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.324 -0.398 . . . . 15.0 111.108 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 478' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.6 mt-10 -61.15 -29.57 69.87 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.179 -0.464 . . . . 15.0 111.524 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 479' ' ' GLU . . . . . 0.55 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 5.5 mm-40 -70.7 -49.03 51.42 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.401 0.143 . . . . 15.0 110.871 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 33.4 mtt -70.4 -46.22 64.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.72 -0.218 . . . . 15.0 111.02 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 481' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 477' ' ' ARG . 88.8 t -60.24 -52.72 58.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.689 0.28 . . . . 15.0 110.607 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 482' ' ' SER . . . . . 0.901 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 40.3 m -57.73 -32.7 67.7 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 116.171 -0.468 . . . . 15.0 110.061 178.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 483' ' ' TYR . . . . . 0.55 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 8.8 t80 -69.04 -30.9 69.36 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.872 -0.604 . . . . 15.0 110.913 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 484' ' ' PHE . . . . . 0.607 ' CE2' HG22 ' A' ' 431' ' ' VAL . 0.1 OUTLIER -74.17 -40.54 62.47 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 110.243 -0.281 . . . . 15.0 110.243 179.279 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.2 tt -83.44 -18.9 37.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 15.0 110.531 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 486' ' ' ARG . . . . . 0.901 ' HB2' ' O ' ' A' ' 482' ' ' SER . 32.9 ttt180 -71.49 -52.22 19.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.345 . . . . 15.0 110.843 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 14.0 t -90.13 19.46 5.0 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.977 -0.556 . . . . 15.0 111.244 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 488' ' ' SER . . . . . 0.56 ' HB2' ' O ' ' A' ' 484' ' ' PHE . 22.8 t -89.75 138.66 31.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.31 -0.405 . . . . 15.0 111.004 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 52.4 m -125.45 78.18 1.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.105 -0.498 . . . . 15.0 110.939 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 4.0 t -75.98 -47.08 33.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.118 -0.492 . . . . 15.0 111.16 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 1.1 mp -122.1 -42.02 2.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.183 -0.462 . . . . 15.0 110.967 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . 142.13 -55.6 0.59 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.911 -0.662 . . . . 15.0 112.48 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 109.95 -138.83 15.09 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.864 -0.684 . . . . 15.0 112.533 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -102.33 -42.13 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.727 0.299 . . . . 15.0 110.951 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 22.3 mmt -104.98 -42.34 5.35 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.263 -0.426 . . . . 15.0 111.057 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 144.78 -83.84 0.19 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.789 -0.719 . . . . 15.0 112.435 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.191 -0.909 . . . . 15.0 110.913 179.988 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 417' ' ' LYS . . . . . 0.543 ' N ' HD23 ' A' ' 422' ' ' LEU . 97.1 mttt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.687 0.28 . . . . 15.0 111.006 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.5 -15.51 4.02 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.338 -0.392 . . . . 15.0 111.109 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.68 ' O ' HG23 ' A' ' 423' ' ' VAL . 0.5 OUTLIER -108.95 129.77 55.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.379 -0.373 . . . . 15.0 111.091 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.754 ' O ' HG23 ' A' ' 424' ' ' VAL . 4.3 tt0 -46.72 -56.52 6.04 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.781 -0.645 . . . . 15.0 111.961 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -63.51 -39.83 95.46 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.438 -0.347 . . . . 15.0 111.485 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.543 HD23 ' N ' ' A' ' 417' ' ' LYS . 5.2 tp -57.33 -51.75 68.13 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.902 -0.59 . . . . 15.0 111.603 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.1 t -81.18 -21.68 10.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 115.67 -0.696 . . . . 15.0 111.929 -177.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 424' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 420' ' ' GLN . 12.0 t -64.05 -48.22 86.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.95 -0.759 . . . . 15.0 108.95 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -72.91 -33.04 65.73 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.37 -0.832 . . . . 15.0 110.629 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' HIS . . . . . 0.644 ' O ' ' HB2' ' A' ' 430' ' ' MET . 2.2 t60 -71.26 -39.32 71.67 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.579 -0.282 . . . . 15.0 110.984 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 427' ' ' ILE . . . . . 0.565 HG13 HG12 ' A' ' 423' ' ' VAL . 41.4 mt -69.29 -50.68 49.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.407 -0.361 . . . . 15.0 110.809 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -58.95 -43.27 91.22 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.088 0.471 . . . . 15.0 110.141 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.611 ' O ' ' HB2' ' A' ' 433' ' ' SER . 92.0 mttt -72.49 -23.04 60.97 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.513 -0.767 . . . . 15.0 110.516 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 430' ' ' MET . . . . . 0.666 ' O ' HG23 ' A' ' 434' ' ' VAL . 4.0 ttt -70.69 -49.55 45.98 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.456 -0.338 . . . . 15.0 110.8 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 427' ' ' ILE . 2.7 t -65.02 -39.07 84.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.269 -0.423 . . . . 15.0 110.008 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -71.38 -31.26 67.1 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.879 -0.601 . . . . 15.0 110.564 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.949 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 12.7 t -70.67 -41.22 72.38 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 116.217 -0.447 . . . . 15.0 111.041 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 430' ' ' MET . 19.4 t -75.1 -42.68 45.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.26 -0.427 . . . . 15.0 110.969 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 435' ' ' PHE . . . . . 0.633 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 14.3 t80 -59.28 -42.08 90.39 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.12 -0.491 . . . . 15.0 111.02 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -84.95 -27.95 26.18 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.548 -0.296 . . . . 15.0 110.953 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' ASN . . . . . 0.949 ' HB2' ' O ' ' A' ' 433' ' ' SER . 2.2 t30 -60.12 -44.89 94.54 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.203 -0.453 . . . . 15.0 111.393 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 438' ' ' PHE . . . . . 0.426 ' CZ ' HD21 ' A' ' 461' ' ' LEU . 45.3 m-85 -94.78 4.84 53.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.372 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 439' ' ' ASP . . . . . 0.633 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 0.3 OUTLIER -126.84 55.2 1.56 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.899 0.38 . . . . 15.0 111.352 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.401 ' H ' HG23 ' A' ' 440' ' ' VAL . 2.5 t -68.64 -8.42 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.129 -0.487 . . . . 15.0 111.325 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -87.97 -6.47 57.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.233 -0.44 . . . . 15.0 111.16 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 62.04 30.19 74.83 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.843 -0.694 . . . . 15.0 111.979 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -90.51 -18.91 24.47 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 122.307 0.243 . . . . 15.0 111.291 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 83.21 -7.33 67.87 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.91 -0.662 . . . . 15.0 112.576 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 445' ' ' HIS . . . . . 0.606 ' HB3' ' SG ' ' A' ' 474' ' ' CYS . 73.3 m-70 -131.84 140.21 49.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.809 0.338 . . . . 15.0 110.602 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 446' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 474' ' ' CYS . 1.5 mp -84.98 98.57 6.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.157 -0.474 . . . . 15.0 111.013 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 29.8 m -68.29 155.33 39.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.82 -0.627 . . . . 15.0 111.016 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -53.67 -40.62 66.09 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.153 -0.476 . . . . 15.0 111.825 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 449' ' ' GLU . . . . . 0.567 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -62.81 -39.42 94.21 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.496 -0.32 . . . . 15.0 111.424 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 450' ' ' GLU . . . . . 0.445 ' OE1' ' HA ' ' A' ' 446' ' ' ILE . 49.7 mt-10 -57.13 -58.83 6.47 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.048 0.451 . . . . 15.0 110.448 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 451' ' ' PHE . . . . . 0.614 ' CZ ' HD23 ' A' ' 461' ' ' LEU . 6.9 t80 -69.05 -20.43 64.11 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.771 -0.649 . . . . 15.0 110.609 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 452' ' ' GLN . . . . . 0.567 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 0.4 OUTLIER -59.31 -54.91 41.39 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.877 -0.601 . . . . 15.0 111.113 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -84.32 -32.5 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.733 -0.667 . . . . 15.0 111.843 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 57.7 mt -64.57 -40.07 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 111.664 0.246 . . . . 15.0 111.664 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 455' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 452' ' ' GLN . 32.0 ptt180 -59.67 -19.09 47.2 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.631 0.253 . . . . 15.0 111.597 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -79.32 -23.55 62.86 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.899 -0.667 . . . . 15.0 112.506 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -88.09 -27.25 22.06 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.642 0.258 . . . . 15.0 111.196 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -121.67 87.77 46.27 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.335 -0.393 . . . . 15.0 110.817 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.41 -3.89 13.36 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.963 2.442 . . . . 15.0 112.67 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -103.54 23.66 12.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.369 -0.378 . . . . 15.0 111.011 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.614 HD23 ' CZ ' ' A' ' 451' ' ' PHE . 2.9 tp -102.29 155.29 18.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.088 -0.505 . . . . 15.0 111.08 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 55.2 m -71.98 172.84 9.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.072 -0.513 . . . . 15.0 111.333 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 463' ' ' ALA . . . . . 0.46 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -91.54 156.64 17.52 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.115 -0.493 . . . . 15.0 111.77 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -45.83 -48.74 15.73 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.695 -0.684 . . . . 15.0 111.568 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -62.37 -23.84 64.97 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.89 -0.596 . . . . 15.0 113.637 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -88.43 -28.95 20.56 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 117.063 0.431 . . . . 15.0 111.592 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 463' ' ' ALA . 0.0 OUTLIER -77.43 -34.91 54.51 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.849 0.356 . . . . 15.0 110.252 178.524 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 468' ' ' ASP . . . . . 0.44 ' OD1' ' HB2' ' A' ' 470' ' ' ASN . 9.1 t70 -130.39 119.77 23.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.893 -0.594 . . . . 15.0 110.496 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -68.19 -28.05 66.93 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.104 -0.498 . . . . 15.0 111.525 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.44 ' HB2' ' OD1' ' A' ' 468' ' ' ASP . 8.6 m120 -76.88 -10.69 59.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.252 -0.431 . . . . 15.0 111.357 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 56.24 34.03 23.25 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.289 -0.414 . . . . 15.0 111.414 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -82.42 -1.89 51.48 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.199 -0.455 . . . . 15.0 111.514 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 65.59 14.95 61.09 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.585 -0.817 . . . . 15.0 111.436 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 474' ' ' CYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 446' ' ' ILE . 4.2 t -135.09 130.92 36.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.248 -0.476 . . . . 15.0 110.403 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.459 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 9.5 mm -105.04 124.88 60.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.982 0.42 . . . . 15.0 111.212 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 50.5 m -103.28 174.79 5.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.707 -0.679 . . . . 15.0 110.615 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -56.02 -49.07 74.7 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.418 -0.356 . . . . 15.0 111.018 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 478' ' ' GLU . . . . . 0.668 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -61.76 -33.44 74.09 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.124 -0.489 . . . . 15.0 111.763 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 479' ' ' GLU . . . . . 0.539 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 5.4 mm-40 -69.5 -53.23 20.15 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 121.228 -0.189 . . . . 15.0 110.983 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 480' ' ' MET . . . . . 0.407 ' SD ' ' HB ' ' A' ' 434' ' ' VAL . 9.9 ttm -69.21 -48.56 61.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.754 -0.203 . . . . 15.0 111.313 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 481' ' ' VAL . . . . . 0.553 HG22 HG11 ' A' ' 431' ' ' VAL . 79.4 t -60.92 -55.77 22.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.575 0.226 . . . . 15.0 111.217 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 482' ' ' SER . . . . . 0.958 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 44.5 m -54.89 -36.96 65.7 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.382 -0.372 . . . . 15.0 110.548 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 483' ' ' TYR . . . . . 0.539 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 1.9 m-85 -71.23 -26.04 62.75 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.236 -0.438 . . . . 15.0 111.321 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 484' ' ' PHE . . . . . 0.519 ' CD2' HG22 ' A' ' 431' ' ' VAL . 1.9 m-85 -73.37 -44.55 58.42 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 110.129 -0.323 . . . . 15.0 110.129 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.4 tt -84.24 -17.61 39.19 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.135 -0.484 . . . . 15.0 110.672 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 486' ' ' ARG . . . . . 0.958 ' HB2' ' O ' ' A' ' 482' ' ' SER . 30.8 ttt180 -70.97 -48.8 51.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.887 0.375 . . . . 15.0 110.758 177.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 52.2 m -82.7 19.26 1.35 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.89 -0.596 . . . . 15.0 111.469 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 66.9 m -88.44 145.14 25.94 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.358 -0.383 . . . . 15.0 111.0 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 13.1 t -98.52 -120.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 15.0 110.833 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 3.4 t -69.82 -49.13 59.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 120.722 0.296 . . . . 15.0 111.122 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 8.1 mt -128.33 -42.8 1.48 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.185 -0.462 . . . . 15.0 110.944 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -174.02 55.91 0.14 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.899 -0.667 . . . . 15.0 112.511 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . -136.34 -145.21 5.0 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.904 -0.665 . . . . 15.0 112.55 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -124.67 -44.59 1.96 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.677 0.275 . . . . 15.0 110.92 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 5.1 tpt -129.62 -42.15 1.31 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.255 -0.43 . . . . 15.0 110.921 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 160.41 -78.77 0.17 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.893 -0.67 . . . . 15.0 112.564 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.232 -0.889 . . . . 15.0 110.834 179.995 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 97.5 mttt . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.7 0.286 . . . . 15.0 110.881 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 11.2 mt -142.91 110.88 5.96 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.206 -0.452 . . . . 15.0 110.789 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.637 ' O ' HG23 ' A' ' 423' ' ' VAL . 1.1 m-20 -148.41 124.27 10.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 15.0 111.107 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.731 ' O ' HG23 ' A' ' 424' ' ' VAL . 45.4 mt-30 -47.62 -56.15 7.81 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.77 -0.65 . . . . 15.0 111.994 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -64.13 -40.94 97.25 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.384 -0.371 . . . . 15.0 111.67 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 5.0 tp -57.4 -53.3 59.65 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.041 -0.527 . . . . 15.0 111.726 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.7 t -80.13 -23.36 11.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.674 -0.694 . . . . 15.0 112.004 -177.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 424' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 420' ' ' GLN . 8.4 t -63.22 -47.66 91.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.02 -0.733 . . . . 15.0 109.02 177.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -71.77 -34.38 69.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.422 -0.808 . . . . 15.0 110.504 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -70.53 -40.39 73.46 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.534 -0.303 . . . . 15.0 110.946 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' ILE . . . . . 0.553 HG13 HG12 ' A' ' 423' ' ' VAL . 35.9 mt -66.36 -53.68 33.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.355 -0.384 . . . . 15.0 110.771 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -57.15 -41.83 79.89 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.105 0.479 . . . . 15.0 110.326 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.632 ' O ' ' HB2' ' A' ' 433' ' ' SER . 89.2 mttt -70.86 -24.7 62.56 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.538 -0.756 . . . . 15.0 110.749 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 430' ' ' MET . . . . . 0.664 ' O ' HG23 ' A' ' 434' ' ' VAL . 33.9 mtp -71.99 -47.49 51.69 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.405 -0.362 . . . . 15.0 110.891 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.588 HG22 ' CE2' ' A' ' 484' ' ' PHE . 0.8 OUTLIER -63.62 -40.98 91.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.065 0.459 . . . . 15.0 109.939 178.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -72.24 -30.35 64.8 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.666 -0.697 . . . . 15.0 110.826 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.837 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 12.2 t -68.75 -43.48 75.76 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.307 -0.406 . . . . 15.0 111.085 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 430' ' ' MET . 7.7 t -75.27 -41.97 43.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.32 -0.4 . . . . 15.0 110.848 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 435' ' ' PHE . . . . . 0.637 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 3.8 t80 -58.39 -41.57 85.16 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.09 -0.504 . . . . 15.0 110.967 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -85.11 -27.17 26.43 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.371 -0.377 . . . . 15.0 110.889 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' ASN . . . . . 0.837 ' HB2' ' O ' ' A' ' 433' ' ' SER . 2.7 t30 -59.36 -44.54 92.68 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.272 -0.422 . . . . 15.0 111.194 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 438' ' ' PHE . . . . . 0.516 ' CE2' HG21 ' A' ' 454' ' ' ILE . 33.1 m-85 -90.2 -5.91 55.87 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.019 -0.537 . . . . 15.0 111.212 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 439' ' ' ASP . . . . . 0.637 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 0.2 OUTLIER -109.82 53.94 0.68 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.838 0.351 . . . . 15.0 111.405 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 3.3 m -70.6 -9.22 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.21 -0.45 . . . . 15.0 111.617 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -88.92 -15.14 35.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.235 -0.439 . . . . 15.0 111.144 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 73.12 37.77 55.36 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.922 -0.656 . . . . 15.0 112.538 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -97.31 -16.39 20.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.653 0.264 . . . . 15.0 111.195 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 86.8 -7.69 78.88 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.825 -0.702 . . . . 15.0 112.374 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 445' ' ' HIS . . . . . 0.49 ' HB2' ' SG ' ' A' ' 474' ' ' CYS . 15.0 p80 -142.39 158.36 43.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.759 0.314 . . . . 15.0 110.712 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 446' ' ' ILE . . . . . 0.766 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.6 mp -77.71 135.99 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 15.0 111.165 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 14.4 t -106.19 148.11 28.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.585 -0.734 . . . . 15.0 110.767 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -50.18 -46.39 54.22 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.214 -0.448 . . . . 15.0 111.507 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 449' ' ' GLU . . . . . 0.469 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -65.42 -35.24 80.33 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.426 -0.352 . . . . 15.0 110.89 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -60.06 -59.56 5.23 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.241 -0.436 . . . . 15.0 110.483 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.36 -23.56 67.01 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.984 -0.553 . . . . 15.0 110.629 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 452' ' ' GLN . . . . . 0.469 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 8.1 mt-30 -60.14 -57.57 12.27 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.802 -0.635 . . . . 15.0 111.234 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 8.7 mm -76.6 -33.05 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.782 -0.645 . . . . 15.0 111.831 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 454' ' ' ILE . . . . . 0.516 HG21 ' CE2' ' A' ' 438' ' ' PHE . 48.5 mt -62.71 -46.98 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.803 -0.18 . . . . 15.0 111.133 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 455' ' ' ARG . . . . . 0.626 ' NH2' ' HA ' ' A' ' 463' ' ' ALA . 10.5 mtt180 -54.79 -34.33 62.56 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.718 0.294 . . . . 15.0 111.551 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -66.05 -30.84 77.74 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.994 -0.622 . . . . 15.0 112.896 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -96.95 -16.32 20.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.667 0.27 . . . . 15.0 111.293 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -132.97 85.79 44.99 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.308 -0.406 . . . . 15.0 110.983 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -72.84 1.74 6.11 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.062 2.508 . . . . 15.0 112.452 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -87.61 6.77 32.89 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.313 -0.403 . . . . 15.0 111.223 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -83.76 142.41 30.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.239 -0.437 . . . . 15.0 111.088 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 43.4 p -70.62 -172.56 0.64 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.161 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 463' ' ' ALA . . . . . 0.73 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -86.93 150.22 24.24 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.365 -0.38 . . . . 15.0 111.264 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 464' ' ' PHE . . . . . 0.731 ' HA ' HD11 ' A' ' 467' ' ' LEU . 80.0 m-85 -59.14 -46.71 87.64 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.023 -0.535 . . . . 15.0 111.371 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -67.68 -16.44 67.84 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.921 -0.656 . . . . 15.0 113.225 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -90.23 -41.35 11.64 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.913 0.356 . . . . 15.0 111.705 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.81 HD13 HD11 ' A' ' 475' ' ' ILE . 0.7 OUTLIER -76.53 -27.47 55.98 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.703 0.287 . . . . 15.0 110.842 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 468' ' ' ASP . . . . . 0.621 ' N ' HD12 ' A' ' 467' ' ' LEU . 10.9 t70 -128.16 112.2 14.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.203 -0.453 . . . . 15.0 110.362 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -67.02 -29.53 69.37 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.011 -0.54 . . . . 15.0 111.312 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -76.52 -13.66 60.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 15.0 111.144 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 60.65 28.05 17.76 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.199 -0.455 . . . . 15.0 111.285 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -71.42 -7.86 50.06 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.137 -0.483 . . . . 15.0 111.838 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.86 18.41 68.51 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.405 -0.902 . . . . 15.0 111.299 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 474' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 445' ' ' HIS . 19.0 t -137.16 130.88 31.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.256 -0.472 . . . . 15.0 110.464 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.81 HD11 HD13 ' A' ' 467' ' ' LEU . 9.0 mm -93.92 120.19 42.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.959 0.409 . . . . 15.0 111.01 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 476' ' ' SER . . . . . 0.464 ' H ' ' HG3' ' A' ' 479' ' ' GLU . 52.9 m -103.38 173.4 6.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.819 -0.628 . . . . 15.0 110.686 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 481' ' ' VAL . 98.8 mtt180 -53.74 -45.38 70.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.427 -0.351 . . . . 15.0 110.959 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 478' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -62.38 -28.36 69.72 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.046 -0.524 . . . . 15.0 111.361 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 479' ' ' GLU . . . . . 0.576 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 43.6 mm-40 -71.15 -50.05 37.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.41 0.147 . . . . 15.0 110.777 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 40.3 mtt -70.58 -46.66 63.03 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.797 -0.183 . . . . 15.0 110.958 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 481' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 477' ' ' ARG . 84.1 t -59.84 -54.12 38.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.758 0.313 . . . . 15.0 110.693 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 482' ' ' SER . . . . . 0.942 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 38.6 m -56.63 -33.11 65.99 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 116.215 -0.448 . . . . 15.0 110.117 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 483' ' ' TYR . . . . . 0.576 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 8.5 t80 -69.27 -29.74 67.7 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.921 -0.581 . . . . 15.0 110.966 177.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 484' ' ' PHE . . . . . 0.588 ' CE2' HG22 ' A' ' 431' ' ' VAL . 0.1 OUTLIER -73.9 -41.93 61.42 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 110.215 -0.291 . . . . 15.0 110.215 179.259 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.5 mp -83.83 -17.78 39.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.308 -0.405 . . . . 15.0 110.556 177.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 486' ' ' ARG . . . . . 0.942 ' HB2' ' O ' ' A' ' 482' ' ' SER . 34.4 ttt180 -71.99 -48.26 46.1 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.323 -0.399 . . . . 15.0 110.812 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 53.3 m -80.58 19.65 0.79 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.872 -0.604 . . . . 15.0 111.502 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 54.6 m -80.7 124.68 29.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.374 -0.376 . . . . 15.0 110.926 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 52.9 m -104.53 -38.5 6.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.084 -0.507 . . . . 15.0 111.145 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 1.8 t -147.91 13.65 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.376 -0.375 . . . . 15.0 110.79 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.51 -40.15 15.55 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.242 -0.435 . . . . 15.0 111.068 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . 144.23 -158.77 27.57 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.879 -0.677 . . . . 15.0 112.546 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . -168.28 -123.73 0.68 Allowed Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.853 -0.689 . . . . 15.0 112.476 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -102.32 -41.54 6.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.628 0.251 . . . . 15.0 110.94 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 64.7 mtt -104.34 145.35 30.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.194 -0.457 . . . . 15.0 110.871 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . -146.58 -64.19 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.905 -0.664 . . . . 15.0 112.522 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.277 -0.868 . . . . 15.0 110.876 -179.994 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 93.3 mttt . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.788 0.327 . . . . 15.0 110.913 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 2.5 pp -153.26 132.92 13.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.108 -0.496 . . . . 15.0 110.681 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.616 ' O ' HG23 ' A' ' 423' ' ' VAL . 0.7 OUTLIER -149.48 124.55 10.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 15.0 111.238 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.732 ' O ' HG23 ' A' ' 424' ' ' VAL . 53.3 mt-30 -47.25 -55.68 8.18 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.819 -0.628 . . . . 15.0 111.879 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -63.14 -40.37 97.39 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.308 -0.405 . . . . 15.0 111.51 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 4.9 tp -57.46 -53.01 62.95 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.009 -0.541 . . . . 15.0 111.673 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.5 t -79.95 -22.65 11.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.658 -0.701 . . . . 15.0 111.973 -177.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 424' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 420' ' ' GLN . 9.9 t -63.43 -47.75 90.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 109.047 -0.723 . . . . 15.0 109.047 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -71.96 -34.17 68.76 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.33 -0.85 . . . . 15.0 110.577 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -70.78 -40.42 72.61 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.612 -0.267 . . . . 15.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' ILE . . . . . 0.561 HG13 HG12 ' A' ' 423' ' ' VAL . 36.9 mt -66.48 -53.34 36.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.362 -0.381 . . . . 15.0 110.667 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -57.24 -42.27 81.12 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.151 0.5 . . . . 15.0 110.143 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -69.87 -25.34 63.67 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.528 -0.76 . . . . 15.0 110.549 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' MET . . . . . 0.681 ' O ' HG23 ' A' ' 434' ' ' VAL . 31.7 mmm -70.67 -47.73 58.44 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.425 -0.352 . . . . 15.0 110.935 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.584 HG22 ' CE2' ' A' ' 484' ' ' PHE . 0.8 OUTLIER -62.93 -40.3 88.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.014 0.435 . . . . 15.0 110.025 179.073 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -72.53 -33.31 66.79 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.733 -0.667 . . . . 15.0 110.978 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.796 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 3.6 m -66.33 -43.47 86.05 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.344 -0.389 . . . . 15.0 111.093 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 430' ' ' MET . 4.9 t -75.94 -38.84 36.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.212 -0.449 . . . . 15.0 110.779 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 435' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 431' ' ' VAL . 4.4 t80 -55.92 -42.87 76.73 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.068 -0.515 . . . . 15.0 110.821 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -89.16 -24.03 22.29 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.401 -0.363 . . . . 15.0 111.284 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 437' ' ' ASN . . . . . 0.796 ' HB2' ' O ' ' A' ' 433' ' ' SER . 4.2 t-20 -59.95 -34.7 73.6 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.987 0.422 . . . . 15.0 110.402 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 438' ' ' PHE . . . . . 0.439 ' O ' ' HB3' ' A' ' 450' ' ' GLU . 7.2 m-85 -71.79 -41.63 68.07 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.622 -0.717 . . . . 15.0 111.888 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 439' ' ' ASP . . . . . 0.722 ' HA ' ' OE2' ' A' ' 450' ' ' GLU . 5.1 p-10 -139.53 82.29 1.87 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.144 0.497 . . . . 15.0 111.91 -178.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.9 m -72.42 -8.57 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.925 -0.579 . . . . 15.0 111.248 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -66.84 -15.39 63.58 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.049 -0.523 . . . . 15.0 111.408 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 91.04 47.3 3.64 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.931 -0.652 . . . . 15.0 112.423 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -101.3 -19.53 15.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.674 0.273 . . . . 15.0 111.207 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 78.94 -13.69 17.7 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.039 -0.6 . . . . 15.0 113.0 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -144.48 168.37 20.29 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.889 0.376 . . . . 15.0 110.806 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 446' ' ' ILE . . . . . 0.594 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.2 mp -74.56 126.56 35.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.021 -0.536 . . . . 15.0 111.24 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 52.9 m -106.36 147.37 29.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.743 -0.662 . . . . 15.0 110.83 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -50.03 -45.59 52.18 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.193 -0.458 . . . . 15.0 111.677 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.72 -40.19 96.14 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.48 -0.327 . . . . 15.0 111.234 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 450' ' ' GLU . . . . . 0.722 ' OE2' ' HA ' ' A' ' 439' ' ' ASP . 5.5 mm-40 -63.33 -56.13 18.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.433 -0.349 . . . . 15.0 110.385 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.83 -28.99 67.96 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.165 -0.471 . . . . 15.0 110.93 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 452' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -61.82 -55.87 25.41 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 115.928 -0.578 . . . . 15.0 111.081 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 2.8 mt -70.86 -28.38 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.914 -0.585 . . . . 15.0 111.624 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 454' ' ' ILE . . . . . 0.453 HG23 ' CD1' ' A' ' 458' ' ' PHE . 30.3 mt -67.24 -56.98 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.67 -0.241 . . . . 15.0 111.183 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -47.93 -36.17 11.93 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.478 -0.328 . . . . 15.0 111.877 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -63.79 -34.05 88.89 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.986 -0.626 . . . . 15.0 112.947 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -104.24 -2.43 25.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.537 0.208 . . . . 15.0 111.345 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' PHE . . . . . 0.453 ' CD1' HG23 ' A' ' 454' ' ' ILE . 81.4 m-85 -128.75 79.96 73.49 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.523 -0.308 . . . . 15.0 111.155 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -75.09 -3.66 14.25 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.075 2.517 . . . . 15.0 112.543 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -107.71 26.41 10.34 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.207 -0.451 . . . . 15.0 111.013 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 2.4 tp -91.62 151.36 20.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.176 -0.466 . . . . 15.0 111.118 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 49.2 m -67.73 176.7 2.36 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.104 -0.498 . . . . 15.0 111.362 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 463' ' ' ALA . . . . . 0.786 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -89.05 153.11 21.26 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.128 -0.487 . . . . 15.0 111.288 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 464' ' ' PHE . . . . . 0.698 ' HA ' HD11 ' A' ' 467' ' ' LEU . 78.1 m-85 -57.41 -49.14 77.17 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.069 -0.514 . . . . 15.0 111.437 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -68.95 -15.48 69.37 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.992 -0.623 . . . . 15.0 113.57 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 466' ' ' ASP . . . . . 0.507 ' OD1' ' HB3' ' A' ' 463' ' ' ALA . 5.1 m-20 -89.83 -41.6 11.74 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.1 0.45 . . . . 15.0 111.712 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.887 HD13 HD11 ' A' ' 475' ' ' ILE . 0.6 OUTLIER -78.0 -27.74 49.05 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.747 0.308 . . . . 15.0 110.714 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 468' ' ' ASP . . . . . 0.589 ' N ' HD12 ' A' ' 467' ' ' LEU . 13.7 t70 -129.83 111.38 12.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.073 -0.512 . . . . 15.0 110.336 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -66.0 -30.25 70.77 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.369 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -76.38 -13.52 60.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.343 -0.389 . . . . 15.0 111.262 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 59.9 28.09 17.55 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.25 -0.432 . . . . 15.0 111.287 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -74.37 -5.26 41.3 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.201 -0.454 . . . . 15.0 111.723 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.72 17.95 67.67 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.403 -0.904 . . . . 15.0 111.265 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 474' ' ' CYS . . . . . . . . . . . . . 15.8 t -136.31 130.96 33.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.226 -0.487 . . . . 15.0 110.496 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.887 HD11 HD13 ' A' ' 467' ' ' LEU . 14.1 mm -95.25 120.81 45.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.899 0.381 . . . . 15.0 110.977 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 476' ' ' SER . . . . . 0.471 ' H ' ' HG3' ' A' ' 479' ' ' GLU . 54.3 m -103.08 171.79 7.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 15.0 110.667 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 481' ' ' VAL . 81.0 mtm180 -53.47 -44.59 69.09 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.417 -0.356 . . . . 15.0 110.931 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 478' ' ' GLU . . . . . 0.523 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.8 mt-10 -62.91 -28.81 70.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.075 -0.511 . . . . 15.0 111.358 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 479' ' ' GLU . . . . . 0.607 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 63.5 mm-40 -70.5 -50.26 39.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.499 0.19 . . . . 15.0 110.875 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 33.7 mtt -70.85 -46.89 61.87 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.709 -0.223 . . . . 15.0 111.168 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 481' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 477' ' ' ARG . 82.1 t -59.81 -53.13 52.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.626 0.251 . . . . 15.0 110.71 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 482' ' ' SER . . . . . 0.955 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 47.0 m -58.25 -32.66 68.57 Favored 'General case' 0 C--O 1.227 -0.104 0 CA-C-N 116.301 -0.408 . . . . 15.0 110.15 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 483' ' ' TYR . . . . . 0.607 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 7.4 t80 -69.62 -30.16 67.83 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.93 -0.577 . . . . 15.0 111.104 177.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 484' ' ' PHE . . . . . 0.584 ' CE2' HG22 ' A' ' 431' ' ' VAL . 0.1 OUTLIER -75.18 -40.51 59.36 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.762 0.315 . . . . 15.0 110.252 179.29 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.3 tt -83.98 -17.3 40.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 15.0 110.585 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 486' ' ' ARG . . . . . 0.955 ' HB2' ' O ' ' A' ' 482' ' ' SER . 25.1 ttt180 -74.14 -47.81 33.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.859 0.362 . . . . 15.0 110.918 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 13.9 t -82.89 19.92 1.28 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.901 -0.59 . . . . 15.0 111.554 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 88.1 p -82.97 121.86 27.54 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.792 0.329 . . . . 15.0 110.919 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 53.1 m -126.55 79.58 1.87 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.129 -0.487 . . . . 15.0 111.001 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.506 ' O ' HD12 ' A' ' 491' ' ' LEU . 2.9 t -77.46 -60.64 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.091 -0.504 . . . . 15.0 110.906 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 490' ' ' VAL . 1.9 mp -142.85 -43.82 0.31 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.22 -0.445 . . . . 15.0 110.918 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . 128.33 53.09 0.12 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.927 -0.654 . . . . 15.0 112.575 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . -158.2 -150.13 5.67 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.875 -0.679 . . . . 15.0 112.507 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -127.66 149.76 50.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.755 0.312 . . . . 15.0 110.944 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -102.35 145.92 28.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.119 -0.491 . . . . 15.0 110.874 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 122.19 78.98 0.48 Allowed Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.824 -0.703 . . . . 15.0 112.533 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 26.2 p90 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.199 -0.905 . . . . 15.0 110.942 -179.975 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 97.2 mttt . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.765 0.317 . . . . 15.0 110.899 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.7 mp -142.24 -44.22 0.33 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.125 -0.489 . . . . 15.0 110.843 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.669 ' O ' HG23 ' A' ' 423' ' ' VAL . 7.6 m-20 -94.21 18.91 10.06 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.238 -0.437 . . . . 15.0 111.098 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.725 ' O ' HG23 ' A' ' 424' ' ' VAL . 6.5 pt20 -46.42 -56.92 5.19 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.087 -0.506 . . . . 15.0 111.784 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 421' ' ' ALA . . . . . 0.418 ' H ' ' HG3' ' A' ' 420' ' ' GLN . . . -68.39 -37.64 80.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.404 -0.362 . . . . 15.0 111.279 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.527 HD13 ' OD2' ' A' ' 419' ' ' ASP . 1.2 tt -57.75 -53.72 55.06 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.882 -0.599 . . . . 15.0 111.701 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.6 t -80.78 -23.8 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 CA-C-N 115.657 -0.701 . . . . 15.0 112.05 -177.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 424' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 420' ' ' GLN . 7.2 t -62.9 -47.87 90.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.093 -0.706 . . . . 15.0 109.093 177.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -71.92 -34.16 68.86 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.486 -0.779 . . . . 15.0 110.561 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -70.72 -39.37 73.43 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.558 -0.292 . . . . 15.0 111.04 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' ILE . . . . . 0.572 ' O ' HG23 ' A' ' 431' ' ' VAL . 37.6 mt -67.84 -51.91 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.37 -0.377 . . . . 15.0 110.732 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -58.4 -42.19 86.61 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.192 0.52 . . . . 15.0 110.303 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.555 ' O ' ' HB2' ' A' ' 433' ' ' SER . 90.2 mttt -71.15 -25.14 62.43 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.521 -0.763 . . . . 15.0 110.707 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 430' ' ' MET . . . . . 0.683 ' O ' HG23 ' A' ' 434' ' ' VAL . 23.3 mmm -71.45 -46.97 58.6 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.448 -0.342 . . . . 15.0 110.908 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 427' ' ' ILE . 2.6 t -65.33 -39.15 84.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.879 0.371 . . . . 15.0 110.061 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -72.16 -31.14 65.68 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.859 -0.61 . . . . 15.0 110.73 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.869 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 14.2 t -70.86 -41.88 70.82 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.196 -0.456 . . . . 15.0 111.06 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 430' ' ' MET . 17.8 t -75.87 -41.29 39.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.249 -0.432 . . . . 15.0 110.956 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -60.58 -41.32 94.4 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.297 -0.41 . . . . 15.0 110.815 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -83.21 -28.62 29.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.504 -0.316 . . . . 15.0 110.681 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' ASN . . . . . 0.869 ' HB2' ' O ' ' A' ' 433' ' ' SER . 2.5 t30 -60.11 -44.54 94.77 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.085 -0.507 . . . . 15.0 111.247 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 438' ' ' PHE . . . . . 0.522 ' CE2' HG21 ' A' ' 454' ' ' ILE . 66.6 m-85 -93.94 0.53 56.14 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.841 -0.618 . . . . 15.0 111.448 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -127.48 53.1 1.77 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.979 0.418 . . . . 15.0 111.179 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.9 t -74.39 -14.24 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.078 -0.51 . . . . 15.0 111.065 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -90.2 -14.74 32.83 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.074 -0.512 . . . . 15.0 111.032 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 64.55 60.06 7.48 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.051 -0.595 . . . . 15.0 112.796 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.44 -10.81 11.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.705 0.288 . . . . 15.0 111.223 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 88.93 -13.55 62.75 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.811 -0.709 . . . . 15.0 112.227 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 445' ' ' HIS . . . . . 0.631 ' HB2' ' SG ' ' A' ' 474' ' ' CYS . 9.5 p80 -141.58 156.81 45.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.602 0.239 . . . . 15.0 110.415 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 446' ' ' ILE . . . . . 0.875 HG12 ' H ' ' A' ' 475' ' ' ILE . 0.9 OUTLIER -82.99 100.85 6.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.366 -0.379 . . . . 15.0 111.143 -179.166 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 7.6 t -67.71 152.12 46.13 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.282 -0.417 . . . . 15.0 110.918 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -51.59 -43.11 62.38 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.07 -0.514 . . . . 15.0 111.951 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 449' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 452' ' ' GLN . 42.7 mt-10 -63.03 -40.09 96.7 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.552 -0.294 . . . . 15.0 111.322 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -58.24 -56.38 22.88 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.935 0.398 . . . . 15.0 110.412 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -66.85 -23.29 66.01 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.935 -0.575 . . . . 15.0 110.608 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 452' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 449' ' ' GLU . 2.6 mm-40 -59.1 -54.84 42.48 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.838 -0.619 . . . . 15.0 111.008 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 8.7 mm -78.98 -31.82 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 115.649 -0.705 . . . . 15.0 111.694 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 454' ' ' ILE . . . . . 0.522 HG21 ' CE2' ' A' ' 438' ' ' PHE . 50.2 mt -61.22 -46.86 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.494 0.188 . . . . 15.0 111.273 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -55.74 -29.97 60.42 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.552 -0.295 . . . . 15.0 111.561 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -66.0 -31.8 80.58 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.963 -0.637 . . . . 15.0 112.759 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -103.64 -11.7 17.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.607 0.242 . . . . 15.0 111.365 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -136.23 78.98 44.52 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 116.465 -0.334 . . . . 15.0 110.985 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.08 2.4 6.71 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.166 2.577 . . . . 15.0 112.624 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -85.2 5.19 31.16 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.325 -0.398 . . . . 15.0 111.285 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -87.76 142.39 27.86 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.263 -0.426 . . . . 15.0 111.063 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 462' ' ' SER . . . . . 0.406 ' HB2' ' H ' ' A' ' 463' ' ' ALA . 5.8 p -81.39 -157.35 0.17 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.066 -0.515 . . . . 15.0 110.975 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 463' ' ' ALA . . . . . 0.555 ' HB3' ' OD2' ' A' ' 466' ' ' ASP . . . -85.4 148.47 25.99 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.926 0.393 . . . . 15.0 111.655 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -51.24 -46.36 62.31 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.771 -0.649 . . . . 15.0 111.121 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -63.57 -19.38 62.5 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.907 -0.588 . . . . 15.0 113.005 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 466' ' ' ASP . . . . . 0.555 ' OD2' ' HB3' ' A' ' 463' ' ' ALA . 7.6 m-20 -87.87 -37.11 16.78 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.765 0.282 . . . . 15.0 110.977 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.442 ' H ' ' HG ' ' A' ' 467' ' ' LEU . 0.1 OUTLIER -68.99 -34.11 74.77 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.96 0.41 . . . . 15.0 110.154 178.34 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 468' ' ' ASP . . . . . 0.467 ' OD2' ' HB2' ' A' ' 470' ' ' ASN . 8.5 t70 -120.34 117.17 27.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.698 -0.683 . . . . 15.0 110.413 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -64.26 -27.68 69.21 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.083 -0.508 . . . . 15.0 111.577 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 470' ' ' ASN . . . . . 0.467 ' HB2' ' OD2' ' A' ' 468' ' ' ASP . 5.0 m-80 -76.94 -9.01 58.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.371 -0.377 . . . . 15.0 111.442 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 54.4 36.01 24.46 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.365 -0.38 . . . . 15.0 111.4 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -88.43 0.78 55.87 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.194 -0.457 . . . . 15.0 111.47 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 65.67 14.08 59.88 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.427 -0.892 . . . . 15.0 111.314 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 474' ' ' CYS . . . . . 0.631 ' SG ' ' HB2' ' A' ' 445' ' ' HIS . 1.2 m -137.69 130.7 30.32 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.202 -0.499 . . . . 15.0 110.508 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.875 ' H ' HG12 ' A' ' 446' ' ' ILE . 2.7 mp -107.89 128.92 62.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.992 0.425 . . . . 15.0 111.246 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 48.8 m -104.33 -179.58 3.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.597 -0.728 . . . . 15.0 110.784 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 481' ' ' VAL . 24.6 ptt180 -62.58 -47.51 83.5 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.364 -0.38 . . . . 15.0 111.214 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 478' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -60.45 -33.95 73.29 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.252 -0.431 . . . . 15.0 111.48 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 479' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 6.8 mm-40 -66.79 -45.21 79.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.562 0.22 . . . . 15.0 110.626 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 40.3 mtt -69.76 -47.58 62.47 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.608 -0.269 . . . . 15.0 110.893 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 481' ' ' VAL . . . . . 0.568 HG22 HG11 ' A' ' 431' ' ' VAL . 89.9 t -60.14 -55.61 23.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.737 0.303 . . . . 15.0 110.937 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 482' ' ' SER . . . . . 0.952 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 75.0 m -54.51 -38.79 66.92 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 116.128 -0.487 . . . . 15.0 110.605 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 483' ' ' TYR . . . . . 0.489 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 2.6 m-85 -71.58 -24.43 61.91 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.036 -0.529 . . . . 15.0 111.555 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 484' ' ' PHE . . . . . 0.533 ' CD2' HG22 ' A' ' 431' ' ' VAL . 3.7 m-85 -75.28 -43.55 50.64 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 120.843 -0.343 . . . . 15.0 110.163 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 485' ' ' LEU . . . . . 0.434 ' HA ' ' OG ' ' A' ' 488' ' ' SER . 5.3 tt -84.16 -18.69 35.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 15.0 110.642 176.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 486' ' ' ARG . . . . . 0.952 ' HB2' ' O ' ' A' ' 482' ' ' SER . 24.2 ttt180 -70.97 -49.57 43.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.899 0.38 . . . . 15.0 110.791 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 14.5 t -83.43 19.68 1.5 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.831 -0.622 . . . . 15.0 111.339 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 488' ' ' SER . . . . . 0.434 ' OG ' ' HA ' ' A' ' 485' ' ' LEU . 74.0 m -80.71 133.72 35.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.335 -0.393 . . . . 15.0 111.001 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 54.0 m -97.69 -36.39 10.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 15.0 111.131 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 50.6 t -148.71 84.93 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.258 -0.428 . . . . 15.0 110.437 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 6.5 tt -124.79 -44.31 1.95 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.086 -0.507 . . . . 15.0 110.803 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . 125.21 161.07 10.92 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.847 -0.692 . . . . 15.0 112.466 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . -100.51 179.91 29.44 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.879 -0.677 . . . . 15.0 112.575 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -100.23 -41.69 6.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.72 0.295 . . . . 15.0 110.861 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 64.5 mtt -114.21 130.25 56.62 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.226 -0.443 . . . . 15.0 110.921 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 128.63 104.72 1.19 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.861 -0.685 . . . . 15.0 112.473 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.219 -0.896 . . . . 15.0 110.927 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 96.8 mttt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.749 0.309 . . . . 15.0 110.922 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 5.3 mp -109.65 -22.82 11.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.148 -0.478 . . . . 15.0 110.981 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.678 ' O ' HG23 ' A' ' 423' ' ' VAL . 8.4 m-20 58.92 28.58 17.76 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.143 -0.48 . . . . 15.0 111.335 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.724 ' O ' HG23 ' A' ' 424' ' ' VAL . 44.4 mt-30 -48.8 -58.05 5.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.089 -0.505 . . . . 15.0 111.864 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -68.09 -38.6 82.52 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.444 -0.344 . . . . 15.0 111.489 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.511 HD13 ' OD2' ' A' ' 419' ' ' ASP . 0.9 OUTLIER -57.36 -54.43 46.95 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.955 -0.566 . . . . 15.0 111.852 -179.241 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.7 t -81.1 -23.47 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-N 115.709 -0.678 . . . . 15.0 112.148 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 424' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 420' ' ' GLN . 7.2 t -63.28 -48.06 89.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.11 -0.7 . . . . 15.0 109.11 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -71.84 -34.0 68.92 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.488 -0.778 . . . . 15.0 110.607 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -70.57 -39.8 73.68 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.621 -0.263 . . . . 15.0 110.99 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 427' ' ' ILE . . . . . 0.583 ' O ' HG23 ' A' ' 431' ' ' VAL . 40.5 mt -67.61 -52.38 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 116.442 -0.345 . . . . 15.0 110.772 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -57.97 -42.04 84.21 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.096 0.474 . . . . 15.0 110.222 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 433' ' ' SER . 89.7 mttt -71.47 -24.86 62.08 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.521 -0.763 . . . . 15.0 110.737 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 430' ' ' MET . . . . . 0.634 ' O ' HG23 ' A' ' 434' ' ' VAL . 26.2 mtp -71.17 -47.68 56.23 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.467 -0.333 . . . . 15.0 110.937 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 427' ' ' ILE . 1.8 t -65.77 -39.03 83.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.913 0.387 . . . . 15.0 110.079 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -72.19 -30.01 64.54 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.842 -0.617 . . . . 15.0 110.681 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.782 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 13.4 t -70.25 -42.66 71.89 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.261 -0.427 . . . . 15.0 110.936 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 430' ' ' MET . 14.4 t -76.09 -40.37 37.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.207 -0.452 . . . . 15.0 110.77 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -58.7 -43.39 90.01 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.191 -0.458 . . . . 15.0 110.579 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -83.52 -25.3 31.15 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.451 -0.34 . . . . 15.0 110.961 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 437' ' ' ASN . . . . . 0.782 ' HB2' ' O ' ' A' ' 433' ' ' SER . 4.9 t-20 -60.11 -38.75 83.95 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.383 -0.372 . . . . 15.0 110.477 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 438' ' ' PHE . . . . . 0.539 ' CE2' HG21 ' A' ' 454' ' ' ILE . 32.6 m-85 -95.36 -12.15 26.53 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.763 -0.653 . . . . 15.0 111.581 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -106.33 54.09 0.69 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.88 0.371 . . . . 15.0 111.375 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.18 -6.46 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.194 -0.457 . . . . 15.0 111.403 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -94.0 -15.04 25.23 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.3 -0.409 . . . . 15.0 111.214 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 68.3 48.07 54.36 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.018 -0.611 . . . . 15.0 112.681 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -110.85 -18.05 13.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.649 0.261 . . . . 15.0 111.168 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 91.27 -5.2 81.06 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.921 -0.657 . . . . 15.0 112.378 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -143.29 156.92 44.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.816 0.341 . . . . 15.0 110.742 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 446' ' ' ILE . . . . . 0.684 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.7 mp -81.77 136.47 22.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.285 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 5.4 m -105.17 149.15 26.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.663 -0.699 . . . . 15.0 110.72 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -47.73 -46.93 30.35 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.176 -0.465 . . . . 15.0 111.776 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -64.69 -38.7 91.88 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.512 -0.313 . . . . 15.0 111.208 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -59.49 -59.07 6.04 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.275 -0.42 . . . . 15.0 110.427 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -63.18 -26.52 68.84 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.797 -0.638 . . . . 15.0 110.83 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 452' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -59.25 -56.94 15.75 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.902 -0.59 . . . . 15.0 111.288 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -78.29 -29.96 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.879 -0.601 . . . . 15.0 111.795 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 454' ' ' ILE . . . . . 0.539 HG21 ' CE2' ' A' ' 438' ' ' PHE . 46.6 mt -63.37 -46.14 96.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 120.397 0.141 . . . . 15.0 111.319 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -52.5 -29.22 23.96 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.802 0.297 . . . . 15.0 111.802 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -74.78 -24.65 71.69 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.833 -0.698 . . . . 15.0 112.676 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -71.6 -56.91 4.95 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.478 0.18 . . . . 15.0 111.402 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -144.59 98.71 4.9 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-O 120.628 0.251 . . . . 15.0 111.117 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.43 4.16 4.68 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.118 2.545 . . . . 15.0 112.594 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -112.29 -24.82 9.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.384 -0.371 . . . . 15.0 111.374 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.4 tp -56.77 -56.24 24.07 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.283 -0.417 . . . . 15.0 111.652 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 5.7 m -135.44 109.01 7.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.766 0.317 . . . . 15.0 111.019 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 463' ' ' ALA . . . . . 0.661 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -77.89 106.4 9.71 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.238 -0.437 . . . . 15.0 110.944 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 464' ' ' PHE . . . . . 0.475 ' HZ ' ' H ' ' A' ' 473' ' ' GLY . 29.3 t80 -40.37 -42.28 1.54 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.905 -0.588 . . . . 15.0 111.99 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -59.82 -36.92 91.59 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.03 -0.605 . . . . 15.0 113.27 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 466' ' ' ASP . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 483' ' ' TYR . 6.3 m-20 -90.48 -21.41 21.88 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.569 0.581 . . . . 15.0 112.569 -178.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 463' ' ' ALA . 0.1 OUTLIER -85.83 -43.24 13.45 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.791 -0.364 . . . . 15.0 110.518 179.383 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 468' ' ' ASP . . . . . 0.478 ' HB2' HD13 ' A' ' 475' ' ' ILE . 24.0 t0 -130.07 110.9 11.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.001 -0.545 . . . . 15.0 111.231 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -85.67 -16.84 37.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.087 -0.506 . . . . 15.0 110.772 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -78.6 -13.83 59.63 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.112 -0.495 . . . . 15.0 111.195 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 60.91 24.18 14.21 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.182 -0.463 . . . . 15.0 111.629 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -75.05 -3.42 32.4 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.41 -0.359 . . . . 15.0 111.645 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 473' ' ' GLY . . . . . 0.475 ' H ' ' HZ ' ' A' ' 464' ' ' PHE . . . 66.57 13.83 61.48 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.634 -0.793 . . . . 15.0 111.431 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 474' ' ' CYS . . . . . . . . . . . . . 14.8 t -133.13 130.81 39.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.374 -0.413 . . . . 15.0 110.609 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.684 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 10.8 mm -103.6 124.25 57.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 120.778 0.323 . . . . 15.0 110.99 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 53.4 m -102.44 167.47 9.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 15.0 110.812 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -53.31 -43.3 67.48 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.245 -0.434 . . . . 15.0 111.127 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 478' ' ' GLU . . . . . 0.67 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -60.4 -32.7 71.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.189 -0.459 . . . . 15.0 111.547 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 479' ' ' GLU . . . . . 0.565 ' OE1' ' HA ' ' A' ' 475' ' ' ILE . 47.6 mt-10 -67.08 -54.26 23.13 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.424 0.154 . . . . 15.0 111.095 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 58.5 mtt -70.07 -49.59 49.58 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.755 -0.202 . . . . 15.0 111.265 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 71.6 t -58.91 -56.78 14.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.57 0.224 . . . . 15.0 111.169 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 482' ' ' SER . . . . . 1.02 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 58.1 m -55.22 -36.59 66.16 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 116.457 -0.338 . . . . 15.0 110.511 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 483' ' ' TYR . . . . . 0.552 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 20.5 t80 -69.37 -26.89 64.88 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.135 -0.484 . . . . 15.0 111.253 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 484' ' ' PHE . . . . . 0.558 ' CD2' HG22 ' A' ' 431' ' ' VAL . 5.1 m-85 -76.15 -44.15 39.56 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 120.902 -0.319 . . . . 15.0 110.533 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.3 tt -83.52 -16.67 44.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.473 -0.33 . . . . 15.0 110.706 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 486' ' ' ARG . . . . . 1.02 ' HB2' ' O ' ' A' ' 482' ' ' SER . 30.7 ttt180 -75.91 -50.28 15.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.525 -0.307 . . . . 15.0 111.284 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 52.3 m -86.25 -51.1 6.48 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.183 -0.462 . . . . 15.0 111.916 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 488' ' ' SER . . . . . 0.52 ' HB3' ' O ' ' A' ' 484' ' ' PHE . 12.5 t -67.23 152.72 45.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.939 0.4 . . . . 15.0 111.448 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 51.9 m -97.2 69.53 2.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.797 -0.638 . . . . 15.0 110.975 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 3.8 t -60.17 -62.09 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.3 -0.409 . . . . 15.0 111.347 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 9.1 mt -142.18 -45.08 0.33 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.292 -0.413 . . . . 15.0 111.067 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -110.45 151.81 17.48 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.867 -0.682 . . . . 15.0 112.564 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . -121.53 -46.19 0.33 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.889 -0.672 . . . . 15.0 112.557 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -99.12 -41.57 7.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.662 0.268 . . . . 15.0 110.954 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 87.4 mtp -102.35 149.66 24.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.229 -0.441 . . . . 15.0 110.919 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 165.56 105.6 0.19 Allowed Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.945 -0.645 . . . . 15.0 112.525 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.2 -0.905 . . . . 15.0 110.937 179.996 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 58.5 mttp . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.759 0.314 . . . . 15.0 110.916 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 9.7 mt -129.81 136.67 49.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.139 -0.482 . . . . 15.0 110.89 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' ASP . . . . . 0.662 ' O ' HG23 ' A' ' 423' ' ' VAL . 8.7 m-20 -96.03 15.34 20.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.074 -0.512 . . . . 15.0 110.926 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 420' ' ' GLN . . . . . 0.726 ' O ' HG23 ' A' ' 424' ' ' VAL . 9.6 tt0 -46.25 -57.64 4.38 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.088 -0.505 . . . . 15.0 111.578 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -68.3 -37.28 80.46 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.306 -0.406 . . . . 15.0 111.238 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' LEU . . . . . 0.414 HD13 ' OD1' ' A' ' 419' ' ' ASP . 1.4 tt -57.39 -54.56 45.39 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.791 -0.641 . . . . 15.0 111.688 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.4 t -81.29 -23.74 10.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.724 -0.671 . . . . 15.0 112.097 -177.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 424' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 420' ' ' GLN . 7.0 t -62.64 -48.43 88.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 109.044 -0.724 . . . . 15.0 109.044 178.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -72.2 -33.96 68.03 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.428 -0.806 . . . . 15.0 110.6 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' HIS . . . . . 0.414 ' HB2' ' O ' ' A' ' 422' ' ' LEU . 2.5 t60 -70.83 -39.11 73.21 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 120.716 0.293 . . . . 15.0 110.995 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 427' ' ' ILE . . . . . 0.579 HG13 HG12 ' A' ' 423' ' ' VAL . 36.4 mt -67.63 -54.0 26.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.328 -0.396 . . . . 15.0 110.658 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -56.93 -42.32 79.8 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.132 0.491 . . . . 15.0 110.153 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.641 ' O ' ' HB2' ' A' ' 433' ' ' SER . 88.1 mttt -70.54 -25.13 62.97 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 115.545 -0.752 . . . . 15.0 110.762 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 430' ' ' MET . . . . . 0.645 ' O ' HG23 ' A' ' 434' ' ' VAL . 18.3 mtm -71.44 -46.54 59.79 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.546 -0.297 . . . . 15.0 110.948 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.611 HG22 ' CD2' ' A' ' 484' ' ' PHE . 0.8 OUTLIER -63.87 -41.87 93.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 121.041 0.448 . . . . 15.0 109.978 178.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -72.45 -29.6 63.83 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.642 -0.708 . . . . 15.0 110.952 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' SER . . . . . 0.853 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 13.3 t -69.43 -43.7 72.84 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.304 -0.407 . . . . 15.0 111.02 -179.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 430' ' ' MET . 12.1 t -75.16 -42.9 44.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.281 -0.418 . . . . 15.0 110.869 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 435' ' ' PHE . . . . . 0.492 ' CZ ' ' HG3' ' A' ' 477' ' ' ARG . 7.7 t80 -56.69 -43.64 80.7 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.113 -0.494 . . . . 15.0 110.902 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -85.55 -23.94 27.45 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.464 -0.335 . . . . 15.0 111.205 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 437' ' ' ASN . . . . . 0.853 ' HB2' ' O ' ' A' ' 433' ' ' SER . 4.4 t-20 -59.84 -40.24 87.85 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.429 -0.351 . . . . 15.0 110.637 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 438' ' ' PHE . . . . . 0.524 ' CE2' HG21 ' A' ' 454' ' ' ILE . 54.8 m-85 -95.71 -13.83 23.89 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.931 -0.577 . . . . 15.0 111.807 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -105.31 54.33 0.71 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.924 0.392 . . . . 15.0 111.239 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 11.1 p -71.95 -16.1 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.13 -0.487 . . . . 15.0 111.338 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 40.2 p30 -79.92 -14.26 58.75 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.144 -0.48 . . . . 15.0 111.341 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 71.29 47.14 37.83 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.869 -0.682 . . . . 15.0 112.386 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -106.5 -18.46 13.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.676 0.274 . . . . 15.0 111.192 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 89.93 -9.32 77.67 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.956 -0.64 . . . . 15.0 112.494 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 445' ' ' HIS . . . . . 0.403 ' HB3' ' SG ' ' A' ' 474' ' ' CYS . 88.8 m-70 -146.01 162.53 37.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.774 0.321 . . . . 15.0 110.709 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 446' ' ' ILE . . . . . 0.598 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.7 mp -77.84 135.13 26.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.225 -0.443 . . . . 15.0 111.179 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.0 m -106.14 148.72 27.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.669 -0.696 . . . . 15.0 110.584 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -48.32 -47.46 36.8 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.257 -0.429 . . . . 15.0 111.697 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 449' ' ' GLU . . . . . 0.435 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.4 mt-10 -64.46 -38.22 90.27 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.423 -0.353 . . . . 15.0 111.329 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -58.37 -61.53 2.51 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.883 0.373 . . . . 15.0 110.605 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.7 -22.69 66.64 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.923 -0.581 . . . . 15.0 110.932 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 452' ' ' GLN . . . . . 0.435 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 0.9 OUTLIER -60.49 -57.55 12.27 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.938 -0.574 . . . . 15.0 111.281 179.49 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -76.87 -33.76 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 115.771 -0.65 . . . . 15.0 111.855 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 454' ' ' ILE . . . . . 0.524 HG21 ' CE2' ' A' ' 438' ' ' PHE . 61.0 mt -62.49 -49.97 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 120.489 0.185 . . . . 15.0 111.284 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 455' ' ' ARG . . . . . 0.515 ' NH2' ' H ' ' A' ' 461' ' ' LEU . 0.1 OUTLIER -57.94 -30.6 66.09 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.524 -0.307 . . . . 15.0 111.521 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -70.57 -33.73 67.44 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.918 -0.658 . . . . 15.0 112.775 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 457' ' ' ASN . . . . . 0.452 ' O ' ' HD3' ' A' ' 459' ' ' PRO . 40.9 m-80 -90.4 -22.21 21.57 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.637 0.256 . . . . 15.0 111.189 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -115.97 84.39 13.34 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.432 -0.349 . . . . 15.0 111.034 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 459' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 457' ' ' ASN . 13.0 Cg_exo -70.83 -10.55 27.93 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.947 2.431 . . . . 15.0 112.545 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -96.84 25.55 5.2 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.318 -0.401 . . . . 15.0 110.974 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 461' ' ' LEU . . . . . 0.515 ' H ' ' NH2' ' A' ' 455' ' ' ARG . 0.7 OUTLIER -98.01 152.07 19.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.218 -0.447 . . . . 15.0 111.061 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 462' ' ' SER . . . . . 0.494 ' OG ' HD23 ' A' ' 467' ' ' LEU . 43.1 p -63.63 175.73 1.02 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.072 -0.513 . . . . 15.0 111.328 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 463' ' ' ALA . . . . . 0.745 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -87.76 148.42 24.73 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.184 -0.462 . . . . 15.0 111.242 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 464' ' ' PHE . . . . . 0.714 ' HA ' HD11 ' A' ' 467' ' ' LEU . 46.0 m-85 -54.44 -48.07 72.13 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.937 -0.574 . . . . 15.0 111.477 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -70.4 -15.62 72.91 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.014 -0.613 . . . . 15.0 113.519 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 466' ' ' ASP . . . . . 0.489 ' OD1' ' HB3' ' A' ' 463' ' ' ALA . 4.1 m-20 -90.26 -36.67 14.59 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 117.089 0.445 . . . . 15.0 111.796 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.855 HD13 HD11 ' A' ' 475' ' ' ILE . 0.5 OUTLIER -82.08 -30.88 31.07 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.9 0.381 . . . . 15.0 110.571 179.193 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 468' ' ' ASP . . . . . 0.595 ' N ' HD12 ' A' ' 467' ' ' LEU . 20.7 t70 -126.47 108.75 11.46 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.976 -0.556 . . . . 15.0 110.273 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -69.22 -22.11 63.89 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.112 -0.494 . . . . 15.0 111.489 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -76.51 -14.11 60.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.226 -0.443 . . . . 15.0 111.326 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 57.38 26.61 12.7 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.224 -0.444 . . . . 15.0 111.413 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -81.23 0.05 38.44 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.257 -0.429 . . . . 15.0 111.551 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 65.89 16.04 63.34 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.469 -0.872 . . . . 15.0 111.227 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 474' ' ' CYS . . . . . 0.403 ' SG ' ' HB3' ' A' ' 445' ' ' HIS . 13.8 t -137.94 131.12 30.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.142 -0.529 . . . . 15.0 110.431 -178.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.855 HD11 HD13 ' A' ' 467' ' ' LEU . 94.9 mt -106.84 127.24 62.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.912 0.387 . . . . 15.0 111.023 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 64.7 m -103.61 177.22 4.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.739 -0.664 . . . . 15.0 111.077 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 477' ' ' ARG . . . . . 0.492 ' HG3' ' CZ ' ' A' ' 435' ' ' PHE . 68.7 mtp180 -58.81 -46.96 86.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.21 -0.45 . . . . 15.0 111.221 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 478' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -60.21 -32.42 71.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.215 -0.448 . . . . 15.0 111.423 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 479' ' ' GLU . . . . . 0.45 ' HB2' HG23 ' A' ' 475' ' ' ILE . 5.5 mm-40 -66.42 -50.22 64.16 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.497 0.189 . . . . 15.0 110.778 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 60.0 mtt -69.86 -47.0 64.32 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.684 -0.234 . . . . 15.0 110.923 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 481' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 477' ' ' ARG . 89.8 t -61.56 -54.01 40.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.702 0.287 . . . . 15.0 110.842 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 482' ' ' SER . . . . . 0.89 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 10.3 m -50.55 -47.17 57.78 Favored 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 116.034 -0.53 . . . . 15.0 110.382 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 483' ' ' TYR . . . . . 0.418 ' HD1' ' O ' ' A' ' 479' ' ' GLU . 8.0 m-85 -69.22 -22.42 63.87 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.423 -0.808 . . . . 15.0 111.856 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 484' ' ' PHE . . . . . 0.778 ' O ' ' HB2' ' A' ' 488' ' ' SER . 0.1 OUTLIER -74.03 -45.94 46.52 Favored 'General case' 0 CA--C 1.527 0.091 0 C-N-CA 120.779 -0.369 . . . . 15.0 110.1 179.05 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 485' ' ' LEU . . . . . 0.612 HD13 ' O ' ' A' ' 485' ' ' LEU . 1.5 tm? -84.43 -16.62 42.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.425 -0.352 . . . . 15.0 110.664 177.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 486' ' ' ARG . . . . . 0.89 ' HB2' ' O ' ' A' ' 482' ' ' SER . 21.3 ttt180 -74.36 -53.32 9.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.451 -0.34 . . . . 15.0 111.578 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 79.7 p -92.58 -54.49 3.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.314 -0.403 . . . . 15.0 112.058 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 488' ' ' SER . . . . . 0.778 ' HB2' ' O ' ' A' ' 484' ' ' PHE . 54.7 m -59.94 150.07 29.92 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.871 0.367 . . . . 15.0 111.492 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 13.8 t -97.8 64.04 1.73 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.886 -0.597 . . . . 15.0 111.106 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 10.3 t -60.74 -55.04 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.327 -0.397 . . . . 15.0 111.152 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 8.9 mt -139.77 -43.43 0.44 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.219 -0.446 . . . . 15.0 110.893 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . 102.25 54.5 0.9 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.884 -0.674 . . . . 15.0 112.539 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . -151.0 -135.04 2.28 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.94 -0.647 . . . . 15.0 112.532 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -126.71 146.89 50.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.737 0.304 . . . . 15.0 110.926 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 8.0 ttt -109.41 -42.12 4.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 15.0 110.932 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . -152.24 -100.91 0.2 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.875 -0.679 . . . . 15.0 112.524 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.305 -0.855 . . . . 15.0 110.885 179.974 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.656 ' O ' HG23 ' A' ' 423' ' ' VAL . 8.9 m-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.747 0.308 . . . . 15.0 111.037 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.732 ' O ' HG23 ' A' ' 424' ' ' VAL . 53.6 mt-30 -44.81 -57.25 3.86 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.053 -0.522 . . . . 15.0 111.607 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -68.48 -36.83 79.51 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.308 -0.406 . . . . 15.0 111.136 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 1.6 tt -57.75 -54.55 45.65 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.826 -0.625 . . . . 15.0 111.668 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.1 t -81.32 -23.48 10.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.665 -0.698 . . . . 15.0 112.039 -177.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 420' ' ' GLN . 6.8 t -62.78 -47.46 92.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 109.047 -0.723 . . . . 15.0 109.047 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -72.97 -33.94 66.18 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.435 -0.802 . . . . 15.0 110.583 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . 0.576 ' O ' ' HB2' ' A' ' 430' ' ' MET . 2.4 t-80 -70.85 -39.38 72.99 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.678 0.275 . . . . 15.0 110.975 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . 0.58 ' O ' HG23 ' A' ' 431' ' ' VAL . 40.1 mt -68.88 -52.0 39.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.372 -0.376 . . . . 15.0 110.715 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -57.32 -43.0 82.95 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.132 0.492 . . . . 15.0 110.197 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -71.83 -24.27 61.68 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 115.559 -0.746 . . . . 15.0 110.542 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . 0.672 ' O ' HG23 ' A' ' 434' ' ' VAL . 8.5 ttm -70.32 -49.82 45.52 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.36 -0.382 . . . . 15.0 110.853 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 427' ' ' ILE . 1.5 t -64.56 -37.34 79.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.918 0.39 . . . . 15.0 110.033 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -71.57 -32.93 68.62 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.826 -0.625 . . . . 15.0 110.692 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.917 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 4.0 m -69.61 -41.11 76.12 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.181 -0.463 . . . . 15.0 111.09 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 430' ' ' MET . 16.4 t -75.36 -42.2 43.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.2 -0.455 . . . . 15.0 110.786 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 9.8 t80 -58.32 -41.71 85.11 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.965 -0.561 . . . . 15.0 111.013 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -86.37 -26.91 24.55 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.436 -0.347 . . . . 15.0 110.933 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . 0.917 ' HB2' ' O ' ' A' ' 433' ' ' SER . 2.6 t-20 -59.73 -45.27 92.71 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.227 -0.442 . . . . 15.0 111.455 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' PHE . . . . . 0.483 ' CE2' HG21 ' A' ' 454' ' ' ILE . 54.8 m-85 -94.33 -2.09 52.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.119 -0.491 . . . . 15.0 111.494 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 1.1 t0 -120.08 54.49 1.03 Allowed 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.918 0.39 . . . . 15.0 111.16 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.26 -9.42 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.054 -0.521 . . . . 15.0 111.32 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -92.35 -3.96 54.57 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.257 -0.429 . . . . 15.0 111.219 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 61.06 51.01 61.18 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.051 -0.595 . . . . 15.0 112.664 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -103.19 -18.09 15.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.645 0.259 . . . . 15.0 111.231 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 87.8 -13.85 59.93 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.933 -0.651 . . . . 15.0 112.302 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . 0.469 ' HB2' ' SG ' ' A' ' 474' ' ' CYS . 14.4 p80 -137.77 154.37 49.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.622 0.248 . . . . 15.0 110.408 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' ILE . . . . . 0.624 ' O ' ' HA ' ' A' ' 474' ' ' CYS . 1.6 mp -85.6 98.95 6.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.072 0.463 . . . . 15.0 111.023 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 52.8 m -63.7 150.89 43.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.705 -0.68 . . . . 15.0 111.072 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -55.33 -37.91 68.05 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.069 -0.514 . . . . 15.0 111.802 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . 0.463 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -63.23 -40.25 96.92 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.522 -0.308 . . . . 15.0 111.38 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -58.55 -60.51 3.7 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.947 0.403 . . . . 15.0 110.507 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -64.61 -24.1 67.48 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.822 -0.627 . . . . 15.0 110.614 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' GLN . . . . . 0.463 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 0.2 OUTLIER -58.9 -57.05 14.76 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.724 -0.671 . . . . 15.0 111.588 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -81.05 -33.61 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.682 -0.69 . . . . 15.0 111.927 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . 0.483 HG21 ' CE2' ' A' ' 438' ' ' PHE . 56.0 mt -63.9 -38.17 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.444 0.164 . . . . 15.0 111.438 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -62.65 -21.74 65.92 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.687 0.28 . . . . 15.0 111.468 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -66.36 -23.94 71.98 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.014 -0.613 . . . . 15.0 112.7 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -116.03 -10.7 11.53 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.676 0.274 . . . . 15.0 111.208 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -127.67 74.7 78.18 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.385 -0.37 . . . . 15.0 111.007 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.04 1.93 8.15 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.189 2.593 . . . . 15.0 112.612 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -81.32 2.5 27.94 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.328 -0.396 . . . . 15.0 111.449 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.4 mp -102.16 152.3 21.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.379 -0.373 . . . . 15.0 111.041 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 50.9 m -74.67 -174.83 2.24 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.079 -0.51 . . . . 15.0 111.288 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . 0.575 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -87.79 156.93 19.17 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.22 -0.446 . . . . 15.0 111.793 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -50.08 -41.67 48.56 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.74 -0.663 . . . . 15.0 111.348 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -62.19 -26.72 68.02 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.944 -0.571 . . . . 15.0 113.35 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -88.44 -33.24 17.93 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.858 0.329 . . . . 15.0 111.433 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 463' ' ' ALA . 0.1 OUTLIER -77.65 -36.32 51.57 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.863 0.363 . . . . 15.0 110.403 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . 0.539 ' HA ' ' OE2' ' A' ' 479' ' ' GLU . 10.4 t70 -123.77 114.62 20.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.876 -0.602 . . . . 15.0 110.47 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -67.28 -33.74 75.94 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.052 -0.522 . . . . 15.0 111.542 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -79.27 -9.44 59.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.397 -0.365 . . . . 15.0 111.413 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 55.86 39.08 30.68 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.27 -0.423 . . . . 15.0 111.382 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -78.56 -0.72 30.79 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.178 -0.464 . . . . 15.0 111.593 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.47 15.09 63.3 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.494 -0.86 . . . . 15.0 111.255 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' CYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 446' ' ' ILE . 1.0 OUTLIER -136.09 131.16 34.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.235 -0.483 . . . . 15.0 110.455 -178.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.572 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 16.7 mm -102.74 124.9 57.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.938 0.399 . . . . 15.0 111.136 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 12.3 t -103.59 175.71 5.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.729 -0.669 . . . . 15.0 110.823 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 477' ' ' ARG . . . . . 0.44 ' O ' HG23 ' A' ' 481' ' ' VAL . 24.7 ptt180 -58.08 -44.48 87.6 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.328 -0.396 . . . . 15.0 111.149 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 478' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.6 mt-10 -62.11 -29.62 70.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.437 . . . . 15.0 111.458 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 479' ' ' GLU . . . . . 0.539 ' OE2' ' HA ' ' A' ' 468' ' ' ASP . 5.3 mm-40 -71.69 -47.99 50.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.496 0.188 . . . . 15.0 110.862 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 60.5 mtt -70.45 -46.2 64.33 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.687 -0.233 . . . . 15.0 110.963 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 481' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 477' ' ' ARG . 79.1 t -60.26 -52.7 58.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 120.738 0.304 . . . . 15.0 110.659 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 482' ' ' SER . . . . . 0.918 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 39.5 m -57.77 -32.96 68.01 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 116.162 -0.472 . . . . 15.0 110.183 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 483' ' ' TYR . . . . . 0.538 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 9.1 t80 -69.02 -30.01 68.31 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.904 -0.589 . . . . 15.0 111.013 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 484' ' ' PHE . . . . . 0.57 ' CD2' HG22 ' A' ' 431' ' ' VAL . 1.9 m-85 -75.16 -40.18 59.77 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.708 0.289 . . . . 15.0 110.332 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.2 tt -83.82 -18.74 36.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 15.0 110.558 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 486' ' ' ARG . . . . . 0.918 ' HB2' ' O ' ' A' ' 482' ' ' SER . 31.0 ttt180 -72.61 -52.98 13.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.433 -0.349 . . . . 15.0 110.882 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 53.4 m -89.26 19.37 4.39 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.979 -0.555 . . . . 15.0 111.354 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 488' ' ' SER . . . . . 0.559 ' HB2' ' O ' ' A' ' 484' ' ' PHE . 22.6 t . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.345 -0.389 . . . . 15.0 110.933 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.637 ' O ' HG23 ' A' ' 423' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.85 0.357 . . . . 15.0 111.114 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.724 ' O ' HG23 ' A' ' 424' ' ' VAL . 4.3 tt0 -47.96 -56.35 7.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.784 -0.643 . . . . 15.0 111.862 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.42 95.96 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.328 -0.397 . . . . 15.0 111.62 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 3.2 tt -57.49 -53.34 59.31 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.077 -0.51 . . . . 15.0 111.743 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.6 t -80.9 -22.54 10.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.736 -0.665 . . . . 15.0 111.966 -176.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 420' ' ' GLN . 9.3 t -64.07 -47.68 89.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 109.056 -0.72 . . . . 15.0 109.056 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -72.61 -33.29 66.57 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.426 -0.807 . . . . 15.0 110.584 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . 0.629 ' O ' ' HB2' ' A' ' 430' ' ' MET . 4.6 t-80 -71.02 -39.29 72.43 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.568 -0.287 . . . . 15.0 111.05 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . 0.555 ' O ' HG23 ' A' ' 431' ' ' VAL . 40.7 mt -68.88 -52.29 36.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 116.352 -0.386 . . . . 15.0 110.77 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -57.7 -43.55 85.25 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.154 0.502 . . . . 15.0 110.169 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -72.04 -22.73 61.35 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.506 -0.77 . . . . 15.0 110.548 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . 0.629 ' HB2' ' O ' ' A' ' 426' ' ' HIS . 0.0 OUTLIER -70.28 -51.37 30.99 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.405 -0.361 . . . . 15.0 110.88 179.077 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.557 HG22 ' CE2' ' A' ' 484' ' ' PHE . 1.0 OUTLIER -63.87 -38.69 83.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.317 -0.402 . . . . 15.0 110.046 179.128 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -71.89 -31.69 66.68 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.823 -0.626 . . . . 15.0 110.878 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.817 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 2.6 m -68.54 -42.68 78.1 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.244 -0.435 . . . . 15.0 111.028 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 430' ' ' MET . 10.2 t -75.32 -41.91 43.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.271 -0.422 . . . . 15.0 110.869 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . 0.61 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 4.1 t80 -56.75 -42.67 79.74 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.037 -0.529 . . . . 15.0 110.749 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 -87.02 -23.55 24.95 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.441 -0.345 . . . . 15.0 111.229 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . 0.817 ' HB2' ' O ' ' A' ' 433' ' ' SER . 5.1 t-20 -59.97 -39.62 86.28 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.863 0.363 . . . . 15.0 110.568 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' PHE . . . . . 0.493 ' CE2' HG21 ' A' ' 454' ' ' ILE . 35.6 m-85 -94.15 -16.51 23.66 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.854 -0.612 . . . . 15.0 111.635 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . 0.61 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 0.3 OUTLIER -99.18 54.03 0.97 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.864 0.364 . . . . 15.0 111.429 -179.525 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.3 -12.85 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.327 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -88.59 -14.82 36.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.119 -0.491 . . . . 15.0 111.171 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 73.7 39.44 48.51 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.004 -0.617 . . . . 15.0 112.508 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -95.79 -17.34 21.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.623 0.249 . . . . 15.0 111.162 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 87.22 -7.73 79.51 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.911 -0.662 . . . . 15.0 112.37 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -144.92 162.18 37.51 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.717 0.294 . . . . 15.0 110.658 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' ILE . . . . . 0.881 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.6 mp -77.78 136.36 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.113 0.483 . . . . 15.0 111.265 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 48.5 m -105.76 147.8 28.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.474 -0.784 . . . . 15.0 110.711 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -50.71 -46.85 59.11 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.169 -0.469 . . . . 15.0 111.606 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . 0.422 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -65.31 -36.91 85.52 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.479 -0.328 . . . . 15.0 111.168 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -60.58 -58.71 7.34 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.295 -0.411 . . . . 15.0 110.543 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.45 -23.73 67.0 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.767 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' GLN . . . . . 0.422 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 1.5 mm-40 -61.07 -56.93 15.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.88 -0.6 . . . . 15.0 111.302 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -76.73 -32.89 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 115.804 -0.635 . . . . 15.0 111.913 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . 0.493 HG21 ' CE2' ' A' ' 438' ' ' PHE . 46.3 mt -64.71 -51.96 60.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.501 0.191 . . . . 15.0 111.244 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -55.32 -33.19 63.09 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.694 0.283 . . . . 15.0 111.46 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -66.84 -30.78 76.66 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.908 -0.663 . . . . 15.0 112.629 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' ASN . . . . . 0.468 ' O ' ' HD3' ' A' ' 459' ' ' PRO . 42.0 m-80 -94.28 -18.99 21.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.687 0.279 . . . . 15.0 111.246 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -115.8 83.29 11.47 Favored Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 116.375 -0.375 . . . . 15.0 110.936 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 457' ' ' ASN . 12.6 Cg_exo -70.78 -10.08 27.03 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.046 2.497 . . . . 15.0 112.631 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -96.53 25.25 5.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.26 -0.427 . . . . 15.0 111.034 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 2.3 tp -100.39 152.55 20.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.16 -0.473 . . . . 15.0 110.975 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 52.5 m -65.54 176.41 1.48 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.115 -0.493 . . . . 15.0 111.378 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . 0.76 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -86.84 150.49 24.09 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.239 -0.437 . . . . 15.0 111.243 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . 0.749 ' HA ' HD11 ' A' ' 467' ' ' LEU . 68.1 m-85 -56.62 -48.76 76.79 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.999 -0.546 . . . . 15.0 111.506 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -68.15 -16.33 68.68 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.962 -0.637 . . . . 15.0 113.459 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -90.13 -39.33 12.93 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.101 0.45 . . . . 15.0 111.776 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.985 HD13 HD11 ' A' ' 475' ' ' ILE . 0.6 OUTLIER -79.06 -28.76 43.18 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.762 0.315 . . . . 15.0 110.755 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . 0.602 ' N ' HD12 ' A' ' 467' ' ' LEU . 12.4 t70 -130.87 110.49 11.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.039 -0.528 . . . . 15.0 110.286 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -66.06 -28.77 69.09 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.008 -0.542 . . . . 15.0 111.454 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.562 ' N ' HD22 ' A' ' 470' ' ' ASN . 0.9 OUTLIER -76.54 -14.11 60.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.249 -0.432 . . . . 15.0 111.214 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 58.67 29.36 18.46 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.238 -0.437 . . . . 15.0 111.306 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -74.35 -4.8 38.58 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.147 -0.479 . . . . 15.0 111.767 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.52 17.57 66.81 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.464 -0.875 . . . . 15.0 111.197 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' CYS . . . . . . . . . . . . . 18.5 t -135.78 131.7 35.81 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.268 -0.466 . . . . 15.0 110.492 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.985 HD11 HD13 ' A' ' 467' ' ' LEU . 11.1 mm -98.79 122.24 50.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 15.0 110.938 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . 0.508 ' H ' ' HG3' ' A' ' 479' ' ' GLU . 15.4 t -102.89 171.12 7.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.918 -0.583 . . . . 15.0 110.672 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -52.86 -45.51 67.44 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.338 -0.392 . . . . 15.0 110.915 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 478' ' ' GLU . . . . . 0.563 ' O ' ' HB2' ' A' ' 482' ' ' SER . 9.4 tt0 -62.51 -28.39 69.81 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.049 -0.523 . . . . 15.0 111.254 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 479' ' ' GLU . . . . . 0.599 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 52.1 mm-40 -70.35 -51.36 30.57 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.505 0.193 . . . . 15.0 110.84 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 44.2 mtt -70.06 -47.18 63.03 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.653 -0.249 . . . . 15.0 111.081 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 82.1 t -59.94 -53.49 47.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.68 0.276 . . . . 15.0 110.85 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 482' ' ' SER . . . . . 0.941 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 43.0 m -57.96 -32.46 67.85 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 116.267 -0.424 . . . . 15.0 110.208 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 483' ' ' TYR . . . . . 0.599 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 8.3 t80 -69.3 -31.05 69.28 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.954 -0.566 . . . . 15.0 111.199 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 484' ' ' PHE . . . . . 0.585 ' HZ ' ' SD ' ' A' ' 430' ' ' MET . 1.6 m-85 -75.9 -39.03 57.12 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.926 -0.31 . . . . 15.0 110.387 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.1 tt -83.74 -19.65 34.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 15.0 110.49 176.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 486' ' ' ARG . . . . . 0.941 ' HB2' ' O ' ' A' ' 482' ' ' SER . 32.1 ttt180 -72.08 -48.55 43.3 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.845 0.355 . . . . 15.0 110.751 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 49.5 p -82.77 19.58 1.31 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.907 -0.588 . . . . 15.0 111.439 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 67.9 m . . . . . 0 C--N 1.332 -0.187 0 CA-C-N 116.279 -0.418 . . . . 15.0 110.961 179.856 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.637 ' O ' HG23 ' A' ' 423' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.775 0.321 . . . . 15.0 110.89 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.736 ' O ' HG23 ' A' ' 424' ' ' VAL . 45.9 mt-30 -48.99 -56.66 8.23 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.878 -0.601 . . . . 15.0 111.731 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -65.91 -38.47 88.8 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.905 0.383 . . . . 15.0 111.43 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 3.4 tt -57.97 -53.09 62.11 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.862 -0.608 . . . . 15.0 111.572 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 419' ' ' ASP . 2.1 t -80.81 -22.7 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 CA-C-N 115.665 -0.698 . . . . 15.0 111.978 -177.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 420' ' ' GLN . 9.6 t -63.83 -48.02 88.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 109.023 -0.732 . . . . 15.0 109.023 177.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -71.7 -33.55 68.88 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.335 -0.848 . . . . 15.0 110.46 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -70.71 -39.8 73.22 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.53 -0.305 . . . . 15.0 110.915 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . 0.574 ' O ' HG23 ' A' ' 431' ' ' VAL . 38.6 mt -67.33 -52.35 43.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.358 -0.383 . . . . 15.0 110.712 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -58.37 -41.99 86.01 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.156 0.503 . . . . 15.0 110.287 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.618 ' O ' ' HB2' ' A' ' 433' ' ' SER . 89.6 mttt -71.29 -24.19 62.1 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 115.473 -0.785 . . . . 15.0 110.74 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . 0.653 ' O ' HG23 ' A' ' 434' ' ' VAL . 25.2 mmm -71.63 -47.53 53.88 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.428 -0.351 . . . . 15.0 110.923 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.588 HG22 ' CD2' ' A' ' 484' ' ' PHE . 2.0 t -65.36 -39.22 84.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.325 -0.398 . . . . 15.0 110.0 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -72.62 -30.45 64.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.916 -0.584 . . . . 15.0 110.756 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.843 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 13.2 t -68.86 -43.11 76.09 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.202 -0.453 . . . . 15.0 110.91 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 430' ' ' MET . 10.6 t -76.53 -40.82 34.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.784 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . 0.551 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 2.9 t80 -56.99 -42.9 81.11 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.065 -0.516 . . . . 15.0 110.673 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -87.41 -23.6 24.47 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.361 -0.382 . . . . 15.0 111.18 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . 0.843 ' HB2' ' O ' ' A' ' 433' ' ' SER . 3.3 t30 -60.0 -38.93 84.07 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.934 0.397 . . . . 15.0 110.515 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' PHE . . . . . 0.459 ' CD2' HD13 ' A' ' 454' ' ' ILE . 33.1 m-85 -94.41 -16.65 23.24 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.802 -0.636 . . . . 15.0 111.55 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 0.6 OUTLIER -99.92 53.44 0.92 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.892 0.377 . . . . 15.0 111.589 -179.323 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.8 t -70.37 -12.49 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.132 -0.485 . . . . 15.0 111.0 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -90.85 -14.96 30.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.079 -0.51 . . . . 15.0 111.048 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 76.56 41.62 24.2 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.971 -0.633 . . . . 15.0 112.509 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -97.64 -18.64 18.78 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.671 0.272 . . . . 15.0 111.149 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 86.2 -4.48 85.97 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.899 -0.667 . . . . 15.0 112.468 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . 0.684 ' HB2' ' SG ' ' A' ' 474' ' ' CYS . 11.1 p-80 -146.18 164.3 32.68 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.757 0.313 . . . . 15.0 110.807 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' ILE . . . . . 0.841 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.2 mp -76.98 135.76 25.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.215 -0.448 . . . . 15.0 110.999 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 9.9 t -106.33 147.53 29.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.823 -0.626 . . . . 15.0 110.789 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -52.42 -47.93 66.03 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.167 -0.469 . . . . 15.0 111.541 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -64.72 -36.85 85.63 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.444 -0.343 . . . . 15.0 111.047 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . 0.419 ' O ' HD12 ' A' ' 454' ' ' ILE . 5.0 mm-40 -61.16 -56.56 19.36 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.317 -0.401 . . . . 15.0 110.279 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' PHE . . . . . 0.522 ' CE2' HD23 ' A' ' 461' ' ' LEU . 0.7 OUTLIER -64.99 -25.07 67.71 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.911 -0.586 . . . . 15.0 110.529 178.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' GLN . . . . . 0.415 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 2.5 mm-40 -60.66 -57.92 10.66 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.76 -0.654 . . . . 15.0 111.389 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 8.8 mm -76.0 -33.04 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.86 -0.609 . . . . 15.0 111.842 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . 0.459 HD13 ' CD2' ' A' ' 438' ' ' PHE . 28.3 mt -63.2 -47.52 91.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 120.489 0.185 . . . . 15.0 111.272 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' ARG . . . . . 0.647 ' NH2' ' HA ' ' A' ' 463' ' ' ALA . 8.1 mtt180 -54.87 -33.68 62.14 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.539 -0.3 . . . . 15.0 111.507 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -64.08 -29.3 74.52 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 121.033 -0.603 . . . . 15.0 112.612 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -97.37 -15.04 20.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.556 0.217 . . . . 15.0 111.162 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . 0.506 ' HB3' HD13 ' A' ' 461' ' ' LEU . 86.0 m-85 -125.47 86.66 56.88 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.39 -0.368 . . . . 15.0 111.044 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -72.53 -2.71 12.2 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.989 2.459 . . . . 15.0 112.589 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -103.35 23.54 12.35 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.319 -0.401 . . . . 15.0 110.998 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.522 HD23 ' CE2' ' A' ' 451' ' ' PHE . 1.0 OUTLIER -89.32 147.77 23.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 15.0 111.084 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 58.2 m -66.78 175.37 2.44 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.044 -0.525 . . . . 15.0 111.329 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . 0.74 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -87.88 149.11 24.3 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.114 -0.494 . . . . 15.0 111.271 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . 0.743 ' HA ' HD11 ' A' ' 467' ' ' LEU . 90.1 m-85 -56.71 -47.6 79.58 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.932 -0.577 . . . . 15.0 111.47 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -69.06 -16.06 70.28 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 121.034 -0.603 . . . . 15.0 113.449 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -89.92 -38.97 13.31 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.202 0.501 . . . . 15.0 111.678 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.912 HD13 HD11 ' A' ' 475' ' ' ILE . 0.6 OUTLIER -80.9 -28.56 35.83 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.815 0.341 . . . . 15.0 110.586 179.57 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . 0.595 ' N ' HD12 ' A' ' 467' ' ' LEU . 12.4 t70 -131.65 111.93 12.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.049 -0.523 . . . . 15.0 110.213 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -62.07 -35.74 79.57 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.029 -0.532 . . . . 15.0 111.788 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -77.88 -10.58 59.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.417 -0.356 . . . . 15.0 111.456 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 57.66 34.13 24.11 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.943 0.402 . . . . 15.0 111.303 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -73.88 -4.44 34.99 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.113 -0.494 . . . . 15.0 111.716 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.72 18.04 67.78 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.489 -0.863 . . . . 15.0 111.277 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' CYS . . . . . 0.684 ' SG ' ' HB2' ' A' ' 445' ' ' HIS . 3.7 t -135.19 130.93 36.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.248 -0.476 . . . . 15.0 110.52 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.912 HD11 HD13 ' A' ' 467' ' ' LEU . 21.1 mm -98.78 123.67 51.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.892 0.377 . . . . 15.0 110.93 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . 0.404 ' H ' ' HG3' ' A' ' 479' ' ' GLU . 14.5 t -101.84 166.96 10.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.931 -0.577 . . . . 15.0 110.577 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -50.49 -46.98 57.38 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.34 -0.391 . . . . 15.0 110.915 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 478' ' ' GLU . . . . . 0.726 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -62.21 -30.84 71.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.031 -0.531 . . . . 15.0 111.473 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 479' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 5.7 mm-40 -69.83 -55.06 10.81 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 121.285 -0.166 . . . . 15.0 110.956 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 6.6 tpp -68.65 -48.46 63.96 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.752 -0.204 . . . . 15.0 111.228 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 76.0 t -60.51 -54.56 33.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 121.148 -0.221 . . . . 15.0 111.128 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 482' ' ' SER . . . . . 0.98 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 36.8 m -56.51 -33.61 66.18 Favored 'General case' 0 C--O 1.227 -0.088 0 CA-C-N 116.515 -0.311 . . . . 15.0 110.462 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 483' ' ' TYR . . . . . 0.573 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 8.5 t80 -70.24 -30.76 67.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.116 -0.493 . . . . 15.0 111.167 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 484' ' ' PHE . . . . . 0.588 ' CD2' HG22 ' A' ' 431' ' ' VAL . 6.0 m-85 -74.16 -41.84 60.86 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 120.888 -0.325 . . . . 15.0 110.372 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.5 tt -83.95 -16.98 42.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.396 . . . . 15.0 110.492 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 486' ' ' ARG . . . . . 0.98 ' HB2' ' O ' ' A' ' 482' ' ' SER . 5.8 tpt180 -71.59 -51.5 23.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.892 0.377 . . . . 15.0 110.844 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 52.5 m -87.55 19.37 3.38 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.961 -0.563 . . . . 15.0 111.55 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 488' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 484' ' ' PHE . 9.3 t . . . . . 0 C--N 1.332 -0.177 0 CA-C-N 116.374 -0.376 . . . . 15.0 111.042 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.661 ' O ' HG23 ' A' ' 423' ' ' VAL . 7.6 m-20 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.826 0.346 . . . . 15.0 111.115 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.739 ' O ' HG23 ' A' ' 424' ' ' VAL . 4.0 tt0 -46.85 -57.42 4.93 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.097 -0.501 . . . . 15.0 111.624 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.82 81.78 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.345 -0.388 . . . . 15.0 111.294 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.543 HD13 ' OD2' ' A' ' 419' ' ' ASP . 1.2 tt -57.82 -53.77 54.4 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.872 -0.604 . . . . 15.0 111.618 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.7 t -80.69 -23.98 11.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.636 -0.711 . . . . 15.0 112.02 -177.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 420' ' ' GLN . 7.3 t -62.74 -47.82 91.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 109.076 -0.713 . . . . 15.0 109.076 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -71.53 -34.53 70.12 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.468 -0.787 . . . . 15.0 110.539 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -70.4 -40.07 74.11 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.569 -0.287 . . . . 15.0 110.936 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . 0.567 HG13 HG12 ' A' ' 423' ' ' VAL . 37.2 mt -66.58 -53.61 33.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.329 -0.396 . . . . 15.0 110.676 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -57.35 -41.97 81.09 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.105 0.479 . . . . 15.0 110.275 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.613 ' O ' ' HB2' ' A' ' 433' ' ' SER . 89.0 mttt -70.24 -24.98 63.17 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.516 -0.765 . . . . 15.0 110.592 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . 0.65 ' O ' HG23 ' A' ' 434' ' ' VAL . 33.7 mmm -71.81 -46.09 59.34 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.469 -0.332 . . . . 15.0 110.898 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.607 HG22 ' CE2' ' A' ' 484' ' ' PHE . 1.0 OUTLIER -64.14 -41.19 91.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.979 0.419 . . . . 15.0 109.974 178.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -72.75 -29.75 63.58 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.708 -0.678 . . . . 15.0 110.992 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.781 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 13.3 t -69.64 -43.39 72.74 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.269 -0.423 . . . . 15.0 110.996 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 430' ' ' MET . 12.7 t -75.77 -41.86 40.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.201 -0.454 . . . . 15.0 110.811 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -57.89 -42.57 84.92 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.222 -0.444 . . . . 15.0 110.706 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -84.52 -25.19 28.97 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.506 -0.315 . . . . 15.0 111.033 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . 0.781 ' HB2' ' O ' ' A' ' 433' ' ' SER . 3.1 t30 -60.38 -38.96 85.55 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.851 0.358 . . . . 15.0 110.498 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -96.81 -10.47 26.56 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.911 -0.586 . . . . 15.0 111.734 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -108.83 53.6 0.68 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.896 0.379 . . . . 15.0 111.481 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 0.413 HG12 ' OE1' ' A' ' 450' ' ' GLU . 8.6 p -74.91 -0.13 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.132 -0.486 . . . . 15.0 110.866 178.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -86.39 -15.13 41.33 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.843 -0.617 . . . . 15.0 111.102 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 67.85 40.9 89.31 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 121.019 -0.61 . . . . 15.0 112.605 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -115.65 -15.56 11.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.651 0.262 . . . . 15.0 111.238 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 89.46 -4.93 84.18 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.876 -0.678 . . . . 15.0 112.487 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -142.64 156.72 45.1 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.793 0.33 . . . . 15.0 110.722 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' ILE . . . . . 0.654 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.7 mp -78.67 134.99 26.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 15.0 111.282 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . 0.697 ' OG ' ' HG3' ' A' ' 450' ' ' GLU . 90.5 p -107.05 149.02 28.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.623 -0.717 . . . . 15.0 110.617 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -48.49 -43.54 35.01 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.182 -0.463 . . . . 15.0 111.852 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.89 -40.68 98.27 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.534 -0.303 . . . . 15.0 111.436 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . 0.697 ' HG3' ' OG ' ' A' ' 447' ' ' SER . 25.9 mt-10 -61.08 -57.72 11.38 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.399 -0.364 . . . . 15.0 110.558 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' PHE . . . . . 0.502 ' O ' ' HG2' ' A' ' 455' ' ' ARG . 3.9 t80 -61.5 -27.16 68.39 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.992 -0.549 . . . . 15.0 110.967 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -61.44 -56.65 17.8 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.029 -0.532 . . . . 15.0 111.197 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 2.1 mt -72.6 -30.14 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.908 -0.587 . . . . 15.0 111.828 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . 0.405 HG23 ' CD1' ' A' ' 458' ' ' PHE . 45.9 mt -66.39 -56.32 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.752 -0.203 . . . . 15.0 111.462 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 451' ' ' PHE . 28.4 ptt180 -51.88 -33.04 34.92 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.931 0.345 . . . . 15.0 111.931 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -69.88 -34.81 71.84 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.901 -0.666 . . . . 15.0 112.83 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' ASN . . . . . 0.411 ' O ' ' HD3' ' A' ' 459' ' ' PRO . 17.2 m120 -92.93 -13.77 28.44 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.589 0.233 . . . . 15.0 111.39 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . 0.405 ' CD1' HG23 ' A' ' 454' ' ' ILE . 81.2 m-85 -116.69 85.59 17.26 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.484 -0.325 . . . . 15.0 111.036 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 457' ' ' ASN . 12.3 Cg_exo -71.37 -11.75 28.88 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.965 2.443 . . . . 15.0 112.507 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -99.51 26.24 6.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.249 -0.432 . . . . 15.0 110.926 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.7 tp -91.09 146.31 23.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.093 -0.503 . . . . 15.0 111.104 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 66.7 m -69.2 -172.55 0.44 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.08 -0.509 . . . . 15.0 111.245 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . 0.683 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -85.06 150.68 24.7 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.227 -0.442 . . . . 15.0 111.461 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . 0.686 ' HA ' HD11 ' A' ' 467' ' ' LEU . 66.0 m-85 -55.46 -51.6 66.39 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.76 -0.655 . . . . 15.0 111.226 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -68.78 -11.97 63.8 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.111 -0.566 . . . . 15.0 113.276 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -88.79 -36.17 16.23 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.078 0.439 . . . . 15.0 111.145 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.686 HD11 ' HA ' ' A' ' 464' ' ' PHE . 0.1 OUTLIER -85.14 -23.99 28.18 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.024 0.44 . . . . 15.0 110.055 178.351 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -135.23 111.06 9.35 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.77 -0.65 . . . . 15.0 110.008 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -61.48 -36.42 80.41 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.053 -0.521 . . . . 15.0 112.041 -178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -77.63 -9.08 58.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.532 -0.304 . . . . 15.0 111.681 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 55.45 34.1 22.3 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.442 -0.344 . . . . 15.0 111.438 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -82.09 1.99 33.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.163 -0.471 . . . . 15.0 111.511 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.22 15.28 63.0 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.457 -0.878 . . . . 15.0 110.981 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' CYS . . . . . . . . . . . . . 13.5 t -136.61 130.56 32.47 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.127 -0.536 . . . . 15.0 110.374 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.654 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 1.4 mp -103.4 127.53 57.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.964 0.411 . . . . 15.0 111.253 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 12.7 t -103.94 175.16 5.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.695 -0.684 . . . . 15.0 110.811 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 477' ' ' ARG . . . . . 0.426 ' O ' HG23 ' A' ' 481' ' ' VAL . 99.0 mtt180 -56.98 -45.3 83.03 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.324 -0.398 . . . . 15.0 111.108 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 478' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.6 mt-10 -61.15 -29.57 69.87 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.179 -0.464 . . . . 15.0 111.524 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 479' ' ' GLU . . . . . 0.55 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 5.5 mm-40 -70.7 -49.03 51.42 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.401 0.143 . . . . 15.0 110.871 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 33.4 mtt -70.4 -46.22 64.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.72 -0.218 . . . . 15.0 111.02 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 481' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 477' ' ' ARG . 88.8 t -60.24 -52.72 58.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.689 0.28 . . . . 15.0 110.607 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 482' ' ' SER . . . . . 0.901 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 40.3 m -57.73 -32.7 67.7 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 116.171 -0.468 . . . . 15.0 110.061 178.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 483' ' ' TYR . . . . . 0.55 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 8.8 t80 -69.04 -30.9 69.36 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.872 -0.604 . . . . 15.0 110.913 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 484' ' ' PHE . . . . . 0.607 ' CE2' HG22 ' A' ' 431' ' ' VAL . 0.1 OUTLIER -74.17 -40.54 62.47 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 110.243 -0.281 . . . . 15.0 110.243 179.279 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.2 tt -83.44 -18.9 37.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 15.0 110.531 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 486' ' ' ARG . . . . . 0.901 ' HB2' ' O ' ' A' ' 482' ' ' SER . 32.9 ttt180 -71.49 -52.22 19.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.345 . . . . 15.0 110.843 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 14.0 t -90.13 19.46 5.0 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.977 -0.556 . . . . 15.0 111.244 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 488' ' ' SER . . . . . 0.56 ' HB2' ' O ' ' A' ' 484' ' ' PHE . 22.8 t . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.31 -0.405 . . . . 15.0 111.004 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.68 ' O ' HG23 ' A' ' 423' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.811 0.338 . . . . 15.0 111.091 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.754 ' O ' HG23 ' A' ' 424' ' ' VAL . 4.3 tt0 -46.72 -56.52 6.04 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.781 -0.645 . . . . 15.0 111.961 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -63.51 -39.83 95.46 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.438 -0.347 . . . . 15.0 111.485 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 5.2 tp -57.33 -51.75 68.13 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.902 -0.59 . . . . 15.0 111.603 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.1 t -81.18 -21.68 10.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 115.67 -0.696 . . . . 15.0 111.929 -177.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 420' ' ' GLN . 12.0 t -64.05 -48.22 86.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.95 -0.759 . . . . 15.0 108.95 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -72.91 -33.04 65.73 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.37 -0.832 . . . . 15.0 110.629 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . 0.644 ' O ' ' HB2' ' A' ' 430' ' ' MET . 2.2 t60 -71.26 -39.32 71.67 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.579 -0.282 . . . . 15.0 110.984 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . 0.565 HG13 HG12 ' A' ' 423' ' ' VAL . 41.4 mt -69.29 -50.68 49.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.407 -0.361 . . . . 15.0 110.809 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -58.95 -43.27 91.22 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.088 0.471 . . . . 15.0 110.141 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.611 ' O ' ' HB2' ' A' ' 433' ' ' SER . 92.0 mttt -72.49 -23.04 60.97 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.513 -0.767 . . . . 15.0 110.516 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . 0.666 ' O ' HG23 ' A' ' 434' ' ' VAL . 4.0 ttt -70.69 -49.55 45.98 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.456 -0.338 . . . . 15.0 110.8 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 427' ' ' ILE . 2.7 t -65.02 -39.07 84.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.269 -0.423 . . . . 15.0 110.008 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -71.38 -31.26 67.1 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.879 -0.601 . . . . 15.0 110.564 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.949 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 12.7 t -70.67 -41.22 72.38 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 116.217 -0.447 . . . . 15.0 111.041 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 430' ' ' MET . 19.4 t -75.1 -42.68 45.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.26 -0.427 . . . . 15.0 110.969 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . 0.633 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 14.3 t80 -59.28 -42.08 90.39 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.12 -0.491 . . . . 15.0 111.02 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -84.95 -27.95 26.18 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.548 -0.296 . . . . 15.0 110.953 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . 0.949 ' HB2' ' O ' ' A' ' 433' ' ' SER . 2.2 t30 -60.12 -44.89 94.54 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.203 -0.453 . . . . 15.0 111.393 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' PHE . . . . . 0.426 ' CZ ' HD21 ' A' ' 461' ' ' LEU . 45.3 m-85 -94.78 4.84 53.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.372 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . 0.633 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 0.3 OUTLIER -126.84 55.2 1.56 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.899 0.38 . . . . 15.0 111.352 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 0.401 ' H ' HG23 ' A' ' 440' ' ' VAL . 2.5 t -68.64 -8.42 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.129 -0.487 . . . . 15.0 111.325 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -87.97 -6.47 57.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.233 -0.44 . . . . 15.0 111.16 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 62.04 30.19 74.83 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.843 -0.694 . . . . 15.0 111.979 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -90.51 -18.91 24.47 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 122.307 0.243 . . . . 15.0 111.291 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 83.21 -7.33 67.87 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.91 -0.662 . . . . 15.0 112.576 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . 0.606 ' HB3' ' SG ' ' A' ' 474' ' ' CYS . 73.3 m-70 -131.84 140.21 49.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.809 0.338 . . . . 15.0 110.602 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 474' ' ' CYS . 1.5 mp -84.98 98.57 6.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.157 -0.474 . . . . 15.0 111.013 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 29.8 m -68.29 155.33 39.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.82 -0.627 . . . . 15.0 111.016 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -53.67 -40.62 66.09 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.153 -0.476 . . . . 15.0 111.825 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . 0.567 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -62.81 -39.42 94.21 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.496 -0.32 . . . . 15.0 111.424 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . 0.445 ' OE1' ' HA ' ' A' ' 446' ' ' ILE . 49.7 mt-10 -57.13 -58.83 6.47 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.048 0.451 . . . . 15.0 110.448 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' PHE . . . . . 0.614 ' CZ ' HD23 ' A' ' 461' ' ' LEU . 6.9 t80 -69.05 -20.43 64.11 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.771 -0.649 . . . . 15.0 110.609 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' GLN . . . . . 0.567 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 0.4 OUTLIER -59.31 -54.91 41.39 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.877 -0.601 . . . . 15.0 111.113 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -84.32 -32.5 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.733 -0.667 . . . . 15.0 111.843 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 57.7 mt -64.57 -40.07 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 111.664 0.246 . . . . 15.0 111.664 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 452' ' ' GLN . 32.0 ptt180 -59.67 -19.09 47.2 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.631 0.253 . . . . 15.0 111.597 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -79.32 -23.55 62.86 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.899 -0.667 . . . . 15.0 112.506 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -88.09 -27.25 22.06 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.642 0.258 . . . . 15.0 111.196 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -121.67 87.77 46.27 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.335 -0.393 . . . . 15.0 110.817 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.41 -3.89 13.36 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.963 2.442 . . . . 15.0 112.67 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -103.54 23.66 12.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.369 -0.378 . . . . 15.0 111.011 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.614 HD23 ' CZ ' ' A' ' 451' ' ' PHE . 2.9 tp -102.29 155.29 18.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.088 -0.505 . . . . 15.0 111.08 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 55.2 m -71.98 172.84 9.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.072 -0.513 . . . . 15.0 111.333 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . 0.46 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -91.54 156.64 17.52 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.115 -0.493 . . . . 15.0 111.77 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -45.83 -48.74 15.73 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.695 -0.684 . . . . 15.0 111.568 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -62.37 -23.84 64.97 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.89 -0.596 . . . . 15.0 113.637 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -88.43 -28.95 20.56 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 117.063 0.431 . . . . 15.0 111.592 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 463' ' ' ALA . 0.0 OUTLIER -77.43 -34.91 54.51 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.849 0.356 . . . . 15.0 110.252 178.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . 0.44 ' OD1' ' HB2' ' A' ' 470' ' ' ASN . 9.1 t70 -130.39 119.77 23.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.893 -0.594 . . . . 15.0 110.496 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -68.19 -28.05 66.93 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.104 -0.498 . . . . 15.0 111.525 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.44 ' HB2' ' OD1' ' A' ' 468' ' ' ASP . 3.9 m-80 -76.88 -10.69 59.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.252 -0.431 . . . . 15.0 111.357 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 56.24 34.03 23.25 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.289 -0.414 . . . . 15.0 111.414 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -82.42 -1.89 51.48 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.199 -0.455 . . . . 15.0 111.514 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 65.59 14.95 61.09 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.585 -0.817 . . . . 15.0 111.436 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' CYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 446' ' ' ILE . 4.2 t -135.09 130.92 36.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.248 -0.476 . . . . 15.0 110.403 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.459 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 9.5 mm -105.04 124.88 60.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.982 0.42 . . . . 15.0 111.212 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 50.5 m -103.28 174.79 5.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.707 -0.679 . . . . 15.0 110.615 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -56.02 -49.07 74.7 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.418 -0.356 . . . . 15.0 111.018 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 478' ' ' GLU . . . . . 0.668 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -61.76 -33.44 74.09 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.124 -0.489 . . . . 15.0 111.763 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 479' ' ' GLU . . . . . 0.539 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 5.4 mm-40 -69.5 -53.23 20.15 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 121.228 -0.189 . . . . 15.0 110.983 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 480' ' ' MET . . . . . 0.407 ' SD ' ' HB ' ' A' ' 434' ' ' VAL . 9.9 ttm -69.21 -48.56 61.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.754 -0.203 . . . . 15.0 111.313 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 481' ' ' VAL . . . . . 0.553 HG22 HG11 ' A' ' 431' ' ' VAL . 79.4 t -60.92 -55.77 22.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.575 0.226 . . . . 15.0 111.217 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 482' ' ' SER . . . . . 0.958 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 44.5 m -54.89 -36.96 65.7 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.382 -0.372 . . . . 15.0 110.548 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 483' ' ' TYR . . . . . 0.539 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 1.9 m-85 -71.23 -26.04 62.75 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.236 -0.438 . . . . 15.0 111.321 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 484' ' ' PHE . . . . . 0.519 ' CD2' HG22 ' A' ' 431' ' ' VAL . 1.9 m-85 -73.37 -44.55 58.42 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 110.129 -0.323 . . . . 15.0 110.129 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.4 tt -84.24 -17.61 39.19 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.135 -0.484 . . . . 15.0 110.672 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 486' ' ' ARG . . . . . 0.958 ' HB2' ' O ' ' A' ' 482' ' ' SER . 30.8 ttt180 -70.97 -48.8 51.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.887 0.375 . . . . 15.0 110.758 177.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 52.2 m -82.7 19.26 1.35 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.89 -0.596 . . . . 15.0 111.469 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 66.9 m . . . . . 0 C--O 1.232 0.166 0 CA-C-N 116.358 -0.383 . . . . 15.0 111.0 179.826 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.637 ' O ' HG23 ' A' ' 423' ' ' VAL . 1.1 m-20 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.857 0.36 . . . . 15.0 111.107 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.731 ' O ' HG23 ' A' ' 424' ' ' VAL . 45.4 mt-30 -47.62 -56.15 7.81 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.77 -0.65 . . . . 15.0 111.994 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -64.13 -40.94 97.25 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.384 -0.371 . . . . 15.0 111.67 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 5.0 tp -57.4 -53.3 59.65 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.041 -0.527 . . . . 15.0 111.726 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.7 t -80.13 -23.36 11.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.674 -0.694 . . . . 15.0 112.004 -177.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 420' ' ' GLN . 8.4 t -63.22 -47.66 91.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.02 -0.733 . . . . 15.0 109.02 177.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -71.77 -34.38 69.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.422 -0.808 . . . . 15.0 110.504 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -70.53 -40.39 73.46 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.534 -0.303 . . . . 15.0 110.946 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . 0.553 HG13 HG12 ' A' ' 423' ' ' VAL . 35.9 mt -66.36 -53.68 33.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.355 -0.384 . . . . 15.0 110.771 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -57.15 -41.83 79.89 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.105 0.479 . . . . 15.0 110.326 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.632 ' O ' ' HB2' ' A' ' 433' ' ' SER . 89.2 mttt -70.86 -24.7 62.56 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.538 -0.756 . . . . 15.0 110.749 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . 0.664 ' O ' HG23 ' A' ' 434' ' ' VAL . 33.9 mtp -71.99 -47.49 51.69 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.405 -0.362 . . . . 15.0 110.891 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.588 HG22 ' CE2' ' A' ' 484' ' ' PHE . 0.8 OUTLIER -63.62 -40.98 91.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.065 0.459 . . . . 15.0 109.939 178.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -72.24 -30.35 64.8 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.666 -0.697 . . . . 15.0 110.826 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.837 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 12.2 t -68.75 -43.48 75.76 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.307 -0.406 . . . . 15.0 111.085 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 430' ' ' MET . 7.7 t -75.27 -41.97 43.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.32 -0.4 . . . . 15.0 110.848 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . 0.637 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 3.8 t80 -58.39 -41.57 85.16 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.09 -0.504 . . . . 15.0 110.967 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -85.11 -27.17 26.43 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.371 -0.377 . . . . 15.0 110.889 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . 0.837 ' HB2' ' O ' ' A' ' 433' ' ' SER . 2.7 t30 -59.36 -44.54 92.68 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.272 -0.422 . . . . 15.0 111.194 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' PHE . . . . . 0.516 ' CE2' HG21 ' A' ' 454' ' ' ILE . 33.1 m-85 -90.2 -5.91 55.87 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.019 -0.537 . . . . 15.0 111.212 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . 0.637 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 0.2 OUTLIER -109.82 53.94 0.68 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.838 0.351 . . . . 15.0 111.405 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 3.3 m -70.6 -9.22 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.21 -0.45 . . . . 15.0 111.617 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -88.92 -15.14 35.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.235 -0.439 . . . . 15.0 111.144 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 73.12 37.77 55.36 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.922 -0.656 . . . . 15.0 112.538 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -97.31 -16.39 20.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.653 0.264 . . . . 15.0 111.195 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 86.8 -7.69 78.88 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.825 -0.702 . . . . 15.0 112.374 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . 0.49 ' HB2' ' SG ' ' A' ' 474' ' ' CYS . 15.0 p80 -142.39 158.36 43.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.759 0.314 . . . . 15.0 110.712 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' ILE . . . . . 0.766 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.6 mp -77.71 135.99 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 15.0 111.165 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 14.4 t -106.19 148.11 28.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.585 -0.734 . . . . 15.0 110.767 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -50.18 -46.39 54.22 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.214 -0.448 . . . . 15.0 111.507 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . 0.469 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -65.42 -35.24 80.33 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.426 -0.352 . . . . 15.0 110.89 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -60.06 -59.56 5.23 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.241 -0.436 . . . . 15.0 110.483 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.36 -23.56 67.01 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.984 -0.553 . . . . 15.0 110.629 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' GLN . . . . . 0.469 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 5.6 mt-30 -60.14 -57.57 12.27 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.802 -0.635 . . . . 15.0 111.234 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 8.7 mm -76.6 -33.05 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.782 -0.645 . . . . 15.0 111.831 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . 0.516 HG21 ' CE2' ' A' ' 438' ' ' PHE . 48.5 mt -62.71 -46.98 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.803 -0.18 . . . . 15.0 111.133 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' ARG . . . . . 0.626 ' NH2' ' HA ' ' A' ' 463' ' ' ALA . 10.5 mtt180 -54.79 -34.33 62.56 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.718 0.294 . . . . 15.0 111.551 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -66.05 -30.84 77.74 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.994 -0.622 . . . . 15.0 112.896 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -96.95 -16.32 20.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.667 0.27 . . . . 15.0 111.293 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -132.97 85.79 44.99 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.308 -0.406 . . . . 15.0 110.983 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -72.84 1.74 6.11 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.062 2.508 . . . . 15.0 112.452 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -87.61 6.77 32.89 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.313 -0.403 . . . . 15.0 111.223 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -83.76 142.41 30.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.239 -0.437 . . . . 15.0 111.088 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 43.4 p -70.62 -172.56 0.64 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.161 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . 0.73 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -86.93 150.22 24.24 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.365 -0.38 . . . . 15.0 111.264 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . 0.731 ' HA ' HD11 ' A' ' 467' ' ' LEU . 80.0 m-85 -59.14 -46.71 87.64 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.023 -0.535 . . . . 15.0 111.371 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -67.68 -16.44 67.84 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.921 -0.656 . . . . 15.0 113.225 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -90.23 -41.35 11.64 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.913 0.356 . . . . 15.0 111.705 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.81 HD13 HD11 ' A' ' 475' ' ' ILE . 0.7 OUTLIER -76.53 -27.47 55.98 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.703 0.287 . . . . 15.0 110.842 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . 0.621 ' N ' HD12 ' A' ' 467' ' ' LEU . 10.9 t70 -128.16 112.2 14.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.203 -0.453 . . . . 15.0 110.362 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -67.02 -29.53 69.37 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.011 -0.54 . . . . 15.0 111.312 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.563 ' N ' HD22 ' A' ' 470' ' ' ASN . 0.9 OUTLIER -76.52 -13.66 60.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 15.0 111.144 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 60.65 28.05 17.76 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.199 -0.455 . . . . 15.0 111.285 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -71.42 -7.86 50.06 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.137 -0.483 . . . . 15.0 111.838 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.86 18.41 68.51 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.405 -0.902 . . . . 15.0 111.299 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 445' ' ' HIS . 19.0 t -137.16 130.88 31.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.256 -0.472 . . . . 15.0 110.464 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.81 HD11 HD13 ' A' ' 467' ' ' LEU . 9.0 mm -93.92 120.19 42.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.959 0.409 . . . . 15.0 111.01 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . 0.464 ' H ' ' HG3' ' A' ' 479' ' ' GLU . 52.9 m -103.38 173.4 6.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.819 -0.628 . . . . 15.0 110.686 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 477' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 481' ' ' VAL . 98.8 mtt180 -53.74 -45.38 70.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.427 -0.351 . . . . 15.0 110.959 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 478' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -62.38 -28.36 69.72 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.046 -0.524 . . . . 15.0 111.361 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 479' ' ' GLU . . . . . 0.576 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 43.6 mm-40 -71.15 -50.05 37.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.41 0.147 . . . . 15.0 110.777 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 40.3 mtt -70.58 -46.66 63.03 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.797 -0.183 . . . . 15.0 110.958 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 481' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 477' ' ' ARG . 84.1 t -59.84 -54.12 38.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.758 0.313 . . . . 15.0 110.693 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 482' ' ' SER . . . . . 0.942 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 38.6 m -56.63 -33.11 65.99 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 116.215 -0.448 . . . . 15.0 110.117 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 483' ' ' TYR . . . . . 0.576 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 8.5 t80 -69.27 -29.74 67.7 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.921 -0.581 . . . . 15.0 110.966 177.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 484' ' ' PHE . . . . . 0.588 ' CE2' HG22 ' A' ' 431' ' ' VAL . 0.1 OUTLIER -73.9 -41.93 61.42 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 110.215 -0.291 . . . . 15.0 110.215 179.259 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.5 mp -83.83 -17.78 39.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.308 -0.405 . . . . 15.0 110.556 177.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 486' ' ' ARG . . . . . 0.942 ' HB2' ' O ' ' A' ' 482' ' ' SER . 34.4 ttt180 -71.99 -48.26 46.1 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.323 -0.399 . . . . 15.0 110.812 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 53.3 m -80.58 19.65 0.79 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.872 -0.604 . . . . 15.0 111.502 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 54.6 m . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 116.374 -0.376 . . . . 15.0 110.926 179.834 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.616 ' O ' HG23 ' A' ' 423' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.83 0.348 . . . . 15.0 111.238 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.732 ' O ' HG23 ' A' ' 424' ' ' VAL . 53.3 mt-30 -47.25 -55.68 8.18 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.819 -0.628 . . . . 15.0 111.879 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -63.14 -40.37 97.39 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.308 -0.405 . . . . 15.0 111.51 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 4.9 tp -57.46 -53.01 62.95 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.009 -0.541 . . . . 15.0 111.673 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.5 t -79.95 -22.65 11.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.658 -0.701 . . . . 15.0 111.973 -177.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 420' ' ' GLN . 9.9 t -63.43 -47.75 90.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 109.047 -0.723 . . . . 15.0 109.047 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -71.96 -34.17 68.76 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.33 -0.85 . . . . 15.0 110.577 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -70.78 -40.42 72.61 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.612 -0.267 . . . . 15.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . 0.561 HG13 HG12 ' A' ' 423' ' ' VAL . 36.9 mt -66.48 -53.34 36.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.362 -0.381 . . . . 15.0 110.667 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -57.24 -42.27 81.12 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.151 0.5 . . . . 15.0 110.143 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -69.87 -25.34 63.67 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.528 -0.76 . . . . 15.0 110.549 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . 0.681 ' O ' HG23 ' A' ' 434' ' ' VAL . 31.7 mmm -70.67 -47.73 58.44 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.425 -0.352 . . . . 15.0 110.935 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.584 HG22 ' CE2' ' A' ' 484' ' ' PHE . 0.8 OUTLIER -62.93 -40.3 88.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.014 0.435 . . . . 15.0 110.025 179.073 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -72.53 -33.31 66.79 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.733 -0.667 . . . . 15.0 110.978 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.796 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 3.6 m -66.33 -43.47 86.05 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.344 -0.389 . . . . 15.0 111.093 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 430' ' ' MET . 4.9 t -75.94 -38.84 36.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.212 -0.449 . . . . 15.0 110.779 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 431' ' ' VAL . 4.4 t80 -55.92 -42.87 76.73 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.068 -0.515 . . . . 15.0 110.821 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -89.16 -24.03 22.29 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.401 -0.363 . . . . 15.0 111.284 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . 0.796 ' HB2' ' O ' ' A' ' 433' ' ' SER . 4.2 t-20 -59.95 -34.7 73.6 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.987 0.422 . . . . 15.0 110.402 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' PHE . . . . . 0.439 ' O ' ' HB3' ' A' ' 450' ' ' GLU . 7.2 m-85 -71.79 -41.63 68.07 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.622 -0.717 . . . . 15.0 111.888 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . 0.722 ' HA ' ' OE2' ' A' ' 450' ' ' GLU . 5.1 p-10 -139.53 82.29 1.87 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.144 0.497 . . . . 15.0 111.91 -178.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.9 m -72.42 -8.57 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.925 -0.579 . . . . 15.0 111.248 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -66.84 -15.39 63.58 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.049 -0.523 . . . . 15.0 111.408 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 91.04 47.3 3.64 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.931 -0.652 . . . . 15.0 112.423 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -101.3 -19.53 15.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.674 0.273 . . . . 15.0 111.207 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 78.94 -13.69 17.7 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.039 -0.6 . . . . 15.0 113.0 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -144.48 168.37 20.29 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.889 0.376 . . . . 15.0 110.806 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' ILE . . . . . 0.594 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.2 mp -74.56 126.56 35.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.021 -0.536 . . . . 15.0 111.24 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 52.9 m -106.36 147.37 29.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.743 -0.662 . . . . 15.0 110.83 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -50.03 -45.59 52.18 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.193 -0.458 . . . . 15.0 111.677 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.72 -40.19 96.14 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.48 -0.327 . . . . 15.0 111.234 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . 0.722 ' OE2' ' HA ' ' A' ' 439' ' ' ASP . 5.5 mm-40 -63.33 -56.13 18.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.433 -0.349 . . . . 15.0 110.385 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.83 -28.99 67.96 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.165 -0.471 . . . . 15.0 110.93 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -61.82 -55.87 25.41 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 115.928 -0.578 . . . . 15.0 111.081 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 2.8 mt -70.86 -28.38 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.914 -0.585 . . . . 15.0 111.624 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . 0.453 HG23 ' CD1' ' A' ' 458' ' ' PHE . 30.3 mt -67.24 -56.98 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.67 -0.241 . . . . 15.0 111.183 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -47.93 -36.17 11.93 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.478 -0.328 . . . . 15.0 111.877 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -63.79 -34.05 88.89 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.986 -0.626 . . . . 15.0 112.947 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -104.24 -2.43 25.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.537 0.208 . . . . 15.0 111.345 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . 0.453 ' CD1' HG23 ' A' ' 454' ' ' ILE . 81.4 m-85 -128.75 79.96 73.49 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.523 -0.308 . . . . 15.0 111.155 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -75.09 -3.66 14.25 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.075 2.517 . . . . 15.0 112.543 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -107.71 26.41 10.34 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.207 -0.451 . . . . 15.0 111.013 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 2.4 tp -91.62 151.36 20.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.176 -0.466 . . . . 15.0 111.118 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 49.2 m -67.73 176.7 2.36 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.104 -0.498 . . . . 15.0 111.362 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . 0.786 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -89.05 153.11 21.26 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.128 -0.487 . . . . 15.0 111.288 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . 0.698 ' HA ' HD11 ' A' ' 467' ' ' LEU . 78.1 m-85 -57.41 -49.14 77.17 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.069 -0.514 . . . . 15.0 111.437 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -68.95 -15.48 69.37 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.992 -0.623 . . . . 15.0 113.57 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . 0.507 ' OD1' ' HB3' ' A' ' 463' ' ' ALA . 5.1 m-20 -89.83 -41.6 11.74 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.1 0.45 . . . . 15.0 111.712 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.887 HD13 HD11 ' A' ' 475' ' ' ILE . 0.6 OUTLIER -78.0 -27.74 49.05 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.747 0.308 . . . . 15.0 110.714 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . 0.589 ' N ' HD12 ' A' ' 467' ' ' LEU . 13.7 t70 -129.83 111.38 12.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.073 -0.512 . . . . 15.0 110.336 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -66.0 -30.25 70.77 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.369 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.541 ' N ' HD22 ' A' ' 470' ' ' ASN . 1.0 OUTLIER -76.38 -13.52 60.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.343 -0.389 . . . . 15.0 111.262 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 59.9 28.09 17.55 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.25 -0.432 . . . . 15.0 111.287 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -74.37 -5.26 41.3 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.201 -0.454 . . . . 15.0 111.723 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.72 17.95 67.67 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.403 -0.904 . . . . 15.0 111.265 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' CYS . . . . . . . . . . . . . 15.8 t -136.31 130.96 33.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.226 -0.487 . . . . 15.0 110.496 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.887 HD11 HD13 ' A' ' 467' ' ' LEU . 14.1 mm -95.25 120.81 45.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.899 0.381 . . . . 15.0 110.977 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . 0.471 ' H ' ' HG3' ' A' ' 479' ' ' GLU . 54.3 m -103.08 171.79 7.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 15.0 110.667 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 477' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 481' ' ' VAL . 81.0 mtm180 -53.47 -44.59 69.09 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.417 -0.356 . . . . 15.0 110.931 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 478' ' ' GLU . . . . . 0.523 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.8 mt-10 -62.91 -28.81 70.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.075 -0.511 . . . . 15.0 111.358 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 479' ' ' GLU . . . . . 0.607 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 63.5 mm-40 -70.5 -50.26 39.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.499 0.19 . . . . 15.0 110.875 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 33.7 mtt -70.85 -46.89 61.87 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.709 -0.223 . . . . 15.0 111.168 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 481' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 477' ' ' ARG . 82.1 t -59.81 -53.13 52.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.626 0.251 . . . . 15.0 110.71 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 482' ' ' SER . . . . . 0.955 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 47.0 m -58.25 -32.66 68.57 Favored 'General case' 0 C--O 1.227 -0.104 0 CA-C-N 116.301 -0.408 . . . . 15.0 110.15 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 483' ' ' TYR . . . . . 0.607 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 7.4 t80 -69.62 -30.16 67.83 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.93 -0.577 . . . . 15.0 111.104 177.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 484' ' ' PHE . . . . . 0.584 ' CE2' HG22 ' A' ' 431' ' ' VAL . 0.1 OUTLIER -75.18 -40.51 59.36 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.762 0.315 . . . . 15.0 110.252 179.29 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.3 tt -83.98 -17.3 40.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 15.0 110.585 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 486' ' ' ARG . . . . . 0.955 ' HB2' ' O ' ' A' ' 482' ' ' SER . 25.1 ttt180 -74.14 -47.81 33.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.859 0.362 . . . . 15.0 110.918 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 13.9 t -82.89 19.92 1.28 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.901 -0.59 . . . . 15.0 111.554 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 88.1 p . . . . . 0 C--N 1.332 -0.169 0 CA-C-O 120.792 0.329 . . . . 15.0 110.919 179.744 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.669 ' O ' HG23 ' A' ' 423' ' ' VAL . 7.6 m-20 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.787 0.327 . . . . 15.0 111.098 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.725 ' O ' HG23 ' A' ' 424' ' ' VAL . 6.5 pt20 -46.42 -56.92 5.19 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.087 -0.506 . . . . 15.0 111.784 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . 0.418 ' H ' ' HG3' ' A' ' 420' ' ' GLN . . . -68.39 -37.64 80.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.404 -0.362 . . . . 15.0 111.279 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.527 HD13 ' OD2' ' A' ' 419' ' ' ASP . 1.2 tt -57.75 -53.72 55.06 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.882 -0.599 . . . . 15.0 111.701 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.6 t -80.78 -23.8 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 CA-C-N 115.657 -0.701 . . . . 15.0 112.05 -177.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 420' ' ' GLN . 7.2 t -62.9 -47.87 90.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.093 -0.706 . . . . 15.0 109.093 177.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -71.92 -34.16 68.86 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.486 -0.779 . . . . 15.0 110.561 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -70.72 -39.37 73.43 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.558 -0.292 . . . . 15.0 111.04 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . 0.572 ' O ' HG23 ' A' ' 431' ' ' VAL . 37.6 mt -67.84 -51.91 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.37 -0.377 . . . . 15.0 110.732 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -58.4 -42.19 86.61 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.192 0.52 . . . . 15.0 110.303 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.555 ' O ' ' HB2' ' A' ' 433' ' ' SER . 90.2 mttt -71.15 -25.14 62.43 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.521 -0.763 . . . . 15.0 110.707 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . 0.683 ' O ' HG23 ' A' ' 434' ' ' VAL . 23.3 mmm -71.45 -46.97 58.6 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.448 -0.342 . . . . 15.0 110.908 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 427' ' ' ILE . 2.6 t -65.33 -39.15 84.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.879 0.371 . . . . 15.0 110.061 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -72.16 -31.14 65.68 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.859 -0.61 . . . . 15.0 110.73 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.869 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 14.2 t -70.86 -41.88 70.82 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.196 -0.456 . . . . 15.0 111.06 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 430' ' ' MET . 17.8 t -75.87 -41.29 39.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.249 -0.432 . . . . 15.0 110.956 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -60.58 -41.32 94.4 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.297 -0.41 . . . . 15.0 110.815 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -83.21 -28.62 29.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.504 -0.316 . . . . 15.0 110.681 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . 0.869 ' HB2' ' O ' ' A' ' 433' ' ' SER . 2.5 t30 -60.11 -44.54 94.77 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.085 -0.507 . . . . 15.0 111.247 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' PHE . . . . . 0.522 ' CE2' HG21 ' A' ' 454' ' ' ILE . 66.6 m-85 -93.94 0.53 56.14 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.841 -0.618 . . . . 15.0 111.448 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -127.48 53.1 1.77 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.979 0.418 . . . . 15.0 111.179 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.9 t -74.39 -14.24 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.078 -0.51 . . . . 15.0 111.065 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -90.2 -14.74 32.83 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.074 -0.512 . . . . 15.0 111.032 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 64.55 60.06 7.48 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.051 -0.595 . . . . 15.0 112.796 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.44 -10.81 11.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.705 0.288 . . . . 15.0 111.223 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 88.93 -13.55 62.75 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.811 -0.709 . . . . 15.0 112.227 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . 0.631 ' HB2' ' SG ' ' A' ' 474' ' ' CYS . 9.5 p80 -141.58 156.81 45.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.602 0.239 . . . . 15.0 110.415 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' ILE . . . . . 0.875 HG12 ' H ' ' A' ' 475' ' ' ILE . 0.9 OUTLIER -82.99 100.85 6.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.366 -0.379 . . . . 15.0 111.143 -179.166 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 7.6 t -67.71 152.12 46.13 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.282 -0.417 . . . . 15.0 110.918 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -51.59 -43.11 62.38 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.07 -0.514 . . . . 15.0 111.951 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 452' ' ' GLN . 42.7 mt-10 -63.03 -40.09 96.7 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.552 -0.294 . . . . 15.0 111.322 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -58.24 -56.38 22.88 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.935 0.398 . . . . 15.0 110.412 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -66.85 -23.29 66.01 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.935 -0.575 . . . . 15.0 110.608 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 449' ' ' GLU . 2.6 mm-40 -59.1 -54.84 42.48 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.838 -0.619 . . . . 15.0 111.008 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 8.7 mm -78.98 -31.82 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 115.649 -0.705 . . . . 15.0 111.694 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . 0.522 HG21 ' CE2' ' A' ' 438' ' ' PHE . 50.2 mt -61.22 -46.86 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.494 0.188 . . . . 15.0 111.273 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -55.74 -29.97 60.42 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.552 -0.295 . . . . 15.0 111.561 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -66.0 -31.8 80.58 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.963 -0.637 . . . . 15.0 112.759 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -103.64 -11.7 17.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.607 0.242 . . . . 15.0 111.365 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -136.23 78.98 44.52 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 116.465 -0.334 . . . . 15.0 110.985 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.08 2.4 6.71 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.166 2.577 . . . . 15.0 112.624 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -85.2 5.19 31.16 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.325 -0.398 . . . . 15.0 111.285 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -87.76 142.39 27.86 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.263 -0.426 . . . . 15.0 111.063 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' SER . . . . . 0.406 ' HB2' ' H ' ' A' ' 463' ' ' ALA . 5.8 p -81.39 -157.35 0.17 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.066 -0.515 . . . . 15.0 110.975 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . 0.555 ' HB3' ' OD2' ' A' ' 466' ' ' ASP . . . -85.4 148.47 25.99 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.926 0.393 . . . . 15.0 111.655 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -51.24 -46.36 62.31 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.771 -0.649 . . . . 15.0 111.121 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -63.57 -19.38 62.5 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.907 -0.588 . . . . 15.0 113.005 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . 0.555 ' OD2' ' HB3' ' A' ' 463' ' ' ALA . 7.6 m-20 -87.87 -37.11 16.78 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.765 0.282 . . . . 15.0 110.977 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.442 ' HG ' ' H ' ' A' ' 467' ' ' LEU . 0.1 OUTLIER -68.99 -34.11 74.77 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.96 0.41 . . . . 15.0 110.154 178.34 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . 0.467 ' OD2' ' HB2' ' A' ' 470' ' ' ASN . 8.5 t70 -120.34 117.17 27.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.698 -0.683 . . . . 15.0 110.413 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -64.26 -27.68 69.21 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.083 -0.508 . . . . 15.0 111.577 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.467 ' HB2' ' OD2' ' A' ' 468' ' ' ASP . 5.0 m-80 -76.94 -9.01 58.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.371 -0.377 . . . . 15.0 111.442 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 54.4 36.01 24.46 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.365 -0.38 . . . . 15.0 111.4 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -88.43 0.78 55.87 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.194 -0.457 . . . . 15.0 111.47 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 65.67 14.08 59.88 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.427 -0.892 . . . . 15.0 111.314 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' CYS . . . . . 0.631 ' SG ' ' HB2' ' A' ' 445' ' ' HIS . 1.2 m -137.69 130.7 30.32 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.202 -0.499 . . . . 15.0 110.508 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.875 ' H ' HG12 ' A' ' 446' ' ' ILE . 2.7 mp -107.89 128.92 62.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.992 0.425 . . . . 15.0 111.246 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 48.8 m -104.33 -179.58 3.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.597 -0.728 . . . . 15.0 110.784 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 477' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 481' ' ' VAL . 24.6 ptt180 -62.58 -47.51 83.5 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.364 -0.38 . . . . 15.0 111.214 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 478' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -60.45 -33.95 73.29 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.252 -0.431 . . . . 15.0 111.48 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 479' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 6.8 mm-40 -66.79 -45.21 79.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.562 0.22 . . . . 15.0 110.626 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 40.3 mtt -69.76 -47.58 62.47 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.608 -0.269 . . . . 15.0 110.893 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 481' ' ' VAL . . . . . 0.568 HG22 HG11 ' A' ' 431' ' ' VAL . 89.9 t -60.14 -55.61 23.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.737 0.303 . . . . 15.0 110.937 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 482' ' ' SER . . . . . 0.952 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 75.0 m -54.51 -38.79 66.92 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 116.128 -0.487 . . . . 15.0 110.605 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 483' ' ' TYR . . . . . 0.489 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 2.6 m-85 -71.58 -24.43 61.91 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.036 -0.529 . . . . 15.0 111.555 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 484' ' ' PHE . . . . . 0.533 ' CD2' HG22 ' A' ' 431' ' ' VAL . 3.7 m-85 -75.28 -43.55 50.64 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 120.843 -0.343 . . . . 15.0 110.163 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . 0.434 ' HA ' ' OG ' ' A' ' 488' ' ' SER . 5.3 tt -84.16 -18.69 35.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 15.0 110.642 176.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 486' ' ' ARG . . . . . 0.952 ' HB2' ' O ' ' A' ' 482' ' ' SER . 24.2 ttt180 -70.97 -49.57 43.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.899 0.38 . . . . 15.0 110.791 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 14.5 t -83.43 19.68 1.5 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.831 -0.622 . . . . 15.0 111.339 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 488' ' ' SER . . . . . 0.434 ' OG ' ' HA ' ' A' ' 485' ' ' LEU . 74.0 m . . . . . 0 C--N 1.331 -0.208 0 CA-C-N 116.335 -0.393 . . . . 15.0 111.001 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.678 ' O ' HG23 ' A' ' 423' ' ' VAL . 8.4 m-20 . . . . . 0 N--CA 1.466 0.366 0 CA-C-O 120.856 0.36 . . . . 15.0 111.335 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.724 ' O ' HG23 ' A' ' 424' ' ' VAL . 44.4 mt-30 -48.8 -58.05 5.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.089 -0.505 . . . . 15.0 111.864 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -68.09 -38.6 82.52 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.444 -0.344 . . . . 15.0 111.489 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.511 HD13 ' OD2' ' A' ' 419' ' ' ASP . 0.9 OUTLIER -57.36 -54.43 46.95 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.955 -0.566 . . . . 15.0 111.852 -179.241 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.7 t -81.1 -23.47 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-N 115.709 -0.678 . . . . 15.0 112.148 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 420' ' ' GLN . 7.2 t -63.28 -48.06 89.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.11 -0.7 . . . . 15.0 109.11 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -71.84 -34.0 68.92 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.488 -0.778 . . . . 15.0 110.607 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -70.57 -39.8 73.68 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.621 -0.263 . . . . 15.0 110.99 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . 0.583 ' O ' HG23 ' A' ' 431' ' ' VAL . 40.5 mt -67.61 -52.38 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 116.442 -0.345 . . . . 15.0 110.772 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -57.97 -42.04 84.21 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.096 0.474 . . . . 15.0 110.222 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 433' ' ' SER . 89.7 mttt -71.47 -24.86 62.08 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.521 -0.763 . . . . 15.0 110.737 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . 0.634 ' O ' HG23 ' A' ' 434' ' ' VAL . 26.2 mtp -71.17 -47.68 56.23 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.467 -0.333 . . . . 15.0 110.937 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 427' ' ' ILE . 1.8 t -65.77 -39.03 83.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.913 0.387 . . . . 15.0 110.079 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -72.19 -30.01 64.54 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.842 -0.617 . . . . 15.0 110.681 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.782 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 13.4 t -70.25 -42.66 71.89 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.261 -0.427 . . . . 15.0 110.936 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 430' ' ' MET . 14.4 t -76.09 -40.37 37.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.207 -0.452 . . . . 15.0 110.77 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -58.7 -43.39 90.01 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.191 -0.458 . . . . 15.0 110.579 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -83.52 -25.3 31.15 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.451 -0.34 . . . . 15.0 110.961 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . 0.782 ' HB2' ' O ' ' A' ' 433' ' ' SER . 4.9 t-20 -60.11 -38.75 83.95 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.383 -0.372 . . . . 15.0 110.477 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' PHE . . . . . 0.539 ' CE2' HG21 ' A' ' 454' ' ' ILE . 32.6 m-85 -95.36 -12.15 26.53 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.763 -0.653 . . . . 15.0 111.581 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -106.33 54.09 0.69 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.88 0.371 . . . . 15.0 111.375 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.18 -6.46 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.194 -0.457 . . . . 15.0 111.403 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -94.0 -15.04 25.23 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.3 -0.409 . . . . 15.0 111.214 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 68.3 48.07 54.36 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.018 -0.611 . . . . 15.0 112.681 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -110.85 -18.05 13.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.649 0.261 . . . . 15.0 111.168 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 91.27 -5.2 81.06 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.921 -0.657 . . . . 15.0 112.378 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -143.29 156.92 44.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.816 0.341 . . . . 15.0 110.742 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' ILE . . . . . 0.684 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.7 mp -81.77 136.47 22.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.285 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 5.4 m -105.17 149.15 26.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.663 -0.699 . . . . 15.0 110.72 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -47.73 -46.93 30.35 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.176 -0.465 . . . . 15.0 111.776 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -64.69 -38.7 91.88 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.512 -0.313 . . . . 15.0 111.208 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -59.49 -59.07 6.04 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.275 -0.42 . . . . 15.0 110.427 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -63.18 -26.52 68.84 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.797 -0.638 . . . . 15.0 110.83 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -59.25 -56.94 15.75 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.902 -0.59 . . . . 15.0 111.288 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -78.29 -29.96 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.879 -0.601 . . . . 15.0 111.795 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . 0.539 HG21 ' CE2' ' A' ' 438' ' ' PHE . 46.6 mt -63.37 -46.14 96.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 120.397 0.141 . . . . 15.0 111.319 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -52.5 -29.22 23.96 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.802 0.297 . . . . 15.0 111.802 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -74.78 -24.65 71.69 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.833 -0.698 . . . . 15.0 112.676 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -71.6 -56.91 4.95 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.478 0.18 . . . . 15.0 111.402 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -144.59 98.71 4.9 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-O 120.628 0.251 . . . . 15.0 111.117 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.43 4.16 4.68 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.118 2.545 . . . . 15.0 112.594 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -112.29 -24.82 9.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.384 -0.371 . . . . 15.0 111.374 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.4 tp -56.77 -56.24 24.07 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.283 -0.417 . . . . 15.0 111.652 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 5.7 m -135.44 109.01 7.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.766 0.317 . . . . 15.0 111.019 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . 0.661 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -77.89 106.4 9.71 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.238 -0.437 . . . . 15.0 110.944 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . 0.475 ' HZ ' ' H ' ' A' ' 473' ' ' GLY . 29.3 t80 -40.37 -42.28 1.54 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.905 -0.588 . . . . 15.0 111.99 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -59.82 -36.92 91.59 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.03 -0.605 . . . . 15.0 113.27 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 483' ' ' TYR . 6.3 m-20 -90.48 -21.41 21.88 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.569 0.581 . . . . 15.0 112.569 -178.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 463' ' ' ALA . 0.1 OUTLIER -85.83 -43.24 13.45 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.791 -0.364 . . . . 15.0 110.518 179.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . 0.478 ' HB2' HD13 ' A' ' 475' ' ' ILE . 24.0 t0 -130.07 110.9 11.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.001 -0.545 . . . . 15.0 111.231 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -85.67 -16.84 37.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.087 -0.506 . . . . 15.0 110.772 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . 0.548 ' N ' HD22 ' A' ' 470' ' ' ASN . 0.8 OUTLIER -78.6 -13.83 59.63 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.112 -0.495 . . . . 15.0 111.195 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 60.91 24.18 14.21 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.182 -0.463 . . . . 15.0 111.629 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -75.05 -3.42 32.4 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.41 -0.359 . . . . 15.0 111.645 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . 0.475 ' H ' ' HZ ' ' A' ' 464' ' ' PHE . . . 66.57 13.83 61.48 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.634 -0.793 . . . . 15.0 111.431 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' CYS . . . . . . . . . . . . . 14.8 t -133.13 130.81 39.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.374 -0.413 . . . . 15.0 110.609 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.684 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 10.8 mm -103.6 124.25 57.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 120.778 0.323 . . . . 15.0 110.99 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 53.4 m -102.44 167.47 9.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 15.0 110.812 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -53.31 -43.3 67.48 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.245 -0.434 . . . . 15.0 111.127 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 478' ' ' GLU . . . . . 0.67 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -60.4 -32.7 71.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.189 -0.459 . . . . 15.0 111.547 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 479' ' ' GLU . . . . . 0.565 ' OE1' ' HA ' ' A' ' 475' ' ' ILE . 47.6 mt-10 -67.08 -54.26 23.13 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.424 0.154 . . . . 15.0 111.095 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 58.5 mtt -70.07 -49.59 49.58 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.755 -0.202 . . . . 15.0 111.265 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 71.6 t -58.91 -56.78 14.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.57 0.224 . . . . 15.0 111.169 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 482' ' ' SER . . . . . 1.02 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 58.1 m -55.22 -36.59 66.16 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 116.457 -0.338 . . . . 15.0 110.511 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 483' ' ' TYR . . . . . 0.552 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 20.5 t80 -69.37 -26.89 64.88 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.135 -0.484 . . . . 15.0 111.253 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 484' ' ' PHE . . . . . 0.558 ' CD2' HG22 ' A' ' 431' ' ' VAL . 5.1 m-85 -76.15 -44.15 39.56 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 120.902 -0.319 . . . . 15.0 110.533 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.3 tt -83.52 -16.67 44.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.473 -0.33 . . . . 15.0 110.706 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 486' ' ' ARG . . . . . 1.02 ' HB2' ' O ' ' A' ' 482' ' ' SER . 30.7 ttt180 -75.91 -50.28 15.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.525 -0.307 . . . . 15.0 111.284 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 52.3 m -86.25 -51.1 6.48 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.183 -0.462 . . . . 15.0 111.916 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 488' ' ' SER . . . . . 0.52 ' HB3' ' O ' ' A' ' 484' ' ' PHE . 12.5 t . . . . . 0 N--CA 1.463 0.224 0 CA-C-O 120.939 0.4 . . . . 15.0 111.448 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' ASP . . . . . 0.662 ' O ' HG23 ' A' ' 423' ' ' VAL . 8.7 m-20 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.754 0.311 . . . . 15.0 110.926 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' GLN . . . . . 0.726 ' O ' HG23 ' A' ' 424' ' ' VAL . 9.6 tt0 -46.25 -57.64 4.38 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.088 -0.505 . . . . 15.0 111.578 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -68.3 -37.28 80.46 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.306 -0.406 . . . . 15.0 111.238 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' LEU . . . . . 0.414 HD13 ' OD1' ' A' ' 419' ' ' ASP . 1.4 tt -57.39 -54.56 45.39 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.791 -0.641 . . . . 15.0 111.688 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.4 t -81.29 -23.74 10.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.724 -0.671 . . . . 15.0 112.097 -177.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 420' ' ' GLN . 7.0 t -62.64 -48.43 88.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 109.044 -0.724 . . . . 15.0 109.044 178.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -72.2 -33.96 68.03 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.428 -0.806 . . . . 15.0 110.6 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . 0.414 ' HB2' ' O ' ' A' ' 422' ' ' LEU . 2.5 t60 -70.83 -39.11 73.21 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 120.716 0.293 . . . . 15.0 110.995 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . 0.579 HG13 HG12 ' A' ' 423' ' ' VAL . 36.4 mt -67.63 -54.0 26.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.328 -0.396 . . . . 15.0 110.658 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -56.93 -42.32 79.8 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.132 0.491 . . . . 15.0 110.153 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.641 ' O ' ' HB2' ' A' ' 433' ' ' SER . 88.1 mttt -70.54 -25.13 62.97 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 115.545 -0.752 . . . . 15.0 110.762 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' MET . . . . . 0.645 ' O ' HG23 ' A' ' 434' ' ' VAL . 18.3 mtm -71.44 -46.54 59.79 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.546 -0.297 . . . . 15.0 110.948 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.611 HG22 ' CD2' ' A' ' 484' ' ' PHE . 0.8 OUTLIER -63.87 -41.87 93.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 121.041 0.448 . . . . 15.0 109.978 178.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -72.45 -29.6 63.83 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.642 -0.708 . . . . 15.0 110.952 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' SER . . . . . 0.853 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 13.3 t -69.43 -43.7 72.84 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.304 -0.407 . . . . 15.0 111.02 -179.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 430' ' ' MET . 12.1 t -75.16 -42.9 44.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.281 -0.418 . . . . 15.0 110.869 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' PHE . . . . . 0.492 ' CZ ' ' HG3' ' A' ' 477' ' ' ARG . 7.7 t80 -56.69 -43.64 80.7 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.113 -0.494 . . . . 15.0 110.902 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -85.55 -23.94 27.45 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.464 -0.335 . . . . 15.0 111.205 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' ASN . . . . . 0.853 ' HB2' ' O ' ' A' ' 433' ' ' SER . 4.4 t-20 -59.84 -40.24 87.85 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.429 -0.351 . . . . 15.0 110.637 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' PHE . . . . . 0.524 ' CE2' HG21 ' A' ' 454' ' ' ILE . 54.8 m-85 -95.71 -13.83 23.89 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.931 -0.577 . . . . 15.0 111.807 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -105.31 54.33 0.71 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.924 0.392 . . . . 15.0 111.239 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 11.1 p -71.95 -16.1 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.13 -0.487 . . . . 15.0 111.338 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 40.2 p30 -79.92 -14.26 58.75 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.144 -0.48 . . . . 15.0 111.341 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 71.29 47.14 37.83 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.869 -0.682 . . . . 15.0 112.386 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -106.5 -18.46 13.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.676 0.274 . . . . 15.0 111.192 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 89.93 -9.32 77.67 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.956 -0.64 . . . . 15.0 112.494 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' HIS . . . . . 0.403 ' HB3' ' SG ' ' A' ' 474' ' ' CYS . 61.7 m80 -146.01 162.53 37.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.774 0.321 . . . . 15.0 110.709 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' ILE . . . . . 0.598 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.7 mp -77.84 135.13 26.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.225 -0.443 . . . . 15.0 111.179 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.0 m -106.14 148.72 27.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.669 -0.696 . . . . 15.0 110.584 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -48.32 -47.46 36.8 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.257 -0.429 . . . . 15.0 111.697 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' GLU . . . . . 0.435 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.4 mt-10 -64.46 -38.22 90.27 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.423 -0.353 . . . . 15.0 111.329 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -58.37 -61.53 2.51 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.883 0.373 . . . . 15.0 110.605 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.7 -22.69 66.64 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.923 -0.581 . . . . 15.0 110.932 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' GLN . . . . . 0.435 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 0.9 OUTLIER -60.49 -57.55 12.27 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.938 -0.574 . . . . 15.0 111.281 179.49 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -76.87 -33.76 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 115.771 -0.65 . . . . 15.0 111.855 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' ILE . . . . . 0.524 HG21 ' CE2' ' A' ' 438' ' ' PHE . 61.0 mt -62.49 -49.97 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 120.489 0.185 . . . . 15.0 111.284 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' ARG . . . . . 0.515 ' NH2' ' H ' ' A' ' 461' ' ' LEU . 0.1 OUTLIER -57.94 -30.6 66.09 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.524 -0.307 . . . . 15.0 111.521 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -70.57 -33.73 67.44 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.918 -0.658 . . . . 15.0 112.775 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' ASN . . . . . 0.452 ' O ' ' HD3' ' A' ' 459' ' ' PRO . 40.9 m-80 -90.4 -22.21 21.57 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.637 0.256 . . . . 15.0 111.189 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -115.97 84.39 13.34 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.432 -0.349 . . . . 15.0 111.034 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 457' ' ' ASN . 13.0 Cg_exo -70.83 -10.55 27.93 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.947 2.431 . . . . 15.0 112.545 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -96.84 25.55 5.2 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.318 -0.401 . . . . 15.0 110.974 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' LEU . . . . . 0.515 ' H ' ' NH2' ' A' ' 455' ' ' ARG . 0.7 OUTLIER -98.01 152.07 19.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.218 -0.447 . . . . 15.0 111.061 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' SER . . . . . 0.494 ' OG ' HD23 ' A' ' 467' ' ' LEU . 43.1 p -63.63 175.73 1.02 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.072 -0.513 . . . . 15.0 111.328 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' ALA . . . . . 0.745 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -87.76 148.42 24.73 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.184 -0.462 . . . . 15.0 111.242 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' PHE . . . . . 0.714 ' HA ' HD11 ' A' ' 467' ' ' LEU . 46.0 m-85 -54.44 -48.07 72.13 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.937 -0.574 . . . . 15.0 111.477 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -70.4 -15.62 72.91 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.014 -0.613 . . . . 15.0 113.519 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' ASP . . . . . 0.489 ' OD1' ' HB3' ' A' ' 463' ' ' ALA . 4.1 m-20 -90.26 -36.67 14.59 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 117.089 0.445 . . . . 15.0 111.796 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' LEU . . . . . 0.855 HD13 HD11 ' A' ' 475' ' ' ILE . 0.5 OUTLIER -82.08 -30.88 31.07 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.9 0.381 . . . . 15.0 110.571 179.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . 0.595 ' N ' HD12 ' A' ' 467' ' ' LEU . 20.7 t70 -126.47 108.75 11.46 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.976 -0.556 . . . . 15.0 110.273 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -69.22 -22.11 63.89 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.112 -0.494 . . . . 15.0 111.489 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -76.51 -14.11 60.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.226 -0.443 . . . . 15.0 111.326 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 57.38 26.61 12.7 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.224 -0.444 . . . . 15.0 111.413 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -81.23 0.05 38.44 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.257 -0.429 . . . . 15.0 111.551 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 65.89 16.04 63.34 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.469 -0.872 . . . . 15.0 111.227 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' CYS . . . . . 0.403 ' SG ' ' HB3' ' A' ' 445' ' ' HIS . 13.8 t -137.94 131.12 30.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.142 -0.529 . . . . 15.0 110.431 -178.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.855 HD11 HD13 ' A' ' 467' ' ' LEU . 94.9 mt -106.84 127.24 62.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.912 0.387 . . . . 15.0 111.023 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 64.7 m -103.61 177.22 4.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.739 -0.664 . . . . 15.0 111.077 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 477' ' ' ARG . . . . . 0.492 ' HG3' ' CZ ' ' A' ' 435' ' ' PHE . 68.7 mtp180 -58.81 -46.96 86.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.21 -0.45 . . . . 15.0 111.221 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 478' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -60.21 -32.42 71.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.215 -0.448 . . . . 15.0 111.423 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 479' ' ' GLU . . . . . 0.45 ' HB2' HG23 ' A' ' 475' ' ' ILE . 5.5 mm-40 -66.42 -50.22 64.16 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.497 0.189 . . . . 15.0 110.778 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 60.0 mtt -69.86 -47.0 64.32 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.684 -0.234 . . . . 15.0 110.923 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 481' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 477' ' ' ARG . 89.8 t -61.56 -54.01 40.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.702 0.287 . . . . 15.0 110.842 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 482' ' ' SER . . . . . 0.89 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 10.3 m -50.55 -47.17 57.78 Favored 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 116.034 -0.53 . . . . 15.0 110.382 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 483' ' ' TYR . . . . . 0.418 ' HD1' ' O ' ' A' ' 479' ' ' GLU . 8.0 m-85 -69.22 -22.42 63.87 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.423 -0.808 . . . . 15.0 111.856 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 484' ' ' PHE . . . . . 0.778 ' O ' ' HB2' ' A' ' 488' ' ' SER . 0.1 OUTLIER -74.03 -45.94 46.52 Favored 'General case' 0 CA--C 1.527 0.091 0 C-N-CA 120.779 -0.369 . . . . 15.0 110.1 179.05 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . 0.612 ' O ' HD13 ' A' ' 485' ' ' LEU . 1.5 tm? -84.43 -16.62 42.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.425 -0.352 . . . . 15.0 110.664 177.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 486' ' ' ARG . . . . . 0.89 ' HB2' ' O ' ' A' ' 482' ' ' SER . 21.3 ttt180 -74.36 -53.32 9.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.451 -0.34 . . . . 15.0 111.578 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 79.7 p -92.58 -54.49 3.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.314 -0.403 . . . . 15.0 112.058 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 488' ' ' SER . . . . . 0.778 ' HB2' ' O ' ' A' ' 484' ' ' PHE . 54.7 m . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.871 0.367 . . . . 15.0 111.492 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 50.3 pttt . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.761 0.315 . . . . 15.0 110.931 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 9.1 mt -102.57 139.07 38.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.085 -0.507 . . . . 15.0 110.889 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.656 ' O ' HG23 ' A' ' 423' ' ' VAL . 8.9 m-20 -97.52 8.95 43.68 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.048 -0.524 . . . . 15.0 111.037 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.732 ' O ' HG23 ' A' ' 424' ' ' VAL . 53.6 mt-30 -44.81 -57.25 3.86 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.053 -0.522 . . . . 15.0 111.607 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -68.48 -36.83 79.51 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.308 -0.406 . . . . 15.0 111.136 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 1.6 tt -57.75 -54.55 45.65 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.826 -0.625 . . . . 15.0 111.668 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.1 t -81.32 -23.48 10.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.665 -0.698 . . . . 15.0 112.039 -177.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 420' ' ' GLN . 6.8 t -62.78 -47.46 92.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 109.047 -0.723 . . . . 15.0 109.047 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -72.97 -33.94 66.18 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.435 -0.802 . . . . 15.0 110.583 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . 0.576 ' O ' ' HB2' ' A' ' 430' ' ' MET . 2.4 t-80 -70.85 -39.38 72.99 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.678 0.275 . . . . 15.0 110.975 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . 0.58 ' O ' HG23 ' A' ' 431' ' ' VAL . 40.1 mt -68.88 -52.0 39.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.372 -0.376 . . . . 15.0 110.715 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -57.32 -43.0 82.95 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.132 0.492 . . . . 15.0 110.197 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -71.83 -24.27 61.68 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 115.559 -0.746 . . . . 15.0 110.542 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . 0.672 ' O ' HG23 ' A' ' 434' ' ' VAL . 8.5 ttm -70.32 -49.82 45.52 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.36 -0.382 . . . . 15.0 110.853 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 427' ' ' ILE . 1.5 t -64.56 -37.34 79.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.918 0.39 . . . . 15.0 110.033 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -71.57 -32.93 68.62 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.826 -0.625 . . . . 15.0 110.692 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.917 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 4.0 m -69.61 -41.11 76.12 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.181 -0.463 . . . . 15.0 111.09 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 430' ' ' MET . 16.4 t -75.36 -42.2 43.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.2 -0.455 . . . . 15.0 110.786 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 9.8 t80 -58.32 -41.71 85.11 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.965 -0.561 . . . . 15.0 111.013 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -86.37 -26.91 24.55 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.436 -0.347 . . . . 15.0 110.933 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . 0.917 ' HB2' ' O ' ' A' ' 433' ' ' SER . 2.6 t-20 -59.73 -45.27 92.71 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.227 -0.442 . . . . 15.0 111.455 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . 0.483 ' CE2' HG21 ' A' ' 454' ' ' ILE . 54.8 m-85 -94.33 -2.09 52.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.119 -0.491 . . . . 15.0 111.494 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 1.1 t0 -120.08 54.49 1.03 Allowed 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.918 0.39 . . . . 15.0 111.16 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.26 -9.42 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.054 -0.521 . . . . 15.0 111.32 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -92.35 -3.96 54.57 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.257 -0.429 . . . . 15.0 111.219 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 61.06 51.01 61.18 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.051 -0.595 . . . . 15.0 112.664 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -103.19 -18.09 15.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.645 0.259 . . . . 15.0 111.231 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 87.8 -13.85 59.93 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.933 -0.651 . . . . 15.0 112.302 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . 0.469 ' HB2' ' SG ' ' A' ' 474' ' ' CYS . 14.4 p80 -137.77 154.37 49.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.622 0.248 . . . . 15.0 110.408 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' ILE . . . . . 0.624 ' O ' ' HA ' ' A' ' 474' ' ' CYS . 1.6 mp -85.6 98.95 6.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.072 0.463 . . . . 15.0 111.023 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 52.8 m -63.7 150.89 43.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.705 -0.68 . . . . 15.0 111.072 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -55.33 -37.91 68.05 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.069 -0.514 . . . . 15.0 111.802 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . 0.463 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -63.23 -40.25 96.92 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.522 -0.308 . . . . 15.0 111.38 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -58.55 -60.51 3.7 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.947 0.403 . . . . 15.0 110.507 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -64.61 -24.1 67.48 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.822 -0.627 . . . . 15.0 110.614 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' GLN . . . . . 0.463 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 0.2 OUTLIER -58.9 -57.05 14.76 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.724 -0.671 . . . . 15.0 111.588 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -81.05 -33.61 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.682 -0.69 . . . . 15.0 111.927 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . 0.483 HG21 ' CE2' ' A' ' 438' ' ' PHE . 56.0 mt -63.9 -38.17 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.444 0.164 . . . . 15.0 111.438 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -62.65 -21.74 65.92 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.687 0.28 . . . . 15.0 111.468 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -66.36 -23.94 71.98 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 121.014 -0.613 . . . . 15.0 112.7 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -116.03 -10.7 11.53 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.676 0.274 . . . . 15.0 111.208 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -127.67 74.7 78.18 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.385 -0.37 . . . . 15.0 111.007 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.04 1.93 8.15 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.189 2.593 . . . . 15.0 112.612 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -81.32 2.5 27.94 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.328 -0.396 . . . . 15.0 111.449 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.4 mp -102.16 152.3 21.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.379 -0.373 . . . . 15.0 111.041 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 50.9 m -74.67 -174.83 2.24 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.079 -0.51 . . . . 15.0 111.288 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . 0.575 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -87.79 156.93 19.17 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.22 -0.446 . . . . 15.0 111.793 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -50.08 -41.67 48.56 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.74 -0.663 . . . . 15.0 111.348 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -62.19 -26.72 68.02 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.944 -0.571 . . . . 15.0 113.35 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -88.44 -33.24 17.93 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.858 0.329 . . . . 15.0 111.433 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 463' ' ' ALA . 0.1 OUTLIER -77.65 -36.32 51.57 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.863 0.363 . . . . 15.0 110.403 178.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . 0.539 ' HA ' ' OE2' ' A' ' 479' ' ' GLU . 10.4 t70 -123.77 114.62 20.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.876 -0.602 . . . . 15.0 110.47 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -67.28 -33.74 75.94 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.052 -0.522 . . . . 15.0 111.542 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -79.27 -9.44 59.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.397 -0.365 . . . . 15.0 111.413 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 55.86 39.08 30.68 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.27 -0.423 . . . . 15.0 111.382 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -78.56 -0.72 30.79 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.178 -0.464 . . . . 15.0 111.593 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.47 15.09 63.3 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.494 -0.86 . . . . 15.0 111.255 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' CYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 446' ' ' ILE . 1.0 OUTLIER -136.09 131.16 34.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.235 -0.483 . . . . 15.0 110.455 -178.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.572 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 16.7 mm -102.74 124.9 57.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.938 0.399 . . . . 15.0 111.136 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 12.3 t -103.59 175.71 5.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.729 -0.669 . . . . 15.0 110.823 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.44 ' O ' HG23 ' A' ' 481' ' ' VAL . 24.7 ptt180 -58.08 -44.48 87.6 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.328 -0.396 . . . . 15.0 111.149 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.6 mt-10 -62.11 -29.62 70.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.437 . . . . 15.0 111.458 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . 0.539 ' OE2' ' HA ' ' A' ' 468' ' ' ASP . 5.3 mm-40 -71.69 -47.99 50.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.496 0.188 . . . . 15.0 110.862 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 60.5 mtt -70.45 -46.2 64.33 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.687 -0.233 . . . . 15.0 110.963 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 477' ' ' ARG . 79.1 t -60.26 -52.7 58.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 120.738 0.304 . . . . 15.0 110.659 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' SER . . . . . 0.918 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 39.5 m -57.77 -32.96 68.01 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 116.162 -0.472 . . . . 15.0 110.183 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' TYR . . . . . 0.538 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 9.1 t80 -69.02 -30.01 68.31 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.904 -0.589 . . . . 15.0 111.013 177.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' PHE . . . . . 0.57 ' CD2' HG22 ' A' ' 431' ' ' VAL . 1.9 m-85 -75.16 -40.18 59.77 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.708 0.289 . . . . 15.0 110.332 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.2 tt -83.82 -18.74 36.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 15.0 110.558 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' ARG . . . . . 0.918 ' HB2' ' O ' ' A' ' 482' ' ' SER . 31.0 ttt180 -72.61 -52.98 13.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.433 -0.349 . . . . 15.0 110.882 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 53.4 m -89.26 19.37 4.39 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.979 -0.555 . . . . 15.0 111.354 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . 0.559 ' HB2' ' O ' ' A' ' 484' ' ' PHE . 22.6 t -87.69 130.16 34.9 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.345 -0.389 . . . . 15.0 110.933 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 51.8 m -95.65 -129.45 0.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.114 -0.493 . . . . 15.0 110.842 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 5.1 t -65.93 -51.65 58.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 116.515 -0.311 . . . . 15.0 111.073 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 1.5 mp -131.47 -42.16 1.06 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.918 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -110.43 -103.75 2.78 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.961 -0.638 . . . . 15.0 112.499 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 164.91 57.63 0.02 OUTLIER Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.824 -0.703 . . . . 15.0 112.512 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -127.94 147.22 50.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.73 0.3 . . . . 15.0 110.913 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 64.1 mtt -122.56 -42.77 2.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.464 . . . . 15.0 110.979 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 126.06 64.28 0.16 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.847 -0.692 . . . . 15.0 112.482 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.295 -0.859 . . . . 15.0 110.904 179.975 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 66.1 mttm . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.723 0.297 . . . . 15.0 111.023 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 11.2 mt -140.18 110.79 6.76 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.199 -0.455 . . . . 15.0 110.814 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.637 ' O ' HG23 ' A' ' 423' ' ' VAL . 0.8 OUTLIER -153.57 126.58 8.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.144 -0.48 . . . . 15.0 111.114 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.724 ' O ' HG23 ' A' ' 424' ' ' VAL . 4.3 tt0 -47.96 -56.35 7.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.784 -0.643 . . . . 15.0 111.862 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.42 95.96 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.328 -0.397 . . . . 15.0 111.62 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 3.2 tt -57.49 -53.34 59.31 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.077 -0.51 . . . . 15.0 111.743 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.6 t -80.9 -22.54 10.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.736 -0.665 . . . . 15.0 111.966 -176.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 420' ' ' GLN . 9.3 t -64.07 -47.68 89.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 109.056 -0.72 . . . . 15.0 109.056 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -72.61 -33.29 66.57 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.426 -0.807 . . . . 15.0 110.584 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . 0.629 ' O ' ' HB2' ' A' ' 430' ' ' MET . 4.6 t-80 -71.02 -39.29 72.43 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.568 -0.287 . . . . 15.0 111.05 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . 0.555 ' O ' HG23 ' A' ' 431' ' ' VAL . 40.7 mt -68.88 -52.29 36.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-N 116.352 -0.386 . . . . 15.0 110.77 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -57.7 -43.55 85.25 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.154 0.502 . . . . 15.0 110.169 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -72.04 -22.73 61.35 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.506 -0.77 . . . . 15.0 110.548 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . 0.629 ' HB2' ' O ' ' A' ' 426' ' ' HIS . 0.0 OUTLIER -70.28 -51.37 30.99 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.405 -0.361 . . . . 15.0 110.88 179.077 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.557 HG22 ' CE2' ' A' ' 484' ' ' PHE . 1.0 OUTLIER -63.87 -38.69 83.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.317 -0.402 . . . . 15.0 110.046 179.128 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -71.89 -31.69 66.68 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.823 -0.626 . . . . 15.0 110.878 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.817 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 2.6 m -68.54 -42.68 78.1 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.244 -0.435 . . . . 15.0 111.028 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 430' ' ' MET . 10.2 t -75.32 -41.91 43.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.271 -0.422 . . . . 15.0 110.869 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . 0.61 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 4.1 t80 -56.75 -42.67 79.74 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.037 -0.529 . . . . 15.0 110.749 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 -87.02 -23.55 24.95 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.441 -0.345 . . . . 15.0 111.229 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . 0.817 ' HB2' ' O ' ' A' ' 433' ' ' SER . 5.1 t-20 -59.97 -39.62 86.28 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.863 0.363 . . . . 15.0 110.568 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . 0.493 ' CE2' HG21 ' A' ' 454' ' ' ILE . 35.6 m-85 -94.15 -16.51 23.66 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.854 -0.612 . . . . 15.0 111.635 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . 0.61 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 0.3 OUTLIER -99.18 54.03 0.97 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.864 0.364 . . . . 15.0 111.429 -179.525 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.3 -12.85 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.327 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -88.59 -14.82 36.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.119 -0.491 . . . . 15.0 111.171 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 73.7 39.44 48.51 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.004 -0.617 . . . . 15.0 112.508 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -95.79 -17.34 21.25 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.623 0.249 . . . . 15.0 111.162 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 87.22 -7.73 79.51 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.911 -0.662 . . . . 15.0 112.37 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -144.92 162.18 37.51 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.717 0.294 . . . . 15.0 110.658 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' ILE . . . . . 0.881 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.6 mp -77.78 136.36 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.113 0.483 . . . . 15.0 111.265 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 48.5 m -105.76 147.8 28.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.474 -0.784 . . . . 15.0 110.711 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -50.71 -46.85 59.11 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.169 -0.469 . . . . 15.0 111.606 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . 0.422 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -65.31 -36.91 85.52 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.479 -0.328 . . . . 15.0 111.168 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -60.58 -58.71 7.34 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.295 -0.411 . . . . 15.0 110.543 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.45 -23.73 67.0 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.882 -0.599 . . . . 15.0 110.767 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' GLN . . . . . 0.422 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 1.5 mm-40 -61.07 -56.93 15.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.88 -0.6 . . . . 15.0 111.302 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -76.73 -32.89 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 115.804 -0.635 . . . . 15.0 111.913 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . 0.493 HG21 ' CE2' ' A' ' 438' ' ' PHE . 46.3 mt -64.71 -51.96 60.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-O 120.501 0.191 . . . . 15.0 111.244 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -55.32 -33.19 63.09 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.694 0.283 . . . . 15.0 111.46 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -66.84 -30.78 76.66 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.908 -0.663 . . . . 15.0 112.629 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' ASN . . . . . 0.468 ' O ' ' HD3' ' A' ' 459' ' ' PRO . 42.0 m-80 -94.28 -18.99 21.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.687 0.279 . . . . 15.0 111.246 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -115.8 83.29 11.47 Favored Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 116.375 -0.375 . . . . 15.0 110.936 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 457' ' ' ASN . 12.6 Cg_exo -70.78 -10.08 27.03 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.046 2.497 . . . . 15.0 112.631 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -96.53 25.25 5.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.26 -0.427 . . . . 15.0 111.034 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 2.3 tp -100.39 152.55 20.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.16 -0.473 . . . . 15.0 110.975 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 52.5 m -65.54 176.41 1.48 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.115 -0.493 . . . . 15.0 111.378 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . 0.76 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -86.84 150.49 24.09 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.239 -0.437 . . . . 15.0 111.243 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . 0.749 ' HA ' HD11 ' A' ' 467' ' ' LEU . 68.1 m-85 -56.62 -48.76 76.79 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.999 -0.546 . . . . 15.0 111.506 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -68.15 -16.33 68.68 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.962 -0.637 . . . . 15.0 113.459 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -90.13 -39.33 12.93 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.101 0.45 . . . . 15.0 111.776 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.985 HD13 HD11 ' A' ' 475' ' ' ILE . 0.6 OUTLIER -79.06 -28.76 43.18 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.762 0.315 . . . . 15.0 110.755 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . 0.602 ' N ' HD12 ' A' ' 467' ' ' LEU . 12.4 t70 -130.87 110.49 11.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.039 -0.528 . . . . 15.0 110.286 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -66.06 -28.77 69.09 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.008 -0.542 . . . . 15.0 111.454 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.562 ' N ' HD22 ' A' ' 470' ' ' ASN . 0.9 OUTLIER -76.54 -14.11 60.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.249 -0.432 . . . . 15.0 111.214 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 58.67 29.36 18.46 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.238 -0.437 . . . . 15.0 111.306 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -74.35 -4.8 38.58 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.147 -0.479 . . . . 15.0 111.767 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.52 17.57 66.81 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.464 -0.875 . . . . 15.0 111.197 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' CYS . . . . . . . . . . . . . 18.5 t -135.78 131.7 35.81 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.268 -0.466 . . . . 15.0 110.492 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.985 HD11 HD13 ' A' ' 467' ' ' LEU . 11.1 mm -98.79 122.24 50.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 15.0 110.938 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . 0.508 ' H ' ' HG3' ' A' ' 479' ' ' GLU . 15.4 t -102.89 171.12 7.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.918 -0.583 . . . . 15.0 110.672 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -52.86 -45.51 67.44 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.338 -0.392 . . . . 15.0 110.915 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' GLU . . . . . 0.563 ' O ' ' HB2' ' A' ' 482' ' ' SER . 9.4 tt0 -62.51 -28.39 69.81 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.049 -0.523 . . . . 15.0 111.254 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . 0.599 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 52.1 mm-40 -70.35 -51.36 30.57 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.505 0.193 . . . . 15.0 110.84 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 44.2 mtt -70.06 -47.18 63.03 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.653 -0.249 . . . . 15.0 111.081 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 82.1 t -59.94 -53.49 47.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.68 0.276 . . . . 15.0 110.85 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' SER . . . . . 0.941 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 43.0 m -57.96 -32.46 67.85 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 116.267 -0.424 . . . . 15.0 110.208 178.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' TYR . . . . . 0.599 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 8.3 t80 -69.3 -31.05 69.28 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.954 -0.566 . . . . 15.0 111.199 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' PHE . . . . . 0.585 ' HZ ' ' SD ' ' A' ' 430' ' ' MET . 1.6 m-85 -75.9 -39.03 57.12 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.926 -0.31 . . . . 15.0 110.387 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.1 tt -83.74 -19.65 34.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 15.0 110.49 176.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' ARG . . . . . 0.941 ' HB2' ' O ' ' A' ' 482' ' ' SER . 32.1 ttt180 -72.08 -48.55 43.3 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.845 0.355 . . . . 15.0 110.751 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 49.5 p -82.77 19.58 1.31 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.907 -0.588 . . . . 15.0 111.439 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 67.9 m -77.25 123.5 26.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.279 -0.418 . . . . 15.0 110.961 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 41.2 p -107.79 -43.68 4.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.106 -0.497 . . . . 15.0 111.16 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 58.1 t -148.44 89.0 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.374 -0.375 . . . . 15.0 110.567 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 4.8 mp -136.1 -40.21 0.67 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.098 -0.501 . . . . 15.0 111.032 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . 142.69 -81.35 0.23 Allowed Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.915 -0.659 . . . . 15.0 112.462 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 102.44 55.37 0.85 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.871 -0.68 . . . . 15.0 112.412 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . 0.416 ' O ' ' HE2' ' A' ' 497' ' ' PHE . 99.6 mtt180 -100.78 -41.05 7.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.688 0.28 . . . . 15.0 110.991 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -105.91 130.15 53.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.25 -0.432 . . . . 15.0 110.893 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 129.75 74.23 0.14 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.938 -0.648 . . . . 15.0 112.51 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . 0.416 ' HE2' ' O ' ' A' ' 494' ' ' ARG . 84.0 m-85 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.286 -0.864 . . . . 15.0 110.933 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 97.1 mttt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.731 0.301 . . . . 15.0 110.923 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.3 mp -143.66 -70.14 0.31 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.131 -0.486 . . . . 15.0 110.902 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.637 ' O ' HG23 ' A' ' 423' ' ' VAL . 0.2 OUTLIER -172.53 140.66 1.07 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.343 -0.389 . . . . 15.0 110.89 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.736 ' O ' HG23 ' A' ' 424' ' ' VAL . 45.9 mt-30 -48.99 -56.66 8.23 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.878 -0.601 . . . . 15.0 111.731 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -65.91 -38.47 88.8 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.905 0.383 . . . . 15.0 111.43 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 3.4 tt -57.97 -53.09 62.11 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.862 -0.608 . . . . 15.0 111.572 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 419' ' ' ASP . 2.1 t -80.81 -22.7 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 CA-C-N 115.665 -0.698 . . . . 15.0 111.978 -177.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 420' ' ' GLN . 9.6 t -63.83 -48.02 88.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 109.023 -0.732 . . . . 15.0 109.023 177.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -71.7 -33.55 68.88 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.335 -0.848 . . . . 15.0 110.46 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -70.71 -39.8 73.22 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.53 -0.305 . . . . 15.0 110.915 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . 0.574 ' O ' HG23 ' A' ' 431' ' ' VAL . 38.6 mt -67.33 -52.35 43.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.358 -0.383 . . . . 15.0 110.712 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -58.37 -41.99 86.01 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.156 0.503 . . . . 15.0 110.287 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.618 ' O ' ' HB2' ' A' ' 433' ' ' SER . 89.6 mttt -71.29 -24.19 62.1 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 115.473 -0.785 . . . . 15.0 110.74 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . 0.653 ' O ' HG23 ' A' ' 434' ' ' VAL . 25.2 mmm -71.63 -47.53 53.88 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.428 -0.351 . . . . 15.0 110.923 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.588 HG22 ' CD2' ' A' ' 484' ' ' PHE . 2.0 t -65.36 -39.22 84.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.325 -0.398 . . . . 15.0 110.0 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -72.62 -30.45 64.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.916 -0.584 . . . . 15.0 110.756 177.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.843 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 13.2 t -68.86 -43.11 76.09 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.202 -0.453 . . . . 15.0 110.91 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 430' ' ' MET . 10.6 t -76.53 -40.82 34.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.784 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . 0.551 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 2.9 t80 -56.99 -42.9 81.11 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.065 -0.516 . . . . 15.0 110.673 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -87.41 -23.6 24.47 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.361 -0.382 . . . . 15.0 111.18 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . 0.843 ' HB2' ' O ' ' A' ' 433' ' ' SER . 3.3 t30 -60.0 -38.93 84.07 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.934 0.397 . . . . 15.0 110.515 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . 0.459 ' CD2' HD13 ' A' ' 454' ' ' ILE . 33.1 m-85 -94.41 -16.65 23.24 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.802 -0.636 . . . . 15.0 111.55 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 0.6 OUTLIER -99.92 53.44 0.92 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.892 0.377 . . . . 15.0 111.589 -179.323 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.8 t -70.37 -12.49 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.132 -0.485 . . . . 15.0 111.0 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -90.85 -14.96 30.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.079 -0.51 . . . . 15.0 111.048 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 76.56 41.62 24.2 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.971 -0.633 . . . . 15.0 112.509 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -97.64 -18.64 18.78 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.671 0.272 . . . . 15.0 111.149 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 86.2 -4.48 85.97 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.899 -0.667 . . . . 15.0 112.468 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . 0.684 ' HB2' ' SG ' ' A' ' 474' ' ' CYS . 11.1 p-80 -146.18 164.3 32.68 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.757 0.313 . . . . 15.0 110.807 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' ILE . . . . . 0.841 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.2 mp -76.98 135.76 25.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.215 -0.448 . . . . 15.0 110.999 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 9.9 t -106.33 147.53 29.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.823 -0.626 . . . . 15.0 110.789 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -52.42 -47.93 66.03 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.167 -0.469 . . . . 15.0 111.541 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -64.72 -36.85 85.63 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.444 -0.343 . . . . 15.0 111.047 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . 0.419 ' O ' HD12 ' A' ' 454' ' ' ILE . 5.0 mm-40 -61.16 -56.56 19.36 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.317 -0.401 . . . . 15.0 110.279 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' PHE . . . . . 0.522 ' CE2' HD23 ' A' ' 461' ' ' LEU . 0.7 OUTLIER -64.99 -25.07 67.71 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.911 -0.586 . . . . 15.0 110.529 178.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' GLN . . . . . 0.415 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 2.5 mm-40 -60.66 -57.92 10.66 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.76 -0.654 . . . . 15.0 111.389 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 8.8 mm -76.0 -33.04 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.86 -0.609 . . . . 15.0 111.842 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . 0.459 HD13 ' CD2' ' A' ' 438' ' ' PHE . 28.3 mt -63.2 -47.52 91.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 120.489 0.185 . . . . 15.0 111.272 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' ARG . . . . . 0.647 ' NH2' ' HA ' ' A' ' 463' ' ' ALA . 8.1 mtt180 -54.87 -33.68 62.14 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.539 -0.3 . . . . 15.0 111.507 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -64.08 -29.3 74.52 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 121.033 -0.603 . . . . 15.0 112.612 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -97.37 -15.04 20.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.556 0.217 . . . . 15.0 111.162 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . 0.506 ' HB3' HD13 ' A' ' 461' ' ' LEU . 86.0 m-85 -125.47 86.66 56.88 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.39 -0.368 . . . . 15.0 111.044 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -72.53 -2.71 12.2 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.989 2.459 . . . . 15.0 112.589 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -103.35 23.54 12.35 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.319 -0.401 . . . . 15.0 110.998 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.522 HD23 ' CE2' ' A' ' 451' ' ' PHE . 1.0 OUTLIER -89.32 147.77 23.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 15.0 111.084 -179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 58.2 m -66.78 175.37 2.44 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.044 -0.525 . . . . 15.0 111.329 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . 0.74 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -87.88 149.11 24.3 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.114 -0.494 . . . . 15.0 111.271 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . 0.743 ' HA ' HD11 ' A' ' 467' ' ' LEU . 90.1 m-85 -56.71 -47.6 79.58 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.932 -0.577 . . . . 15.0 111.47 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -69.06 -16.06 70.28 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 121.034 -0.603 . . . . 15.0 113.449 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -89.92 -38.97 13.31 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 117.202 0.501 . . . . 15.0 111.678 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.912 HD13 HD11 ' A' ' 475' ' ' ILE . 0.6 OUTLIER -80.9 -28.56 35.83 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.815 0.341 . . . . 15.0 110.586 179.57 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . 0.595 ' N ' HD12 ' A' ' 467' ' ' LEU . 12.4 t70 -131.65 111.93 12.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.049 -0.523 . . . . 15.0 110.213 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -62.07 -35.74 79.57 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.029 -0.532 . . . . 15.0 111.788 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -77.88 -10.58 59.64 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.417 -0.356 . . . . 15.0 111.456 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 57.66 34.13 24.11 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.943 0.402 . . . . 15.0 111.303 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -73.88 -4.44 34.99 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.113 -0.494 . . . . 15.0 111.716 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.72 18.04 67.78 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.489 -0.863 . . . . 15.0 111.277 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' CYS . . . . . 0.684 ' SG ' ' HB2' ' A' ' 445' ' ' HIS . 3.7 t -135.19 130.93 36.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.248 -0.476 . . . . 15.0 110.52 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.912 HD11 HD13 ' A' ' 467' ' ' LEU . 21.1 mm -98.78 123.67 51.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.892 0.377 . . . . 15.0 110.93 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . 0.404 ' H ' ' HG3' ' A' ' 479' ' ' GLU . 14.5 t -101.84 166.96 10.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.931 -0.577 . . . . 15.0 110.577 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -50.49 -46.98 57.38 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.34 -0.391 . . . . 15.0 110.915 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' GLU . . . . . 0.726 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -62.21 -30.84 71.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.031 -0.531 . . . . 15.0 111.473 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 5.7 mm-40 -69.83 -55.06 10.81 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 121.285 -0.166 . . . . 15.0 110.956 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 6.6 tpp -68.65 -48.46 63.96 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.752 -0.204 . . . . 15.0 111.228 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 76.0 t -60.51 -54.56 33.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 121.148 -0.221 . . . . 15.0 111.128 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' SER . . . . . 0.98 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 36.8 m -56.51 -33.61 66.18 Favored 'General case' 0 C--O 1.227 -0.088 0 CA-C-N 116.515 -0.311 . . . . 15.0 110.462 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' TYR . . . . . 0.573 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 8.5 t80 -70.24 -30.76 67.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.116 -0.493 . . . . 15.0 111.167 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' PHE . . . . . 0.588 ' CD2' HG22 ' A' ' 431' ' ' VAL . 6.0 m-85 -74.16 -41.84 60.86 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 120.888 -0.325 . . . . 15.0 110.372 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.5 tt -83.95 -16.98 42.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.396 . . . . 15.0 110.492 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' ARG . . . . . 0.98 ' HB2' ' O ' ' A' ' 482' ' ' SER . 5.8 tpt180 -71.59 -51.5 23.02 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.892 0.377 . . . . 15.0 110.844 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 52.5 m -87.55 19.37 3.38 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.961 -0.563 . . . . 15.0 111.55 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 484' ' ' PHE . 9.3 t -121.55 157.27 31.08 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.374 -0.376 . . . . 15.0 111.042 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 52.9 m -94.56 161.0 14.38 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.046 -0.525 . . . . 15.0 110.915 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 60.1 t -148.9 90.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.2 -0.454 . . . . 15.0 110.516 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 2.4 tp -97.69 -42.04 7.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.015 -0.539 . . . . 15.0 111.032 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -118.73 -101.98 2.05 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.877 -0.678 . . . . 15.0 112.527 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 102.57 88.58 2.05 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.85 -0.69 . . . . 15.0 112.465 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -102.64 135.03 45.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.775 0.322 . . . . 15.0 110.933 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 64.8 mtt -102.13 -42.12 6.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.148 -0.478 . . . . 15.0 110.998 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 128.62 91.64 0.68 Allowed Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.849 -0.691 . . . . 15.0 112.512 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.315 -0.85 . . . . 15.0 110.862 -179.987 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . 0.584 ' HD3' ' OE1' ' A' ' 420' ' ' GLN . 97.6 mttt . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.792 0.329 . . . . 15.0 110.86 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 2.7 tp -144.49 -47.4 0.25 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.123 -0.49 . . . . 15.0 110.871 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.661 ' O ' HG23 ' A' ' 423' ' ' VAL . 7.6 m-20 -92.0 20.63 5.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.136 -0.484 . . . . 15.0 111.115 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.739 ' O ' HG23 ' A' ' 424' ' ' VAL . 4.0 tt0 -46.85 -57.42 4.93 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.097 -0.501 . . . . 15.0 111.624 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.82 81.78 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.345 -0.388 . . . . 15.0 111.294 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.543 HD13 ' OD2' ' A' ' 419' ' ' ASP . 1.2 tt -57.82 -53.77 54.4 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.872 -0.604 . . . . 15.0 111.618 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.7 t -80.69 -23.98 11.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.636 -0.711 . . . . 15.0 112.02 -177.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 420' ' ' GLN . 7.3 t -62.74 -47.82 91.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 109.076 -0.713 . . . . 15.0 109.076 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -71.53 -34.53 70.12 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.468 -0.787 . . . . 15.0 110.539 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -70.4 -40.07 74.11 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.569 -0.287 . . . . 15.0 110.936 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . 0.567 HG13 HG12 ' A' ' 423' ' ' VAL . 37.2 mt -66.58 -53.61 33.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.329 -0.396 . . . . 15.0 110.676 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -57.35 -41.97 81.09 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.105 0.479 . . . . 15.0 110.275 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.613 ' O ' ' HB2' ' A' ' 433' ' ' SER . 89.0 mttt -70.24 -24.98 63.17 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.516 -0.765 . . . . 15.0 110.592 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . 0.65 ' O ' HG23 ' A' ' 434' ' ' VAL . 33.7 mmm -71.81 -46.09 59.34 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.469 -0.332 . . . . 15.0 110.898 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.607 HG22 ' CE2' ' A' ' 484' ' ' PHE . 1.0 OUTLIER -64.14 -41.19 91.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.979 0.419 . . . . 15.0 109.974 178.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -72.75 -29.75 63.58 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.708 -0.678 . . . . 15.0 110.992 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.781 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 13.3 t -69.64 -43.39 72.74 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.269 -0.423 . . . . 15.0 110.996 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 430' ' ' MET . 12.7 t -75.77 -41.86 40.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.201 -0.454 . . . . 15.0 110.811 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -57.89 -42.57 84.92 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.222 -0.444 . . . . 15.0 110.706 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -84.52 -25.19 28.97 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.506 -0.315 . . . . 15.0 111.033 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . 0.781 ' HB2' ' O ' ' A' ' 433' ' ' SER . 3.1 t30 -60.38 -38.96 85.55 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.851 0.358 . . . . 15.0 110.498 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -96.81 -10.47 26.56 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.911 -0.586 . . . . 15.0 111.734 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -108.83 53.6 0.68 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.896 0.379 . . . . 15.0 111.481 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.413 HG12 ' OE1' ' A' ' 450' ' ' GLU . 8.6 p -74.91 -0.13 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.132 -0.486 . . . . 15.0 110.866 178.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -86.39 -15.13 41.33 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.843 -0.617 . . . . 15.0 111.102 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 67.85 40.9 89.31 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 121.019 -0.61 . . . . 15.0 112.605 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -115.65 -15.56 11.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.651 0.262 . . . . 15.0 111.238 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 89.46 -4.93 84.18 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.876 -0.678 . . . . 15.0 112.487 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -142.64 156.72 45.1 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.793 0.33 . . . . 15.0 110.722 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' ILE . . . . . 0.654 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.7 mp -78.67 134.99 26.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 15.0 111.282 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . 0.697 ' OG ' ' HG3' ' A' ' 450' ' ' GLU . 90.5 p -107.05 149.02 28.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.623 -0.717 . . . . 15.0 110.617 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -48.49 -43.54 35.01 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.182 -0.463 . . . . 15.0 111.852 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -62.89 -40.68 98.27 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.534 -0.303 . . . . 15.0 111.436 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . 0.697 ' HG3' ' OG ' ' A' ' 447' ' ' SER . 25.9 mt-10 -61.08 -57.72 11.38 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.399 -0.364 . . . . 15.0 110.558 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' PHE . . . . . 0.502 ' O ' ' HG2' ' A' ' 455' ' ' ARG . 3.9 t80 -61.5 -27.16 68.39 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.992 -0.549 . . . . 15.0 110.967 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -61.44 -56.65 17.8 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.029 -0.532 . . . . 15.0 111.197 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 2.1 mt -72.6 -30.14 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.908 -0.587 . . . . 15.0 111.828 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . 0.405 HG23 ' CD1' ' A' ' 458' ' ' PHE . 45.9 mt -66.39 -56.32 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.752 -0.203 . . . . 15.0 111.462 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 451' ' ' PHE . 28.4 ptt180 -51.88 -33.04 34.92 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.931 0.345 . . . . 15.0 111.931 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -69.88 -34.81 71.84 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.901 -0.666 . . . . 15.0 112.83 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' ASN . . . . . 0.411 ' O ' ' HD3' ' A' ' 459' ' ' PRO . 17.2 m120 -92.93 -13.77 28.44 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.589 0.233 . . . . 15.0 111.39 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . 0.405 ' CD1' HG23 ' A' ' 454' ' ' ILE . 81.2 m-85 -116.69 85.59 17.26 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.484 -0.325 . . . . 15.0 111.036 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 457' ' ' ASN . 12.3 Cg_exo -71.37 -11.75 28.88 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.965 2.443 . . . . 15.0 112.507 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -99.51 26.24 6.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.249 -0.432 . . . . 15.0 110.926 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.7 tp -91.09 146.31 23.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.093 -0.503 . . . . 15.0 111.104 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 66.7 m -69.2 -172.55 0.44 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.08 -0.509 . . . . 15.0 111.245 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . 0.683 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -85.06 150.68 24.7 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.227 -0.442 . . . . 15.0 111.461 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . 0.686 ' HA ' HD11 ' A' ' 467' ' ' LEU . 66.0 m-85 -55.46 -51.6 66.39 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.76 -0.655 . . . . 15.0 111.226 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -68.78 -11.97 63.8 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.111 -0.566 . . . . 15.0 113.276 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -88.79 -36.17 16.23 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.078 0.439 . . . . 15.0 111.145 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.686 HD11 ' HA ' ' A' ' 464' ' ' PHE . 0.1 OUTLIER -85.14 -23.99 28.18 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.024 0.44 . . . . 15.0 110.055 178.351 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -135.23 111.06 9.35 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.77 -0.65 . . . . 15.0 110.008 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -61.48 -36.42 80.41 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.053 -0.521 . . . . 15.0 112.041 -178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -77.63 -9.08 58.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.532 -0.304 . . . . 15.0 111.681 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 55.45 34.1 22.3 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.442 -0.344 . . . . 15.0 111.438 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -82.09 1.99 33.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.163 -0.471 . . . . 15.0 111.511 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.22 15.28 63.0 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.457 -0.878 . . . . 15.0 110.981 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' CYS . . . . . . . . . . . . . 13.5 t -136.61 130.56 32.47 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.127 -0.536 . . . . 15.0 110.374 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.654 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 1.4 mp -103.4 127.53 57.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.964 0.411 . . . . 15.0 111.253 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 12.7 t -103.94 175.16 5.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.695 -0.684 . . . . 15.0 110.811 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.426 ' O ' HG23 ' A' ' 481' ' ' VAL . 99.0 mtt180 -56.98 -45.3 83.03 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.324 -0.398 . . . . 15.0 111.108 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.6 mt-10 -61.15 -29.57 69.87 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.179 -0.464 . . . . 15.0 111.524 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . 0.55 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 5.5 mm-40 -70.7 -49.03 51.42 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.401 0.143 . . . . 15.0 110.871 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 33.4 mtt -70.4 -46.22 64.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.72 -0.218 . . . . 15.0 111.02 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 477' ' ' ARG . 88.8 t -60.24 -52.72 58.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.689 0.28 . . . . 15.0 110.607 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' SER . . . . . 0.901 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 40.3 m -57.73 -32.7 67.7 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-N 116.171 -0.468 . . . . 15.0 110.061 178.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' TYR . . . . . 0.55 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 8.8 t80 -69.04 -30.9 69.36 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.872 -0.604 . . . . 15.0 110.913 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' PHE . . . . . 0.607 ' CE2' HG22 ' A' ' 431' ' ' VAL . 0.1 OUTLIER -74.17 -40.54 62.47 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 110.243 -0.281 . . . . 15.0 110.243 179.279 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.2 tt -83.44 -18.9 37.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 15.0 110.531 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' ARG . . . . . 0.901 ' HB2' ' O ' ' A' ' 482' ' ' SER . 32.9 ttt180 -71.49 -52.22 19.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.442 -0.345 . . . . 15.0 110.843 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 14.0 t -90.13 19.46 5.0 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.977 -0.556 . . . . 15.0 111.244 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . 0.56 ' HB2' ' O ' ' A' ' 484' ' ' PHE . 22.8 t -89.75 138.66 31.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.31 -0.405 . . . . 15.0 111.004 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 52.4 m -125.45 78.18 1.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.105 -0.498 . . . . 15.0 110.939 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 4.0 t -75.98 -47.08 33.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.118 -0.492 . . . . 15.0 111.16 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 1.1 mp -122.1 -42.02 2.4 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.183 -0.462 . . . . 15.0 110.967 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . 142.13 -55.6 0.59 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.911 -0.662 . . . . 15.0 112.48 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . 109.95 -138.83 15.09 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.864 -0.684 . . . . 15.0 112.533 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -102.33 -42.13 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.727 0.299 . . . . 15.0 110.951 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 22.3 mmt -104.98 -42.34 5.35 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.263 -0.426 . . . . 15.0 111.057 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 144.78 -83.84 0.19 Allowed Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.789 -0.719 . . . . 15.0 112.435 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.191 -0.909 . . . . 15.0 110.913 179.988 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . 0.543 ' N ' HD23 ' A' ' 422' ' ' LEU . 97.1 mttt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.687 0.28 . . . . 15.0 111.006 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.5 -15.51 4.02 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.338 -0.392 . . . . 15.0 111.109 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.68 ' O ' HG23 ' A' ' 423' ' ' VAL . 0.5 OUTLIER -108.95 129.77 55.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.379 -0.373 . . . . 15.0 111.091 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.754 ' O ' HG23 ' A' ' 424' ' ' VAL . 4.3 tt0 -46.72 -56.52 6.04 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.781 -0.645 . . . . 15.0 111.961 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -63.51 -39.83 95.46 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.438 -0.347 . . . . 15.0 111.485 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.543 HD23 ' N ' ' A' ' 417' ' ' LYS . 5.2 tp -57.33 -51.75 68.13 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.902 -0.59 . . . . 15.0 111.603 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.1 t -81.18 -21.68 10.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-N 115.67 -0.696 . . . . 15.0 111.929 -177.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 420' ' ' GLN . 12.0 t -64.05 -48.22 86.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.95 -0.759 . . . . 15.0 108.95 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -72.91 -33.04 65.73 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.37 -0.832 . . . . 15.0 110.629 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . 0.644 ' O ' ' HB2' ' A' ' 430' ' ' MET . 2.2 t60 -71.26 -39.32 71.67 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.579 -0.282 . . . . 15.0 110.984 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . 0.565 HG13 HG12 ' A' ' 423' ' ' VAL . 41.4 mt -69.29 -50.68 49.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.407 -0.361 . . . . 15.0 110.809 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -58.95 -43.27 91.22 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.088 0.471 . . . . 15.0 110.141 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.611 ' O ' ' HB2' ' A' ' 433' ' ' SER . 92.0 mttt -72.49 -23.04 60.97 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.513 -0.767 . . . . 15.0 110.516 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . 0.666 ' O ' HG23 ' A' ' 434' ' ' VAL . 4.0 ttt -70.69 -49.55 45.98 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.456 -0.338 . . . . 15.0 110.8 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 427' ' ' ILE . 2.7 t -65.02 -39.07 84.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.269 -0.423 . . . . 15.0 110.008 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -71.38 -31.26 67.1 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.879 -0.601 . . . . 15.0 110.564 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.949 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 12.7 t -70.67 -41.22 72.38 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 116.217 -0.447 . . . . 15.0 111.041 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 430' ' ' MET . 19.4 t -75.1 -42.68 45.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.26 -0.427 . . . . 15.0 110.969 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . 0.633 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 14.3 t80 -59.28 -42.08 90.39 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.12 -0.491 . . . . 15.0 111.02 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -84.95 -27.95 26.18 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.548 -0.296 . . . . 15.0 110.953 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . 0.949 ' HB2' ' O ' ' A' ' 433' ' ' SER . 2.2 t30 -60.12 -44.89 94.54 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.203 -0.453 . . . . 15.0 111.393 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . 0.426 ' CZ ' HD21 ' A' ' 461' ' ' LEU . 45.3 m-85 -94.78 4.84 53.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.372 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . 0.633 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 0.3 OUTLIER -126.84 55.2 1.56 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.899 0.38 . . . . 15.0 111.352 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.401 ' H ' HG23 ' A' ' 440' ' ' VAL . 2.5 t -68.64 -8.42 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.129 -0.487 . . . . 15.0 111.325 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -87.97 -6.47 57.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.233 -0.44 . . . . 15.0 111.16 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 62.04 30.19 74.83 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.843 -0.694 . . . . 15.0 111.979 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -90.51 -18.91 24.47 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 122.307 0.243 . . . . 15.0 111.291 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 83.21 -7.33 67.87 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.91 -0.662 . . . . 15.0 112.576 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . 0.606 ' HB3' ' SG ' ' A' ' 474' ' ' CYS . 73.3 m-70 -131.84 140.21 49.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.809 0.338 . . . . 15.0 110.602 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 474' ' ' CYS . 1.5 mp -84.98 98.57 6.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.157 -0.474 . . . . 15.0 111.013 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 29.8 m -68.29 155.33 39.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.82 -0.627 . . . . 15.0 111.016 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -53.67 -40.62 66.09 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.153 -0.476 . . . . 15.0 111.825 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . 0.567 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -62.81 -39.42 94.21 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.496 -0.32 . . . . 15.0 111.424 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . 0.445 ' OE1' ' HA ' ' A' ' 446' ' ' ILE . 49.7 mt-10 -57.13 -58.83 6.47 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.048 0.451 . . . . 15.0 110.448 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' PHE . . . . . 0.614 ' CZ ' HD23 ' A' ' 461' ' ' LEU . 6.9 t80 -69.05 -20.43 64.11 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.771 -0.649 . . . . 15.0 110.609 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' GLN . . . . . 0.567 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 0.4 OUTLIER -59.31 -54.91 41.39 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.877 -0.601 . . . . 15.0 111.113 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -84.32 -32.5 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.733 -0.667 . . . . 15.0 111.843 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . . . . . . . . . 57.7 mt -64.57 -40.07 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 111.664 0.246 . . . . 15.0 111.664 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 452' ' ' GLN . 32.0 ptt180 -59.67 -19.09 47.2 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.631 0.253 . . . . 15.0 111.597 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -79.32 -23.55 62.86 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.899 -0.667 . . . . 15.0 112.506 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -88.09 -27.25 22.06 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.642 0.258 . . . . 15.0 111.196 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -121.67 87.77 46.27 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.335 -0.393 . . . . 15.0 110.817 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.41 -3.89 13.36 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.963 2.442 . . . . 15.0 112.67 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -103.54 23.66 12.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.369 -0.378 . . . . 15.0 111.011 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.614 HD23 ' CZ ' ' A' ' 451' ' ' PHE . 2.9 tp -102.29 155.29 18.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.088 -0.505 . . . . 15.0 111.08 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 55.2 m -71.98 172.84 9.27 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.072 -0.513 . . . . 15.0 111.333 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . 0.46 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -91.54 156.64 17.52 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.115 -0.493 . . . . 15.0 111.77 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -45.83 -48.74 15.73 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.695 -0.684 . . . . 15.0 111.568 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -62.37 -23.84 64.97 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.89 -0.596 . . . . 15.0 113.637 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -88.43 -28.95 20.56 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 117.063 0.431 . . . . 15.0 111.592 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 463' ' ' ALA . 0.0 OUTLIER -77.43 -34.91 54.51 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.849 0.356 . . . . 15.0 110.252 178.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . 0.44 ' OD1' ' HB2' ' A' ' 470' ' ' ASN . 9.1 t70 -130.39 119.77 23.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.893 -0.594 . . . . 15.0 110.496 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -68.19 -28.05 66.93 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.104 -0.498 . . . . 15.0 111.525 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.44 ' HB2' ' OD1' ' A' ' 468' ' ' ASP . 3.9 m-80 -76.88 -10.69 59.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.252 -0.431 . . . . 15.0 111.357 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 56.24 34.03 23.25 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.289 -0.414 . . . . 15.0 111.414 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -82.42 -1.89 51.48 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.199 -0.455 . . . . 15.0 111.514 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 65.59 14.95 61.09 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.585 -0.817 . . . . 15.0 111.436 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' CYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 446' ' ' ILE . 4.2 t -135.09 130.92 36.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.248 -0.476 . . . . 15.0 110.403 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.459 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 9.5 mm -105.04 124.88 60.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.982 0.42 . . . . 15.0 111.212 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 50.5 m -103.28 174.79 5.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.707 -0.679 . . . . 15.0 110.615 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -56.02 -49.07 74.7 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.418 -0.356 . . . . 15.0 111.018 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' GLU . . . . . 0.668 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -61.76 -33.44 74.09 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.124 -0.489 . . . . 15.0 111.763 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . 0.539 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 5.4 mm-40 -69.5 -53.23 20.15 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 121.228 -0.189 . . . . 15.0 110.983 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . 0.407 ' SD ' ' HB ' ' A' ' 434' ' ' VAL . 9.9 ttm -69.21 -48.56 61.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.754 -0.203 . . . . 15.0 111.313 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' VAL . . . . . 0.553 HG22 HG11 ' A' ' 431' ' ' VAL . 79.4 t -60.92 -55.77 22.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.575 0.226 . . . . 15.0 111.217 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' SER . . . . . 0.958 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 44.5 m -54.89 -36.96 65.7 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.382 -0.372 . . . . 15.0 110.548 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' TYR . . . . . 0.539 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 1.9 m-85 -71.23 -26.04 62.75 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.236 -0.438 . . . . 15.0 111.321 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' PHE . . . . . 0.519 ' CD2' HG22 ' A' ' 431' ' ' VAL . 1.9 m-85 -73.37 -44.55 58.42 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 110.129 -0.323 . . . . 15.0 110.129 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.4 tt -84.24 -17.61 39.19 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.135 -0.484 . . . . 15.0 110.672 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' ARG . . . . . 0.958 ' HB2' ' O ' ' A' ' 482' ' ' SER . 30.8 ttt180 -70.97 -48.8 51.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.887 0.375 . . . . 15.0 110.758 177.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 52.2 m -82.7 19.26 1.35 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.89 -0.596 . . . . 15.0 111.469 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 66.9 m -88.44 145.14 25.94 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.358 -0.383 . . . . 15.0 111.0 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 13.1 t -98.52 -120.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 15.0 110.833 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 3.4 t -69.82 -49.13 59.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 120.722 0.296 . . . . 15.0 111.122 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 8.1 mt -128.33 -42.8 1.48 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.185 -0.462 . . . . 15.0 110.944 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -174.02 55.91 0.14 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.899 -0.667 . . . . 15.0 112.511 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . -136.34 -145.21 5.0 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.904 -0.665 . . . . 15.0 112.55 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -124.67 -44.59 1.96 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.677 0.275 . . . . 15.0 110.92 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 5.1 tpt -129.62 -42.15 1.31 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.255 -0.43 . . . . 15.0 110.921 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 160.41 -78.77 0.17 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.893 -0.67 . . . . 15.0 112.564 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.232 -0.889 . . . . 15.0 110.834 179.995 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 97.5 mttt . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.7 0.286 . . . . 15.0 110.881 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 11.2 mt -142.91 110.88 5.96 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.206 -0.452 . . . . 15.0 110.789 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.637 ' O ' HG23 ' A' ' 423' ' ' VAL . 1.1 m-20 -148.41 124.27 10.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 15.0 111.107 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.731 ' O ' HG23 ' A' ' 424' ' ' VAL . 45.4 mt-30 -47.62 -56.15 7.81 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.77 -0.65 . . . . 15.0 111.994 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -64.13 -40.94 97.25 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.384 -0.371 . . . . 15.0 111.67 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 5.0 tp -57.4 -53.3 59.65 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.041 -0.527 . . . . 15.0 111.726 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.7 t -80.13 -23.36 11.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 115.674 -0.694 . . . . 15.0 112.004 -177.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 420' ' ' GLN . 8.4 t -63.22 -47.66 91.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.02 -0.733 . . . . 15.0 109.02 177.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -71.77 -34.38 69.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.422 -0.808 . . . . 15.0 110.504 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -70.53 -40.39 73.46 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.534 -0.303 . . . . 15.0 110.946 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . 0.553 HG13 HG12 ' A' ' 423' ' ' VAL . 35.9 mt -66.36 -53.68 33.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.355 -0.384 . . . . 15.0 110.771 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -57.15 -41.83 79.89 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.105 0.479 . . . . 15.0 110.326 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.632 ' O ' ' HB2' ' A' ' 433' ' ' SER . 89.2 mttt -70.86 -24.7 62.56 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.538 -0.756 . . . . 15.0 110.749 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . 0.664 ' O ' HG23 ' A' ' 434' ' ' VAL . 33.9 mtp -71.99 -47.49 51.69 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.405 -0.362 . . . . 15.0 110.891 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.588 HG22 ' CE2' ' A' ' 484' ' ' PHE . 0.8 OUTLIER -63.62 -40.98 91.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.065 0.459 . . . . 15.0 109.939 178.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -72.24 -30.35 64.8 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.666 -0.697 . . . . 15.0 110.826 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.837 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 12.2 t -68.75 -43.48 75.76 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.307 -0.406 . . . . 15.0 111.085 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 430' ' ' MET . 7.7 t -75.27 -41.97 43.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.32 -0.4 . . . . 15.0 110.848 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . 0.637 ' O ' ' HB2' ' A' ' 439' ' ' ASP . 3.8 t80 -58.39 -41.57 85.16 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.09 -0.504 . . . . 15.0 110.967 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -85.11 -27.17 26.43 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.371 -0.377 . . . . 15.0 110.889 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . 0.837 ' HB2' ' O ' ' A' ' 433' ' ' SER . 2.7 t30 -59.36 -44.54 92.68 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.272 -0.422 . . . . 15.0 111.194 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . 0.516 ' CE2' HG21 ' A' ' 454' ' ' ILE . 33.1 m-85 -90.2 -5.91 55.87 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.019 -0.537 . . . . 15.0 111.212 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . 0.637 ' HB2' ' O ' ' A' ' 435' ' ' PHE . 0.2 OUTLIER -109.82 53.94 0.68 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.838 0.351 . . . . 15.0 111.405 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 3.3 m -70.6 -9.22 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.21 -0.45 . . . . 15.0 111.617 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -88.92 -15.14 35.07 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.235 -0.439 . . . . 15.0 111.144 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 73.12 37.77 55.36 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.922 -0.656 . . . . 15.0 112.538 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -97.31 -16.39 20.33 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.653 0.264 . . . . 15.0 111.195 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 86.8 -7.69 78.88 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.825 -0.702 . . . . 15.0 112.374 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . 0.49 ' HB2' ' SG ' ' A' ' 474' ' ' CYS . 15.0 p80 -142.39 158.36 43.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.759 0.314 . . . . 15.0 110.712 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' ILE . . . . . 0.766 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.6 mp -77.71 135.99 25.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 15.0 111.165 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 14.4 t -106.19 148.11 28.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.585 -0.734 . . . . 15.0 110.767 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -50.18 -46.39 54.22 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.214 -0.448 . . . . 15.0 111.507 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . 0.469 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.6 mt-10 -65.42 -35.24 80.33 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.426 -0.352 . . . . 15.0 110.89 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -60.06 -59.56 5.23 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.241 -0.436 . . . . 15.0 110.483 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.36 -23.56 67.01 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.984 -0.553 . . . . 15.0 110.629 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' GLN . . . . . 0.469 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 5.6 mt-30 -60.14 -57.57 12.27 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.802 -0.635 . . . . 15.0 111.234 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 8.7 mm -76.6 -33.05 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.782 -0.645 . . . . 15.0 111.831 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . 0.516 HG21 ' CE2' ' A' ' 438' ' ' PHE . 48.5 mt -62.71 -46.98 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.803 -0.18 . . . . 15.0 111.133 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' ARG . . . . . 0.626 ' NH2' ' HA ' ' A' ' 463' ' ' ALA . 10.5 mtt180 -54.79 -34.33 62.56 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.718 0.294 . . . . 15.0 111.551 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -66.05 -30.84 77.74 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.994 -0.622 . . . . 15.0 112.896 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -96.95 -16.32 20.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.667 0.27 . . . . 15.0 111.293 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -132.97 85.79 44.99 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.308 -0.406 . . . . 15.0 110.983 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -72.84 1.74 6.11 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.062 2.508 . . . . 15.0 112.452 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -87.61 6.77 32.89 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.313 -0.403 . . . . 15.0 111.223 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -83.76 142.41 30.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.239 -0.437 . . . . 15.0 111.088 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 43.4 p -70.62 -172.56 0.64 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.038 -0.528 . . . . 15.0 111.161 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . 0.73 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -86.93 150.22 24.24 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.365 -0.38 . . . . 15.0 111.264 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . 0.731 ' HA ' HD11 ' A' ' 467' ' ' LEU . 80.0 m-85 -59.14 -46.71 87.64 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.023 -0.535 . . . . 15.0 111.371 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -67.68 -16.44 67.84 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.921 -0.656 . . . . 15.0 113.225 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -90.23 -41.35 11.64 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.913 0.356 . . . . 15.0 111.705 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.81 HD13 HD11 ' A' ' 475' ' ' ILE . 0.7 OUTLIER -76.53 -27.47 55.98 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.703 0.287 . . . . 15.0 110.842 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . 0.621 ' N ' HD12 ' A' ' 467' ' ' LEU . 10.9 t70 -128.16 112.2 14.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.203 -0.453 . . . . 15.0 110.362 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -67.02 -29.53 69.37 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.011 -0.54 . . . . 15.0 111.312 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.563 ' N ' HD22 ' A' ' 470' ' ' ASN . 0.9 OUTLIER -76.52 -13.66 60.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.276 -0.42 . . . . 15.0 111.144 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 60.65 28.05 17.76 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.199 -0.455 . . . . 15.0 111.285 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -71.42 -7.86 50.06 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.137 -0.483 . . . . 15.0 111.838 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.86 18.41 68.51 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.405 -0.902 . . . . 15.0 111.299 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 445' ' ' HIS . 19.0 t -137.16 130.88 31.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.256 -0.472 . . . . 15.0 110.464 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.81 HD11 HD13 ' A' ' 467' ' ' LEU . 9.0 mm -93.92 120.19 42.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.959 0.409 . . . . 15.0 111.01 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . 0.464 ' H ' ' HG3' ' A' ' 479' ' ' GLU . 52.9 m -103.38 173.4 6.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.819 -0.628 . . . . 15.0 110.686 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 481' ' ' VAL . 98.8 mtt180 -53.74 -45.38 70.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.427 -0.351 . . . . 15.0 110.959 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -62.38 -28.36 69.72 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.046 -0.524 . . . . 15.0 111.361 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . 0.576 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 43.6 mm-40 -71.15 -50.05 37.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.41 0.147 . . . . 15.0 110.777 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 40.3 mtt -70.58 -46.66 63.03 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.797 -0.183 . . . . 15.0 110.958 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 477' ' ' ARG . 84.1 t -59.84 -54.12 38.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.758 0.313 . . . . 15.0 110.693 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' SER . . . . . 0.942 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 38.6 m -56.63 -33.11 65.99 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 116.215 -0.448 . . . . 15.0 110.117 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' TYR . . . . . 0.576 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 8.5 t80 -69.27 -29.74 67.7 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.921 -0.581 . . . . 15.0 110.966 177.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' PHE . . . . . 0.588 ' CE2' HG22 ' A' ' 431' ' ' VAL . 0.1 OUTLIER -73.9 -41.93 61.42 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 110.215 -0.291 . . . . 15.0 110.215 179.259 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.5 mp -83.83 -17.78 39.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.308 -0.405 . . . . 15.0 110.556 177.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' ARG . . . . . 0.942 ' HB2' ' O ' ' A' ' 482' ' ' SER . 34.4 ttt180 -71.99 -48.26 46.1 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.323 -0.399 . . . . 15.0 110.812 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 53.3 m -80.58 19.65 0.79 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.872 -0.604 . . . . 15.0 111.502 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 54.6 m -80.7 124.68 29.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.374 -0.376 . . . . 15.0 110.926 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 52.9 m -104.53 -38.5 6.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.084 -0.507 . . . . 15.0 111.145 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 1.8 t -147.91 13.65 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.376 -0.375 . . . . 15.0 110.79 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.51 -40.15 15.55 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.242 -0.435 . . . . 15.0 111.068 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . 144.23 -158.77 27.57 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.879 -0.677 . . . . 15.0 112.546 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . -168.28 -123.73 0.68 Allowed Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.853 -0.689 . . . . 15.0 112.476 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -102.32 -41.54 6.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.628 0.251 . . . . 15.0 110.94 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 64.7 mtt -104.34 145.35 30.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.194 -0.457 . . . . 15.0 110.871 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . -146.58 -64.19 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.905 -0.664 . . . . 15.0 112.522 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.277 -0.868 . . . . 15.0 110.876 -179.994 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 93.3 mttt . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.788 0.327 . . . . 15.0 110.913 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 2.5 pp -153.26 132.92 13.05 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.108 -0.496 . . . . 15.0 110.681 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.616 ' O ' HG23 ' A' ' 423' ' ' VAL . 0.7 OUTLIER -149.48 124.55 10.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 15.0 111.238 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.732 ' O ' HG23 ' A' ' 424' ' ' VAL . 53.3 mt-30 -47.25 -55.68 8.18 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.819 -0.628 . . . . 15.0 111.879 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -63.14 -40.37 97.39 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.308 -0.405 . . . . 15.0 111.51 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . . . . . . . . . 4.9 tp -57.46 -53.01 62.95 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.009 -0.541 . . . . 15.0 111.673 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.5 t -79.95 -22.65 11.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.658 -0.701 . . . . 15.0 111.973 -177.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 420' ' ' GLN . 9.9 t -63.43 -47.75 90.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 109.047 -0.723 . . . . 15.0 109.047 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -71.96 -34.17 68.76 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.33 -0.85 . . . . 15.0 110.577 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -70.78 -40.42 72.61 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.612 -0.267 . . . . 15.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . 0.561 HG13 HG12 ' A' ' 423' ' ' VAL . 36.9 mt -66.48 -53.34 36.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.362 -0.381 . . . . 15.0 110.667 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -57.24 -42.27 81.12 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.151 0.5 . . . . 15.0 110.143 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -69.87 -25.34 63.67 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.528 -0.76 . . . . 15.0 110.549 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . 0.681 ' O ' HG23 ' A' ' 434' ' ' VAL . 31.7 mmm -70.67 -47.73 58.44 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.425 -0.352 . . . . 15.0 110.935 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.584 HG22 ' CE2' ' A' ' 484' ' ' PHE . 0.8 OUTLIER -62.93 -40.3 88.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.014 0.435 . . . . 15.0 110.025 179.073 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -72.53 -33.31 66.79 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.733 -0.667 . . . . 15.0 110.978 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.796 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 3.6 m -66.33 -43.47 86.05 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.344 -0.389 . . . . 15.0 111.093 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 430' ' ' MET . 4.9 t -75.94 -38.84 36.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.212 -0.449 . . . . 15.0 110.779 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' A' ' 431' ' ' VAL . 4.4 t80 -55.92 -42.87 76.73 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.068 -0.515 . . . . 15.0 110.821 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -89.16 -24.03 22.29 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.401 -0.363 . . . . 15.0 111.284 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . 0.796 ' HB2' ' O ' ' A' ' 433' ' ' SER . 4.2 t-20 -59.95 -34.7 73.6 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.987 0.422 . . . . 15.0 110.402 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . 0.439 ' O ' ' HB3' ' A' ' 450' ' ' GLU . 7.2 m-85 -71.79 -41.63 68.07 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.622 -0.717 . . . . 15.0 111.888 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . 0.722 ' HA ' ' OE2' ' A' ' 450' ' ' GLU . 5.1 p-10 -139.53 82.29 1.87 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.144 0.497 . . . . 15.0 111.91 -178.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.9 m -72.42 -8.57 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.925 -0.579 . . . . 15.0 111.248 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -66.84 -15.39 63.58 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.049 -0.523 . . . . 15.0 111.408 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 91.04 47.3 3.64 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.931 -0.652 . . . . 15.0 112.423 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -101.3 -19.53 15.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.674 0.273 . . . . 15.0 111.207 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 78.94 -13.69 17.7 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.039 -0.6 . . . . 15.0 113.0 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -144.48 168.37 20.29 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.889 0.376 . . . . 15.0 110.806 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' ILE . . . . . 0.594 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.2 mp -74.56 126.56 35.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.021 -0.536 . . . . 15.0 111.24 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 52.9 m -106.36 147.37 29.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.743 -0.662 . . . . 15.0 110.83 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -50.03 -45.59 52.18 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.193 -0.458 . . . . 15.0 111.677 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.72 -40.19 96.14 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.48 -0.327 . . . . 15.0 111.234 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . 0.722 ' OE2' ' HA ' ' A' ' 439' ' ' ASP . 5.5 mm-40 -63.33 -56.13 18.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.433 -0.349 . . . . 15.0 110.385 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.83 -28.99 67.96 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.165 -0.471 . . . . 15.0 110.93 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -61.82 -55.87 25.41 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 115.928 -0.578 . . . . 15.0 111.081 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 2.8 mt -70.86 -28.38 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.914 -0.585 . . . . 15.0 111.624 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . 0.453 HG23 ' CD1' ' A' ' 458' ' ' PHE . 30.3 mt -67.24 -56.98 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.67 -0.241 . . . . 15.0 111.183 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -47.93 -36.17 11.93 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.478 -0.328 . . . . 15.0 111.877 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -63.79 -34.05 88.89 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.986 -0.626 . . . . 15.0 112.947 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -104.24 -2.43 25.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.537 0.208 . . . . 15.0 111.345 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . 0.453 ' CD1' HG23 ' A' ' 454' ' ' ILE . 81.4 m-85 -128.75 79.96 73.49 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.523 -0.308 . . . . 15.0 111.155 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -75.09 -3.66 14.25 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.075 2.517 . . . . 15.0 112.543 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -107.71 26.41 10.34 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.207 -0.451 . . . . 15.0 111.013 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 2.4 tp -91.62 151.36 20.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.176 -0.466 . . . . 15.0 111.118 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 49.2 m -67.73 176.7 2.36 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.104 -0.498 . . . . 15.0 111.362 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . 0.786 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -89.05 153.11 21.26 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.128 -0.487 . . . . 15.0 111.288 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . 0.698 ' HA ' HD11 ' A' ' 467' ' ' LEU . 78.1 m-85 -57.41 -49.14 77.17 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.069 -0.514 . . . . 15.0 111.437 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -68.95 -15.48 69.37 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.992 -0.623 . . . . 15.0 113.57 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . 0.507 ' OD1' ' HB3' ' A' ' 463' ' ' ALA . 5.1 m-20 -89.83 -41.6 11.74 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.1 0.45 . . . . 15.0 111.712 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.887 HD13 HD11 ' A' ' 475' ' ' ILE . 0.6 OUTLIER -78.0 -27.74 49.05 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.747 0.308 . . . . 15.0 110.714 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . 0.589 ' N ' HD12 ' A' ' 467' ' ' LEU . 13.7 t70 -129.83 111.38 12.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.073 -0.512 . . . . 15.0 110.336 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -66.0 -30.25 70.77 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.369 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.541 ' N ' HD22 ' A' ' 470' ' ' ASN . 1.0 OUTLIER -76.38 -13.52 60.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.343 -0.389 . . . . 15.0 111.262 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 59.9 28.09 17.55 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.25 -0.432 . . . . 15.0 111.287 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -74.37 -5.26 41.3 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.201 -0.454 . . . . 15.0 111.723 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 66.72 17.95 67.67 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.403 -0.904 . . . . 15.0 111.265 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' CYS . . . . . . . . . . . . . 15.8 t -136.31 130.96 33.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.226 -0.487 . . . . 15.0 110.496 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.887 HD11 HD13 ' A' ' 467' ' ' LEU . 14.1 mm -95.25 120.81 45.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.899 0.381 . . . . 15.0 110.977 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . 0.471 ' H ' ' HG3' ' A' ' 479' ' ' GLU . 54.3 m -103.08 171.79 7.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 15.0 110.667 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 481' ' ' VAL . 81.0 mtm180 -53.47 -44.59 69.09 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.417 -0.356 . . . . 15.0 110.931 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' GLU . . . . . 0.523 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.8 mt-10 -62.91 -28.81 70.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.075 -0.511 . . . . 15.0 111.358 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . 0.607 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 63.5 mm-40 -70.5 -50.26 39.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.499 0.19 . . . . 15.0 110.875 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 33.7 mtt -70.85 -46.89 61.87 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.709 -0.223 . . . . 15.0 111.168 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 477' ' ' ARG . 82.1 t -59.81 -53.13 52.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.626 0.251 . . . . 15.0 110.71 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' SER . . . . . 0.955 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 47.0 m -58.25 -32.66 68.57 Favored 'General case' 0 C--O 1.227 -0.104 0 CA-C-N 116.301 -0.408 . . . . 15.0 110.15 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' TYR . . . . . 0.607 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 7.4 t80 -69.62 -30.16 67.83 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.93 -0.577 . . . . 15.0 111.104 177.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' PHE . . . . . 0.584 ' CE2' HG22 ' A' ' 431' ' ' VAL . 0.1 OUTLIER -75.18 -40.51 59.36 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.762 0.315 . . . . 15.0 110.252 179.29 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.3 tt -83.98 -17.3 40.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 15.0 110.585 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' ARG . . . . . 0.955 ' HB2' ' O ' ' A' ' 482' ' ' SER . 25.1 ttt180 -74.14 -47.81 33.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.859 0.362 . . . . 15.0 110.918 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 13.9 t -82.89 19.92 1.28 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.901 -0.59 . . . . 15.0 111.554 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 88.1 p -82.97 121.86 27.54 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.792 0.329 . . . . 15.0 110.919 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 53.1 m -126.55 79.58 1.87 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.129 -0.487 . . . . 15.0 111.001 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.506 ' O ' HD12 ' A' ' 491' ' ' LEU . 2.9 t -77.46 -60.64 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.091 -0.504 . . . . 15.0 110.906 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 490' ' ' VAL . 1.9 mp -142.85 -43.82 0.31 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.22 -0.445 . . . . 15.0 110.918 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . 128.33 53.09 0.12 Allowed Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.927 -0.654 . . . . 15.0 112.575 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . -158.2 -150.13 5.67 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.875 -0.679 . . . . 15.0 112.507 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -127.66 149.76 50.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.755 0.312 . . . . 15.0 110.944 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -102.35 145.92 28.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.119 -0.491 . . . . 15.0 110.874 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 122.19 78.98 0.48 Allowed Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.824 -0.703 . . . . 15.0 112.533 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 26.2 p90 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.199 -0.905 . . . . 15.0 110.942 -179.975 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 97.2 mttt . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.765 0.317 . . . . 15.0 110.899 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 4.7 mp -142.24 -44.22 0.33 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.125 -0.489 . . . . 15.0 110.843 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.669 ' O ' HG23 ' A' ' 423' ' ' VAL . 7.6 m-20 -94.21 18.91 10.06 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.238 -0.437 . . . . 15.0 111.098 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.725 ' O ' HG23 ' A' ' 424' ' ' VAL . 6.5 pt20 -46.42 -56.92 5.19 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.087 -0.506 . . . . 15.0 111.784 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . 0.418 ' H ' ' HG3' ' A' ' 420' ' ' GLN . . . -68.39 -37.64 80.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.404 -0.362 . . . . 15.0 111.279 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.527 HD13 ' OD2' ' A' ' 419' ' ' ASP . 1.2 tt -57.75 -53.72 55.06 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.882 -0.599 . . . . 15.0 111.701 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.6 t -80.78 -23.8 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 CA-C-N 115.657 -0.701 . . . . 15.0 112.05 -177.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 420' ' ' GLN . 7.2 t -62.9 -47.87 90.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.093 -0.706 . . . . 15.0 109.093 177.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -71.92 -34.16 68.86 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.486 -0.779 . . . . 15.0 110.561 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -70.72 -39.37 73.43 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.558 -0.292 . . . . 15.0 111.04 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . 0.572 ' O ' HG23 ' A' ' 431' ' ' VAL . 37.6 mt -67.84 -51.91 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.37 -0.377 . . . . 15.0 110.732 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -58.4 -42.19 86.61 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.192 0.52 . . . . 15.0 110.303 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.555 ' O ' ' HB2' ' A' ' 433' ' ' SER . 90.2 mttt -71.15 -25.14 62.43 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.521 -0.763 . . . . 15.0 110.707 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . 0.683 ' O ' HG23 ' A' ' 434' ' ' VAL . 23.3 mmm -71.45 -46.97 58.6 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.448 -0.342 . . . . 15.0 110.908 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 427' ' ' ILE . 2.6 t -65.33 -39.15 84.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.879 0.371 . . . . 15.0 110.061 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -72.16 -31.14 65.68 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.859 -0.61 . . . . 15.0 110.73 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.869 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 14.2 t -70.86 -41.88 70.82 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.196 -0.456 . . . . 15.0 111.06 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 430' ' ' MET . 17.8 t -75.87 -41.29 39.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.249 -0.432 . . . . 15.0 110.956 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -60.58 -41.32 94.4 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.297 -0.41 . . . . 15.0 110.815 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -83.21 -28.62 29.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.504 -0.316 . . . . 15.0 110.681 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . 0.869 ' HB2' ' O ' ' A' ' 433' ' ' SER . 2.5 t30 -60.11 -44.54 94.77 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.085 -0.507 . . . . 15.0 111.247 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . 0.522 ' CE2' HG21 ' A' ' 454' ' ' ILE . 66.6 m-85 -93.94 0.53 56.14 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.841 -0.618 . . . . 15.0 111.448 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -127.48 53.1 1.77 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.979 0.418 . . . . 15.0 111.179 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.9 t -74.39 -14.24 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.078 -0.51 . . . . 15.0 111.065 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -90.2 -14.74 32.83 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.074 -0.512 . . . . 15.0 111.032 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 64.55 60.06 7.48 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.051 -0.595 . . . . 15.0 112.796 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.44 -10.81 11.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.705 0.288 . . . . 15.0 111.223 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 88.93 -13.55 62.75 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.811 -0.709 . . . . 15.0 112.227 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . 0.631 ' HB2' ' SG ' ' A' ' 474' ' ' CYS . 9.5 p80 -141.58 156.81 45.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.602 0.239 . . . . 15.0 110.415 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' ILE . . . . . 0.875 HG12 ' H ' ' A' ' 475' ' ' ILE . 0.9 OUTLIER -82.99 100.85 6.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.366 -0.379 . . . . 15.0 111.143 -179.166 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 7.6 t -67.71 152.12 46.13 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.282 -0.417 . . . . 15.0 110.918 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -51.59 -43.11 62.38 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.07 -0.514 . . . . 15.0 111.951 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 452' ' ' GLN . 42.7 mt-10 -63.03 -40.09 96.7 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.552 -0.294 . . . . 15.0 111.322 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -58.24 -56.38 22.88 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.935 0.398 . . . . 15.0 110.412 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -66.85 -23.29 66.01 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.935 -0.575 . . . . 15.0 110.608 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 449' ' ' GLU . 2.6 mm-40 -59.1 -54.84 42.48 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.838 -0.619 . . . . 15.0 111.008 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 8.7 mm -78.98 -31.82 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 115.649 -0.705 . . . . 15.0 111.694 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . 0.522 HG21 ' CE2' ' A' ' 438' ' ' PHE . 50.2 mt -61.22 -46.86 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.494 0.188 . . . . 15.0 111.273 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -55.74 -29.97 60.42 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.552 -0.295 . . . . 15.0 111.561 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -66.0 -31.8 80.58 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.963 -0.637 . . . . 15.0 112.759 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -103.64 -11.7 17.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.607 0.242 . . . . 15.0 111.365 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -136.23 78.98 44.52 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 116.465 -0.334 . . . . 15.0 110.985 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.08 2.4 6.71 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.166 2.577 . . . . 15.0 112.624 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -85.2 5.19 31.16 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.325 -0.398 . . . . 15.0 111.285 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -87.76 142.39 27.86 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.263 -0.426 . . . . 15.0 111.063 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' SER . . . . . 0.406 ' HB2' ' H ' ' A' ' 463' ' ' ALA . 5.8 p -81.39 -157.35 0.17 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.066 -0.515 . . . . 15.0 110.975 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . 0.555 ' HB3' ' OD2' ' A' ' 466' ' ' ASP . . . -85.4 148.47 25.99 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.926 0.393 . . . . 15.0 111.655 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -51.24 -46.36 62.31 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.771 -0.649 . . . . 15.0 111.121 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -63.57 -19.38 62.5 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.907 -0.588 . . . . 15.0 113.005 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . 0.555 ' OD2' ' HB3' ' A' ' 463' ' ' ALA . 7.6 m-20 -87.87 -37.11 16.78 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.765 0.282 . . . . 15.0 110.977 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.442 ' HG ' ' H ' ' A' ' 467' ' ' LEU . 0.1 OUTLIER -68.99 -34.11 74.77 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.96 0.41 . . . . 15.0 110.154 178.34 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . 0.467 ' OD2' ' HB2' ' A' ' 470' ' ' ASN . 8.5 t70 -120.34 117.17 27.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.698 -0.683 . . . . 15.0 110.413 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -64.26 -27.68 69.21 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.083 -0.508 . . . . 15.0 111.577 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.467 ' HB2' ' OD2' ' A' ' 468' ' ' ASP . 5.0 m-80 -76.94 -9.01 58.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.371 -0.377 . . . . 15.0 111.442 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 54.4 36.01 24.46 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.365 -0.38 . . . . 15.0 111.4 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -88.43 0.78 55.87 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.194 -0.457 . . . . 15.0 111.47 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 65.67 14.08 59.88 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.427 -0.892 . . . . 15.0 111.314 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' CYS . . . . . 0.631 ' SG ' ' HB2' ' A' ' 445' ' ' HIS . 1.2 m -137.69 130.7 30.32 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.202 -0.499 . . . . 15.0 110.508 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.875 ' H ' HG12 ' A' ' 446' ' ' ILE . 2.7 mp -107.89 128.92 62.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.992 0.425 . . . . 15.0 111.246 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 48.8 m -104.33 -179.58 3.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.597 -0.728 . . . . 15.0 110.784 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 481' ' ' VAL . 24.6 ptt180 -62.58 -47.51 83.5 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.364 -0.38 . . . . 15.0 111.214 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -60.45 -33.95 73.29 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.252 -0.431 . . . . 15.0 111.48 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 483' ' ' TYR . 6.8 mm-40 -66.79 -45.21 79.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.562 0.22 . . . . 15.0 110.626 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 40.3 mtt -69.76 -47.58 62.47 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.608 -0.269 . . . . 15.0 110.893 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' VAL . . . . . 0.568 HG22 HG11 ' A' ' 431' ' ' VAL . 89.9 t -60.14 -55.61 23.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.737 0.303 . . . . 15.0 110.937 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' SER . . . . . 0.952 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 75.0 m -54.51 -38.79 66.92 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 116.128 -0.487 . . . . 15.0 110.605 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' TYR . . . . . 0.489 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 2.6 m-85 -71.58 -24.43 61.91 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.036 -0.529 . . . . 15.0 111.555 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' PHE . . . . . 0.533 ' CD2' HG22 ' A' ' 431' ' ' VAL . 3.7 m-85 -75.28 -43.55 50.64 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 120.843 -0.343 . . . . 15.0 110.163 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . 0.434 ' HA ' ' OG ' ' A' ' 488' ' ' SER . 5.3 tt -84.16 -18.69 35.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 15.0 110.642 176.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' ARG . . . . . 0.952 ' HB2' ' O ' ' A' ' 482' ' ' SER . 24.2 ttt180 -70.97 -49.57 43.95 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.899 0.38 . . . . 15.0 110.791 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 14.5 t -83.43 19.68 1.5 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.831 -0.622 . . . . 15.0 111.339 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . 0.434 ' OG ' ' HA ' ' A' ' 485' ' ' LEU . 74.0 m -80.71 133.72 35.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.335 -0.393 . . . . 15.0 111.001 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 54.0 m -97.69 -36.39 10.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 15.0 111.131 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 50.6 t -148.71 84.93 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.258 -0.428 . . . . 15.0 110.437 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 6.5 tt -124.79 -44.31 1.95 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.086 -0.507 . . . . 15.0 110.803 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . 125.21 161.07 10.92 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.847 -0.692 . . . . 15.0 112.466 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . -100.51 179.91 29.44 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.879 -0.677 . . . . 15.0 112.575 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -100.23 -41.69 6.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.72 0.295 . . . . 15.0 110.861 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 64.5 mtt -114.21 130.25 56.62 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.226 -0.443 . . . . 15.0 110.921 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 128.63 104.72 1.19 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.861 -0.685 . . . . 15.0 112.473 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.219 -0.896 . . . . 15.0 110.927 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 96.8 mttt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.749 0.309 . . . . 15.0 110.922 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 5.3 mp -109.65 -22.82 11.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.148 -0.478 . . . . 15.0 110.981 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.678 ' O ' HG23 ' A' ' 423' ' ' VAL . 8.4 m-20 58.92 28.58 17.76 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.143 -0.48 . . . . 15.0 111.335 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.724 ' O ' HG23 ' A' ' 424' ' ' VAL . 44.4 mt-30 -48.8 -58.05 5.42 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.089 -0.505 . . . . 15.0 111.864 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -68.09 -38.6 82.52 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.444 -0.344 . . . . 15.0 111.489 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.511 HD13 ' OD2' ' A' ' 419' ' ' ASP . 0.9 OUTLIER -57.36 -54.43 46.95 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.955 -0.566 . . . . 15.0 111.852 -179.241 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.7 t -81.1 -23.47 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 CA-C-N 115.709 -0.678 . . . . 15.0 112.148 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 420' ' ' GLN . 7.2 t -63.28 -48.06 89.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.11 -0.7 . . . . 15.0 109.11 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -71.84 -34.0 68.92 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.488 -0.778 . . . . 15.0 110.607 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -70.57 -39.8 73.68 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.621 -0.263 . . . . 15.0 110.99 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . 0.583 ' O ' HG23 ' A' ' 431' ' ' VAL . 40.5 mt -67.61 -52.38 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 116.442 -0.345 . . . . 15.0 110.772 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -57.97 -42.04 84.21 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.096 0.474 . . . . 15.0 110.222 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 433' ' ' SER . 89.7 mttt -71.47 -24.86 62.08 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.521 -0.763 . . . . 15.0 110.737 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . 0.634 ' O ' HG23 ' A' ' 434' ' ' VAL . 26.2 mtp -71.17 -47.68 56.23 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.467 -0.333 . . . . 15.0 110.937 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 427' ' ' ILE . 1.8 t -65.77 -39.03 83.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.913 0.387 . . . . 15.0 110.079 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -72.19 -30.01 64.54 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.842 -0.617 . . . . 15.0 110.681 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.782 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 13.4 t -70.25 -42.66 71.89 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.261 -0.427 . . . . 15.0 110.936 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 430' ' ' MET . 14.4 t -76.09 -40.37 37.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.207 -0.452 . . . . 15.0 110.77 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -58.7 -43.39 90.01 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.191 -0.458 . . . . 15.0 110.579 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -83.52 -25.3 31.15 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.451 -0.34 . . . . 15.0 110.961 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . 0.782 ' HB2' ' O ' ' A' ' 433' ' ' SER . 4.9 t-20 -60.11 -38.75 83.95 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.383 -0.372 . . . . 15.0 110.477 178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . 0.539 ' CE2' HG21 ' A' ' 454' ' ' ILE . 32.6 m-85 -95.36 -12.15 26.53 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.763 -0.653 . . . . 15.0 111.581 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -106.33 54.09 0.69 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.88 0.371 . . . . 15.0 111.375 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.18 -6.46 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.194 -0.457 . . . . 15.0 111.403 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -94.0 -15.04 25.23 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.3 -0.409 . . . . 15.0 111.214 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 68.3 48.07 54.36 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.018 -0.611 . . . . 15.0 112.681 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -110.85 -18.05 13.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.649 0.261 . . . . 15.0 111.168 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 91.27 -5.2 81.06 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.921 -0.657 . . . . 15.0 112.378 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -143.29 156.92 44.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.816 0.341 . . . . 15.0 110.742 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' ILE . . . . . 0.684 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.7 mp -81.77 136.47 22.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.076 -0.511 . . . . 15.0 111.285 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 5.4 m -105.17 149.15 26.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.663 -0.699 . . . . 15.0 110.72 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -47.73 -46.93 30.35 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.176 -0.465 . . . . 15.0 111.776 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -64.69 -38.7 91.88 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.512 -0.313 . . . . 15.0 111.208 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -59.49 -59.07 6.04 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.275 -0.42 . . . . 15.0 110.427 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -63.18 -26.52 68.84 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.797 -0.638 . . . . 15.0 110.83 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -59.25 -56.94 15.75 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.902 -0.59 . . . . 15.0 111.288 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -78.29 -29.96 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.879 -0.601 . . . . 15.0 111.795 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . 0.539 HG21 ' CE2' ' A' ' 438' ' ' PHE . 46.6 mt -63.37 -46.14 96.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 120.397 0.141 . . . . 15.0 111.319 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -52.5 -29.22 23.96 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.802 0.297 . . . . 15.0 111.802 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -74.78 -24.65 71.69 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.833 -0.698 . . . . 15.0 112.676 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -71.6 -56.91 4.95 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.478 0.18 . . . . 15.0 111.402 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -144.59 98.71 4.9 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-O 120.628 0.251 . . . . 15.0 111.117 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.43 4.16 4.68 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.118 2.545 . . . . 15.0 112.594 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -112.29 -24.82 9.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.384 -0.371 . . . . 15.0 111.374 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . . . . . . . . . 3.4 tp -56.77 -56.24 24.07 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.283 -0.417 . . . . 15.0 111.652 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' SER . . . . . . . . . . . . . 5.7 m -135.44 109.01 7.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.766 0.317 . . . . 15.0 111.019 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . 0.661 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -77.89 106.4 9.71 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.238 -0.437 . . . . 15.0 110.944 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . 0.475 ' HZ ' ' H ' ' A' ' 473' ' ' GLY . 29.3 t80 -40.37 -42.28 1.54 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.905 -0.588 . . . . 15.0 111.99 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -59.82 -36.92 91.59 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.03 -0.605 . . . . 15.0 113.27 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 483' ' ' TYR . 6.3 m-20 -90.48 -21.41 21.88 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.569 0.581 . . . . 15.0 112.569 -178.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 463' ' ' ALA . 0.1 OUTLIER -85.83 -43.24 13.45 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 120.791 -0.364 . . . . 15.0 110.518 179.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . 0.478 ' HB2' HD13 ' A' ' 475' ' ' ILE . 24.0 t0 -130.07 110.9 11.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.001 -0.545 . . . . 15.0 111.231 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -85.67 -16.84 37.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.087 -0.506 . . . . 15.0 110.772 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . 0.548 ' N ' HD22 ' A' ' 470' ' ' ASN . 0.8 OUTLIER -78.6 -13.83 59.63 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.112 -0.495 . . . . 15.0 111.195 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 60.91 24.18 14.21 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.182 -0.463 . . . . 15.0 111.629 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -75.05 -3.42 32.4 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.41 -0.359 . . . . 15.0 111.645 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . 0.475 ' H ' ' HZ ' ' A' ' 464' ' ' PHE . . . 66.57 13.83 61.48 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.634 -0.793 . . . . 15.0 111.431 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' CYS . . . . . . . . . . . . . 14.8 t -133.13 130.81 39.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.374 -0.413 . . . . 15.0 110.609 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.684 ' H ' ' HB ' ' A' ' 446' ' ' ILE . 10.8 mm -103.6 124.25 57.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-O 120.778 0.323 . . . . 15.0 110.99 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 53.4 m -102.44 167.47 9.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.986 -0.552 . . . . 15.0 110.812 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -53.31 -43.3 67.48 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.245 -0.434 . . . . 15.0 111.127 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' GLU . . . . . 0.67 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -60.4 -32.7 71.58 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.189 -0.459 . . . . 15.0 111.547 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . 0.565 ' OE1' ' HA ' ' A' ' 475' ' ' ILE . 47.6 mt-10 -67.08 -54.26 23.13 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.424 0.154 . . . . 15.0 111.095 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 58.5 mtt -70.07 -49.59 49.58 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.755 -0.202 . . . . 15.0 111.265 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' VAL . . . . . . . . . . . . . 71.6 t -58.91 -56.78 14.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.57 0.224 . . . . 15.0 111.169 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' SER . . . . . 1.02 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 58.1 m -55.22 -36.59 66.16 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 116.457 -0.338 . . . . 15.0 110.511 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' TYR . . . . . 0.552 ' HB2' ' O ' ' A' ' 479' ' ' GLU . 20.5 t80 -69.37 -26.89 64.88 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.135 -0.484 . . . . 15.0 111.253 178.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' PHE . . . . . 0.558 ' CD2' HG22 ' A' ' 431' ' ' VAL . 5.1 m-85 -76.15 -44.15 39.56 Favored 'General case' 0 N--CA 1.461 0.114 0 C-N-CA 120.902 -0.319 . . . . 15.0 110.533 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . . . . . . . . . 5.3 tt -83.52 -16.67 44.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.473 -0.33 . . . . 15.0 110.706 177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' ARG . . . . . 1.02 ' HB2' ' O ' ' A' ' 482' ' ' SER . 30.7 ttt180 -75.91 -50.28 15.44 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.525 -0.307 . . . . 15.0 111.284 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 52.3 m -86.25 -51.1 6.48 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.183 -0.462 . . . . 15.0 111.916 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . 0.52 ' HB3' ' O ' ' A' ' 484' ' ' PHE . 12.5 t -67.23 152.72 45.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.939 0.4 . . . . 15.0 111.448 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 51.9 m -97.2 69.53 2.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.797 -0.638 . . . . 15.0 110.975 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 3.8 t -60.17 -62.09 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.3 -0.409 . . . . 15.0 111.347 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 9.1 mt -142.18 -45.08 0.33 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.292 -0.413 . . . . 15.0 111.067 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -110.45 151.81 17.48 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.867 -0.682 . . . . 15.0 112.564 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . -121.53 -46.19 0.33 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.889 -0.672 . . . . 15.0 112.557 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -99.12 -41.57 7.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.662 0.268 . . . . 15.0 110.954 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 87.4 mtp -102.35 149.66 24.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.229 -0.441 . . . . 15.0 110.919 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . 165.56 105.6 0.19 Allowed Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.945 -0.645 . . . . 15.0 112.525 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.2 -0.905 . . . . 15.0 110.937 179.996 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' LYS . . . . . . . . . . . . . 58.5 mttp . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.759 0.314 . . . . 15.0 110.916 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 9.7 mt -129.81 136.67 49.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.139 -0.482 . . . . 15.0 110.89 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' ASP . . . . . 0.662 ' O ' HG23 ' A' ' 423' ' ' VAL . 8.7 m-20 -96.03 15.34 20.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.074 -0.512 . . . . 15.0 110.926 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' GLN . . . . . 0.726 ' O ' HG23 ' A' ' 424' ' ' VAL . 9.6 tt0 -46.25 -57.64 4.38 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.088 -0.505 . . . . 15.0 111.578 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' ALA . . . . . . . . . . . . . . . -68.3 -37.28 80.46 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.306 -0.406 . . . . 15.0 111.238 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' LEU . . . . . 0.414 HD13 ' OD1' ' A' ' 419' ' ' ASP . 1.4 tt -57.39 -54.56 45.39 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.791 -0.641 . . . . 15.0 111.688 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 419' ' ' ASP . 1.4 t -81.29 -23.74 10.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.724 -0.671 . . . . 15.0 112.097 -177.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 420' ' ' GLN . 7.0 t -62.64 -48.43 88.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 109.044 -0.724 . . . . 15.0 109.044 178.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -72.2 -33.96 68.03 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.428 -0.806 . . . . 15.0 110.6 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . 0.414 ' HB2' ' O ' ' A' ' 422' ' ' LEU . 2.5 t60 -70.83 -39.11 73.21 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 120.716 0.293 . . . . 15.0 110.995 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . 0.579 HG13 HG12 ' A' ' 423' ' ' VAL . 36.4 mt -67.63 -54.0 26.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.328 -0.396 . . . . 15.0 110.658 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -56.93 -42.32 79.8 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.132 0.491 . . . . 15.0 110.153 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.641 ' O ' ' HB2' ' A' ' 433' ' ' SER . 88.1 mttt -70.54 -25.13 62.97 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 115.545 -0.752 . . . . 15.0 110.762 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' MET . . . . . 0.645 ' O ' HG23 ' A' ' 434' ' ' VAL . 18.3 mtm -71.44 -46.54 59.79 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.546 -0.297 . . . . 15.0 110.948 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.611 HG22 ' CD2' ' A' ' 484' ' ' PHE . 0.8 OUTLIER -63.87 -41.87 93.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 121.041 0.448 . . . . 15.0 109.978 178.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -72.45 -29.6 63.83 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.642 -0.708 . . . . 15.0 110.952 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' SER . . . . . 0.853 ' O ' ' HB2' ' A' ' 437' ' ' ASN . 13.3 t -69.43 -43.7 72.84 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.304 -0.407 . . . . 15.0 111.02 -179.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 430' ' ' MET . 12.1 t -75.16 -42.9 44.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.281 -0.418 . . . . 15.0 110.869 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' PHE . . . . . 0.492 ' CZ ' ' HG3' ' A' ' 477' ' ' ARG . 7.7 t80 -56.69 -43.64 80.7 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.113 -0.494 . . . . 15.0 110.902 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -85.55 -23.94 27.45 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.464 -0.335 . . . . 15.0 111.205 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' ASN . . . . . 0.853 ' HB2' ' O ' ' A' ' 433' ' ' SER . 4.4 t-20 -59.84 -40.24 87.85 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.429 -0.351 . . . . 15.0 110.637 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . 0.524 ' CE2' HG21 ' A' ' 454' ' ' ILE . 54.8 m-85 -95.71 -13.83 23.89 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.931 -0.577 . . . . 15.0 111.807 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -105.31 54.33 0.71 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.924 0.392 . . . . 15.0 111.239 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 11.1 p -71.95 -16.1 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.13 -0.487 . . . . 15.0 111.338 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' ASP . . . . . . . . . . . . . 40.2 p30 -79.92 -14.26 58.75 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.144 -0.48 . . . . 15.0 111.341 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' GLY . . . . . . . . . . . . . . . 71.29 47.14 37.83 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.869 -0.682 . . . . 15.0 112.386 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -106.5 -18.46 13.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.676 0.274 . . . . 15.0 111.192 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . 89.93 -9.32 77.67 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.956 -0.64 . . . . 15.0 112.494 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' HIS . . . . . 0.403 ' HB3' ' SG ' ' A' ' 474' ' ' CYS . 61.7 m80 -146.01 162.53 37.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.774 0.321 . . . . 15.0 110.709 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' ILE . . . . . 0.598 ' HB ' ' H ' ' A' ' 475' ' ' ILE . 1.7 mp -77.84 135.13 26.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.225 -0.443 . . . . 15.0 111.179 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' SER . . . . . . . . . . . . . 3.0 m -106.14 148.72 27.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.669 -0.696 . . . . 15.0 110.584 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -48.32 -47.46 36.8 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.257 -0.429 . . . . 15.0 111.697 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' GLU . . . . . 0.435 ' HA ' ' HB2' ' A' ' 452' ' ' GLN . 42.4 mt-10 -64.46 -38.22 90.27 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.423 -0.353 . . . . 15.0 111.329 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -58.37 -61.53 2.51 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.883 0.373 . . . . 15.0 110.605 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.7 -22.69 66.64 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.923 -0.581 . . . . 15.0 110.932 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' GLN . . . . . 0.435 ' HB2' ' HA ' ' A' ' 449' ' ' GLU . 0.9 OUTLIER -60.49 -57.55 12.27 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.938 -0.574 . . . . 15.0 111.281 179.49 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' ILE . . . . . . . . . . . . . 1.9 mt -76.87 -33.76 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 115.771 -0.65 . . . . 15.0 111.855 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' ILE . . . . . 0.524 HG21 ' CE2' ' A' ' 438' ' ' PHE . 61.0 mt -62.49 -49.97 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 120.489 0.185 . . . . 15.0 111.284 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' ARG . . . . . 0.515 ' NH2' ' H ' ' A' ' 461' ' ' LEU . 0.1 OUTLIER -57.94 -30.6 66.09 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.524 -0.307 . . . . 15.0 111.521 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -70.57 -33.73 67.44 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.918 -0.658 . . . . 15.0 112.775 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' ASN . . . . . 0.452 ' O ' ' HD3' ' A' ' 459' ' ' PRO . 40.9 m-80 -90.4 -22.21 21.57 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.637 0.256 . . . . 15.0 111.189 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -115.97 84.39 13.34 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.432 -0.349 . . . . 15.0 111.034 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 457' ' ' ASN . 13.0 Cg_exo -70.83 -10.55 27.93 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.947 2.431 . . . . 15.0 112.545 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -96.84 25.55 5.2 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.318 -0.401 . . . . 15.0 110.974 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' LEU . . . . . 0.515 ' H ' ' NH2' ' A' ' 455' ' ' ARG . 0.7 OUTLIER -98.01 152.07 19.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.218 -0.447 . . . . 15.0 111.061 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' SER . . . . . 0.494 ' OG ' HD23 ' A' ' 467' ' ' LEU . 43.1 p -63.63 175.73 1.02 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.072 -0.513 . . . . 15.0 111.328 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' ALA . . . . . 0.745 ' O ' ' HG ' ' A' ' 467' ' ' LEU . . . -87.76 148.42 24.73 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.184 -0.462 . . . . 15.0 111.242 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' PHE . . . . . 0.714 ' HA ' HD11 ' A' ' 467' ' ' LEU . 46.0 m-85 -54.44 -48.07 72.13 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.937 -0.574 . . . . 15.0 111.477 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . -70.4 -15.62 72.91 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.014 -0.613 . . . . 15.0 113.519 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' ASP . . . . . 0.489 ' OD1' ' HB3' ' A' ' 463' ' ' ALA . 4.1 m-20 -90.26 -36.67 14.59 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 117.089 0.445 . . . . 15.0 111.796 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.855 HD13 HD11 ' A' ' 475' ' ' ILE . 0.5 OUTLIER -82.08 -30.88 31.07 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.9 0.381 . . . . 15.0 110.571 179.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . 0.595 ' N ' HD12 ' A' ' 467' ' ' LEU . 20.7 t70 -126.47 108.75 11.46 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.976 -0.556 . . . . 15.0 110.273 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -69.22 -22.11 63.89 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.112 -0.494 . . . . 15.0 111.489 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -76.51 -14.11 60.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.226 -0.443 . . . . 15.0 111.326 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 57.38 26.61 12.7 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.224 -0.444 . . . . 15.0 111.413 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -81.23 0.05 38.44 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.257 -0.429 . . . . 15.0 111.551 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' GLY . . . . . . . . . . . . . . . 65.89 16.04 63.34 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.469 -0.872 . . . . 15.0 111.227 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' CYS . . . . . 0.403 ' SG ' ' HB3' ' A' ' 445' ' ' HIS . 13.8 t -137.94 131.12 30.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.142 -0.529 . . . . 15.0 110.431 -178.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.855 HD11 HD13 ' A' ' 467' ' ' LEU . 94.9 mt -106.84 127.24 62.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.912 0.387 . . . . 15.0 111.023 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' SER . . . . . . . . . . . . . 64.7 m -103.61 177.22 4.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.739 -0.664 . . . . 15.0 111.077 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' ARG . . . . . 0.492 ' HG3' ' CZ ' ' A' ' 435' ' ' PHE . 68.7 mtp180 -58.81 -46.96 86.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.21 -0.45 . . . . 15.0 111.221 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' A' ' 482' ' ' SER . 42.5 mt-10 -60.21 -32.42 71.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.215 -0.448 . . . . 15.0 111.423 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . 0.45 ' HB2' HG23 ' A' ' 475' ' ' ILE . 5.5 mm-40 -66.42 -50.22 64.16 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.497 0.189 . . . . 15.0 110.778 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' MET . . . . . . . . . . . . . 60.0 mtt -69.86 -47.0 64.32 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.684 -0.234 . . . . 15.0 110.923 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 477' ' ' ARG . 89.8 t -61.56 -54.01 40.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.702 0.287 . . . . 15.0 110.842 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' SER . . . . . 0.89 ' O ' ' HB2' ' A' ' 486' ' ' ARG . 10.3 m -50.55 -47.17 57.78 Favored 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 116.034 -0.53 . . . . 15.0 110.382 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' TYR . . . . . 0.418 ' HD1' ' O ' ' A' ' 479' ' ' GLU . 8.0 m-85 -69.22 -22.42 63.87 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.423 -0.808 . . . . 15.0 111.856 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' PHE . . . . . 0.778 ' O ' ' HB2' ' A' ' 488' ' ' SER . 0.1 OUTLIER -74.03 -45.94 46.52 Favored 'General case' 0 CA--C 1.527 0.091 0 C-N-CA 120.779 -0.369 . . . . 15.0 110.1 179.05 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . 0.612 ' O ' HD13 ' A' ' 485' ' ' LEU . 1.5 tm? -84.43 -16.62 42.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.425 -0.352 . . . . 15.0 110.664 177.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' ARG . . . . . 0.89 ' HB2' ' O ' ' A' ' 482' ' ' SER . 21.3 ttt180 -74.36 -53.32 9.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.451 -0.34 . . . . 15.0 111.578 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' SER . . . . . . . . . . . . . 79.7 p -92.58 -54.49 3.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.314 -0.403 . . . . 15.0 112.058 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . 0.778 ' HB2' ' O ' ' A' ' 484' ' ' PHE . 54.7 m -59.94 150.07 29.92 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.871 0.367 . . . . 15.0 111.492 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 13.8 t -97.8 64.04 1.73 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.886 -0.597 . . . . 15.0 111.106 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 10.3 t -60.74 -55.04 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.327 -0.397 . . . . 15.0 111.152 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 8.9 mt -139.77 -43.43 0.44 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.219 -0.446 . . . . 15.0 110.893 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . 102.25 54.5 0.9 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.884 -0.674 . . . . 15.0 112.539 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . . . . . . . . . . . -151.0 -135.04 2.28 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.94 -0.647 . . . . 15.0 112.532 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 494' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -126.71 146.89 50.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.737 0.304 . . . . 15.0 110.926 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 495' ' ' MET . . . . . . . . . . . . . 8.0 ttt -109.41 -42.12 4.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 15.0 110.932 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 496' ' ' GLY . . . . . . . . . . . . . . . -152.24 -100.91 0.2 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.875 -0.679 . . . . 15.0 112.524 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 497' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.305 -0.855 . . . . 15.0 110.885 179.974 . . . . . . . . 0 0 . 1 stop_ save_